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Summary
Generally depicted as single- or double-stranded molecules, nucleic 
acids sequences can adopt various forms of  stable secondary structures. 
In particular, guanine-rich sequence of  DNA and RNA can form atypical 
four-stranded helical structures termed G-quadruplexes (G4). While 
the functional relevance of  G4 structures is still a mater of  debate, an 
increasing number of  evidence suggests that these structures can form 
in various regions of  the genome and may be implicated in a wide array 
of  processes such as gene expression regulation and telomere protection. 
Owing to their high-thermodynamic stability, in vivo conversion of  G4 
structures to single-stranded nucleic acid requires specialised proteins with 
G4 destabilising/unwinding activity. RHAU is a human RNA helicase of  
the DEAH-box family that exhibits ATP-dependent G4 resolving activity 
with high affinity and specificity for its substrate in vitro. However, how 
RHAU recognises G4 and what are its substrates in cells are key questions 
that needed to be addressed.
In the first part of  this research work, we undertook to address 
the molecular mechanisms underlying the specific recognition of  
G4 structures by RHAU. Through biochemical analysis of  truncated 
and mutated recombinant forms of  RHAU, we have uncovered the 
functional importance of  the amino-terminal region for interaction with 
G4 structures and further identified within this region the evolutionary 
conserved RSM (RHAU-specific motif) domain as a major affinity 
and specificity determinant. We also show that the G4-RNA substrate 
specificity and resolving activity shown by RHAU is an evolutionary 
conserved attribute in higher eukaryotes, insofar as CG9323, the Drosophila 
orthologue of  RHAU, binds and readily unwinds G4 structures.
In the second part of  this work, we sought RNAs bound by RHAU 
in living cells. To this end, we employed high-throughput gene array 
technologies to identify RNAs associated with RHAU on a genome-wide 
scale. Approximately 100 RNAs were found to be significantly enriched 
with RHAU. Computational analysis of  RNA sequences for potential 
intramolecular G4 structures revealed the preferential association of  
RHAU with transcripts bearing G4-forming motifs, suggesting direct targeting 
of  G4-RNAs by RHAU. Among the most abundant RNAs selectively enriched, 
we identified the human telomerase RNA template TERC as a bona fide target 
of  RHAU. Remarkably, binding of  RHAU to TERC depended on the presence 
of  a stable G4 structure in the 5'-region of  TERC, both in vivo and in vitro. 
In-depth studies further revealed that RHAU was also part of  the telomerase 
holoenzyme through direct interaction with TERC G4 structure. Collectively, 
these data provide the first evidence of  a specific and direct interaction between 
a G4 resolvase enzyme and a potentially relevant intramolecular G4-RNA 
substrate, and more generally support the idea that intramolecular G4-RNAs 
are naturally occurring substrates of  RHAU. Furthermore, these results provide 
circumstantial evidence for the existence of  a G4-RNA structure in a fraction of  
the telomerase holoenzyme.
Overall, the present work brings new insight into the mechanisms of  G4 
substrate recognition by RHAU and supports its potential role as a G4 resolvase 
enzyme in vivo.
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RNA helicases
The RNA folding problem
RNAs constitute essential structural and multifunctional 
components of  the gene expression machinery. RNAs are highly 
polymorphic molecules that can function as transitory carriers of  genetic 
information (mRNAs), catalysts of  biochemical reactions (23S rRNA, 
ribonuclease P RNA), adapter molecules (tRNAs, snoRNAs, miRNAs), 
or as structural molecules in ribonucleoproteins (rRNAs, ref. 1). In cells, 
most of  RNAs have to fold into well-defined structures to be biologically 
active. However, due to the single-strandedness of  nascent RNA, the 
relative simplicity of  its molecular composition and its possibility to 
form non-Watson-Crick base-pairing, RNA molecules are prone to 
adopt a multitude of  non-functional and thermodynamically stable 
conformations. Moreover, even during their normal metabolic process, 
many RNAs undergo conformational changes or are transiently base-
paired with other RNA species. Rearrangement of  intra- or intermolecular 
base-pairings in vivo is achieved by RNA chaperones that facilitate 
conformational changes of  RNA to its active form (for reviews, see 
ref. 2,3). Among these chaperones are the RNA helicases, which couple 
the hydrolysis of  nucleotide 5′-triphosphates (NTPs) with structural and 
functional rearrangement of  the RNA (4). RNA helicases represent a 
large group of  proteins that have been identified in all biological systems, 
viruses included. Functionally, they have been shown to disrupt RNA–
RNA or RNA–DNA duplexes (5,6) and to dissociate proteins from RNA 
molecules (7,8). In eukaryotes, RNA helicases form by far the largest 
group of  proteins dedicated to RNA metabolism (9).
Chapter 1 Introduction
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RNA helicases and the superfamily of helicases
RNA helicases (EC 3.6.4.13) belongs to the helicase class of  enzymes that 
also includes DNA helicases. Helicases are NTP-driven molecular motors that 
dissociate double-stranded nucleic acids or displace nucleic acid bound proteins. 
A large fraction of  the eukaryotic and prokaryotic genomes encode helicases. In 
the yeast Saccharomyces cerevisiae, about two percents of  the protein-encoding genes 
encode helicase-related proteins (10) and nearly one percent of  the open reading 
frames of  the human genome encodes putative DNA and RNA helicases (11). 
Helicases are characterised by the presence of  several conserved and discrete 
motifs in the core region that are involved in NTP-binding/hydrolysis and 
nucleic acid binding. These motifs essentially form the motor which converts 
the chemical energy derived from NTP hydrolysis into mechanical force and 
drives helicase movements leading to the disruption of  DNA or RNA base 
pairs. These conserved motifs provide also the basis for classifying helicases into 
six phylogenetically distinct superfamilies, designated SF1 to SF6 (12,13). These 
superfamilies presumably represent evolutionary relationships and may have 
evolved from a common ancestor. Although this classification is currently still 
employed, it was established before the availability of  structural and functional 
information. It is now clear that these conserved helicases motifs are present in 
a wide range of  NTP-dependent nucleic acid enzymes (14), many of  which are 
not bona fide helicases (15) and some of  which do not even seem to translocate 
along nucleic acids (6). Therefore, in many respects, these motifs more generally 
denote nucleic acid-stimulated NTPases rather than purely and simply helicases.
Superfamilies 1 and 2 form the largest and most closely related groups of  
helicases. They include both DNA and RNA helicases and appear to be active 
essentially as monomers or dimers (16,17). Structurally, the helicase core regions 
of  SF1 and SF2 helicases manifest the same overall folding patterns and consist 
of  two abutting RecA-like domains (18). Additionally, SF1 and SF2 proteins 
display similarities in both occurrence and sequence composition of  their 
helicase motifs. Both superfamilies are indeed characterised by the presence of  
at least seven conserved helicase motifs. In contrast, superfamilies 3 to 6 are 
essentially ring-shaped DNA helicases (13). Most of  them are involved in DNA 
replication by unwinding dsDNA ahead of  the DNA polymerase (for reviews, 
see ref. 19,20). The ring-shape of  these helicases results from the assembly of  
six individual RecA-like domains into a hexameric structure with ssDNA in the 
center of  the ring. Each subunit of  hexameric helicases contains only two to five 
conserved helicases motifs, and ATP-hydrolysis occurs at every interface of  the 
six subunits (13).
Main features of superfamily 2 (SF2) helicases
Most RNA helicases are members of  the SF2, a large and versatile 
superfamily that includes functionally diverse RNA and DNA helicases. 
Actually, only a few putative RNA helicases, the Upf1-like family as well as 
some viral RNA helicases belong to the SF1. The SF2 constitutes by far the 
largest superfamily of  helicases. For instance, the human genome encodes 
112 SF2 proteins, out of  which 65 seem to be dedicated to RNA metabolism 
(Figure 1). Based on comparative genomic approaches, the SF2 can be further 
divided into seven phylogenetically distinct families: DEAD-box, DEAH-box, 
Ski2, RIG-I, RecQ, Rad3 and Swi2/Snf2. Each family is characterised by the 
presence of  nine conserved and family-specific motifs (Q, I, Ia, Ib, and II–VI) 
that delineate the helicase core region (Figure 2A). Among these seven families, 
four consist essentially of  RNA helicases (DEAD-box, DEAH-box, Ski2 and 
RIG-I) and three of  DNA helicases (RecQ, Rad3 and Swi2/Snf2). The RecQ- 
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Figure 1 | Phylogeny of the human superfamily 2 helicases. The unrooted phyologenetic tree was compute by MAFFT using the neighbor-joining method 
on 157 ungapped sites (substitution model = JTT; heterogeneity among sites (α) = ∞; bootstrap resampling = 100). When available, a representative X-ray 
structure is depicted per family (DEAD-box: Drosophila Vasa (DDX4), 2DB3; DEAH-box: yeast Prp43 (DHX15), 3KX2; Ski2: Archaeoglobus fulgidus Hel308 
(HELQ), 2P6R; Rad3: Thermoplasma acidophilum XPD (ERCC2), 2VSF; Swi2/Snf2: zebrafish Rad54, 1Z3I; RecQ: human RecQ1 (RECQ1), 2WWY). For 
each structure, the helicase core region is shown in colour. Boldfaced protein names denote helicases with reported in vitro G-quadruplexe resolving activity 
(WRN, BLM, DDX11, FANCJ, DHX9 and DHX36).
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and Rad3-related proteins are bona fide helicases which function in replication, 
recombination and repair of  DNA, and are essential for the maintenance 
of  genomic stability (21-23). In contrast, the Swi2/Snf2-related proteins are 
chromatin-remodelling enzymes that translocate along dsDNA and catalyse 
chromatin rearrangements important for transcription (15,24).
The SF2 RNA helicases fall into four phylogenetically distinct groups: 
the DEAD-box, the DEAH-box, the Ski2 and the RIG-I helicases (Figure 1). In 
almost all eukaryotes, the DEAD-box and DEAH-box proteins constitute by 
far the two largest families; they usually represent more than half  of  all RNA 
helicases. Comparatively, the smaller Ski2-like and RIG-I-like families include 
only a few members. Besides, although a majority of  the DEAD-box proteins 
take part in ribosome biogenesis (25,26), none of  these four helicase families are 
functionally specialised in a particular domain of  RNA metabolism. In fact, the 
various families of  RNA helicases stand out rather by the mechanisms whereby 
they unwind or translocate along nucleic acids. Notably, DEAD-box proteins 
are non-processive helicases that catalyse unwinding of  weak RNA duplexes by 
local bending of  the nucleic acid (6,27). They may as well facilitate displacement 
of  RNA-bound proteins or function as ATP-dependent clamps to ensure the 
unidirectionality of  reactions (28). In particular, DEAD-box proteins stand out 
from other RNA helicases in that they do not show any strict unwinding polarity. 
In contrast, DEAH-box, Ski2-like and RIG-I-like proteins translocate along 
single-stranded RNAs with a 3′-to-5′ polarity (Table III and references therein). 
They usually manifest as well a better processivity and can resolve longer RNA 
duplexes than DEAD-box proteins (29,30).
Structurally speaking, while showing low sequence similarities, the helicase 
core regions of  SF2 helicases present a remarkably conserved folding pattern. 
It consists of  two tandemly repeated RecA-like domains (hereafter referred to 
as RecA1 and RecA2) coupled by a short linker (Figures 1 and 2). The amino-
terminal RecA1 domain contains the composite helicase motifs Q, I, Ia, Ib, II 
and III, while motifs IV, V and VI are located on the carboxy-terminal RecA2 
domain. All SF2 helicases bind and hydrolyse NTP at the interface cleft of  the 
two RecA-like domains. Motifs Q, I (aka Walker-A or P-loop), II (aka Walker-B) 
and VI are directly implicated in NTP-binding/hydrolysis. The other conserved 
helicases motifs (Ia, Ib, III, IV and V) are less well studied, but evidence suggests 
that they are involved either in nucleic acid binding or in coupling of  the NTP 
hydrolytic state to protein conformational transitions (31). Besides the helicase 
core region, most SF2 helicases harbour ancillary N- and C-terminal flanking 
regions that are essential for the various functions of  these enzymes.
SF2 helicase classification and nomenclature
The SF2 helicases are often referred to as the DExD/H-box proteins with 
regard to the consensus amino acid sequence of  their helicase motif  II (Figure 2A). 
Originally, helicases of  the SF2 superfamily were classified into various groups 
termed DEAD-, DEAH- and DExH-box proteins. This classification was done 
prior to the availability of  structural and functional data and the nomenclature 
of  these groups depended essentially on amino acid variations in the helicase 
motif  II. However, phylogenetic, functional and structural studies of  human SF2 
proteins pointed out that the superfamily should instead be divided into seven 
distinct families (Figure 1). Examination of  motif  II consensus sequences within the 
different families (Figure 2A) reveals that the amino acid composition of  motif  II 
alone is not sufficient to assign a given SF2 protein to one of  the seven families. 
The sequence heterogeneity of  the Walker-B motif  within a certain family of  
helicases renders the initial Walker-B-based nomenclature somewhat inaccurate. 
This has led to generate a lot of  confusion in classification. To further illustrate 
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this aspect, several RNA helicases like RHAU or the RNA helicase A (alias RHA 
or DHX9), both of  which harbour an Asp–Glu–Ile–His motif  II, were (and 
are still) erroneously referred to as DExH-box proteins while their helicase core 
domains showed extensive similarities with those of  DEAH-box proteins like 
the prototypical yeast Prp2, Prp16, Prp22 and Prp43 RNA helicases (32-34). On 
the other hand, some RecQ-like and Rad3-like DNA helicases are sometimes 
incorrectly referred as DEAH-box proteins (35), because most of  them hold 
the Asp–Glu–Ala–His motif  within their Walker-B site (Figure 2A). However, 
both RecQ-like and Rad3-like proteins are structurally and functionally different 
from DEAH-box RNA helicases (Figure 1). Thus, a given SF2 helicase cannot be 
Figure 2 | Conserved ATPase/helicase motifs in superfamily 2 (SF2) helicases. (A) Sequence logos of the conserved and family-specfic helicase motifs 
involved in NTP binding/hydrolysis and nucleic acid binding for human SF2 helicases. Amino acids are coloured according to their biochemical properties: 
green for polar, blue for basic, red for acidic and black for hydrophobic. SF2 cons., SF2 helicase consensus sequence. (B) Structure of the helicase core 
domain of the yeast DEAH-box helicase Prp43 (2XAU, aa. 69–451). The conserved helicase motifs implicated in NTP binding/hydrolysis and nucleic acid 
binding are shown in red and green, respectively. (C) Schematic secondary structure topology of the helicase core of DEAH-box helicases. The position of 
the conserved helicase motifs is indicated using the same colour scheme as for panel (B).
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classified exclusively by its sequence of  motif  II, but by the sequence identity 
of  all characteristic helicases motifs. The terms ‘DEAD-box’, ‘DEAH-box’ and 
‘DExH-box’ are somehow misnomers and should clearly be defined once and 
for all to avoid ambiguities. However, the terms ‘DEAD-box’ and ‘DEAH-box’ 
will likely be kept for historical reasons, although not all the members of  these 
families of  RNA helicases harbour the expected Asp–Glu–Ala–Asp or Asp–
Glu–Ala–His signatures within their Walker B site.
The term ‘DEAH-box’ hereafter will be employed exclusively to refer to 
RNA helicases of  the ‘DEAH-box’ group/family as depicted in Figures 1 and 3. 
As for ‘DExD/H-box’, it will be employed as a synonym of  SF2 helicases.
The DEAH-box protein family of RNA helicases
The DEAH-box protein family of  RNA helicases was first recognised 
in 1991 following the discovery of  three novel putative SF2 helicases in 
S. cerevisiae (36). The examination of  the conserved helicase motifs of  the yeast 
Prp2, Pr16 and Prp22 proteins revealed that they could neither be classified as 
members of  the DEAD-box family nor as viral RNA helicase-like proteins. 
Thus, it was proposed that these proteins constituted a novel family of  RNA-
helicase-like proteins, which was termed ‘DEAH-box’ on the basis of  the 
sequence (Asp–Glu–Ala–His) of  their conserved motif  II. Following this 
finding, four additional DEAH-box proteins have been identified in S. cerevisiae 
and many others in various organisms. In fact, DEAH-box proteins constitute 
a widely spread family of  RNA helicases that have been identified in almost all 
species, from bacteria to mammals.
Biological functions of DEAH-box proteins
DEAH-box proteins play an essential role in RNA biology. Indeed, they 
harbour a wide range of  biological functions and have been shown to take part 
in nearly all aspects of  the RNA metabolism, ranging from transcriptions to 
RNA decay (Table I and references therein). Although RNA helicase activity 
has been confirmed for a few of  them, the precise function of  DEAH-box 
proteins in these contexts remains mostly elusive. As for DEAD-box proteins, 
they are thought to function in remodelling the structure and/or composition 
of  ribonucleoprotein (RNP) complexes by locally melting RNA duplexes or 
displacing proteins from RNA molecules. It should also be mentioned that while 
DEAH-box proteins in yeast have been extensively investigated on functional 
and biochemical aspects, the biological significance of  a majority of  their 
counterparts in higher eukaryotes is largely unknown (Figure 3).
Genetic studies in yeast have demonstrated that DEAH-box proteins 
achieve highly specific tasks. In most cases, they are required at a specific 
stage of  RNA metabolism and a majority of  them are highly specific for their 
substrates. As revealed by the lethality of  null mutants in yeast, most DEAH-box 
proteins are essential, suggesting tight target specificity for each protein (26,37). 
Nevertheless, in rare occasions, some RNA helicases have emerged to harbour 
multiple facets acting at different steps of  the RNA metabolism or even showing 
activity on DNA (33,38,39). For instance, the yeast DEAH-box protein Prp43 was 
initially identified as a pre-mRNA splicing factor acting in the release of  the 
intron lariat from the spliceosome (40-42). However, it was subsequently shown 
to function also in ribosome biogenesis (43-45). Otherwise, as shown in Table I, 
RNA helicase A is a multifunctional mammalian helicase that was shown to 
function as a transcriptional activator and to take part as well in the translation 
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Table I | Biological	functions	of	DEAH-box	RNA	helicases from E. coli (Ec), S. cerevisiae (Sc), C. elegans (Ce), D. melanogaster (Dm) 
and H. sapiens (Hs).
Symbol Org. Protein Function Remarks
hrpA Ec hrpA Takes part in the ribosome-mediated cleavage of the daa mRNA (46).
DHX8 Sc Prp22
Takes part in pre-mRNA splicing. Mediates the release of the spliced mRNA from 
spliceosome (36,47-50). Was also shown to repress the splicing of aberrant splicing 
intermediates (51).
Essential
Ce mog-5 Takes part in the post-transcriptional control of the switch from spermatogenesis to oogenesis (52,53). Embryonic lethal
Hs DHX8 Takes part in pre-mRNA splicing. Mediates the release of the spliced mRNA from spliceosome (109,110).
DHX9 Ce RHA
Required for germ cell proliferation, normal germ cell nuclear morphology, RNA-
mediated interference of germline-expressed genes, and silencing of germline-
expressed transgenes (54,55).
Not essential
Dm Mle
Is an essential component of the dosage compensation machinery required for 
increased transcription of X-chromosome linked genes in males (56-60). Is also 
involved in RNA editing process (61).
Essential for males
Hs RHA / NDH-II
Multifunctional helicase (62). Functions as a transcriptional activator (63-67). Is 
involved in the expression and nuclear export of retroviral RNAs (68-71). Takes also 
part in translation of selected mRNAs through interaction with their 5’-untranslated 
region (72). Was identified as a RISC component and shown to functions in RISC 
as an siRNA-loading factor (73). Was shown to be associated with SMN protein 
and possible involvement for RHA in pre-mRNA processing (74).
Early embryonic (E7.0) 
lethality for Rha−/− knock-
out mice (237)
DHX15 Sc Prp43
Takes part in pre-mRNA splicing. Mediates the disassembly of spliceosome after 
the release of mature mRNA (40,41). Takes also part in the processing of 35S rRNA 
precursor (43-45,75).
Essential
Hs DHX15 Pre-mRNA processing factor involved in disassembly of spliceosomes after the release of mature mRNA (76-78).
DHX16 Sc Prp2 Takes part in pre-mRNA splicing. Mediate the activation of the spliceosome before the first transesterification step (79-81). Essential
Ce mog-4 Take part in the post-transcriptional control of the switch from spermatogenesis to oogenesis (52,53). Embryonic lethal
Hs DHX16
Likely involved in pre-mRNA splicing since expression of DHX16 gene in S. pombe 
partially rescued the temperature-sensitive phenotype of dhx16 null mutant cells 
(82).
DHX29 Hs DHX29
Takes part in translation initiation. Required for efficient initiation on mammalian 
mRNAs with structured 5’-UTRs by promoting efficient NTPase-dependent 48S 
complex formation (83,84).
DHX30 Hs DHX30 Required for optimal function of the zinc-finger antiviral protein (ZAP, ref. 85).
DHX32 Hs DHX32 Might be involved in regulating T-cell response to certain apoptotic stimuli (86). Not essential in mouse*
DHX34 Ce SMGL-2 Involved in non-sense-mediated mRNA decay process (87). Essential (87)
Hs DHX34 Involved in non-sense-mediated mRNA decay process (87).
DHX36 Dm CG9323 Possesses in vitro G4-RNA-resolvase activity (88).
Hs RHAU
Involved in ARE-mediated decay of uPA mRNA (32). Possesses in vitro G4 re-
solvase activity and was identified as the major source of G4 resolving activity in 
HeLa cell lysates (33,89).
Early embryonic (E7.5) 
lethality for Rhau−/− 
knockout mice (90)
DHX37 Sc Dhr1 Takes part in the processing of 18S rRNA (91-93). Essential
DHX38 Sc Prp16
Takes part in pre-mRNA splicing. Required during the second catalytic step and 
promotes 3' splice site cleavage, exon ligation as well as conformational change in 
the spliceosome (94-97).
Essential
Ce mog-1 Takes part in the post-transcriptional control of the switch from spermatogenesis to oogenesis (98). Embryonic lethal
Hs DHX38 Takes part in pre-mRNA splicing. Required during the second catalytic step (99).
TDRD9 Dm Spindle-E
Component of the piRNA pathway. Plays a central role during meiosis by forming 
complexes composed of piRNAs and Piwi and govern the methylation and subse-
quent repression of transposable elements (100-103). Takes also part in the control 
of telomere maintenance in the germline (104).
Essential
Hs TDRD9 Takes part to the repression of transposable elements during spermatogenesis. Acts via the piRNA metabolic process (105).
*Abdelhaleem, M. unpublished data.
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of  specific mRNAs. Therefore, RNA helicases may also achieve more than one 
task acting on different RNAs depending on interactions with protein cofactors.
Evolutionary aspects of the DEAH-box family of RNA helicases
Comparative genomic analyses have revealed that SF2 RNA helicases are 
ubiquitously distributed over a wide range of  organisms, viruses included (9). 
While DEAD-box, RIG-I and Ski2-relatated RNA helicases are widespread in 
all three domains of  life (archaea, bacteria and eukarya), DEAH-box proteins 
are in contrast only found in bacteria and in eukaryotes. The hrpA gene product 
is the only bacterial representative of  the DEAH-box protein family (Figure 3). 
True orthologues of  this gene are also found in proteobacteria and spirochaetes 
phyla as well as in Deinococcus genus (deinococcus-thermus phylum). This 
suggests dissemination via horizontal gene transfer among bacteria, although 
the initial direction of  horizontal transfer responsible for the bacterio-eukaryotic 
distribution remains obscure. HrpA is implicated in mRNA processing (46), and 
like all DEAD-box proteins in Escherichia coli, its function is not essential for 
cell viability under standard culture conditions (46,106). A paralogue of  hrpA 
gene, named hrpB, is also found in E. coli. It may have appeared following gene 
duplication. However, as shown in Figure 3, the hrpB gene product is distantly 
related to hrpA and to other DEAH-box proteins found in eukaryotes.
DExD/H-box RNA helicases are more widespread in eukaryotes than in 
prokaryotes and most of  them are essential (26). The yeast S. cerevisiae genome 
encodes seven DEAH-box proteins out of  which six are required for cell viability. 
Four of  these helicase (Prp2, Prp16, Prp22 and Prp43) have been shown to take 
part in pre-mRNA splicing (36,40,79,94,107) and Prp43 was later demonstrated to 
be as well required during the processing of  the 35S rRNA precursor (43-45). 
Two extra DEAH-box RNA helicases, Dhr1 and Dhr2, have been shown to 
take part in the processing of  the 18S rRNA (91). Finally, the open reading frame 
Ylr419w is the only known DEAH-box helicase in yeast that was found to be 
dispensable for cell viability and whose function is not yet determined (91). 
As shown in Figure 3, five yeast DEAH-box proteins followed a conservative 
pattern of  evolution, insofar as true orthologues of  Prp2, Prp16, Prp22, Prp43 
and Dhr1 proteins are found in metazoan species. In several cases, direct data 
support similar roles of  these proteins in higher eukaryotes (76-78,82,99,108-
111). However, one apparent exception is mog-1, the C. elegans orthologue of  
Prp16, which is not explicitly required for pre-mRNA splicing (112). Mog genes 
in nematodes take part in the sex determination process of  the germline. Two 
other DEAH-box proteins, mog-4 and mog-5, corresponding to Prp2 and 
Prp22, respectively, are also required for the posttranscriptional regulation of  the 
switch from spermatogenesis to oogenesis (53). Although it is still possible that 
mog-1, mog-4 and mog-5 have switched to completely new functions, one cannot 
exclude the possibility that these three DEAH-box proteins are still involved 
in splicing and that the Mog (masculinisation of  germline) phenotype results 
indirectly from abnormal splicing of  factors implicated in the sex determination 
process (112).
Finally, although the yeast spliceosomal DEAH-box proteins manifest 
a conservative evolutionary pattern, the genes related to ylr419w have largely 
diversified in metazoans. Ylr419w has no clear orthologue in higher eukaryotes, 
which suggest that the paralogue forms of  this gene found in metazoans may 
have arisen from several gene duplication events. The large number of  biological 
functions assigned to this group of  proteins (sometimes referred to as the ‘RHA 
protein group’; ref. 14,30) indicates that DEAH-box RNA helicases have gained 
and diversified their functions to fit with some aspects of  RNA metabolism in 
metazoans with respect to yeasts.
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Modular architecture of DEAH-box proteins
Structurally, DExD/H-box proteins contain of  a highly conserved catalytic 
core composed of  two RecA-like domains that couples NTP hydrolysis with the 
helicase activity. The helicase core domain is often flanked by N- and C-terminal 
regions of  variable length and sequence (Figure 4). While the core domain of  
RNA helicases has been extensively investigated, much less is known about 
the biological role of  these N- and C-terminal regions. The helicase core of  
DExD/H-box proteins is assumed not to contribute directly to the substrate 
specificity of  the enzyme because in all crystal structures, the highly conserved 
helicase core region interacts only with the phosphoribose backbone of  the 
bound single-stranded nucleic acid and not with the nucleobases. In contrast to 
the helicase core, the N- and C-terminal flanking regions are usually unique, with 
the exception of  certain identifiable sequence features. On several occasions, 
these regions have been shown to provide substantial substrate specificity 
through their interaction with RNAs or with protein partners that modulate the 
activity and/or the specificity of  the helicase (for reviews, see ref. 6,37). Thus, the 
helicase flanking regions can be regarded as ancillary domains that endow the 
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enzyme with specificity, thereby positioning the helicase core in close proximity 
to its substrate.
DEAH-box RNA helicases differ from their DEAD-box counterparts, 
insofar as their C-terminal region is conserved over 300 amino acids beyond 
the helicase core region. First evidence of  this distinctive feature emerged from 
an early characterisation of  the yeast spliceosomal DEAH-box proteins (36). 
Since deletions of  the C-terminal region resulted in the loss of  interaction 
with the spliceosome, it was initially assumed that this conserved region could 
mediate the interaction of  the helicase with the spliceosome. However, such a 
scenario now seems less plausible, because all DEAH-box proteins, whether 
they are implicated in splicing or not, contain a conserved C-terminal region 
of  300 amino acid length [hereafter referred to as the ‘helicase associated’ (HA) 
region; Figure 4]. Compared to the helicase core, the HA region has so far received 
relatively little attention. Thus, its function is less well understood than that of  
the helicase core. However, several experimental observations strongly suggest 
its requirement for the proper function of  DEAH-box helicase in vivo and in 
vitro (41,113-118). Notably, deletion experiments carried out on the prototypical 
Prp2, Prp16, Prp22 and Prp43 RNA helicases revealed that the most extreme 
and non-conserved part of  the C-terminal region was not essential (Figure 5). 
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Conversely, severe growth defect phenotypes were observed for mutants 
harbouring deletions in the HA region. The prevalence of  the HA region among 
DEAH-box proteins and its apparent functional significance strongly support 
the idea that it constitutes an extension of  the helicase core. Pattern and profile 
searches of  the HA region in other proteins indeed have revealed that this 
domain is unique among DEAH-box proteins and is always associated with the 
helicase core region. Further evidence for the importance of  this conserved 
sequence element came from the examination of  the shortest DEAH-box 
proteins. Interestingly, the human DHX33 and DHX35 consist exclusively of  
the helicase core and the HA region and therefore represent minimal DEAH-
box proteins (Figure 4). Taken together, these observations suggest that within 
the DEAH-box family of  helicases, the two RecA domains together with the 
HA region define a minimal helicase enzymatic core region. Likewise, family-
specific C-terminal conserved flanking regions of  the viral NS3, the RecQ- and 
the Ski2-related helicases, being associated with the helicase core region, have 
already been shown to contribute to the unwinding process (29,119,120).
Structural aspects of DEAH-box proteins
Until recently, a molecular understanding of  DEAH-box helicase function 
was significantly limited due to the unavailability of  structural models. However, 
two independent X-ray structures of  the yeast spliceosomal Prp43 were released 
in 2010 (113,121). In both models (RCSB PDB ID: 3KX2, 2XAU), full length 
Prp43 was cocrystallised in the presence of  ADP. The two studies have proposed 
essentially the same structure, with a root mean square deviation (RMSD) of  
0.27 Å for all corresponding C
α
 atoms.
Prp43 provides a good model for DEAH-box protein. Its amino acid 
sequence displays explicit similarity with other members of  the DEAH-box 
family over 86 % of  its length (Figure 6A). Only the first 70 amino acids and 
the last 40 amino acids of  its N- and C-terminal regions, respectively, are 
unique to Prp43. Thus, as all DEAH-box helicases share the same domain 
organisation (Figure 4), structural observations made on Prp43 helicase core and 
HA regions can be readily extrapolated to the other members of  the family.
The crystal structure of  Prp43 reveals that the helicase core and the HA 
region consist of  five structural domains (Figure 6B and C). The helicase core 
region consists of  two abutting RecA-fold domains connected by a short linker. 
The RecA domains 1 and 2 contain the composite helicase motifs involved 
in ATP binding, hydrolysis and nucleic acid binding. The overall structure of  
Prp43 helicase core region more resembles the core region of  the viral helicases 
than that of  DEAD-box proteins (Figure 7A and Supplementary Figure 2). Like the 
Figure 5 | Requirement of the helicase 
associated (HA) region for DEAH-box 
protein function. Phenotypic growth effects 
of C-terminal deletions on the S. cerevisiae 
spliceosomal DEAH-box proteins. The 
position and the severity of the deletions 
are indicated above the protein by coloured 
arrows. All proteins and domains are shown 
to scale.
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flavivirin NS3 related helicases [hepatitis C virus (HCV, ref. 122), Murray Valley 
encephalitis virus (123) or yellow fever virus (124)], the RecA2 domain of  Prp43 
possesses a long and twisted antiparallel β-hairpin positioned between motifs 
V and VI that inserts into a cleft of  the HA region (Figures 6B and 7A). In NS3 
helicases, the corresponding β-hairpin is assumed to act as a pivot point that 
allows to lock the RecA2 domain orientation in the ADP state relative to the 
rest of  the molecule (125). Both the β-hairpin and the residues it contacts are in 
overall highly conserved among various strains of  virus.
The HA region of  Prp43 consists of  three distinct domains; two of  which 
displays an unanticipated structural similarity with the C-terminal region of  the 
HELQ-related archaeal Hel308 and Hjm DNA helicases (Ski2 family of  helicases, 
ref. 29,126; Figure 7B). This was an unexpected finding since Prp43 displays very 
little sequence similarity (<10 % identity) with Ski2-related helicases (Supplementary 
Figure 3). The two first domains of  the HA region fold respectively into of  a 
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Figure 6 | Structure of the yeast DEAH-box protein Prp43. (A) Schematic representation of the domain organisation and amino acid conservation 
of S. cerevisiae Prp43 protein. The conserved ATPase/helicase motifs I–VI of the DEAH-box family are indicated within the helicase core region (HCR) 
by vertical bars. The HCR is flanked by the N-terminal (NTR) and C-terminal (HA–CTR) regions of 68 aa. and 316 aa., respectively. Each residue of 
Prp43 sequence is represented with a colour code that denotes its degree of conservation amongst various paralogous DEAH-box protein sequences 
(Supplementary Figure 1). Similarity is shown in red for 100 %, yellow for 99–80 % and blue for 79–60 %. Average values of identity (Id.) and similarity 
(Sim.) for NTR, HCR, HA and CTR regions are indicated. (B) Front and (C) side view of Prp43 structure (aa. 69–725). The unique NTR (aa. 1–68) and CTR 
(aa. 726–767) are omitted for clarity. The five structural domains are coloured as in panel (A).
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winged-helix (WH) motif  and a seven-helix bundle. The WH motif  is tightly 
packed against the RecA1 domain, while the seven-helix bundle, referred as the 
‘Ratchet’ domain in Hel308 owing to its putative function as a ratchet for nucleic 
acid, binds across the two RecA-like domains. The third and last domain of  
the HA region consists of  an oligonucleotide/oligosaccharide-binding (OB) 
motif  arranged in a five-stranded β-barrel. The OB-fold domain is linked to the 
Ratchet domain by an α-helix, which extensively packs with the Ratchet domain.
Mechanism of rNTP binding and hydrolysis by DEAH-box 
proteins
As for the other SF2 proteins, the catalytic site for rNTP hydrolysis in 
Prp43 is located at the interface cleft of  the two RecA-like domains. However, 
the orientation of  the nucleoside moiety differs appreciably from that observed 
in other human SF2 helicases and more resembles that of  the viral helicases. 
In Prp43, the pyrophosphate moiety of  the nucleotide is likewise orientated as 
in DEAD-box proteins relative to motifs I and II. However, the adenine ring 
is rotated by about 140° around the triphosphate axis compared to that in the 
DEAD-box protein and points inward (Figure 8A). Unlike other families of  SF2 
helicases, DEAH-box proteins lack the Q-motif, which hydrogen-bonds to 
the N6 and N7 positions of  the adenine base, thereby providing ATP-binding 
specificity (127,128). Instead, in Prp43, the adenine ring is stacked between the side 
chains of  an Arg residue from the RecA1 domain and the phenyl ring of  a Phe 
from RecA2 domain. The corresponding Arg and Phe residues are conserved in 
almost all DEAH-box proteins, suggesting the existence of  a similar nucleotide 
binding site among members of  the family (Supplementary Figure 1). By analogy to 
the Q-motif, these two residues and the few conserved surrounding amino acids 
will be referred to as the R- and the F-motifs, respectively (Figure 9). The R-motif  
is located on an α-helix positioned between domains Ia and Ib, while the F-motif  
is situated on another α-helix between domain IV and V. According to this 
binding mechanism, the base moiety of  the NTP is exclusively maintained by 
hydrophobic effect. Hence the base is not specifically recognised by the helicase, 
indicating why DEAH-box proteins are so promiscuous in term of  their rNTP/
dNTP specificity (Table III and references therein).
Figure 7 | Structural similarities between 
Prp43 and the NS3 and Ski2-like helicases. 
(A) Three-dimensional protein structure super-
position of Prp43 helicase core (yellow, RCSB 
PDB ID: 2XAU, aa. 105–451) with two flavivirin 
NS3 related helicases [pink, 2WV9 (Murray 
Valley encephalitis virus); cyan, 1YKS (yellow 
fever virus)]. (B) Three-dimensional protein 
structure superposition of Prp43 helicase core 
and HA regions (yellow, 2XAU, aa. 90–634) 
with the Ski2-related Hjm helicase (pink, 
2ZJA). The adenosine cofactor is shown in 
cyan for Prp43 and in blue for Hjm.
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Apart from the newly identified R- and F-motifs, the nucleotide binding 
pocket of  DEAH-box proteins is formed by the helicases motifs I, II, V and 
VI (Figure 8B). Motif  I contains the characteristic P-loop and makes several 
contacts with the triphosphate part of  the nucleotide directly and through Mg2+ 
ion and water. The carboxyl groups of  Asp-II* and Glu-II coordinate the Mg2+ 
ion of  Mg∙ADP/ATP through outer-sphere electrostatic interactions. The 
Glu-II residue is also thought to act as a catalytic base during ATP hydrolysis. In 
Prp43, several residues from motifs V and VI in the RecA2 domain also contact 
the nucleotide. However, in both available Prp43 structures, the helicase was 
crystallised with ADP in the open conformation state, which does not reflect 
the correct positioning of  the residues necessary for NTP hydrolysis. Closure 
of  the inter-domain cleft between the two RecA domains was shown to occur 
upon cooperative binding of  NTP and RNA by the helicase and provides the 
cadre of  the ATP binding and hydrolysis site (129,130). Structural basis of  NTP 
hydrolysis by Prp43 can be inferred from the analysis of  the structurally related 
dengue virus (DENV) NS3 helicase which was crystallised at several stages 
along its catalytic cycle (129). Unlike the open conformation of  Prp43, the closed 
conformation state of  the DENV NS3 helicase reveals that the RecA2 domain 
interacts with the NTP through several amino acids from motif  V and the 
evolutionary conserved Gln-VI, Arg
2
-VI and Arg
3
-VI (Figure 8C). In both Prp43 
and DENV NS3 structures, the 2′-hydroxyl group of  the ribose is contacted 
by residues from motif  V. However, this interaction does not appear to play 
a decisive role in discriminating rNTPs from dNTPs, since Prp43 along with 
* Hereafter, the conserved amino acids of  the helicase motifs will be designated as follow: the 
amino acid in question is referred using the three letter code; the subscript index (when neces-
sary) corresponds to the rank of  the amino acid when presents in multiple instances in a given 
motif; the roman numeral refers to the helicase motif. E.g. ‘Arg
3
-VI’ denotes the third con-
served arginine in helicase motif  VI (QRxGRAGR). 
A
B
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Figure 8 | NTP binding by DEAH-box RNA 
helicases. (A) ATP binding by DEAH-box 
proteins versus DEAD-box proteins. Three-
dimensional protein structure superposition 
of the helicase core of Prp43 (dark green, 
RCSB PDB ID: 2XAU, aa. 105–451) with that 
of the human DDX19 (violet, 3G0H, 60–466). 
The adenosine cofactor is shown in green 
for Prp43 and in violet for DDX19. The side 
chains of Gln-119 (Q-motif, DDX19), Arg-159 
(R-motif, Prp43) and Phe-357 (F-motif, Prp43) 
are depicted as coloured sticks. (B) Close-
up view of the NTP binding and hydrolysis 
site of Prp43 in its open conformation state. 
(C) Close-up view of the NTP binding and 
hydrolysis site of the dengue virus DENV NS3 
helicase (2JLV) in its closed conformation 
state. The catalytic water is shown in red.
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many other DEAH-box proteins can irrespectively hydrolyse dNTPs besides 
rNTPs (96,107,118,131,132). In the closed conformation state, the Lys-I bridges 
the β- and γ-phosphates and is thought to coordinate the γ-phosphate during 
the hydrolysis step (133,134). On the RecA2 domain, Arg
2
-VI was proposed to 
function like an ‘arginine finger’ (135). It contacts the γ-phosphate and might 
stabilise the transition state in the course of  ATP hydrolysis (27,134,136). In 
addition, the conserved Glu-II and Gln-VI residues are in close proximity. Their 
side chain hydrogen-bond a water molecule which is positioned at right distance 
for an in-line nucleophilic attack of  the γ-phosphate. Activation of  the catalytic 
water was proposed to occur through proton transfer to the Glu-II and/or 
polarisation by Gln-VI (129). Following hydrolysis of  the β–γ phosphoanhydride 
bond of  the bound rNTP, both phosphate and rNDP moieties are released from 
the inter-domain cleft.
In addition to these structural data, several mutagenesis studies carried 
out essentially on the prototypical DEAH-box proteins Prp2, Prp16, Prp22 
and Prp43 have confirmed the significance of  the conserved amino acids in 
motifs I, II and VI for the ATPase activity of  DEAH-box proteins (Table II and 
references therein). In particular, amino acid substitution of  the conserved 
Lys-I, Asp-II, Glu-II and Gln-VI residues have been shown to reduce the 
ATPase activity of  wild-type proteins by more than 90 %. Finally, the allosteric 
conformational changes of  the catalytic site for ATP hydrolysis in response to 
RNA binding clarify the causes of  the cooperativity between rNTPs and nucleic 
acid binding (137) and explains the substantial stimulation of  the basal ATPase 
activity of  DEAH-box proteins in the presence ssRNAs (32,41,48,83,94,107).
Mechanisms of ssRNA binding by DEAH-box proteins
Although Prp43 was not crystallised together with a bound 
oligoribonucleotide, insight into the bases of  RNA recognition by DEAH-box 
proteins can be inferred from the study of  the archaeal Hel308 (RCSB PDB 
Figure 9 | NTP and nucleic acid binding 
by conserved ATPase/helicase motifs 
in DEAH-box proteins. In Prp43, the NTP 
cofactor is contacted directly or undirectly by 
several residues from motifs: I, R, II, III, F, V 
and VI. The numbered yellow dots above the 
sequence logos refer to the part of the NTP 
moiety they bind. Motifs Ia, Ic, Ib, IV, IVa and 
V are implicated in single-stranded nucleic 
acid binding. The pink diamonds beneath 
sequence logos denotes amino acids that may 
contact the translocating nucleic acid. These 
residues have been mapped based on the 
structural similarity between Prp43 and NS3 or 
Hel308 helicases which have been crystallised 
in complex with nucleic acids (Supplementary 
Figures 2 and 3). All the sequence logos 
were constructed from the multiple sequence 
aligment shown in Supplementary Figure 1.
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ID: 2P6R) and the viral NS3 (RCSB PDB ID: 2JLV, 3KQL) helicases which 
have been crystallised in complex with nucleic acids. In both Hel308 and NS3 
structures, the single-stranded nucleic acid is located in the groove that separates 
the helicase core from the C-terminal region (29,122,129). The nucleic acid is 
extensively contacted by residues localised in the loops between secondary 
structure elements from the two RecA-like domains. Both the location and 
polarity of  the bound nucleic acid are similar to that previously observed in 
DEAD-box protein–RNA complexes (27,133,138,139). The RecA1 domain binds 
the 3′-end of  the nucleic acid substrate through motifs Ia, Ib and Ic while motifs 
IV, IVa and V from the RecA2 domain binds the 5′-extremity. Motif  Ic is located 
between motifs Ia and Ib and is equivalent to the GG-doublet found in many 
DEAD-box helicases (31). As for motif  IVa (140), which is situated between motifs 
IV and V, it corresponds to the QxxR motif  of  DEAD-box proteins. Nucleic 
acid binding by Hel308 and NS3 proteins is similar to that found in DEAD-box 
proteins, insofar as the helicase motifs Ia, Ib, Ic, IV, IVa and V interact essentially 
in a sequence-independent manner with the phosphoribose backbone of  the 
single-stranded nucleic acid. No interaction occurs between the helicase core 
and the bases of  the nucleic acid, explaining the lack of  sequence specificity. 
However, direct contacts to the 2′-hydroxyl groups of  the ribose moieties leads 
to discrimination against DNA as a substrate. Finally, several contacts to the 
nucleic acid involve only the peptide backbone, explaining the occasionally low 
sequence conservation of  the nucleic acid binding motifs (Figure 2A).
Superposition of  Prp43 with either Hel308 or NS3 revealed that Prp43 
contains a similar single-stranded nucleic acid-binding cavity, formed by the two 
A
B
motif Ia
motif Ic
motif Ib
motif IV
motif IVa
motif V
Figure 10 | Nucleic acid binding motifs 
in helicase core region of HCV NS3 and 
Prp43 DEAH-box helicases. (A) Surface 
representation of HCV NS3 helicase core 
region (RCSB PDB ID: 3KQL, aa. 189–481) 
in complex with ssDNA (dA6, yellow). The 
conserved helicase motifs (Ia, Ic, Ib, IV, IVa 
and V) implicated in binding of single-stranded 
nucleic acid are depicted in colour with 
transparency surface. Amino acids that make 
direct contacts with the oligodoxynucleotide are 
shown as sticks. (B) Surface representation of 
Prp43 helicase core (2XAU, aa. 69–451) in the 
same orientation as NS3 in panel (A). Amino 
acids that may form direct contacts with the 
translocating nucleic acid are depicted as 
coloured sticks.
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RecA-like domains and the three domains of  the HA region. As for Hel308 and 
NS3, the conserved motifs Ia, Ib, Ic, IV, IVa and V of  Prp43 are positioned at the 
interface of  the cavity and superpose remarkably well on those of  Hel308 and 
NS3 (Figure 10 and Supplementary Figures 2 and 3). Actually, little is know regarding 
the functional contribution of  motifs Ia, Ib, Ic, IV, IVa and V in single-stranded 
nucleic acid binding by DEAH-box proteins. In Prp43, motif  Ia may contact 
RNA through conserved Pro-Ia and Arg
2
-Ia residues. The corresponding amino 
acids in DEAD-box, Hel308 and NS3 helicases make contact with nucleic acid, 
and mutation of  Arg
2
-Ia residue in Prp22 and Prp43 proteins causes a cold-
sensitive phenotype (118,141). Motifs Ib, Ic and IVa have not been investigated by 
mutagenesis in DEAH-box proteins and putative nucleic-acid binding residues 
depicted in Figure 9 were proposed solely based on structural similarity between 
Prp43 and NS3 or Hel308 helicases. The conserved Thr
1
-V residue in RecA2 
domain likely contacts RNA in DEAH-box proteins. Mutation of  the equivalent 
residues in Prp22 and Prp43 affects both helicase and RNA-dependent ATPase 
activities and prevents the mutated proteins to complement the corresponding 
∆prp22 and ∆prp43 yeast strains (118,141). Substitution of  Thr
1
-V residue, in 
contrast, does not affect the RNA-independent ATPase activity, indicating that 
this mutation in motif  V does not impair the ability to hydrolyze ATP but rather 
affect the responsiveness to RNA cofactors. In the crystal structures of  DENV 
NS3 or Hel308, the Thr
1
-V contacts a phosphate in the nucleic acid (29,129). 
Similarly to Prp22 and Prp43, replacing the corresponding threonine by alanine 
abolished NS3 helicase activity while mutated NS3 protein retained basal ATPase 
activity, which could not be stimulated by nucleic acid (142).
Besides the two RecA-like domains, RNA is also likely contacted by the 
HA region in DEAH-box proteins. As mentioned earlier, the two first domains 
of  the Prp43 HA region are structurally homologous to the WH and Ratchet 
domains of  HELQ-related DNA helicases. Both WH and Ratchet domains 
have been shown to contact nucleic acid in Hel308 structure (ref. 29; Supplementary 
Figure 3). Opposing interactions between residues of  the Ratchet domain and 
the base moieties of  the single-stranded nucleic acid were proposed to provide 
further stabilisation of  the unwound nucleic acid and are probably important for 
translocation processivity. In particular, the last 25 amino acid-long α-helix of  
the Hel308 Ratchet domain constitutes an ideal hook for directional transport 
of  ssDNA across the two RecA-like domains. The stacking of  Arg-592 and 
Trp-599 of  this helix with DNA base moieties is assumed to function as a 
ratchet on the nucleic acid strand, which would allow Hel308 to processively 
translocate along the single-strand nucleic acid to unwind the DNA duplex (29). 
Prp43 and other DEAH-box proteins contain a similar long α-helix at the end 
of  their Ratchet domain (Figure 6B and Supplementary Figure 3). Although the Hel308 
Arg-592 and Trp-599 residues are not conserved among DEAH-box proteins, 
others residues from the ratchet helix may form stacking interactions with the 
base moieties of  the bound nucleic acid. Hence, the corresponding ratchet helix 
might also function similarly in DEAH-box proteins.
Finally, the last domain of  the HA region of  Prp43 and other DEAH-box 
proteins consists of  an OB-fold domain which is also supposed to contribute 
to single-stranded nucleic acid binding (113). OB-folds have been shown to bind 
various ligands, such as single-stranded nucleic acids, oligosaccharides, proteins, 
metal ions and catalytic substrates (143). Interestingly, a DALI search for 
structural homologues (144) reveals that Prp43 OB-fold domain is most closely 
related to OB-folds found in cold shock proteins (Csps). Csps comprise a family 
of  small proteins (7–8 kDa) that are structurally highly conserved and bind 
to single-stranded nucleic acids through their five-stranded β-barrel OB-fold 
domain (145,146). Csps function as RNA chaperones by preventing formation 
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of  stable secondary structures of  RNA which occurs under suboptimal 
temperatures. Structural alignment of  Prp43 OB-fold domain with the bacterial 
CspA and CspB proteins reveals only moderate degree of  sequence similarity 
(Supplementary Figure 4A and B). However, residues from the two RNP motifs by 
which Csps bind single-stranded nucleic acids are also conserved in Prp43. The 
nucleic acid-binding interface in OB-fold domains is generally defined by the 
groove formed by the β2 and β3 strands, and the loops L
12
, L
3η
 and L
45
 (147). 
In Prp43, the OB-fold domain is optimally orientated to interact with RNA at 
the entrance of  the nucleic acid cavity and may provide extra stabilisation of  
the unwound RNA strand (Supplementary Figure 4C). The substantial contribution 
of  the OB-fold domain in RNA-binding by Prp43 was confirmed in vitro by 
deletion or mutation experiments which resulted in defective Prp43 proteins 
Table II | Phenotypes resulting from mutations of helicase motifs in five prototypical DEAH-box RNA helicases. A, ATPase activity; B, nucleic acid 
binding; F, biological function; G, cell growth; H, helicase activity; −, reduced activity; n, normal activity; +, enhanced activity.
M
ot
if
R
es
i. hrpA Prp2 Prp16 Prp22 Prp43
Mut Ph Ref Mut Ph Ref Mut Ph Ref Mut Ph Ref Mut Ph Ref
I
G G373A Gn (115)
E E374A Gn (115)
T T375A Gn (115)
G G376A Gn (115)
S S377A Gn (115)
G G105A F− (46) G378A G−, A− (115,149)
K K106A F− (46) K379A G−, A− (115,149) K512A G−, A−, H−, F− (47,48, K122A G−, A− (41)
T T107A F− (46) T380A G− (115) 149,150) T123A G−, A− (41)
Ia
T T534A Gn (141) T146A Gn (118)
Q Q535A Gn (141) Q147A Gn (118)
P P536A Gn (141) P148A Gn (118)
R R537A Gn (141) R149A Gn (118)
R R538A G− (141) R150A G− (118)
II
D D197A F− (46) D473A G−, A− (115,149) D603A G−, A−, F− (149,150) D215A G−, A− (41)
E E198A F− (46) E474A G−, A− (115,149) E604A G−, A−, F− (149,150) E216A G−, A− (41)
A
H H200A Fn (46) H476A G−, A−, Fn (115,149) H606A G−, A+, F− (150,151) H218A Gn, A− (41)
III
S S378L G−, A−, F− (152) S505A Gn, A−, Fn (115,149) S635A G−, An, H−, F− (149,150) S247A G−, A− (41)
A
T T507A Gn, A−, Fn (115,149) T637A G−, A+, H−, F− (150,151) T249A Gn, An (41)
IV
F F697A G−, A−, B−, H−, F− (141) F309A G− (118)
L
T T699A Gn (141) T311A Gn (118)
G G700A Gn (141) G312A Gn (118)
V
T T757A G−, A−, Bn, H−, F− (141) T376A G−, A−, B−, H−, Fn (118)
N N758A G− (141) N377A Gn (118)
I
A
E E761A G− (141) E380A Gn (118)
T T762A Gn (141) T381A Gn (118)
S S763A G− (141) S382A Gn (118)
L I764A G−, A+, Bn, H−, F− (141) L383A G− (118)
T T765A G−, A+, Bn, H−, F− (141) T384A G−, An, Bn, Hn, F− (118)
VI
Q Q395A F− (46) Q548H G− (153) Q685A G−, A− (115,149) Q804A G−, A−, F− (149,150) Q423A G−, A−, F− (41,45)
R R396A F− (46) R686A G− (115) R805A G− (150,151) R424A G− (41)
a S687A Gn (115)
G G398A F− (46) G551N G− (153) G688A G− (115) G807A G− (150) G426A G− (41)
R R399A F− (46) R689A G−, A− (115,149) R808A G−, A−, F− (149,150) R427A G− (41)
A
G G691A Gn (115) G810A G− (150) G429A Gn (41)
R R402A F− (46) R692A G−, A− (115,149) R811A G− (150) R430A G− (41)
In Prp16, the S505L substitution is lethal.
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with reduced RNA-dependent ATPase and RNA-binding activities (113). 
Furthermore, the importance of  the OB-fold domain for the proper function 
of  DEAH-box proteins in vivo is indicated by the results of  deletion experiments 
with Prp2, Prp16, Prp22 and Prp43, which revealed that DEAH-box proteins 
with truncated OB-fold domain could not rescue the corresponding null mutant 
allele in yeast (ref. 41,114,115-117; Figure 5).
In sum, it emerges that DEAH-box proteins bind to ssRNA using residues 
from both the helicase core and the adjacent C-terminal HA region. Nevertheless, 
due to the lack of  structural and functional studies, it is still difficult to provide 
a more detailed overview of  how these helicases grasp RNA. Besides, it should 
be kept in mind that many DEAH-box helicases harbour as well additional 
classical RNA-binding motifs and/or low complexity sequences in their N- and 
C-terminal flanking regions that can also confer extra affinity or specificity for 
some nucleic acid structures (ref. 148; Figure 4).
Insight into RNA unwinding by DEAH-box RNA 
helicases
With the exception of  Prp2 and DHX29, all DEAH-box proteins whose 
unwinding activity has been investigated in vitro demonstrate rNTP-dependent 
nucleic acid strand separation activity (Table III and references therein). Although 
DEAH-box proteins are not as processive as the hexameric DNA helicases 
which unwind thousands of  base pairs, most of  the DEAH-box RNA helicases 
display higher processivity than DEAD-box proteins and can readily dissociate 
a 30-bp RNA duplex. Unfortunately, there is currently almost no structural and 
mechanistic data available on how DEAH-box proteins catalyse RNA strand 
separation.
Many structural and functional studies have evidenced that DExD/H-box 
proteins undergo conformational transitions in the course of  their NTPase and 
helicase activities. However, the molecular mechanisms by which ATP hydrolysis 
is coupled to structural changes in the RNA substrates are somehow not fully 
understood. The greater part of  the knowledge about nucleic acid unwinding by 
SF2 helicases follows from studies of  DEAD-box and flavivirin NS3 helicases. 
However, because SF2 helicases are forming a large and versatile group of  
functionally and structurally diverse proteins, there is no emerging consensus 
and several different working models have been proposed. In particular, the 
recent observations made on the non-processive DEAD-box proteins are quite 
difficult to transpose on helicases of  the DEAH-box family. The latter presents 
a much greater structural ressemblence to helicases of  the Ski2-like family 
for which little information is currently available. Actually, from a structural 
perspective, DEAH-box proteins rather look like a sort of  hybrid protein family. 
Their helicase core region shares a remarkable resemblance with that of  viral 
NS3-like helicases whereas a major part of  their HA region is structurally similar 
to the C-terminal WH and Ratchet domains of  Ski2-like helicases (113,121). 
Therefore one of  the main challenges lies in adapting the most recent functional 
models developed for NS3 or Ski2-related helicase to DEAH-box proteins.
Coupling of rNTP hydrolysis with nucleic acid strand separation
First evidence that DExD/H-box proteins convert chemical energy 
released by rNTP hydrolysis into mechanical force leading to the disruption of  
nucleic acid structures was obtained by mutagenesis studies. Substitution of  a 
few amino acids in the helicase motifs III, IV and V has indeed been reported 
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to uncouple NTP-hydrolysis from duplex unwinding without severely affecting 
binding of  rNTP or nucleic acid (41,118,141,150,154-156).
Motif  III was initially suggested to couple ATP binding and hydrolysis to 
helicase activity, since mutation in this motif  drastically interfered with substrate 
unwinding without affecting ATP binding and hydrolysis in vitro (150,154-
156). However, there is a notable divergence of  observations for the effects 
of  the mutations of  motif  III on different SF2 proteins in vitro and in vivo. In 
some helicases, mutations in motif  III cause a loss of  rNTPase activity (157). 
Furthermore, the role of  this motif  remains somewhat ambiguous, as mutations 
do not always impair protein function in vivo (41,115,158,159). Recently, motif  III 
was proposed to facilitate the proper alignment of  the two RecA-like domains in 
response to rNTP binding and to create a high-affinity binding site for RNA (160). 
In most of  the DExD/H-box protein, motif  III bridges residues from motifs 
II and VI as well as the γ-phosphate (27,133,138,139). Indeed, Ser-III and Thr-III 
residues form hydrogen bonds with His-II and Gln-VI, respectively (Asp
2
-II 
and His-VI in DEAD-box proteins), and Ala-III contacts the γ-phosphate of  
rNTP through a water molecule (Figure 11A). Therefore, motif  III is optimally 
positioned to coordinate the conformational reorganisation of  the helicase core 
in response to rNTP binding.
Actually, structural studies of  DExD/H-box proteins have revealed the 
existence of  a vast network of  non-covalent interactions between the various 
conserved helicase motifs that may convey the nucleotide-binding state to 
the RNA-binding motifs and contribute thereby to RNA unwinding (28). For 
instance, in DEAD-box proteins, the rNTP-binding motif  VI contacts the 
RNA-binding motif  IV through van der Waals and cation-π interactions between 
the side chains of  the conserved Phe-IV and Arg
1
-VI residues (161). Likewise, 
these two residues are highly conserved among DEAH-box proteins (Figures 2A 
and 9). In the reported two structures of  Prp43, Phe-IV and Arg
1
-VI residues 
are properly positioned to form energetically significant cation-π interactions 
(−2.49 ± 0.08 kcal∙mol−1; Figure 11B) as predicted by CaPTURE (162). Furthermore, 
as for DEAD-box proteins, mutations of  either Phe-IV or Arg
1
-VI residues 
in DEAH-box proteins entailed a loss-of-function phenotype in vivo and 
in vitro (Table II and references therein). As Phe-IV mutants are still ATPase-
proficient but failed to unwind dsRNA (141), Phe-IV along with Arg
1
-VI may 
couple rNTP binding and hydrolysis to a mechanical step that promotes duplex 
A
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Figure 11 | Inter-motif interaction network 
around the rNTP binding site. (A) Close-
up view of the NTP binding and hydrolysis 
site of the dengue virus DENV NS3 helicase 
(2JLV). In the closed conformation state, motif 
III (orange) is optimally positionned to bridge 
helicase motif II (red) in the RecA1 domain 
with motif VI (light blue) in the RecA2 domain. 
(B) Close-up representation of the inter-
motif interaction between the nucleic acid 
binding motif IV and the rNTP binding motif 
VI in Prp43. Motifs IV (green) and VI (blue) 
interact through van der Waals and cation-π 
interactions through the side chains of 
Phe-309 (motif IV) and Arg-424 (motif VI). The 
mesh around residues Phe-309 and Arg-424 
depicts the electron density map. In motif IV, 
amino acids that may form direct contacts with 
the translocating nucleic acid (Thr-311 and 
Glu-313) are depicted as sticks.
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unwinding. Similarly, (Ile/Leu)
2
-V and Thr
3
-V have also been proposed to link 
rNTP hydrolysis to the RNA cofactor (118,141). Motif  V is unusual with regard 
to the other helicase motifs, because it is the only motif  that interacts with both 
nucleic acid and ATP (27,122,129). Although Prp22 and Prp43 proteins with 
mutations in (Ile/Leu)
2
-V and Thr
3
-V residues are still capable to bind RNA and 
to hydrolyse ATP, they failed to catalyse RNA unwinding and mRNA release 
from the spliceosome.
Translocation and unwinding mechanism
Almost all DEAH-box proteins tested in vitro unwind nucleic acid structures 
with a 3′-to-5′ polarity (Table III and references therein). However, considering the 
relative paucity of  experimental studies, the molecular details of  the translocation 
and unwinding mechanisms for DEAH-box proteins remain purely speculative. 
Considering the structural resemblance between Prp43 and Hel308 helicases, 
Walbott et al. (113) proposed a mechanism for DEAH-box protein translocation 
and unwinding based on Hel308 model (29). It was suggested that rNTP binding 
entails the closure of  the inter-domain cleft in the helicase core resulting in a 
3′-to-5′ translocation of  the ssRNA overhang across the RecA1 domain by one 
nucleotide. This conformational transition is assumed to cause the displacement 
of  the so-called ‘ratchet helix’ in the HA region and pull the ssRNA across the 
RecA1 domain. The RecA2 domain is supposed to regain its initial state upon 
rNTP hydrolysis and/or phosphate release. This would permit the antiparallel 
β-hairpin from RecA2 domain to disrupt one base-pair from the dsRNA 
structure (Figure 12). Actually, this model of  translocation is reminiscent of  the 
Brownian motor mechanism put forward to explain the 3′-to-5′ translocation 
and nucleic acid unwinding by HCV NS3 helicase (163). According to this model, 
the helicase alternates between tight (ATP-free, open conformation) and weak 
(ATP-bound, closed conformation) RNA binding conformational states as a 
result of  its ATPase activity. In the ATP-bound conformation, the helicase form 
fewer contacts with the ssRNA and could potentially slide either upstream or 
downstream of  its current position. The net unidirectional translocation follows 
from the presence of  residues which function as a ratchet and prevent the 
helicase to slide backward (122).
Finally, it is currently impossible to predict whether RNA unwinding 
by DEAH-box proteins resort to a passive or an active mechanism. Recent 
structural work on HCV NS3 helicase indicates that the Brownian motor model 
could be compatible with a passive unwinding mechanism (164). According 
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Figure 12 | Model for the translocation and unwinding mechanism by DEAH-box proteins.  In the open (NTP-free) conformation state, the helicase 
is supposed to bind avidly to the translocating ssRNA sequence.  The closure of the inter-domain cleft between the two RecA domains occurs upon 
cooparative binding of NTP and RNA. This conformational transition is assumed to be accompanied by a translational motion of the ratchet helix in the HA 
region. The ratchet helix functions as a hook and drags the ssRNA across the RecA1 domain.  NTP hydrolysis and/or phosphate release may allow the 
RecA2 domain to get back to its inital state. During this last step, the protruding β-hairpin from RecA2 domain may work as a wedge that passively separates 
the two complementary strands by disrupting base stacking interactions.
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to such a model, nucleic acid strand separation would simply result from the 
directional translocation of  the helicase. Considering the structural resemblance 
between NS3 and the archaeal Hel308 helicase, it was hypotesised that the 
protruding antiparallel β-hairpin in the RecA2 domain may function as a 
wedge to physically separates the dsRNA substrate (165). However, one cannot 
exclude the possibility that NS3-related and DEAH-box proteins resort to a 
more active unwinding mechanism. As it stands, there is a clear need of  more 
structural and functional studies in order to get a better understanding of  the 
mechanism whereby DEAH-box proteins couple rNTP-hydrolysis to directional 
translocation and RNA unwinding.
Table III | Nucleotide specificity, helicase polarity and nucleic acid substrate characteristics of 
some characterised DEAH-box RNA helicases. rNTP, unspecific rNTPase activity; dNTP, unspe-
cific dNTPase activity; ND, not determined.
Protein rNTPase dNTPase Helicase	activity Polarity
RNA	stem	
substrate Ref.
Prp2 rNTP ND ND ND ND (107)
Prp16 rNTP dNTP Yes 3′ → 5′ 18 nt dsRNA (96,166)
Prp22 rNTP dNTP Yes 3′ → 5′ 29-40 nt dsRNA (48,131,141)
Prp43 rNTP dNTP Yes Bidirectional? 30 nt dsRNA (118)
MLE rNTP ND Yes 3′ → 5′ 40 nt dsRNA (57,148)
RHA rNTP ND Yes 3′ → 5′ 29 nt dsRNA (132)
DHX29 rNTP ND Poor ND 10 nt dsRNA (83)
CG9323 ND ND Yes ND 5 nt G4-RNA (88)
RHAU rNTP dNTP Yes 3′ → 5′ 5 nt G4-RNA (89)
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Guanine-quadruplex nucleic acid structures
In cells, double-stranded nucleic acid is the most common and widespread 
form of  substrate for helicases. Nonetheless, single strands of  nucleic acids can 
also embrace a multitude of  non-canonical and stable secondary structures that 
also need to be resolved (169-171). Notably, DNA and RNA sequences containing 
tandem repeats of  guanine tracts can form G-quadruplexes (G4) motifs, a 
thermodynamically stable four-stranded helical arrangement (for reviews, see 
ref. 172,173). The building block of  G4 structures is the G-quartet (aka G-tetrad), 
a square-planar assembly of  four guanines held together by Hoogsteen hydrogen 
bonding (Figure 13A and B). G4 structures follow from the consecutive π-stacking 
of  two or more G-quartets (Figure 13C) and are further stabilised by alkali metal 
cations such as Na+ or K+ that position along the helix axis and coordinate the 
O6 keto oxygens of  the tetrad-forming guanines (Figure 13B and C; ref. 174,175). G4 
scaffolds are extremely polymorphic regarding the relative orientation of  strands 
(parallel, antiparallel or mixed configurations), the glycosidic conformation of  
guanine (syn or anti), as well as for the length, sequences and conformations of  
the loops connecting the G-tracts. In addition, in vitro, G4 can follow from the 
assembly of  one (intramolecular G4) or more (bi- or tetramolecular-G4) nucleic 
acid strands (Figure 13E).
Historical aspect
The propensity of  GMP or guanine-rich sequence of  nucleic acids to 
self-assemble into G4 in vitro has now been recognised for over 50 years (176). 
As early as 1910, concentrated solution of  guanylic acid were reported to be 
extremely viscous and, if  cooled, to form a clear gel (177). The observation that 
guanosine 5′-monophosphate (GMP) forms helical aggregates with four units 
per helical step dates back to the pioneering work in the 1960s by Gellert and 
Davies (Figure 13B; ref. 167). Such an arrangement of  guanines was proposed as 
an explanation for the remarkable stability of  macrostructures resulting from 
the assembly of  tri- and tetranucleotides of  deoxyriboguanylic acid observed 
in the course of  the same year by Ralph and co-workers (Figure 13D; ref. 168). 
Nevertheless, because of  the lack of  evidence that such structures really exist 
in vivo, G4 structures were considered for more than two decades as a structural 
curiosity without relevance for living organisms. In the late 1980s and early 1990s, 
nucleic acid was rediscovered to adopt a variety of  atypical structures in addition 
to the canonical Watson-Crick conformation (178,179). This sudden increase of  
interest in these singular structures resulted from the discovery that guanine-
rich sequences from a variety of  functional genomic regions such as telomeres 
or immunoglobulin class switches could adopt G4 conformations under near 
physiological conditions (179-183) along with the finding that formation of  G4 
telomeric structures hindered the activity of  telomerase in vitro (184).
Evidence for the existence of G4 nucleic acid structures in vivo 
While G4 structures have been extensively investigated in vitro, thus far, 
direct experimental demonstration of  their existence in vivo is sorely lacking. 
Nevertheless, a large number of  observations provide circumstantial evidence 
for the existence and the physiological relevance of  G4 structures in cells. 
Firstly, a large number of  biochemical and biophysical studies have shown in 
vitro that stable G4 structures can form spontaneously from G-rich regions 
of  single-stranded nucleic acid under near physiological conditions (173,185). 
Secondly, genome-wide computational surveys showed that the incidence of  
potential intramolecular G4-forming sequences (PQS) in the human genome 
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Figure 13 | Guanine-quadruplex nucleic acid structures. (A) Molecular diagram of the GMP unit in the anti-glycosidic conformation. Interconversion 
between the anti- and syn-conformations arises upon rotation of the base around the glycosidic bond. In the G-quartet motif, each guanine unit serves as 
both donor and acceptor of two hydrogen bonds (Hoogsteen bondings). (B) A colourised version of the original representation of the G-quartet motif as 
proposed by Davies and colleagues in 1962 (167). The G-quartet consists of a cyclic and planar array of four guanine bases linked by Hoogsteen hydrogen 
bonding (cyan dashes). In 1978, Miles and Fraser suggested that G-quadruplex structures could be further stabilised by axial ions. The monovalent or 
divalent cations (M+) reside between two successive G-quartets and each ion coordinates (violet dashes) eight O6 keto oxygens. (C) Crystal structure of 
the potassium-containing antiparallel bimolecular G4 scaffold formed from the Oxytricha nova telomeric d(GGGTTTTGGG) sequence. The two diagonal 
d(TTTT) connecting loops are omitted for clarity. (D) Thermodynamic stability analysis of DNA macrostructures resulting from the assembly of tetra-
deoxyribunucleotide d(GGGG) sequences by Ralph and colleagues in 1962 (168). (E) A non-exhaustive schematic representation of the structural diversity 
for G4 scaffolds. –, tetramolecular G4; &, bimolecular G4; –, intramolecular G4; ,&, all-parallel strand orientation.
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is about a third lower than would be expected by chance, suggesting that they 
were subjected to natural selection over time (186,187). Even so, these studies 
still identified more than 300'000 PQS within the human genome (186,188) and 
revealed a higher prevalence of  these sequences in functional genomic regions 
such as telomeres (182,183), promoters (187,189), untranslated regions (UTRs, 
ref. 190,191), and first introns (192). Taken together, these observations show that 
PQS are not randomly distributed in the genome and that they may participate in 
regulating various nucleic acid processes, such as telomere homeostasis (193), the 
control of  gene expression (194) or the initiation of  DNA replication (195). In 
support of  these observations, several recent findings concur with the existence 
of  G4 structures in cells. Indeed, both a G4-specific dye and antibodies raised 
against telomeric G4-DNA specifically stained telomeres in human and ciliate 
cells, respectively (196-198). In addition, several PQS in promoters were shown to 
form stable intramolecular G4 structures in vitro and to affect gene expression 
in vivo (199,200). A possible contribution of  G4 to regulating promoter activity 
was indicated by impairment of  the transcriptional activity of  several genes by 
G4-stabilising ligands (200) or a single-chain antibody specific for intramolecular 
G4-DNA (201), in a manner correlating with the occurrence of  predicted G4 
structures in the control regions (202).
Like DNA, RNA can also form G4 structures. Although, to date, G4-
RNAs have not attracted as much attention as their DNA counterparts, the 
formation of  G4 structures in RNA is emerging as a plausible regulatory factor 
in gene expression. RNA is more prone than DNA to form G4 structures due 
to its single-strandedness, and G4-RNAs have also proved to be generally more 
stable than their cognate G4-DNA under near physiological conditions (203-
206). Bioinformatics analyses of  human 5′-UTR sequences revealed potential 
G4-forming motifs in as many as 3'000 different RNAs (190,207). Moreover, the 
formation of  G4 structures in 5′-UTR was shown to impede translation initia-
tion (190,208-210). Given that PQS have also been identified within IRES (211,212) 
or near splicing (213-216) and polyadenylation sites (217-219), G4 formation 
may as well affect RNA metabolism at several different stages. Furthermore, 
formation of  parallel G4-RNA structures has also been reported for telomeric 
RNA repeats (TERRA, ref. 220,221-223) and for the human telomerase template 
RNA (TERC/hTR, ref. 224), suggesting that G4-RNA may also occur in non-
coding RNAs.
G4 binding and unwinding proteins
Although evidence is accumulating for the existence of  G4 structures in 
cells, it is still unclear whether regulatory functions can be imputed to these 
structures or whether they should merely be regarded as non-functional 
misfolded conformations of  nucleic acids. Nevertheless, G4 structure formation 
can constitute an obstacle for gene expression or DNA replication and, hence, 
be a possible source of  nuisance for the cells if  not resolved (239-242). However 
because of  their elevated stability, in vivo conversion of  G4 structures to single-
stranded nucleic acid requires specialised proteins with G4 destabilising or 
unwinding activities. Among these proteins, several DNA helicases such as the 
RecQ family proteins BLM (227,243), WRN (226) and Sgs1 (244), the Rad3-like 
family proteins FANCJ/DOG-1 (228) and DDX11 (aka ChlR1, ref. 230), as well 
as the SF1 helicases Pif1 (Pif1-like helicase, ref. 233,245) and Dna2 (Upf1-like 
helicase, ref. 246) have been shown to manifest ATP-dependent G4 resolving 
activity in vitro (Table IV). Consistent with these observations, several functional 
studies underscored the fundamental role played by these helicases in the 
maintenance of  G-rich genomic regions (22,23,228,239,240,247-249). Notably, several 
inherited human diseases, characterised by genomic instability, high cancer 
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predispositions or premature aging are caused by loss-of-function mutations in 
RecQ (Werner and Bloom syndromes), FANCJ (Fanconi anemia) and DDX11 
(Warsaw breakage syndrome) helicases (231,250-253).
In the last few years, a growing number of  proteins have also been 
discovered to interact with various synthetic and bona fide G4-RNA 
structures (Table V). Among these G4-RNA binding proteins, two DEAH-
box RNA helicases (RHA/DHX9 and RHAU/DHX36) have been shown to 
unwind synthetic tetramolecular G4-RNA structures in vitro (89,238). However 
little is known regarding the in vivo substrate of  these helicases as their actual 
roles as G4 resolving enzymes in cells. Actually, the only reliable evidence of  
proteins functioning as potential regulators of  G4 structures in RNA biology 
emanate from studies of  the fragile X mental retardation proteins FMRP and 
FMR2P. FMRP is an RNA-binding protein showing high affinity for G4-RNA 
structures in vitro and preferentially binding to RNAs bearing PQS in vivo (254). 
FMRP was proposed to function as a translational repressor through its 
interaction with G4 structures in RNA. Protein expression of  several FMRP 
target RNAs was notably found to be inversely correlated with levels of  FMRP 
in cells (255-258). Alternatively, FMRP as well as the functionally related FMR2P 
Table V | Mammalian G4-RNA binding proteins and their identified G4-containing target RNAs. ND, not determined. Adapted 
from Millevoi et al. (260).
Protein Description G4-RNA	related	activity In vivo	G4-RNA	targets Ref.
AFF4 AF4/FMR2 family member G4 binding protein ND (261)
CBF-A hnRNP family member G4 stabilising protein FMR1 5′-UTR (CGG)n repeats (262)
EWS Ewing sarcoma breakpoint region 1 G4 binding protein ND (263)
FMRP Fragile X mental retardation protein G4 stabilising protein FMR1 exon 15, TCF19, MAP1B (254)
FMR2P AF4/FMR2 family member G4 binding protein FMR1 exon 15 (259)
hnRNP A2 hnRNP family member G4 destabilising FMR1 5′-UTR (CGG)n repeats (262)
hnRNP D0 hnRNP family member G4 binding protein ND (264)
hnRNP H/F hnRNP family member G4 binding protein TP53 3′-UTR (219)
LAF-4 AF4/FMR2 family member G4 binding protein ND (261)
MSP58 58-kDa microspherule protein G4 binding protein ND (265)
RHA DEAH-box family helicase G4 unwinding ND (238)
RHAU DEAH-box family helicase G4 unwinding ND (89)
TRF2 Shelterin complex component G4 binding protein TERRA (266)
XRN1 5′ → 3′ exoribonuclease G4 ribonuclease ND (267)
Table IV | G4 unwinding polarity, G4 substrate specificity and loss of function phenotype for mammalian G4 helicases. 
ND, not determined. Adapted from Wu and Brosh (225).
Protein Polarity G4	substrate Loss	of	function	phenotype Ref.
WRN 3′ → 5′ G4-DNA Werner syndrome: premature aging, genomic instability. (22,226)
BLM 3′ → 5′ G4-DNA Bloom syndrom: cancer, elevated sister-chromatid exchanges, genomic instability. (22,227)
FANCJ 5′ → 3′ G4-DNA Fanconi anemia, breast cancer, defective interstrand cross-link repair and slow S phase progression.
(23,228,
229)
DDX11 5′ → 3′ G4-DNA Warsaw breakage syndrome: abnormal sister chromatid cohesion, chromosomal breakages. (230-232)
Pif1 5′ → 3′ G4-DNA Possible telomere defects. (233,234)
Dna2 5′ → 3′ G4-DNA Cell-cycle delay and aberrant cell division, genomic and mitochon-drial DNA instability. (235,236)
RHA ND G4-RNA, G4-DNA Early embryonic (E7.0) lethality for Rha−/− knockout mice. (237,238)
RHAU 3′ → 5′ G4-RNA, G4-DNA Early embryonic (E7.5) lethality for Rhau−/− knockout mice. (33,89,90)
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were both shown to act as a splicing regulator of  various genes harbouring G4 
motifs close to alternative splicing sites (215,259). As for the majority of  recently 
identified G4-RNA binding proteins, there is still a relative lack of  functional 
studies demonstrating causal links between their in vitro G4-related biochemical 
properties and known biological processes. However, this situation will no doubt 
change considering the abundance of  PQS in RNAs and the recent gain of  
interest in this research field.
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The RNA helicase RHAU
RHAU (alias DHX36 or G4R1) is a human RNA helicase of  the DEAH-
box family. RHAU acronym stands for ‘RNA helicase associated with AU-
rich element’ reflecting the fact the protein was initially identified as a factor 
associated with the 3′-UTR AU-rich element (ARE) of  the urokinase-type 
plasminogen activator (uPA) mRNA (32).
Structural aspects
RHAU is a 1008 amino acid-long modular protein (Figure 14). It consists of  
a ~440-amino-acid helicase core comprising all signature motifs of  the DEAH-
box family of  helicases as well as N- and C-terminal flanking regions of  about 
180 and 380 amino acids, respectively. Like all the DEAH-box proteins, RHAU 
harbour a HA domain adjacent to the helicase core region that occupies 75 % 
of  the C-terminal region. Based on comparative sequence analysis, RHAU has 
clear orthologues in almost all species of  the animal kingdom ranging from 
choanoflagellates to humans (Supplementary Figure 5). A multiple sequence alignment 
between eight of  these orthologues showed the helicase core (aa. 183–625) 
together with the C-terminal region (aa. 626–1008) of  RHAU to be evolutionary 
conserved (Figure 14). In contrast, sequence in the N-terminal region (aa. 1–182) 
show little similarity with the exception of  a cluster of  13 highly conserved 
amino acids, termed RSM (RHAU specific motif, aa. 54–66; ref. 268). The RSM 
domain does not share any similarity with any known functional sequence 
elements and proved to be highly specific to RHAU, hence its name. Vertebrate 
forms of  RHAU harbour also a ~40 amino acid-long low-complexity Gly-rich 
domain immediately upstream of  the RSM domain.
Subcellular localisation
RHAU is a nucleocytoplasmic shuttling protein found predominantly in the 
nucleus and to a lesser extent in the cytoplasm (32,269). Further characterisation 
revealed that RHAU does not localise uniformly in the nucleus, but accumulates 
in subnuclear structures, termed nuclear speckles, that are enriched in pre-
mRNA splicing factors (269). The molecular bases of  the translocation of  
RHAU to the nucleus remain obscure, insofar as it does not harbour an apparent 
nuclear localisation signal and ATPase-deficient forms of  RHAU localise 
exclusively in the cytoplasm (268,269). The nuclear exclusion of  the ATPase-
deficient forms of  RHAU is not a consequence of  protein misfolding since 
RHAU
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Figure 14 | Domain architecture of human RHAU. Schematic representation of the domain organisation and amino acid conservation of the 1008-amino 
acid RHAU protein. The conserved ATPase/helicase motifs I–VI of the DEAH-box family are indicated within the helicase core region (HCR) by vertical bars. 
The HCR is flanked by the N-terminal (NTR) and C-terminal (CTR) regions of 182 aa. and 383 aa., respectively. The N-terminal Gly-rich (aa. 10–51) and 
RSM (RHAU-specific motif, aa. 54–66) domains are indicated. Each residue of human RHAU sequence is represented with a colour code that denotes its 
degree of conservation amongst eight orthologous sequences (Supplementary Figure 5). Similarity is shown in red for 100 %, yellow for 99–80 % and blue 
for 79–60 %. Average values of identity (Id.) and similarity (Sim.) for NTR, HCR and CTR regions are indicated.
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ATPase deficient forms of  RHAU are stable and still bind to RNA avidly (268). 
Moreover, ATPase deficient forms of  RHAU are not trapped in the cytoplasm 
by strong and irreversible interaction with RNA since a double mutated form of  
RHAU showing markedly reduced RNA binding and ATPase activity remained 
essentially in the cytoplasm (268). Therefore, the translocation of  RHAU to 
the nucleus is probably regulated by its ATPase activity. Likewise, comparable 
ATPase-dependent nuclear localisation was already reported for the Xenopus 
laevis DEAD-box helicase DDX3 (270).
In addition to its nuclear localisation, RHAU was recently shown to 
accumulate in stress granules upon translational arrest induced by various 
environmental stresses (268). Stress granules are temporary sites of  accumulation 
of  stress-induced stalled translation initiation RNP complexes (271,272). The 
recruitment of  RHAU to stress granules is mediated by RNA interaction, and 
deletion experiments revealed that a region of  the first 105 amino acids including 
Gly-rich and RSM domains was critical for RNA binding and relocalisation of  
RHAU to stress granules (268). Importantly this 105 amino acid-long region alone 
had the ability in vivo to bind RNA and relocalise to stress granules. Furthermore, 
the ATPase activity of  RHAU was shown to play a determining role in regulating 
in vivo RNA interaction and the retention of  RHAU in stress granules.
Role of RHAU in uPA mRNA decay
RHAU was initially identified as an ARE-associated factor of  uPA 
mRNA (32). Further characterisation of  RHAU revealed that a cytoplasmic 
isoform that lacks a 14 amino acid stretch between helicase motifs IV and V 
promoted mRNA deadenylation and decay by recruiting the poly(A) ribonuclease 
PARN and the exosome to uPA transcripts. In agreement with other known 
DExD/H-box RNA helicases, the RHAU-mediated decay of  AREuPA-containing 
transcripts was shown to be dependent on its ATPase activity.
However, despite the apparent role of  RHAU in regulating uPA mRNA 
stability, further investigations showed that its influence on gene expression 
was essentially not linked with the regulation of  mRNA decay process. Indeed, 
analysis of  global gene expression at different time points revealed that only 
one percent of  the mRNAs manifesting differential expression levels upon 
RHAU knockdown showed corresponding variations in mRNA stability (269). 
Therefore, RHAU is not really considered as a common regulator of  ARE-
mediated decay process.
RHAU is a G4 resolvase enzyme with 3′-to-5′ polarity
At about the same time of  the finding RHAU facilitates deadenylation and 
decay of  uPA mRNA, RHAU was discovered to harbour in vitro ATP-dependant 
G4 resolvase activity on tetramolecular G4 nucleic substrates (Figure 15A; ref. 33,89). 
Like other DEAH-box proteins, RHAU is a unidirectional 3′-to-5′ helicase and 
requires a minimal 9-nt 3′-overhang for efficient unwinding activity (Figure 15B 
and C). RHAU displays a clear preference for G4 substrates over classical double-
stranded nucleic acids (ref. 33,89 and Tran, H., unpublished data) and binds 
various types of  G4 structures with sub-nanomolar affinity (Figure 15D; ref. 89). 
Consistent with these biochemical observations, RHAU was also identified as the 
major source of  tetramolecular RNA-resolving activity in HeLa cell lysates (89). 
Despite these advances, little is known regarding the fundamental mechanism by 
which RHAU recognises and resolves G4 structures. Besides, there is a clear lack 
of  information on the RNAs that may serve as physiologically relevant targets 
for RHAU and about its role as a G4 resolvase in cells.
Figure 15 | G4-RNA unwinding and binding 
activities of RHAU. (A) 3'-tailed G4-RNA 
substrate unwinding by RHAU. (B) 5'-tailed 
G4-RNA substrate unwinding by RHAU. 
(C) Analysis of the dependency of the 
3'-overhang length on the G4-RNA substrate 
unwinding activity of RHAU (Vaughn, 
J.P. and Akman, S.A., unpublished data). 
(D) Tetramolecular G4-RNA binding by RHAU.
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Murine RHAU is essential for embryogenesis and 
haematopoiesis
According to BioGPS database (273-275), RHAU is ubiquitously expressed 
in all human and mouse tissues (Supplementary Figure 6). Relatively high mRNA 
expression levels are detectable in human haematopoietic cells and mouse brain 
tissues. Besides, several standard cell lines like HeLa, HEK293, PC-3 and mouse 
undifferentiated embryonic stem cells (CCE) express high levels of  RHAU. 
Despite its abundance, down-regulation of  RHAU by RNA interference (RNAi) 
did not affect cell growth and viability of  many common cell lines, suggesting 
that RHAU is not an essential protein for cell proliferation. However, to clarify 
the requirement of  RHAU protein in vivo, mouse models were developed 
in which RHAU could be knocked-out (90). As mentioned earlier, RHAU is 
evolutionary highly conserved and the murine orthologue is nearly identical to 
the human form. Both proteins display 91 % identity and 95 % similarity and 
differ only by seven amino acids in length (Supplementary Figure 7). Thus, the mouse 
form of  RHAU is expected to possess the same biochemical properties than 
its human orthologue. A mouse model in which RHAU can be knocked-out 
constitutes therefore an excellent tool to investigate in vivo the biological role of  
this protein.
Homozygosity for the null mutant allele of  RHAU led to early embryonic 
lethality with no effect on the implantation efficiency of  the embryo (90). 
Knockout embryos degenerated around seven days post-fertilisation (Figure 16A), 
revealing the requirement of  RHAU for the normal progression of  gastrulation. 
Unfortunately, molecular basis of  this requirement has not been further 
explored. However, similar critical roles of  RNA helicases during mammalian 
embryogenesis have already been reported for the DEAD-box protein 
p68 (alias DDX5) and the DEAH-box RNA helicase A (237,276). Furthermore, 
severe developmental defects have also been observed in C. elegans, Drosophila 
and zebrafish as a result of  abnormal expression of  many DEAH-box 
proteins (53,87,98,277-279).
Considering the high expression levels of  RHAU in several lineages of  
the haematopoietic system (Supplementary Figure 6), a second model of  mouse 
was conjointly developed in which RHAU could be specifically knocked-
out in haematopoietic cells (90). Unlike conventional RHAU knockout mice, 
conditional RHAU knockout animals were viable, although manifesting a 
severe anaemia (Figure 16B). Further characterisation revealed that conditional 
knockout mice developed splenomegaly and hepatomegaly (Figure 16C), a phe-
notype frequently related to anaemia (280). Actually, depletion of  RHAU in 
the haematopoietic system did not exclusively impinge on the development 
of  erythrocytes, but impacted on the entire haematopoietic system (Figure 16D) 
pointing out the functional relevance of  RHAU during haematopoiesis. Taken 
together, these data demonstrate that RHAU is an essential gene in the mouse.
RHAU senses microbial DNA in human plasmacytoid dendritic 
cells
A recent study in plasmacytoid dendritic cells (pDCs) has shown that 
RHAU as well as RNA helicase A take part in the cytoplasmic recognition of  
CpG motifs (unmethylated CG dinucleotides present in viral DNA, ref. 281). 
CpG motifs are specifically recognised by Toll-like receptor 9 (TLR9) that leads 
to the production of  anti-viral cytokines type I interferons (IFN-α and IFN-β) 
through the signal transducer MyD88 protein. However, recent reports suggest 
the presence of  a TLR9-independent recognition of  viral DNA that leads to 
the production of  IFN-α by pDCs (282-284). Interestingly, Kim and co-workers 
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showed that RHAU specifically recognises class A CpGs (CpG-A) and induces 
the expression of  IFN-α through its interaction with MyD88. Furthermore, 
downregulation of  RHAU entailed a 50 % reduction of  IFN-α secretion by 
human pDC cell line in response to Herpes simplex virus infection. Thus, these 
observations led to the proposal that RHAU is implicated in the detection of  
viral replication through the recognition of  CpG motifs. On the basis of  this 
study, RHAU emerges as a novel component of  the innate immune system in 
humans. Similar critical role of  RNA helicases dedicated to sensing microbial 
nucleic acid have already been reported for several members (IFIH1/MDA5, 
DHX58/LGP2, DDX58/RIG-I and DICER1) of  the RIG-I-like family of  
helicases (ref. 285,286; Figure 1).
Figure 16 | Requirement of RHAU for early embryogenesis and haematopoiesis in mouse. (A) Homozygous RHAU knockout (RHAU−/−) embryos 
degenerate before 7.5 days post-fertilisation (dpf). Heterozygous RHAU knockout (RHAU+/−) embryos served as a control. Scale bar, 1 mM. (B) Anemic 
phenotype of newborn mice with conditional RHAU knockout (RHAUfl/fl:vav-iCre) in the haematopoietic system. RHAUfl/fl mice served as a control. (C)  Livers, 
spleens, thymus and kidneys of conditional RHAU knockout (RHAUfl/fl:vav-iCre) and control (RHAUfl/fl) mice. Scale bar, 1 cm. (D) Conceptual schematic 
diagram of blood cell development. The symbols on the right of cell type names denote the relative abundance of each cell type in conditional RHAU 
knockout (RHAUfl/fl:vav-iCre) animals with respect to control (RHAUfl/fl) mice. −, reduced cell number; ≈, normal cell number; +, increased cell number. HSC, 
haematopoietic stem cell; CMP, common myeloid progenitor; CLP, common lymphoid progenitor; NK-cell, natural killer cell. Adapted from Lai et al. (90).
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Methods
Chapter 2
Role of the amino terminal RSM domain in 
the recognition and resolution of guanine 
quadruplex-RNAs by RHAU
Plasmid constructs, cloning and mutagenesis
The plasmid used for the expression of  GST-RHAU(1–200) protein 
in bacteria and the baculoviral expression vector used for the expression 
of  GST-RHAU have been described previously (32,268). Plasmids for the 
expression of  C-terminal FLAG-tagged recombinant RHAU proteins: 
RHAU-FLAG, RHAU(∆Gly)-FLAG, RHAU(∆Gly–RSM)-FLAG, 
RHAU(DAIH)-FLAG and RHAU(1–105)-FLAG have been described 
previously (268). CG9323 cDNA was obtained from the Drosophila 
Genomics Resource Center (Bloomington, IN) and was subcloned by PCR 
amplification into pIRES.EGFP-FLAG-N1 (268). For the RHAU(∆RSM)-
FLAG plasmid, the RSM (aa. 54–66) excision was performed using a 
standard overlapping PCR method (287,288). The resulting PCR product 
was subcloned into pIRES.EGFP-FLAG-N1. For RHAU(RSM-
mutx)-FLAG and CG9323(RSM-mut), the RSM coding sequence was 
mutagenised using a variation of  the classical QuikChange® (Stratagene) 
site-directed mutagenesis PCR method (289). Construction of  all these 
plasmids was confirmed by sequencing. Sequences of  oligonucleotides 
used in this work and detailed descriptions of  the plasmid constructions 
are available upon request.
Cell culture
Human embryonic kidney HEK293T cells were maintained in 
Dulbecco’s modified Eagle’s medium supplemented with 10 % fetal calf  
serum (FCS) and 2 mM l-glutamine at 37 °C in a humidified 5 % CO
2
 
incubator. Spodoptera frugiperda Sf9 cells were maintained in Grace’s insect 
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cells medium (Invitrogen) supplemented with 10 % FCS, 4.11 mM l-glutamine, 
3.33 g∙l−1 lactalbumin hydrolysate and 3.33 g∙l−1 yeastolate at 27 °C.
Expression and purification of recombinant RHAU proteins
GST-RHAU(1–200) protein was expressed in E. coli strain BL21-
CodonPlus(DE3)-RIPL (Stratagene). Cultures were inoculated from a single 
colony of  freshly transformed cells and maintained in logarithmic growth 
at 37 °C in 2× YT medium supplemented with ampicillin (0.1 mg∙ml−1) to 
a final volume of  1 l. When the OD
600
 reached 0.3, the temperature was 
adjusted to 25 °C and cells were cultured to an OD
600
 of  0.6. Isopropyl β-d-
thiogalactopyranoside was added to 0.4 mM and the cultures were incubated for 
12 h at 25 °C with constant shaking. Cells were harvested by centrifugation and 
the pellets stored at −80 °C. All subsequent operations were performed at 4 °C. 
The cell pellets were resuspended in 50 ml of  lysis buffer [1× PBS supplemented 
with NaCl to a final concentration of  300 mM, 1 % Triton X-100, 5 mM EDTA, 
5 mM DTT, 1× protease inhibitor cocktail (Complete EDTA-free, Roche)]. 
Lysozyme was added to 1 mg∙ml−1 and the suspensions were lysed for 30 min, 
followed by sonication (3× 10 s) to reduce viscosity. Insoluble material was 
removed by centrifugation (39'000g, 30 min, 4 °C) in a Beckman JA-17 rotor 
and the resulting supernatant was filtered through a 0.22-μm Express PLUS 
Membrane (Millipore). The resulting filtrate was applied to a 1-ml GSTrap 
4B column (GE Healthcare). The column was washed with 30 ml washing 
buffer (1× PBS supplemented with NaCl to a final concentration of  300 mM, 
5 mM DTT) and the recombinant protein was recovered in elution buffer 
[50 mM Tris-HCl (pH 8.0 at 4 °C), 10 mM reduced glutathione, 5 mM DTT]. 
The fraction containing the recombinant protein were pooled and elution 
buffer was exchanged to storage buffer [20 mM HEPES-KOH (pH 7.7 at room 
temperature), 50 mM KCl, 0.01 % Nonidet P-40, 0.5 mM EDTA, 5 mM DTT, 
10 % glycerol, 2 mM AEBSF (4-(2-aminoethyl)-benzenesulfonyl fluoride 
hydrochloride)] by repeated concentration and dilution steps in Amicon Ultra-15 
centrifugal filters (Millipore). Recombinant proteins were stored at −80 °C. 
Purity of  protein preparations was assessed by SDS-PAGE (Supplementary Figure 8) 
and protein concentrations were determined photometrically at 280 nm using 
the calculated extinction coefficient ε = 71'905 M−1∙cm−1.
GST-RHAU protein was expressed in Sf9 cells according to the supplier’s 
instructions (PharMingen). Three days post-baculoviral infection, cells were 
harvested by centrifugation and the pellets were stored at −80 °C. All subsequent 
operations were performed at 4 °C. The cell pellets were resuspended in insect 
cell lysis buffer [10 mM Tris-HCl (pH 7.5 at 4 °C), 10 mM sodium phosphate, 
300 mM NaCl, 1 % Triton X-100, 10 mM sodium pyrophosphate, 10 % glycerol, 
5 mM EDTA, 5 mM DTT, 1× protease inhibitor cocktail (Complete EDTA-
free, Roche)] and lysed for 30 min. All subsequent purification steps were carried 
out as described above for the purification of  GST-RHAU(1–200) protein. 
Purity of  protein preparations was assessed by SDS-PAGE (Supplementary Figure 8) 
and protein concentrations were determined photometrically at 280 nm using 
the calculated extinction coefficient ε = 166'615 M−1∙cm−1.
All C-terminal FLAG-tagged recombinant RHAU and CG9323 
proteins [RHAU-FLAG, RHAU(∆Gly)-FLAG, RHAU(∆Gly–RSM)-FLAG, 
RHAU(∆RSM)-FLAG, RHAU(RSM-mutx)-FLAG, RHAU(DAIH)-FLAG, 
RHAU(1–105)-FLAG, CG9323-FLAG and CG9323(RSM-mut2)-FLAG] 
were transiently expressed in HEK293T. Transfections were performed with 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. 
Cells were harvested 24–36 h post-transfection, washed with ice-cold PBS 
and resuspended in lysis buffer (1× PBS supplemented with NaCl to a final 
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concentration of  600 mM, 1 % Nonidet P-40, 2 mM EDTA, 2 mM AEBSF, 
1× protease inhibitor cocktail) for 30 min. Cell lysates were sonicated (1× 10 s) 
to reduce the viscosity and insoluble material removed by centrifugation 
(39'000g, 20 min, 4 °C) in a Beckman JA-17 rotor. The soluble lysates were 
mixed for 5 h with 200 μl of  a 50 % slurry of  anti-FLAG M2-agarose affinity 
gel (Sigma) that had been equilibrated in lysis buffer. The resin was recovered by 
centrifugation, washed 3× with 1 ml of  lysis buffer follow by 3 washes with 1 ml 
of  IP-washing buffer [50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 0.1 % Nonidet 
P-40, 5 mM EDTA]. The bound proteins were eluted with 600 μl elution 
solution [0.1 mg∙ml−1 FLAG peptide, 10 mM Tris-HCl (pH 7.5), 150 mM NaCl] 
for 10 min at 37 °C and stored at −20 °C. Purity of  protein preparations 
was assessed by SDS-PAGE and protein concentrations were determined by 
Bradford assay with BSA as the standard.
Tetraplex G4-RNA preparation
Unlabelled and 5′-TAMRA-labelled 35-mer oligoribonucleotides 5′-A
15
–
G
5
–A
15
-3′ were used to form tetramolecular G4-RNA and are referred to 
hereafter as ‘rAGA’. rAGA were purchased from Dharmacon Research and 
were dissolved in RNase-free solution [100 mM KCl, 10 mM Tris-HCl (pH 7.5), 
1 mM EDTA] to a final concentration of  500 μM. To form tetramolecular 
quadruplex by annealing of  rAGA, the solution was aliquoted into PCR tubes 
and incubated in a PCR thermocycler at 98 °C for 10 min and then held at 
80 °C. EDTA was added immediately to a final concentration of  25 mM and 
the solution was allowed to cool slowly to room temperature. rAGA aliquots 
were pooled together and stored at 4 °C for 2–3 days. By this procedure, the 
conversion of  monomeric rAGA to a stable tetramolecular quadruplex form 
was almost complete as judged by native PAGE (Figure 17A and C). Circular 
dichroism analysis of  the purified, annealed rAGA oligomers revealed a typical 
spectrum of  a parallel G4 structure with positive and negative peaks at 263 nm 
and 245 nm, respectively (Figure 17B). The above prepared tetramolecular G4-
rAGA were stored at −20 °C.
Circular dichroism spectropolarimetry
Circular dichroism (CD) experiments were performed with an AVIV Model 
202 spectrophotometer equipped with a thermoelectrically controlled cell holder. 
G4-rAGA at a concentration of  1 μM were prepared in RNase-free solution 
[10 mM Tris-HCl (pH 7.5), 1 mM EDTA] supplemented with 50 mM KCl, 
NaCl or LiCl. Quartz cells with 1 cm path length were used for all experiments. 
CD spectra were recorded at 25 °C in the UV region (200–350 nm) with 1 nm 
increments and an averaging time of  2 s.
Thermodynamic analysis of the stability of tetramolecular G4-
rAGA structures
Preformed 5′-TAMRA-labelled tetramolecular G4-rAGA at a concentration 
of  100 nM were prepared in RNase-free solution [10 mM Tris-HCl (pH 7.5), 
1 mM EDTA] supplemented with 50 mM KCl, NaCl or LiCl. Tetramolecular G4-
rAGA structures were incubated for 5 min at various temperatures ranging from 
20 to 99 °C and were immediately subjected to separation by electrophoresis for 
3 h on a pre-electrophoresed 10 % polyacrylamide native gel (19:1 acrylamide:bis 
ratio) in 0.5× TBE at 25 °C. After electrophoresis, gels were scanned on a 
Typhoon 9210 Imager (GE Healthcare) and analysed with Multi Gauge software 
(Fuji). The fraction of  undenatured G4-rAGA was quantitated as the ratio of  
the signal from the tetramolecular form to the sum of  the tetramolecular and 
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the denatured ssRNA. The apparent temperature of  mid-transition (T
m
) was 
determined by representing the fraction of  undenatured G4-rAGA as a function 
of  the temperature. Reported T
m
 values are representative of  three independent 
experiments.
Electromobility shift assay and apparent Kd determination
Recombinant RHAU proteins at concentrations from 1 to 1000 nM were 
incubated with 100 pM 5′-32P-labelled G4-RNA in K-Res buffer [50 mM Tris-
acetate (pH 7.8), 100 mM KCl, 10 mM NaCl, 3 mM MgCl
2
, 70 mM glycine, 
10 % glycerol], supplemented with 10 mM EDTA and 0.2 U∙μl−1 SUPERase-In 
(Ambion) in a 15-μl reaction. The reactions were incubated at 37 °C for 30 min. 
RNA-protein complexes were resolved on a pre-electrophoresed 6 % poly-
acrylamide native gel (37.5:1 acrylamide:bis ratio) in 0.5× TBE at 4 °C for 90 min. 
After electrophoresis, gels were fixed for 1 h in 10 % isopropanol/7 % acetic 
acid. RNA-protein complexes were detected by Phosphor-Imaging, scanned on 
a Typhoon 9400 Imager (GE Healthcare) and analysed with ImageQuant TL 
software (Nonlinear Dynamics).
G4-RNA resolvase assay
Recombinant RHAU proteins at concentrations from 1 to 100 nM were 
incubated with 4 nM 5′-32P-labelled G4-RNA in K-Res buffer supplemented 
with 1 mM ATP and 0.2 U∙μl−1 SUPERase-In in a 15-μl reaction. Reactions 
were allowed to proceed at 30 °C for 30 min, stopped by transfer to ice and 
addition of  1:10 vol. of  10× loading buffer [33 mM Tris-HCl (pH 8.0), 
25 % (w∙v−1) Ficoll-400, 110 mM EDTA, 0.17 % SDS]. Reaction products 
were resolved on a pre-electrophoresed 10 % polyacrylamide native gel (19:1 
acrylamide:bis ratio) in 0.5× TBE at 4 °C for 90 min. After electrophoresis, 
gels were fixed for 1 h in 10 % isopropanol/7 % acetic acid and exposed to a 
Phosphor-Imaging screen.
ATPase assay
Recombinant RHAU proteins at concentrations from 25 to 200 nM 
were incubated with 1 μl [γ-32P]ATP (3'000 Ci∙mmol−1, 0.4 mCi∙ml−1) in 
ATPase assay buffer [50 mM Tris-HCl (pH 8.0), 100 mM KCl, 3 mM MgCl
2
, 
1 mM ATP, 1 mM DTT] supplemented with 0.4 U∙μl−1 RNasin (Promega) and 
1 μg∙μl−1 homopolymeric poly(U) RNA (Sigma) in a 20-μl reaction. Reactions 
were allowed to proceed at 37 °C for 15 min. The reactions were stopped by 
addition of  1 ml of  a 5 % (w∙v−1) suspension of  activated charcoal (Sigma) 
in 20 mM phosphoric acid. The samples were incubated on ice for 10 min 
and the charcoal containing the adsorbed unhydrolysed ATP was pelleted by 
centrifugation (21'000g, 15 min, 4 °C). The supernatants (containing free γ-32P
i
) 
were transferred to new tubes and the radioactivity was quantified by liquid 
scintillation counting (Cerenkov counts).
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RHAU binds an intramolecular G4 structure 
in TERC and associates with telomerase 
holoenzyme
Plasmid constructs, cloning and mutagenesis
The baculoviral expression vector employed for the expression of  GST-
RHAU and the plasmids used for the expression of  the C-terminal FLAG-tagged 
recombinant RHAU proteins RHAU-FLAG and RHAU(∆RSM)-FLAG were 
previously described (32,88,268). The pIRES.EGFP-myc-N1 vector expressing 
the C-terminal myc-tagged recombinant RHAU protein was derived from the 
previously described pIRES.EGFP-FLAG-N1/RHAU expression vector (268) 
by substituting the FLAG sequence with the myc epitope sequence. Human 
TERT cDNA (clone: IOH36343, mapped sequence: NM_198253) was obtained 
from ImaGenes GmbH (Berlin, Germany) and subcloned by PCR amplification 
into the pSL1-FLAG-N1 mammalian expression vector. The pSL1-FLAG-N1 
vector was derived from pEGFP-N1 (Clontech) by replacing the EGFP open 
reading frame with the FLAG epitope sequence. The human TERC genomic 
region was PCR-amplified from the genomic DNA of  HEK293T cells to yield 
a 2.1-kb fragment encompassing 1080 bp of  the TERC promoter, its coding 
sequence, and 553 bp of  the 3′ flanking genomic region. This fragment was 
blunt-cloned into pGEM-T Easy vector (Promega) at the HincII/EcoRV sites. 
The G4 motif  sequence of  TERC was mutagenised using a variation of  the 
classical QuikChange® (Stratagene) site-directed mutagenesis PCR method (289). 
To prepare templates for in vitro run-off  transcription, the T7 or SP6 phage 
promoters were inserted upstream of  the TERC coding sequence by PCR. The 
resulting PCR products were cloned into the pSL1-FLAG-N1 vector at the 
NheI/AgeI sites. Following linearization with NarI or AgeI, in vitro transcription 
of  these templates yielded the TERC(1–71 nt) and full-length TERC(1–
451 nt) RNA fragments, respectively. Constructions of  all these plasmids were 
confirmed by sequencing. Sequences of  oligonucleotides used in this work and 
detailed descriptions of  the plasmid constructs are available upon request.
Cell culture and transfection
Human cervical carcinoma HeLa and embryonic kidney HEK293T cell 
lines were maintained in Dulbecco’s modified Eagle’s medium supplemented 
with 10 % fetal calf  serum (FCS) and 2 mM l-glutamine at 37 °C in a humidified 
5 % CO
2
 incubator. Transient transfections were performed with Lipofectamine 
2000 (Invitrogen) according to the manufacturer’s instructions. Transfected 
cells were cultured for 24-36 h prior to testing for transgene expression. 
T-REx™-HeLa cell lines stably transfected with pTER-shRHAU or pTER-
shGFP were maintained as described previously (269). To induce and maintain 
short hairpin RNA (shRNA) expression, cells were cultured in the presence 
of  1 μg∙ml−1 doxycycline for at least 7 days prior to testing for RHAU down-
regulation efficiency.
RIP-chip assay
Cells were harvested 24-36 h post-transfection, washed with ice-cold PBS 
and resuspended in lysis buffer [1× PBS, 1 % v∙v−1 Nonidet P-40, 2 mM EDTA, 
2 mM AEBSF, 1× protease inhibitor cocktail (Complete EDTA-free, Roche), 
0.2 U∙μl−1 RNasin® Plus (Promega)] for 30 min. All subsequent operations were 
performed at 4 °C. The lysates were cleared by centrifugation (21'000g, 15 min) and 
mixed with 10 μl of  a 50 % slurry of  anti-FLAG M2-agarose affinity gel (Sigma) 
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that had been equilibrated in lysis buffer. After gentle agitation for 5 h, the resin 
was recovered by centrifugation, washed 3× with 500 μl lysis buffer, followed 
by three washes with 500μl IP-washing buffer [50 mM Tris–HCl (pH 7.5), 
300 mM NaCl, 0.1 % v∙v−1 Nonidet P-40, 5 mM EDTA, 0.4 U∙μl−1 RNasin® 
Plus]. The resin was resuspended in 1 ml TRIzol (Invitrogen) for protein analysis 
and RNA extraction. For microarray analysis, 100 ng RNA was converted to 
cRNA according to the manufacturer’s guidelines and the reaction products 
hybridised to GeneChip® Human Gene 1.0 ST arrays (Affymetrix). The resulting 
raw expression values were RMA-normalised using R/BioConductor (290) and 
the Oligo Package (version 1.14.0, ref. 291). Probesets were linked to Entrez 
Gene entries using Affymetrix annotation (NetAffx release 28, March 11, 2009), 
retaining a single probeset per gene. Genes not clearly detected in input samples 
[average log
2
(expression value) < 6.0] were discarded. Differential expression 
was determined using the Limma package (292), selecting genes with a minimal 
fold-change of  2.0 and an FDR-adjusted P-value of  less than 0.01. RHAU targets 
were identified as transcripts enriched in RHAU-FLAG IP versus RHAU-FLAG 
input samples but not enriched in control IP versus control RHAU-myc input 
samples.
G4-RNA structure prediction and bioinformatics analysis
Human RNA sequences were retrieved from Entrez Nucleotide database. 
Non-overlapping putative intramolecular G4-forming sequences (PQS) and 
the corresponding G4-score values were computed with the QGRS Mapper 
algorithm (293) using the default parameters (window size = 30 nt, Min. 
G-group = 2, loop size = 0-36). For each transcript, the ∑(G4-score) value was 
calculated as the sum of  all non-overlapping G4-scores computed by QGRS 
Mapper. To obtain a normalised ∑(G4-score) value, the ∑(G4-score) value 
was divided by the RNA length (kb). Randomisation of  RNA sequences by 
single- or dinucleotide shuffling was performed using the Altschul-Erickson 
algorithm (294).
Protein immunoprecipitation assay
Protein immunoprecipitation experiments were performed under the same 
conditions employed for the RIP-chip assay. Cleared cell lysates were mixed 
with rProtein A or Protein G Sepharose™ Fast Flow beads (GE Healthcare) and 
appropriate antibodies [mouse mAb anti-RHAU (12F33, ref. 268), rabbit pAb anti-
dyskerin (H-300, Santa Cruz Biotechnology)]. After gentle agitation for 5 h, the 
beads were washed. For telomere repeat amplification protocol (TRAP) assays, 
beads were resuspended in 40 μl TRAP lysis buffer [10 mM Tris-HCl (pH 8.0), 
150 mM NaCl, 1 mM MgCl
2
, 1 mM EDTA (pH 8.0), 1 % v∙v−1 Nonidet P-40, 
0.25 mM Na-deoxycholate, 10 % v∙v−1 glycerol, 5 mM 2-mercaptoethanol, 
0.1 mM AEBSF]. For protein and RNA analysis, beads were resuspended 
in 1 ml TRIzol and extraction performed according to the manufacturer’s 
instructions. Input and co-purified RNA samples were analysed by RT-qPCR. 
For protein analysis only, beads were directly resuspended in sodium dodecyl 
sulphate (SDS)-gel loading buffer. Input and immunoprecipitated protein 
samples were separated by SDS-PAGE and analysed by Western blotting.
RNA analysis by quantitative (RT-qPCR) and semi-quantitative 
RT-PCR
Reverse transcription was performed using the ImProm-II™ Reverse 
Transcription System (Promega) with oligo(dT)
15
 or random hexamer primers, 
according to the manufacturer’s instructions. For monitoring first-strand cDNA 
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synthesis, the reverse transcription reaction was performed in the presence of  
20 μCi [α-32P]dATP (3'000 Ci∙mmol−1). The reaction products were separated by 
agarose gel electrophoresis and visualised by Phosphor-Imaging. Quantitative 
and semi-quantitative PCR reactions were performed in technical duplicates 
using the ABsolute™ QPCR SYBR® Green ROX Mix (Thermo Fisher Scientific), 
according to the manufacturer’s instructions, on an ABI Prism 7000 Sequence 
Detection System (SDS) and analysed with the ABI Prism 7000 SDS 1.0 
Software (Applied Biosystems). Relative transcript levels were determined using 
the 2−∆Ct method (295). For each primer pair (Supplementary Table I), the efficiency of  
amplification was determined to be equal or superior to 1.8. Control reactions 
lacking the reverse transcriptase or template RNA confirmed the specificity of  
the amplification reactions.
TRAP assays
Immunopurified ribonucleoprotein (RNP) complexes were assayed 
for telomerase activity by the TRAP assay (296). Four microliters of  bead-
immobilised RNP complexes in TRAP lysis buffer were incubated (30 min, 
25 °C) in 50 μl TRAP reaction buffer [20 mM Tris–HCl (pH 8.3 at room 
temperature), 63 mM KCl, 1.5 mM MgCl
2
, 0.2 mM dNTP mix (50 μM each of  
dATP, dTTP, dGTP and dCTP), 0.05 % v∙v−1 Tween®-20, 1 mM EGTA (pH 8.0), 
4 ng∙μl−1 Cy5-TS primer, 2 ng∙μl−1 ACX primer (Supplementary Table I), 
1 U∙μl−1 RNasin® Plus, 0.4 mg∙ml−1 BSA, 0.04 U∙μl−1 Thermo-Start™ Taq 
DNA Polymerase (Thermo Fisher Scientific)]. The reaction was followed by a 
15-min incubation step at 95 °C, followed by 15-17 cycles of  amplification (30 s 
at 95 °C, 30 s at 52 °C, 45 s at 72 °C). The reaction products were resolved 
on a pre-electrophoresed 10 % non-denaturing polyacrylamide gel (19:1 
acrylamide:bis ratio) in 0.5× TBE at 4 °C for 90 min. After electrophoresis, gels 
were fixed [500 mM NaCl, 50 % v∙v−1 ethanol, 40 mM Na-acetate (pH 4.2)] 
for 30 min, scanned on a Typhoon 9400 Imager (GE Healthcare) and analysed 
with ImageQuant TL software (Nonlinear Dynamics). For immunodepletion 
experiments of  RHAU, the residual telomerase activity in cell extracts was 
quantified by the quantitative TRAP assay (qTRAP, ref. 296). An aliqot of  250 ng 
protein from immunodepleted HEK293T cell extracts in TRAP lysis buffer 
was incubated (30 min, 25 °C) in 25 μl qTRAP reaction buffer [1× ABsolute™ 
QPCR SYBR® Green ROX Mix, 1 mM EGTA (pH 8.0), 4 ng∙μl−1 TS primer, 
4 ng∙μl−1 ACX primer (Supplementary Table I), 0.2 U∙μl−1 RNasin® Plus]. The reaction 
was followed by a 15-min incubation step at 95 °C, followed by 40 cycles of  
amplification (15 s at 95 °C, 60 s at 60 °C) on an ABI Prism 7000 Sequence 
Detector. The relative telomerase activity was determined using a standard curve 
and linear equation model (296).
Expression and purification of recombinant RHAU protein
Recombinant wild-type and ATPase deficient [RHAU(DAIH)] N-terminal 
GST-tagged RHAU proteins were expressed in Sf9 cells according to the 
supplier’s instructions (PharMingen) and purified to homogeneity as described 
previously (88). Purified recombinant GST-RHAU proteins were stored at 
−80 °C. Purity of  protein preparations was assessed by SDS-PAGE (Supplementary 
Figure 11) and protein concentrations determined photometrically at 280 nm using 
the calculated extinction coefficient ε = 166'615 M−1∙cm−1.
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In vitro synthesis of 32P-labelled TERC transcripts and 
intramolecular G4-RNA preparation
Synthetic radio-labelled wild-type and mutant (G4-MT) telomerase RNAs 
were prepared by in vitro transcription using 50 μCi [α-32P]UTP (3'000 Ci∙mmol−1) 
and T7 or SP6 RNA polymerases (Promega), respectively, according to the 
manufacturer’s instructions. The transcripts were purified by denaturing PAGE, 
ethanol precipitated and recovered by centrifugation. The purified RNAs 
were resuspended in potassium- or lithium-based storage buffer [10 mM Li-
cacodylate (pH 7.4), 100 mM KCl or LiCl] and annealed by heating at 95 °C 
for 2 min, followed by slow cooling to room temperature. G4-annealed radio-
labelled RNAs were stored at −80 °C.
RNA electromobility shift assay (REMSA)
Purified recombinant GST-RHAU protein at concentrations from 1-320 nM 
were incubated with 100 pM 32P-labelled G4-RNA in K-Res buffer [50 mM Tris-
acetate (pH 7.8), 100 mM KCl, 10 mM NaCl, 3 mM MgCl
2
, 70 mM glycine, 
10 % glycerol], supplemented with 10 mM EDTA and 0.2 U∙μl−1 SUPERase-
In (Ambion) in a 10-μl reaction. The reactions were equilibrated at 22 °C for 
30 min. RNA-protein complexes were resolved on a pre-electrophoresed 
6 % non-denaturing polyacrylamide gel (37.5:1 acrylamide:bis ratio) in 
0.5× TBE at 4 °C for 90 min. After electrophoresis, gels were fixed for 1 h in 
10 % isopropanol/7 % acetic acid. RNA-protein complexes were detected by 
Phosphor-Imaging, scanned on a Typhoon 9400 Imager (GE Healthcare) and 
analysed with ImageQuant TL software (Nonlinear Dynamics).
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Structural model of the helicase core and HA 
regions of RHAU
Homology modelling and model quality estimation
The three-dimensional (3-D) model of  RHAU was built by homology 
modelling based on the high-resolution (1.9 Å) and high-quality (R = 0.184, 
R
free
 = 0.224) X-ray structure of  the S. cerivisiae Prp43 protein (RCSB PDB 
ID: 2XAU chain A, ref. 113). The pairwise sequence alignment between RHAU 
and Prp43 template was obtained from a multiple sequence alignment of  various 
E. coli, S. cerevisiae, D. melanogaster and H. sapiens DEAH-box proteins (Supplementary 
Figure 1). Homology modelling was carried out using the MODELLER (v. 9.9) 
program (297,298). Quality assessment of  the modelled RHAU structure was 
carried out with QMEAN6 (299) and ModFOLD (300) tools. Three-dimensional 
protein structure superposition and calculations of  the RMSD values were 
performed using the CEalign function in PyMOL (v. 1.5, ref. 301) by fitting 
C
α
-backbones of  the analysed protein molecules. The ADP bound model of  
RHAU was generated by superposing the helicase core region of  Prp43·ADP 
complex to that of  RHAU and masking Prp43 structure. The nucleic acid bound 
model of  RHAU was obtained by fitting Hel308·DNA complex (RCSB PDB 
ID: 2P6R) to that of  RHAU and hiding Hel308 structure.
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Characterisation of the tetramolecular 
G4 structure formed by rAGA 
oligoribonucleotides
AImS AND RAT IoNALE
In vivo tetramolecular G4 structures are probably less frequent than 
intramolecular G4 structures because of  their very slow folding kinetic, 
however they have been extensively employed for in vitro investigations of  
protein with G4 binding and resolving activities (33,89,227-229,243,302,303). 
Despite their somewhat unusual aspect, tetramolecular G4 structures may 
be seen as simpler models of  biologically relevant G-tetrads (204). The 
conformation of  the stem of  the tetramolecular quadruplexes is indeed 
very close to the central core of  intramolecular parallel quadruplexes 
found in human telomeric repeats or other motifs (304,305). Importantly, 
the use of  a tetramolecular G4 structure facilitates unwinding analysis, 
insofar as the tetraplex form can be readily separated from the unwound 
single stranded product by electrophoresis. The investigation of  the 
unwinding of  intramolecular G4 structure is indeed tricky and requires 
trapping the unwound nucleic acid with a complementary strand to 
prevent its readoption of  G4-conformation. Nevertheless, the usage of  
a tetramolecular G4 substrate to characterise the G4 resolvase activity 
of  RHAU does not deprive its biological significance insofar as we also 
provide evidence that RHAU binds intramolecular G4 structures.
RESULTS  AND DIScUSS IoN
In a part of  this work, we employed the tetramolecular G4-rAGA 
substrate to characterise the G4-RNA binding and resolving activity of  
RHAU in vitro. AGA oligonucleotide was already employed as a G4-DNA 
substrate to characterise the enzymatic activity of  RHAU (33). G4-rAGA 
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substrate was derived from the Z33 oligomer by substituting the 3′ and 5′ 
overhangs flanking the guanine core with two tails of  15 adenosine residues. 
Considering that adenosine cannot base-pair with itself  or with the five central 
guanosine residues, we could in that way prevent the formation of  undesired 
secondary structures that would bias the study of  G4 binding and resolving 
activity of  RHAU.
As shown in Figure 17A, rAGA oligoribonucleotides form a high ordered 
structure when they are incubated at a high concentration (micromolar range) in 
a potassium-containing solution. As analysed by native PAGE, the characteristic 
monomer band was also diminished, indicating the formation of  a larger RNA 
structure in a manner dependent on RNA concentration. By comparison with a 
25-bp dsRNA resulting from the hybridisation of  rAGA oligoribonucleotide with 
its complementary strand 5′-U
15
–C
5
–U
15
-3′ (rUCU), the size of  the slow mobility 
band turned out to be of  higher complexity, since its migration was much slower 
than that of  the dsRNA species. When diluted at a low concentration (nanomolar 
range) in a solution deprived of  monovalent cations (K+, Na+ or Li+), the rAGA 
oligoribonucleotide remained in a monomeric state. The conversion of  the 
monomeric form to the high ordered structure was also suppressed when two 
guanines of  the central core were replaced with adenines. This demonstrates 
the significance of  the five central guanines for the stability of  the structure. In 
contrast, the flanking adenosine residues could all be substituted with uridines 
without affecting the formation of  the high ordered structure indicating that 
they were not essential for the self-assembly of  rAGA oligomer.
Circular dichroism analysis of  the purified high ordered structure formed 
by rAGA oligomers revealed a positive and a negative peak at 263 nm and 
245 nm, respectively (Figure 17B). This characteristic CD spectrum signature with 
a strong maximum ellipticity at 263 nm is typical of  a parallel G4 structure whose 
all stacked quartets have the same polarity (306-308). Antiparallel G4 structures 
have indeed been shown to have a different profile with positive and negative 
peaks at 295 nm and a 265 nm, respectively. In fact, in G4-RNA structures, the 
parallel strand conformation is strongly favoured over the antiparallel one. This 
distinctive feature arises because of  the C3′-endo sugar pucker conformation of  
the ribose (as opposed to the C2′-endo conformation of  deoxyribose) that entails 
the base to adopt the anti conformation (309). Circular dichroism spectrum 
analysis also revealed that the amplitude of  the signal at 263 nm and 245 nm was 
reduced in the absence of  cations. This suggests that the G4-rAGA structure is 
more stable in the presence of  monovalent cations, which is consistent with the 
known alkali metal cation dependency of  G4 structures (174,175,179). Although 
K+ and Na+ ions are known to be better stabilisers of  G4 structures than Li+ ions, 
this effect is not apparent at 25 °C but occurs at higher temperatures (Figure 17C 
and D).
Compared to conventional double-stranded nucleic acids, tetramolecular 
G4 structures are extremely stable (170,173,185,204,310). Moreover the thermal 
stability of  most of  them shows a strict alkali cation dependency in the order 
of: K+ > Na+ >> Li+. From a kinetic point of  view, formation of  tetramolecular 
G4 structures is a very slow process that follows a fourth-order reaction with 
respect to strand concentration. In contrast, the dissociation of  tetramolecular 
G4 structures follows a first order kinetic. Therefore at low concentrations, 
thermal denaturation of  short parallel quadruplexes is often irreversible. We 
actually took advantage of  this irreversibility to determine the thermodynamic 
stability of  preformed G4-rAGA structure as a function of  the nature of  
the monovalent cation by electrophoresis for direct visualisation. As shown 
in Figure 17C and D, the apparent temperature of  mid-transition (T
m
) of  G4-
rAGA structure ranged from 60 °C in LiCl to more than 100 °C in KCl with 
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an intermediate value of  88 °C in NaCl. This result shows that K+ stabilises 
G4-rAGA structure better than Na+ or Li+, which is consistent with the known 
hierarchy of  tetramolecular G4 structure stabilisation by different monovalent 
cations (179). Taken together, these data provide strong evidence that rAGA 
oligoribonucleotides form a stable and parallel interstrand G4 structure and its 
high ordered form constitutes an adequate substrate to investigate the G4-RNA 
binding and resolving activity of  RHAU protein.
Figure 17 | Characterisation of the tetramolecular G4-rAGA structure. (A) Native PAGE analysis of monomeric and annealed forms of rAGA oligomer. 
The positions of the single-stranded oligoribonucleotides (ssRNA) and of the annealed double-stranded (dsRNA) or tetraplex (G4-RNA) RNA are denoted 
on the left. Sequences of the employed oligomers are indicated underneath with mutated residues marked in red. (B) Circular dicroism spectra of G4-
rAGA structure at 25 °C in the presence of 50 mM of either LiCl, NaCl or KCl. (C) Thermodynamic stability analysis of preformed G4-rAGA structure 
as a function of the nature of the monovalent cations. 5'-TAMRA-labelled tetramolecular rAGA at a concentration of 100 nM were incubated at various 
temperatures for 5 min in the presence of 50 mM of either LiCl, NaCl or KCl and immediately subjected to separation by electrophoresis under native 
conditions. (D) Determination of the apparent temperature of mid-transition (Tm) of G4-rAGA structure as a function of the nature of the monovalent cations.
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Role of the amino terminal RSM domain in 
the recognition and resolution of guanine 
quadruplex-RNAs by RHAU
AImS AND RAT IoNALE
RHAU displays high affinity and specificity for G4 nucleic acid structures 
in vitro (33,89), however little is know regarding the mechanisms by which RHAU 
recognises and resoves its substrates. Previous work showed that RHAU 
associates with mRNAs and relocalises to stress granules upon translational 
arrest induced by various environmental stresses (268). Deletion analysis of  the 
N-terminal region of  RHAU revealed that a region of  the first 105 amino acids 
was critical for RNA binding and relocalisation of  RHAU to stress granules. 
Importantly, this 105 amino acid-long region alone had the ability in vivo to bind 
RNA and relocalise to stress granules. The apparent significance of  the first 
105 amino acids for RHAU interaction with RNA prompted us to determine 
whether the N-terminal domain of  RHAU also contributes to the recognition of  
G4 structures in vitro. To address this question, a series of  N-terminal deletion 
mutants of  RHAU was generated as shown in Figure 18A. Through biochemical 
analysis of  these mutants, we have uncovered the functional importance of  the 
first 105 amino acids of  RHAU for interaction with G4 structures and further 
revealed among this region that the previously identified RSM (RHAU-specific 
motif, aa. 54–66) domain (268) is essential to the high affinity for G4 structures 
shown by RHAU. Here, we show that the N-terminal region of  RHAU alone 
can bind to G4-RNA structures, albeit with lower affinity than the full-length 
protein. Besides, we also show that the G4 resolving activity of  RHAU is 
conserved in higher eukaryotes, insofar as CG9323, the Drosophila orthologue 
of  RHAU, readily unwinds G4 structures in the presence of  ATP. Finally, we 
show that a variant form of  CG9323 harbouring mutations in the RSM domain 
manifests reduced G4 binding activity, suggesting that RSM functions similarly 
in Drosophila and human RHAU proteins.
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Figure 18 | N-terminal deletion mutants of RHAU. (A) Schematic representation of the 1008-aa. RHAU protein and its N-terminal truncated mutants. The 
conserved ATPase/helicase motifs I–VI of the DEAH-box family are indicated within the helicase core region (HCR) by vertical bars. The HCR is flanked 
by N-terminal (NTR) and C-terminal (CTR) regions of 182 aa and 383 aa, respectively. The N-terminal Gly-rich (aa 10–51) and RSM (RHAU-specific motif, 
aa. 54–66) domains are indicated. WT, 1–1008 aa.; ∆Gly, 50–1008 aa.; ∆Gly–RSM, 105–1008 aa.; ∆RSM, RHAU harbouring a deletion of aa. 54–66; 
RSM-mut, RHAU with mutagenised RSM (see Figure 23A for details about aa. substitutions); Gly–RSM, 1–105 aa.; DAIH, D335A ATPase deficient mutant. 
(B) SDS-PAGE separation and Coomassie staining of purified FLAG-tagged recombinant wild-type and mutant RHAU proteins (2 μg protein per lane). The 
positions and sizes (kDa) of marker proteins are indicated at the left. The marks (t and v) on the right indicate the positions of the purified proteins.
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RESULTS
The first 105 amino acids of RHAU are required for binding and 
resolving G4 structures
We demonstrated previously in vivo and in vitro that amino acids 1–105 of  
RHAU delineate a functional domain of  prime importance for the interaction 
of  RHAU with RNA (268). To assess the significance of  this region for the 
G4 resolvase activity of  RHAU, we constructed a series of  FLAG-tagged 
N-terminal truncated mutants of  RHAU (Figure 18A). These truncated forms were 
expressed in HEK293T cells and purified from soluble lysates by anti-FLAG 
immunoaffinity chromatography. The purity of  these preparations as judged by 
Coomassie staining after SDS-PAGE was very similar (Figure 18B). To test whether 
the truncated form of  RHAU lacking the first 105 amino acids [RHAU(∆Gly–
RSM)] could resolve G4 structures, RHAU protein was incubated with 
32P-labelled tetramolecular rAGA and ATP. The products were analysed by 
native PAGE after disruption of  RNA-protein interactions by addition of  SDS. 
The free single-stranded 32P-labelled oligos migrated faster than the quadruplex 
substrate. As shown previously, wild-type (WT) RHAU efficiently resolved G4 
structures into single-stranded oligos (Figure 19A). The labelled product of  the 
resolvase reaction co-migrated during electrophoresis with the single-stranded 
species released by thermal denaturation of  the substrate and was proportional 
to the level of  input protein. In contrast to RHAU(WT), RHAU(∆Gly–RSM) 
failed to resolve the G4 substrate, suggesting that the N-terminal region of  
RHAU is essential for its G4 resolvase activity.
Being critical for the enzymatic activity and containing an atypical RNA-
binding domain (268), the N-terminal region of  RHAU is most likely to play a 
role in substrate recognition. Therefore, we examined whether this N-terminal 
region was also essential for the recognition of  G4 structures. To address this 
question, we performed RNA electromobility shift assays (REMSA) using G4 
substrate as the ligand. RHAU protein was incubated with 32P-labelled G4 in the 
absence of  ATP (to prevent G4 resolution) and the mixtures were analysed by 
native PAGE. In the absence of  protein, the 32P-labelled G4 structures migrated 
as a single species in the gel (Figure 19B). Addition of  increasing amounts of  
RHAU(WT) protein resulted in the appearance of  a protein–G4 complex with 
reduced mobility. The bound complexes appeared as two main band regions 
in the gel, which might reflect multiple forms of  the complexes. By contrast, 
the RHAU(∆Gly–RSM) mutant protein failed to form a stable complex with 
Figure 19 | G4-RNA unwinding and binding 
by N-terminal truncated RHAU proteins. 
(A) G4-RNA unwinding assay: radiolabelled 
tetramolecular rAGA at a concentration 
of 4 nM was incubated in the presence of 
ATP without protein (−) or with increasing 
amounts (1, 3, 10 and 30 nM) of wild-type (WT) 
RHAU or ∆Gly–RSM mutant. The reaction 
products were resolved by native PAGE 
after disrupting RNA-protein interactions with 
SDS. An autoradiogram of the gel is shown. 
The positions of the tetraplex substrate 
RNA (G4-RNA) and the unwound single-
stranded product (ssRNA) are denoted on the 
left. An aliquot of the tetraplex substrate that 
was heat-denatured (95 °C, 5 min) and then 
quenched (∆T) serves as a marker for the 
position of single-stranded RNA. (B) G4-RNA 
binding assay: radiolabelled tetramolecular 
rAGA at a concentration of 100 pM was 
incubated without protein (−) or with increasing 
amounts (1, 3, 10 and 30 nM) of WT RHAU 
or ∆Gly–RSM mutant in the absence of ATP. 
The reaction mixtures were analysed by native 
PAGE. An autoradiogram of the gel is shown. 
The positions of the free tetramolecular RNA 
substrate and the protein-RNA complex are 
indicated on the left.
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G4 structures. Taken together, these results demonstrate that the N-terminal 
region encompassing residues 1–105 of  RHAU protein is indispensable for 
both binding and the resolving of  G4 structures by RHAU. These results are 
in agreement with our previous report that the N-terminal region of  RHAU is 
critical for its RNA binding in vivo and its relocalisation to stress granules (268).
The N-terminal region of RHAU binds but cannot alone resolve 
G4 structures
In view of  their uniqueness, the N-terminal regions of  DEAH-box proteins 
may have regulatory functions such as subcellular localisation and/or interaction 
with RNAs or other proteins (6,37). With prima facie evidence that the N-terminal 
region of  RHAU is important for both binding to and resolving G4 structures, 
we examined whether this region has G4 binding activity. As shown by REMSA, 
increasing amounts of  RHAU(1–105) protein formed proportionately slow-
migrating complexes with G4-RNA (Figure 20A). That the observed mobility shift 
was due to binding of  RHAU(1–105) protein was confirmed by addition of  anti-
FLAG antibody to binding reactions. As shown in Figure 20B, anti-FLAG antibody 
caused a supershift of  the protein-probe complex but not of  the free probe.
Given that some G4 binding proteins destabilise G4 structures in a non-
catalytic fashion without requiring ATP hydrolysis (262), we examined whether 
the N-terminal region of  RHAU may also destabilise G4 structures in a similar 
manner. However, as shown in Figure 20C, binding of  the N-terminal region to G4 
Figure 20 | G4-RNA binding and resolving 
activities of the N-terminal domain of 
RHAU. (A) Gel mobility shift assay for G4-RNA 
binding: radiolabelled tetramolecular rAGA at a 
concentration of 100 pM was incubated without 
protein (−) or with increasing amounts (30, 100, 
300 and 1000 nM) of RHAU(Gly–RSM) in the 
absence of ATP. The reaction mixtures were 
analysed by native PAGE. An autoradiogram 
of the gel is shown. (B) Supershift of G4-
RNA binding complex by a specific antibody: 
radiolabelled tetramolecular rAGA at a 
concentration of 100 pM was incubated with 
RHAU(Gly–RSM) at 300 nM in the presence 
or absence of anti-FLAG antibodies (2.5 μg 
per lane), as indicated. The reaction mixtures 
were electrophoresed on a native gel. An 
autoradiogram of the gel is shown. The 
positions of the free tetramolecular RNA 
substrate, the protein-RNA complex and the 
supershifted complex are indicated on the left. 
(C) G4-RNA unwinding assay: radiolabelled 
tetramolecular rAGA at a concentration of 4 nM 
was incubated in the presence of ATP without 
protein (−) or with increasing amounts (1, 3, 
10 and 30 nM) of WT RHAU or Gly–RSM 
RHAU mutant (30, 100, 300 and 1000 nM). 
The reaction products were resolved by 
native PAGE after disrupting of RNA-protein 
interactions with SDS. An autoradiogram of 
the gel is shown. An aliquot of the tetraplex 
substrate that was heat-denatured (95 °C, 
5 min) and then quenched (∆T) serves as 
a marker for the position of single-stranded 
RNA.
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structures is not sufficient to destabilise it. In agreement with the observation 
that RHAU cannot resolve G4 structures in the absence of  ATP (33), this result 
demonstrates that the N-terminal region alone lacks G4 destabilising activity and 
that the G4 resolving activity is likely a property of  the central catalytically active 
core domain.
The helicase core domain, together with the N-terminal region, 
contributes to tight G4 binding of RHAU
Considering that RHAU has a high affinity for G4 structures (89), we next 
examined whether the N-terminal region itself  accounts for the high affinity 
for G4 structures of  the whole protein. N-terminal region [RHAU(1–200)] 
and full-length RHAU (WT) were expressed as GST fusion proteins in bacteria 
and Sf9 insect cells, respectively, and purified to homogeneity as shown in 
Supplementary Figure 8. Their apparent dissociation constants (K
d
) for G4 structures 
were determined by REMSA. Titration of  RHAU(WT) and RHAU(1–200) 
proteins gave half-saturation points for G4 binding of  14 nM and 440 nM, 
respectively (Figure 21A and B). This 30-fold difference between the two proteins 
indicates that the N-terminal region does not constitute by itself  an independent 
and high-affinity G4-RNA binding domain. We propose that the helicase core 
domain provides RHAU with substantial additional binding activity through 
interactions with the RNA phosphate backbone, as already shown for many 
DExD/H-box proteins (27,118,138,139,141,311,312). It should be mentioned that 
the observed K
d
 value obtained here is higher than that previously reported (89), 
which may reflect the difference of  the type and location of  tags attached to 
RHAU (N-GST versus C-His
6
) and of  the way how proteins were purified.
The RSM domain, but not the Gly-rich sequence, in the 
N-terminal region is crucial for the recognition and resolution of 
G4 structures by RHAU
The functional N-terminal region encompassing residues 1–105 of  RHAU 
protein consists of  two abutting domains (Figure 18A): a 41 amino acid-long low-
complexity Gly-rich domain followed by the evolutionary conserved 13 amino 
acid-long RSM (aa. 54–66). We demonstrated previously in vivo that deletion of  
Figure 21 | G4-RNA binding properties of RHAU and the N-terminal region. (A) Gel mobility shift assay for G4-RNA binding: radiolabelled tetramolecular 
rAGA at a concentration of 100 pM was incubated without protein (−) or with increasing amounts of either GST-tagged WT RHAU or RHAU(1–200) in the 
absence of ATP. The reaction mixtures were analysed by native PAGE. An autoradiogram of the gel is shown. At concentrations from 10 to 1000 nM, GST 
protein alone had no effect on G4-RNA mobility (not shown). (B) Quantification of gel mobility shift assays for wild-type RHAU (WT, ●) and RHAU N-terminal 
region (1–200, ○) binding to tetramolecular rAGA. The data represent means ± SEM from three independent experiments.
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the Gly-rich region [RHAU(∆Gly)] significantly impinged on the relocalisation 
of  the protein to stress granules and on its association with RNA (268). To 
characterise the individual contributions of  each of  the two domains to the 
interaction of  RHAU with G4 structures, we performed REMSA experiments 
using corresponding deletion mutants (Figure 22A). As already shown in Figure 19B, 
RHAU(∆Gly–RSM) lacking the first 105 amino acids failed to form a stable 
complex with G4 structures. In contrast, RHAU(∆Gly) still harbouring the 
RSM was able to bind to G4 structures with the same efficiency as RHAU(WT). 
Contrary to the deletion of  the Gly-rich sequence, a RHAU mutant with an 
RSM deletion [RHAU(∆RSM)] abrogated the interaction with G4 structures. 
We further assessed the consequence of  loss of  G4-recognition on the in 
vitro resolvase activity of  RHAU (Figure 22B). As expected, RHAU(∆RSM), like 
RHAU(∆Gly–RSM), failed to resolve G4 structures, while RHAU(∆Gly), like 
RHAU(WT), did. Similar results with strict RSM-dependency could also be 
reproduced with other G4-RNA structures (data not shown). Together, these 
results indicate that the presence of  the RSM but no further sequence of  the 
N-terminal region is a prerequisite for the recognition and the resolution of  G4 
structures by RHAU in vitro.
Figure 22 | G4-RNA binding and unwinding 
by Gly-rich and RSM truncated RHAU 
proteins. (A) Gel mobility shift assay for G4-
RNA binding: radiolabelled tetramolecular 
rAGA at a concentration of 100 pM was 
incubated without protein (−) or with 
increasing amounts (6, 20 and 60 nM) of 
either WT RHAU, and ∆Gly, ∆Gly–RSM or 
∆RSM RHAU mutants in the absence of ATP. 
The reaction mixtures were analysed by native 
PAGE. An autoradiogram of the gel is shown. 
(B) G4-RNA unwinding assay: radiolabelled 
tetramolecular rAGA at a concentration of 
4 nM was incubated in the presence of ATP 
without protein (−) or with increasing amounts 
(6, 20 and 60 nM) of either WT RHAU, or 
∆Gly, ∆Gly–RSM or ∆RSM RHAU mutants. 
The reaction products were resolved by 
native PAGE after disrupting of RNA-protein 
interactions with SDS. An autoradiogram of 
the gel is shown. An aliquot of the tetraplex 
substrate that was heat-denatured (95 °C, 
5 min) and then quenched (∆T) serves as 
a marker for the position of single-stranded 
RNA.
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Figure 23 | G4-RNA binding and unwinding by RSM-mutated forms of RHAU. (A) Conservation of the RSM among RHAU orthologues throughout 
evolution. Multiple sequence alignment was carried out with MAFFT (version 6, ref. 313). Similarity analysis was made by GeneDoc (version 2.7) using 
the BLOSUM62 scoring matrix. Similarity is shown in red for 100 %, yellow for 99–80 % and blue for 79–60 %. Amino acids that are identical between the 
nine sequences are indicated by asterisks below the alignment. Secondary structure prediction was performed by JPRED (314) and is indicated on the top. 
The RSM and its consensus sequence derived from 40 different RHAU orthologues (Supplementary Figure 9) are shown below the alignment (π = small 
side chain, ζ = hydrophilic, [+] = basic, Ψ = aliphatic, Ω = aromatic). The site-directed substitutions of the RSM mutants employed in this study are listed 
with the amino acid changes indicated underneath. Species and accession numbers of RHAU orthologues listed are: human (Homo sapiens, NP_065916), 
mouse (Mus musculus, NP_082412), chicken (Gallus gallus, XP_422834), frog (Xenopus tropicalis, ENSXETP00000016958), zebrafish (Danio rerio, 
NP_001122016), fruit fly (Drosophila melanogaster, NP_610056), blood fluke (Schistosoma mansoni, XP_002577014), placozoan (Trichoplax adhaerens, 
XP_002110272), choanoflagellate (Monosiga brevicollis, XP_001747335). (B) Gel mobility shift assay for G4-RNA binding: radiolabelled tetramolecular 
rAGA at a concentration of 100 pM was incubated without protein (−) or with increasing amounts (6, 20 and 60 nM) of either WT RHAU or the indicated RSM 
A
B WT
bound G4
free G4
−
RSM-mut1 RSM-mut3RSM-mut6RSM-mut2∆RSM
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
C
−
ssRNA
G4-RNA
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
WT RSM-mut1 RSM-mut3RSM-mut6RSM-mut2∆RSM
RSM consensus
WT : PGHLKGREIGMWY
RSM-mut1 : G············
54 57 59 6263
RSM-mut2 : G··A·A··AA···
RSM-mut3 : ····A·AA·····
RSM-mut6 : ·····P···P···
∆RSM : −−−−−−−−−−−−−
PпxLζG+ζIGΨΩΩ
Human :
Mouse :
Chicken :
Frog :
Zebrafish :
Fruit fly :
Blood fluke :
Placozoan :
Choanoflagellate :
GGGGGGRGGRGRHPGHLKGREIGMWYAKKQGQK-----NKEA----ERQERAV-----VHMDERREEQIVQLLNSVQ
GGGGGGRGGRGRHPAHLKGREIGLWYAKKQTQK-----NKEA----ERQERAV-----VHMDERREEQIVQLLNSVQ
GGHGGRGGGRGRHPSHLKGREIGLWYARKQGQK-----SKET----DRQQRAV-----VRMDERREEQIVQLLNAVQ
SMENSGGEQREKPPPHLKGREIGLWHARRQGQR-----SKEK----ERQERAV-----VKMDESREQHITRLLNSVQ
GLGGCRRGGRGKHPSHLKGREIGLWYAKWGGIK-----KSEA----ERRSRAV-----VHMDESREKHITQLLNTVQ
RDSSGSNARKGNRPPGLRGKDIGLYYRNLARQQ-----KKDRGENAESKEPQIRLGCNVSAPSGVLERVKELMEDYS
VCISMSRANKGHRPPGLRGKEIGLWHAAQSKNRCTGHLDYQT----KFASMPL-----VGLNLPKIQSVIQEFVEPV
GNRGGGRGGGVGRPPGLSGKEIGMYYANLSRTR-----KKEK----EKIERAV-----IELDDGKQHAIASIVDQVE
GGGGGGGGGGGGPPAGLSGRDIGMWYARQGQAA-----RKQQ----ERRERPI-----VSFDSHKHRDIQQLLSSAR
* * * **
: 103
: 96
: 91
: 96
: 110
: 76
: 81
: 84
: 164
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Conserved residues within the RSM domain are essential for the 
recognition of G4 structures by RHAU
Multiple sequence alignments of  RHAU orthologues of  various species 
from choanoflagelates to humans unveiled a highly conserved cluster of  13 
amino acids presenting the RSM domain embedded in a moderately conserved 
region of  about 50 amino acids (aa. 54–100; Figure 23A). In contrast, the rest of  the 
N-terminus surrounding this region is poorly conserved. The RSM consensus 
sequence as determined from 40 different RHAU orthologue sequences is: 
P–π–x–L–ζ–G–[+]–ζ–I–G–Ψ–Ω–Ω† (Supplementary Figure 9). The motif  consists 
of  five invariant amino acids (Pro-54, Leu-57, Gly-59, Ile-62 and Gly-63) and 
seven highly conserved residues of  similar biochemical properties (π-55, ζ-58, 
[+]-60, ζ-61, Ψ-64, Ω-65, Ω-66). In addition, computation-based secondary 
structure prediction of  the sequences used for alignment suggested that RSM 
is partially structured, sitting astride an unstructured loop (aa. 54–59) and an 
α-helix (aa. 60–66; Figure 23A). We further examined by site-specific mutagenesis 
in vitro the contribution of  conserved amino acids within the RSM domain to the 
recognition and resolution of  G4 structures (Figure 23A). To this end, conserved 
residues of  the RSM were substituted with alanines, prolines or glycines. We 
focussed on Pro-54, Gly-59 and Gly-63 because they may provide the RSM 
with substantial structural rigidity (Pro-54) or flexibility (Gly-59 and Gly-63). As 
shown in Figure 23B, mutation of  the five invariant residues of  the RSM (RSM-
mut2) considerably reduced the binding affinity of  RHAU for G4-RNA, albeit 
to a lesser extent than the RSM-deleted form of  RHAU (∆RSM). Interestingly, 
substitution of  the invariant Gly-59 and Gly-63 residues with prolines (RSM-
mut6) caused a stronger reduction of  G4 binding activity than the RHAU(RSM-
mut2) in which these two amino acids are mutated to alanines. Since prolines may 
induce a structural constraint on the RSM, this result suggests that recognition 
of  G4 structures may depend on the conformational organisation of  the RSM. 
Finally, as observed with RHAU(RSM-mut1) and RHAU(RSM-mut3) mutants, 
Pro-54 as well as the polar residues Lys-58, Arg-60 and Glu-61 appear to be 
dispensable.
As expected, RHAU proteins with mutated RSM and displaying strong 
G4-RNA binding deficiency (RSM-mut2 and 6) also had reduced G4 resolving 
activity (Figure 23C). In contrast, despite the slight reduction of  G4 binding activity 
observed for RHAU(RSM-mut1) and RHAU(RSM-mut3), these two mutants 
unwound G4 structures with an efficiency comparable to wild-type RHAU. We 
concluded from these in vitro mutagenesis experiments that the highly conserved 
residues in the RSM domain are essential for RHAU G4 structure binding and 
resolving activities.
ATPase activity of RHAU N-terminal truncated mutants
Hitherto, it could not be excluded that the introduced mutations caused 
significant conformational changes in the helicase core domain that resulted in 
enzymatically defective proteins. To define whether loss of  G4 resolvase activity 
was due to loss of  G4 binding by the N-terminal domain or to impairment of  
the basic activity of  the helicase core domain, we compared the ATPase activities 
† Consensus RSM is listed according to the Seefeld convention (315), symbol nomenclature 
stands for: π (pi) = small side chain, ζ (zeta) = hydrophilic, [+] = basic, Ψ (Psi) = aliphatic, 
Ω (Omega) = aromatic.
mutants in the absence of ATP. The reaction mixtures were analysed by native PAGE. An autoradiogram of the gel is shown. (C) G4-RNA unwinding assay: 
radiolabelled tetramolecular rAGA at a concentration of 4 nM was incubated in the presence of ATP without protein (−) or with increasing amounts (6, 20 and 
60 nM) of either WT RHAU or the indicated RSM mutants. The reaction products were resolved by native PAGE after disrupting RNA-protein interactions 
with SDS. An autoradiogram of the gel is shown. An aliquot of the duplex substrate that was heat-denatured (95 °C, 5 min) and then quenched (∆T) serves 
as a marker for the position of single-stranded RNA.
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of  RHAU mutants and wild-type RHAU. As shown previously (32), RHAU 
exhibited significant ATPase activity in the absence of  nucleic acids, which was 
stimulated substantially by the presence of  homopolymeric poly(U) (Figure 24A). 
Both the RNA-dependent and -independent ATPase activities were proportional 
to the amount of  input RHAU protein. To exclude the possibility that the 
RNA-independent ATPase activity observed was due to contaminants derived 
from HEK293T cells, we substituted the Glu-335 residue with Ala within the 
Walker B site (DEIH → DAIH), which abolishes RHAU ATPase activity (32). 
RHAU(DAIH) protein was prepared according to the protocol employed for 
wild-type RHAU protein, with comparable yield and purity (Supplementary Figure 11). 
In contrast to wild-type RHAU, RHAU(DAIH) showed no ATPase activity, even 
in the presence of  poly(U) (Figure 24B). Thus, we concluded that wild-type RHAU 
harbours intrinsic RNA-independent ATPase activity, which can be further 
stimulated by homopolymeric RNA.
To clarify the biochemical basis of  the absence of  G4 resolvase activity 
in the RHAU(∆RSM) mutant, we measured the rate of  ATP hydrolysis by this 
mutant and compared it to that of  the wild-type RHAU and the RHAU(∆Gly) 
mutant that was still proficient in G4-unwinding. In the absence of  RNA 
cofactor, the ATPase activity of  RHAU(∆RSM) protein was the same as 
RHAU(WT) and RHAU(∆Gly) proteins (Figure 24C), suggesting that the deletion 
of  the Gly-rich (∆Gly) or the RSM (∆RSM) domains does not affect the 
basal ATPase activity of  RHAU. However, the extent of  poly(U)-dependent 
stimulation of  ATPase activity of  RHAU(∆RSM) was about 60 % of  that of  
RHAU(WT) and similar to that of  RHAU(∆Gly). Taken together, these results 
indicate that deletion of  the N-terminal region of  RHAU does not cause any 
significant conformational changes to the helicase core but renders the RHAU 
protein less responsive to RNA in the stimulation of  its ATPase activity. Given 
that RHAU(∆RSM) retained significant RNA-dependent ATPase activity, 
equivalent to the G4 resolvase proficient RHAU(∆Gly) mutant, we concluded 
that the lack of  G4 resolving activity in the RHAU(∆RSM) mutant resulted from 
the loss of  G4 binding by the N-terminal domain.
CG9323, the Drosophila orthologue of RHAU efficiently unwinds 
G4-RNA
Based on sequence analysis, RHAU has clear orthologues in almost all 
species of  the animal kingdom ranging from choanoflagellates to humans. A 
multiple sequence alignment between eight of  these orthologues showed the 
helicase core (aa. 183–625) together with the C-terminal region (aa. 626–1008) of  
RHAU to be evolutionary conserved (Supplementary Figure 5). In contrast, sequences 
Figure 24 | ATPase activity of wild-type 
RHAU and N-terminal mutants. (A) The 
extent of ATP hydrolysis by wild-type RHAU 
in the presence (○) or absence (●) of poly(U) 
plotted as a function of input RHAU. The 
ATPase activity is expressed as a function 
of the activity obtained with WT RHAU at 
a concentration of 200 nM when poly(U) 
was omitted. (B) Influence of poly(U) on the 
ATPase activity of WT RHAU and DAIH 
ATPase-deficient mutant (200 nM). The 
ATPase activity was represented relatively to 
that of WT RHAU in the absence of poly(U), 
that was set to 1. (C) Influence of poly(U) on 
the ATPase activity of WT RHAU and ∆Gly or 
∆RSM RHAU mutants (200 nM). The basal 
ATPase activity (without nucleic acid cofactor) 
of WT RHAU is indicated (dashed line). The 
data represent the means ± SEM from three 
independent experiments
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of  the N-terminal region (aa. 1–182) show little similarity with the exception 
of  the highly conserved RSM (aa. 54–66) and its surrounding region (aa. 54–
100). Considering the apparent importance of  the RSM in the recognition of  
G4 structures and the high conservation of  its sequence together with the rest 
of  RHAU protein, we surmised that the G4 binding and resolving activity of  
the RHAU protein are conserved among higher eukaryotes. To validate this 
hypothesis, we cloned and characterised CG9323, the Drosophila orthologue of  
RHAU.
CG9323 is a 942 amino acid-long protein, which like RHAU comprises all 
the typical signature motifs of  the DEAH-box family of  RNA helicases (Figure 25). 
RHAU :
CG9323 :
* * * * 50 * *
MSYDYHQNWGRDGGPRSSGGGYGGGPAGGHGGNRGSGGGGGGGGGGRGGRGRH AKKQGQKNKEAERQER-------
MQRDRDS------------------------------------SGSNARKGNR RNLARQQKKDRGENAESKEPQIR
: 82
: 53
RHAU :
CG9323 :
* 100 * * * * 150 * *
--AVVHMDERREEQIVQLLNSVQAKNDKESEAQISWFAPEDHGYGTEVSTKNTPCSENKLDIQEKKLINQE-KKMFRIRNRSYIDRDSE
LGCNVSAPSGVLERVKELMEDY---SR----APSRQN-----------VDDKNV-------------DAKFQQQFRHLL-----SVNFE
: 168
: 106
RHAU :
CG9323 :
* * 200 * * * * 250 *
YLLQ--------ENEPDGTLDQKLLEDLQKKKNDLRYIEMQHFREKLPSYGMQKELVNLIDNHQVTVISGETGCGKTTQVTQFILDNYI
EFVAETKERNADLDWVNPKLDERLQLELGQRQLEENAKKRLEARKKLPTMKYADDIIQAVRENQVILIVGSTGCGKTTQVPQILLDDAI
: 249
: 195
RHAU :
CG9323 :
* * * 300 * * * * 350
ERGKGSACRIVCTQPRRISAISVAERVAAERAESCGSGNSTGYQIRLQSRLPRKQGSILYCTTGIILQWLQSDPYLSSVSHIVLDEIHE
SRGCASSCRIICTQPRRISAIAIAEWVSYERCESLG--NSVGYQIRLESRKARERASITYCTTGVLLQQLQSDPLMHNLSVLILDEIHE
: 338
: 282
RHAU :
CG9323 :
* * * * 400 * * * *
RNLQSDVLMTVVKDLLNFRSDLKVILMSATLNAEKFSEYFGNCPMIHIPGFTFPVVEYLLEDVIEKIRYVPEQKE-HRCQFKRGFMQGH
RSVETDLLMGLLKVILPHRPDLKVILMSATVREQDFCDYFNNCPMFRIEGVMFPVKMLYLEDVLSKTNYEFQKFRDRRP-K--------
: 426
: 362
RHAU :
CG9323 :
450 * * * * 500 * * *
VNRQEKEEKEAIYKERWPDYVRELRRRYSASTVDVIEMMEDDKV-DLNLIVALIRYIVLEEEDGAILVFLPGWDNISTLHDLLMSQVMF
---RDPPERRMKHEAMIEPYLRRIRNSYDSRVLDKLRLPESEGCEDIDFIADLVYYICENEPEGAILVFLPGYDKISQLYNILDKPKTS
: 514
: 448
RHAU :
CG9323 :
* 550 * * * * 600 * *
KS----DKFLIIPLHSLMPTVNQTQVFKRTPPGVRKIVIATNIAETSITIDDVVYVIDGGKIKETHFDTQNNISTMSAEWVSKANAKQR
KGQRWRDHMAVFPLHSLMQSGEQQAVFRRPPAGQRKVIISTIIAETSVTIDDVVYVINSGRTKATNYDIETNIQSLDEVWVTKANTQQR
: 599
: 537
RHAU :
CG9323 :
* * 650 * * * * 700 *
KGRAGRVQPGHCYHLYNGLRASLLDDYQLPEILRTPLEELCLQIKILRLGGIAYFLSRLMDPPSNEAVLLSIRHLMELNALDKQEELTP
RGRAGRVRPGICYNLFSRAREDRMDDIPTPEILRSKLESIILSLKLLHIDDPYRFLQTLINAPNPEAIKMGVELLKRIEALDQTGTLTP
: 688
: 626
RHAU :
CG9323 :
* * * 750 * * * * 800
LGVHLARLPVEPHIGKMILFGALFCCLDPVLTIAASLSFKDPFVIPLGKEKIADARRKELAKDTRSDHLTVVNAFEGWEEARRRGFRYE
LGMHLAKLPIDPQMGKMILMSALFCCLDPITSAAAALSFKSPFYSPLGKESRVDEIKRRMARNMRSDHLMVHNTIIAYRDSRYS--HAE
: 777
: 713
RHAU :
CG9323 :
* * * * 850 * * * *
KDYCWEYFLSSNTLQMLHNMKGQFAEHLLGAGFVSSRNPKDPESNINSDNEKIIKAVICAGLYPKVAKIRLNLGKKRKM---VKVYTKT
RDFCYKNFLSSMTLQQLERMKNQFSELLYNYKFLASSNCKDAASNKNSEKIPLLRAIIGAGLYPNMAHLRKSRQIKNRVRAIHTMATDD
: 863
: 802
RHAU :
CG9323 :
900 * * * * 950 * *
DGLVAVHPKSVNVEQTDFHYNWLIYHLKMRTSSIYLYDCTEVSPYCLLFFGGDISIQKDNDQETIAVDEWIVFQSPARIAHLVKELRKE
GRRVNFHPSSVNSGESGFDSAYFVYFQRQKSTDLFLLDSTMVFPMALIIFGDGVEAGVTQNTPYLCVAKTYYFKCNRETADVVIQLRSN
: 952
: 891
RHAU :
CG9323 :
* * 1000 * * *
LDILLQEKIESPHPVDWNDTKSRDCAVLSAIIDLIKTQEKATPRNFPPRFQD--GYYS
LEKLLLKKALYPAPIEENG---YEKQLIKAIELLLSLDERLGED----YISSDEIDDI
: 1008
: 942
*
PGHLKGREIGMWY
PPGLRGKDIGLYY
RSMNTR
I
Ia
IV
III
V
VI
Ib II
HCRNTR
HCR CTR
CTR
Figure 25 | Pairwise alignment of RHAU with its Drosophila orthologue CG9323. Amino acids that are identical or similar between the two sequences 
are shaded in black and grey, respectively. The RSM domain as well as helicase motifs I–VI are indicated below the sequences. Gly residues of the Gly-rich 
domain (aa. 10–51) of RHAU are depicted in orange. N-terminal (NTR, aa. 1–182), helicase core (HCR, aa. 183–625) and C-terminal (CTR, aa. 626–1008) 
regions are delineated with a coloured dashed line in red, green and blue, respectively.
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The overall identity and similarity between CG9323 and RHAU 
are 34 % and 52 %, respectively, but not evenly distributed along 
the entire sequence. Sequence similarity with RHAU is particularly 
high (41 % identity and 60 % similarity) for the helicase core and 
the C-terminal regions of  CG9323. Nevertheless, apart from the 
conserved RSM, the CG9323 N-terminal region lacks evident 
sequence resemblance to RHAU. In addition, the CG9323 
N-terminal region is 25 % shorter than that of  RHAU, mainly 
due to the absence of  the Gly-rich sequence upstream of  the 
RSM.
To check whether the Drosophila orthologue of  RHAU 
retains G4 binding and resolving activities, CG9323 was expressed 
as a FLAG-tagged recombinant protein and immunopurified to 
homogeneity as shown in Supplementary Figure 10. The ability of  
purified recombinant CG9323 protein to unwind and to bind 
G4 structures was assessed under the conditions previously 
employed for RHAU. As shown in Figure 26A, CG9323 efficiently 
unwound the G4-RNA substrate. As for RHAU, the extent of  
products resolved by CG9323 was proportional to the input 
protein. Furthermore, CG9323 failed to resolve G4 substrates in 
the presence of  the non-hydrolysable ATP analogue AMP-PNP, 
indicating that G4-unwinding by CG9323 requires the hydrolysis 
of  nucleosides triphosphate.
Similar to RHAU, CG9323 also formed a stable 
complex with G4 substrates in the absence of  hydrolysable 
rNTPs (Figure 26B). In binding experiments, CG9323 turned out to 
be more specific for G4-RNA relative to ssRNAs, since CG9323 
bound tetramolecular rAGA with a 10-fold higher affinity than 
monomeric single-stranded rAGA oligoribonucleotides of  
the same sequence. This observation, by analogy, is consistent 
with earlier observations that RHAU has poor sequence-
specific recognition of  ssRNAs (32,89). Finally, a variant form of  
CG9323, in which highly conserved residues of  the RSM were 
mutagenised, displayed reduced G4 binding activity, suggesting 
that the RSM is essential for the recognition of  G4 structures 
by CG9323 (Figure 26C). In conclusion, these results provide 
compelling evidence that the G4 binding and resolving activities 
of  RHAU have been conserved from Drosophila to human, with 
the RSM playing a pivotal role.
DIScUSS IoN
Owing to their bulky and thermodynamically stable features, 
G4 structures have been shown in many respects to impede 
normal nucleic acid metabolism (190,200,208,209,228,229,316,317). 
To cope with this problem, proteins are produced that mitigate 
Figure 26 | G4-RNA unwinding and binding by CG9323. (A) G4-RNA unwinding assay: radiolabelled tetramolecular rAGA at a concentration of 4 nM was 
incubated in the presence of ATP or AMP-PNP (as indicated) without protein (−) or with increasing amounts (2, 6, 20 and 60 nM) of purified recombinant 
CG9323 protein. The reaction products were resolved by native PAGE after disrupting RNA-protein interactions with SDS. An autoradiogram of the gel is 
shown. An aliquot of the duplex substrate that was heat-denatured (95 °C, 5 min) and then quenched (∆T) serves as a marker for the position of single-
stranded RNA. (B) G4- and single-stranded-RNA binding assay: tetramolecular (left) or monomeric (right) radiolabelled rAGA at a concentration of 100 pM 
were incubated without protein (−) or with increasing amounts (10, 30 and 100 nM) of CG9323 in the absence of ATP. The reaction mixtures were analysed 
by native PAGE. An autoradiogram of the gel is shown. (C) G4-RNA binding assay: radiolabelled tetramolecular rAGA at a concentration of 100 pM was 
incubated without protein (−) or with increasing amounts (3, 10 and 30 nM) of WT or RSM-mut2 CG9323 proteins in the absence of ATP. The reaction mixture 
were analysed by native PAGE. An autoradiogram of the gel is shown.
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effects of  these atypical stable structures. Eight human helicases, including 
RHAU, have been shown so far to harbour G4 resolving activity in vitro. These 
include the SF1 helicases Pif1 (233) and Dna2 (246), as well as the RecQ family 
proteins BLM (227,243) and WRN (226), the Rad3-like helicases FANCJ (228) 
and DDX11 (230) as well as the DEAH-box RNA helicase A (DHX9, ref. 238). 
Apart from DHX9 and RHAU, these proteins are all DNA helicases that have 
been clearly implicated in the maintenance of  genome integrity (22,23,248,249,318). 
Both RHAU and DHX9 belong to the DEAH-box family of  RNA helicases 
and show very little sequence similarity with the above mentioned helicases. 
Curiously, RHAU was initially identified as a G4-DNA resolvase enzyme (33). 
The possibility that G4-RNA structures are targets of  RHAU emerged from 
in vivo UV-crosslinking results showing RHAU binding mainly to RNA (268). 
Subsequent characterisation of  RHAU demonstrated its aptitude to resolve G4-
RNA better than G4-DNA (89). This finding was a remarkable breakthrough, 
since RHAU was the first helicase to possess G4-RNA resolvase activity. 
Furthermore, RHAU is one of  the rare DExD/H-box proteins that exhibit high 
affinity and specificity for its substrate in vitro independent of  accessory proteins. 
Since this finding, efforts have been made to understand the mechanism 
underlying recognition of  G4 structures by RHAU. The present study shows 
that the N-terminal region of  RHAU is essential and responsible for binding of  
RHAU to G4 structures. Further investigations dissecting the N-terminal region, 
coupled with site-directed mutagenesis, have demonstrated that the RSM makes 
a decisive contribution to the high affinity of  RHAU for G4 structures. Sequence 
comparisons of  RHAU orthologues from various species showed the RSM to be 
the unique highly conserved part of  the N-terminal region. Hence, we predicted 
that all orthologous forms should possess G4 resolving activity based on the 
functional significance and sequence conservation of  the RSM domain and the 
catalytic region. This hypothesis was supported by the robust ATP-dependent 
G4-RNA resolvase activity found for CG9323, the Drosophila form of  RHAU. 
As expected, and also shown for RHAU, the binding of  CG9323 to G4-RNAs 
depended on RSM integrity, which further indicated similar functions for this 
motif  in both proteins.
Recognition of G4-RNA by RHAU depends on the N-terminal 
RSM
RHAU shares with most helicases a global scheme of  modular architecture 
that combines a conserved central helicase core domain with peripheral regions 
of  various lengths and sequences (319). Together with previous findings (268,320-
322), our results indicate that the helicase core alone cannot account for the 
high specificity of  function usually attributed to DExD/H-box proteins. In 
this regard, these data also agree with numerous structural observations that 
the helicase core region of  DEAD-box proteins interacts essentially in a non-
sequence-specific manner with the phosphoribose backbone of  single-stranded 
nucleic acid (27,138,139,311,312). Such contacts suffice to discriminate RNA from 
DNA by means of  the 2′-hydroxyl groups of  the ribose moieties, but not to 
distinguish between sequences of  varying nucleotide composition. In the 
present work, we have shown the importance of  the unique N-terminal flanking 
region in adapting the conserved catalytic core to a specific function. The 
present investigation has also shown clearly that, although necessary, ATPase 
activity by itself  is not sufficient for RHAU to unwind G4 structures. Our data 
strongly suggest that the establishment of  a stable complex between RHAU 
and its G4 substrate is a prerequisite for the subsequent ATPase-dependent 
unwinding of  the G4 structure. We propose that the N-terminal RSM endows 
the enzyme with specificity by binding the G4 substrate, thereby positioning 
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the helicase core in close proximity to the substrate. Likewise, critical roles for 
N- and C-terminal flanking regions have been reported for several DExD/H-
box proteins, exerting specific functions by interacting with particular RNA 
species/structures or with other regulatory proteins (320,323-325). For example, 
the prototypical yeast DEAH-box proteins Prp16 and Prp22 and the human 
orthologue HRH1 (alias DHX8 or hPrp22) have been shown to associate with 
the spliceosome via their non-conserved N-terminal regions (110,116,117). The 
Drosophila maleless (MLE) protein, more closely related to RHAU, harbours 
two copies of  dsRNA binding motifs (dsRBM) in its N-terminal region (326). 
Their deletion, as with the N-terminal truncation of  RHAU, caused the loss 
of  RNA-binding and unwinding activities in vitro and subcellular mislocalisation 
of  the protein in vivo (148). Together, these examples emphasise the role of  the 
peripheral domains of  DExD/H-box proteins in adapting a common catalytic 
core to a broad spectrum of  specific functions.
Potential role of the RSM in RHAU relocalisation to stress granules
The present work underscores the essential nature of  the conserved RSM, 
which endows RHAU with a high affinity for G4 structures in vitro. Determining 
the mechanisms whereby RHAU resolves G4 substrates in vivo is an important 
issue to be addressed in future. It is tempting to draw a parallel between the 
present observation and a previous report that the stress-induced recruitment of  
RHAU to stress granules is mediated by interactions of  RHAU with RNA (268). 
Similar to our observations, the region identified as essential for this activity 
included the RSM together with the upstream Gly-rich domain, underscoring 
the functional relevance of  the RSM and its surrounding region for the 
biological activity of  RHAU. The N-terminal region of  RHAU alone was also 
found to be sufficient to drive RNA binding in vivo as well to relocalise to stress 
granules (268). This observation, however, contrasts with the data presented 
here in that, although required for functional specificity, the N-terminal region 
alone does not constitute an independent and high affinity G4-RNA-binding 
domain. In this regard, our data rather suggest that both the N-terminal and 
helicase core regions are required for the productive interaction of  RHAU 
with G4 structures. Since the nucleic acid binding motifs Ia, Ib, IV and V of  
DEAH-box proteins have been proposed to contact RNA (118,141), we surmise 
that, for RHAU, the helicase core may also provide the protein with substantial 
binding activity by interacting in a non-specific manner with the phosphoribose 
backbone of  the single-stranded tail flanking the tetramolecular G4 structure. 
Further investigations into the functional contribution of  the RNA binding site 
of  the helicase core are needed to further challenge this hypothesis. In addition, 
our previous finding that the ATPase-deficient form of  RHAU [RHAU(DAIH)] 
stalls in stress granules (268) agrees with the observation that, once bound to 
G4-RNA, RHAU(DAIH) cannot dissociate itself  from its substrate, even in 
the presence of  ATP (data not shown). This indicates that the G4-unwinding 
reaction requires ATP hydrolysis, rather than ATP binding per se, and further 
suggests that the release of  the RNA substrate occurs only after G4-unwinding. 
Stress granules may constitute a favourable environment for the formation of  
intermolecular G4-RNA structures, as they are temporary sites of  accumulation 
of  stress-induced stalled translation initiation RNP complexes (271,272). However, 
an important question that we have not yet addressed is whether RHAU 
relocalises to stress granules upon binding to G4-RNA structures. Interestingly, 
however, we noticed that RSM-mutated forms of  RHAU that are deficient for 
G4 structure recognition in vitro, manifest reduced association with RNA in vivo 
concomitantly with reduced relocalisation to stress granules (Chalupnikova, K., 
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unpublished data). Thus, this finding raises the possibility that at least a fraction 
of  RHAU is recruited to stress granules via interactions with G4 structures.
The mechanism by which RHAU recognises G4 structures is an important 
issue that needed to be addressed to improve our understanding of  RHAU. 
So far, however, little is known about its biological function as a potential G4 
resolvase enzyme. Recently, G4 structures in RNA have attracted considerable 
attention as a plausible means of  regulating gene expression (260,327). Formation 
of  G4 structures in the 5′-untranslated region has been shown to affect mRNA 
translation (190,208,209) and bioinformatics studies have identified more than 
50'000 potential G4 structures near splicing and polyadenylation sites of  
various human and mouse genes. This raises the possibility that G4-formation 
impedes RNA metabolism at many different stages (214). At the moment, we 
lack a corresponding understanding of  how cells negotiate with G4 structures 
in various RNA molecules. However, from the findings presented here, RHAU 
emerges as a promising regulator of  G4 structure-based RNA metabolism and 
merits future investigation of  its potential roles in different biological contexts.
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RHAU binds an intramolecular G4 structure 
in TERC and associates with telomerase 
holoenzyme
AImS AND RAT IoNALE
Although considerable information is available regarding the enzymatic 
activity of  RHAU in vitro (33,39,88,89), almost nothing is known about its 
biological function as a G4 binding/resolving enzyme in vivo. To address this 
question, we sought RNAs bound by RHAU in living cells, surmising that the 
identification of  RHAU-bound RNAs and understanding the effects of  RHAU 
should provide important clues to its function in vivo. To this end, we employed 
high-throughput gene array technologies to identify and quantify the co-purified 
RNAs on a genome-wide scale. With this screen, we identified about 100 RNAs 
significantly enriched by RHAU. Computational analysis of  RNA sequences for 
potential intramolecular G4 structures revealed the preferential association of  
RHAU with transcripts bearing G4-forming motifs, suggesting direct targeting 
of  G4-RNAs by RHAU. Amongst the RNAs with the potential to form G4 
structures and selectively enriched with RHAU, we identified TERC as a bona 
fide target of  RHAU. Characterisation of  the RHAU-TERC interaction in vivo 
and in vitro showed binding of  TERC by RHAU to be strictly dependent on 
the formation of  a G4 structure on the 5′-extremity of  TERC RNA and to 
require the N-terminal RSM domain of  RHAU. Finally, we have demonstrated 
that RHAU not only interacts with TERC stricto sensu, but is also part of  the 
fully assembled telomerase complex through direct interaction with TERC G4 
structure. Taken together, these data demonstrate that intramolecular G4-RNAs 
are naturally occurring substrates of  RHAU in vivo. Moreover, they provide 
indirect but strong support for the existence of  a G4-RNA structure in the 
telomerase RNP.
RESULTS
Microarray identification of RHAU-associated RNAs
To identify endogenous RNAs associated with RHAU in vivo on a genome-
wide scale, we designed a RIP-chip assay (RNA immunoprecipitation coupled 
to microarray analysis). Subsets of  RHAU target RNAs were isolated by 
immunoprecipitation (IP) assays under optimised conditions that preserved 
RNA-protein complexes. Briefly, HeLa cells were transfected with a vector 
expressing FLAG-tagged or myc-tagged RHAU. Immunoprecipitations of  non-
cross-linked whole-cell extracts were carried out using anti-FLAG antibodies. 
Anti-FLAG IP from cells expressing myc-tagged RHAU was employed as 
a control (IP
ctrl
) to assess nonspecific interactions that may occur during RIP. 
Following IP, co-fractionated RNAs were recovered and purified by standard 
phenol-chloroform extraction and converted to cRNA. Products were 
subsequently hybridised to human oligonucleotide arrays.
Western blot analysis of  immunoprecipitated proteins revealed that RHAU-
FLAG, but not RHAU-myc, was efficiently enriched from HeLa cell extracts 
following IP with anti-FLAG antibody (Figure 27A, bottom). Oligo(dT)-primed 
reverser-transcription of  co-immunoprecipitated RNAs showed the presence 
of  polyadenylated RNAs with sizes similar to the input (Figure 27A, top, compare 
lane 2 to lanes 3 and 4). With regard to the RHAU-FLAG IP fraction, very little 
background RNA signal was detected in the control immunoprecipitate (lane 1), 
demonstrating specific co-immunoprecipitation of  mRNAs with RHAU. The 
association between RHAU and target RNAs was deemed specific as the 
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anti-FLAG antibody exhibited no obvious cross-reactivity with other cellular 
proteins (data not shown). 
Microarray analysis of  the purified RNAs recovered from input and 
immunoprecipitated fractions revealed that 9'354 (49 %) of  the 19'089 total genes 
available on the chip were significantly expressed in HeLa cells overexpressing 
RHAU (data not shown). In order to maximise the chance of  identifying true 
RNA targets of  RHAU as well as to minimise the occurrence of  false positives, 
only those RNAs were chosen that were significantly (adjusted P-value < 0.01) 
enriched and were at least two-fold more abundant in the RHAU-FLAG IP 
fraction than in the control. Of  these potential RHAU targets, we discarded 
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Figure 27 | Analysis of the RNAs co-immunoprecipitated with RHAU RNPs. (A) RHAU associates with poly(A)+ RNAs in HeLa cells. First strand cDNA 
synthesis from input (lanes 3 and 4) and co-immunoprecipitated (lanes 1 and 2) RNAs was monitored by incorporation of [α-32P]dATP. The RT-PCR reaction 
products were separated by agarose gel electrophoresis. An autoradiogram of the gel is shown. The positions and sizes (kb) of marker DNAs are indicated 
at the left. Signal intensities are expressed relative to the average signal intensity of the input fractions (lanes 3 and 4). Expression and specific enrichment 
of RHAU-FLAG in input and FLAG-IP fractions were verified by Western blot analysis. (B) Scatter plot representation of the differential enrichment of RHAU-
bound versus nonspecific RNAs as quantified by microarray analysis. The pink rectangle delineates the area of RNA specifically enriched by RHAU. RNAs 
whose enrichment was further validated by semi-quantitative RT-PCR are indicated. (C) Validation of novel RHAU-bound target RNAs. The abundance 
of 10 potential RHAU targets and 4 non-targeted RNAs in total input RNA (lanes 3 and 4), control IP (lane 1) and RHAU-FLAG IP (lane 2) fractions was 
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those that were also significantly enriched in the RHAU-myc expressing cells 
and might thus be RHAU-independent RNAs binding non-specifically to the 
anti-FLAG antibody matrix.
Thus, of  the 9'354 genes expressed in HeLa cells, 108 RNAs (1.2 %) 
were found to be significantly enriched in RHAU-FLAG IP fraction compared 
with total input RNA (Figure 27B). Finally, after subtraction of  two non-target 
RNAs based on the above-mentioned criteria that were associated with the 
antibody or the beads, 106 RNAs were judged to be specifically enriched by 
RHAU (Supplementary Table II). The most abundant transcripts of  these potential 
RHAU targets were selected for further analysis.
Validation of potential RHAU target RNAs
To assess independently the validity and reproducibility of  the identified 
RHAU-associated transcripts, RNA abundance in total input RNA, control IP 
and RHAU-FLAG IP fractions from fresh whole-cell extracts were analysed by 
semi-quantitative RT-PCR. As shown in Figure 27C, ten RNAs randomly selected 
from the group of  plausible RHAU targets were confirmed to be enriched more 
than two-fold in the RHAU-FLAG IP fraction than in the control IP or input 
fractions. Besides, four non-targeted RNAs were included as negative control to 
monitor RHAU binding to non-specific RNAs. None of  them were found to be 
enriched in the RHAU-FLAG IP fraction despite their relatively high abundance 
in the input fraction. Taken together, these independents results validate the 
previous RIP-chip data. We assume that the remaining RNA species are also 
part of  RHAU RNPs, although additional experiments would be necessary to 
confirm this supposition.
G4-content analysis for RNAs enriched by RHAU
As RHAU shows a high affinity for G4-RNA structures in vitro (89), we 
next carried out a bioinformatics search for RNAs with potential intramolecular 
G4 structures. The rationale was that if  RHAU binds G4-RNA in vivo, the 
proportion of  potential G4-forming sequences should be higher among RNAs 
enriched by RHAU than among non-enriched RNAs. Of  the various available 
methods for predicting intramolecular G4 motif  sequences, we used QGRS 
Mapper that identifies and scores each potential G4-forming sequence according 
to their predicted stabilities (293). Being aware that only limited experimental 
data so far support the scoring method of  QGRS Mapper, we employed the 
algorithm to identify potential G4-forming sequences, but we also included the 
G4-score-based analysis as Supplementary Material (Supplementary Figure 12), since 
the two approaches provided similar results. In fact, with almost eight potential 
intramolecular G4-forming sequences (PQS) per kilobase, the occurrence of  
G4 motif  sequences was higher in the fraction enriched by RHAU than in any 
other fraction (Figure 28A and Supplementary Figure 12A). In addition, there was a 
weak (R2 = 0.10) but significant positive correlation between the predicted G4 
motif  density per transcript and the magnitude of  RNA enrichment by RHAU. 
Randomisation of  RHAU target sequences, retaining single- or even di-nucleotide 
frequencies of  the original transcripts, significantly reduced the proportion of  
potential G4-forming sequences (Figure 28B and Supplementary Figure 12B). Thus, the 
proportion of  G4 motif  sequences among RHAU-associated transcripts cannot 
be explained by a mere bias in nucleotide composition.
It should be mentioned that our prediction is likely to overestimate 
the number of  G4-forming motif  sequences per transcript. In fact, we also 
considered G4 structures consisting of  only two successive G-tetrads as these 
metastable structures have also been demonstrated to have biologically relevant 
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Figure 28 | Computational analysis of potential intramolecular G4-forming sequences (PQS) among RNAs enriched by RHAU. (A) Box plot 
representation of the density of potential intramolecular G4-forming sequences per transcript (PQS∙kb−1) as a function of their level of enrichment by RHAU. 
The lower and upper boundaries of the boxes indicate the 25th and 75th percentiles, respectively. The white lines within the boxes mark the median. The width 
of the boxes is proportional to the number of transcripts found within a group. The error bars indicate the 10th and 90th percentiles and the filled circles the 5th 
and 95th percentiles. The pink rectangle refers to the group of 106 RNAs specifically enriched by RHAU and serves as a control group for multiple comparison 
analysis. Statistical significance was determined by Kruskal-Wallis one-way ANOVA on ranks and the Dunn’s test. nsP ≥ 0.05; *P < 0.05; **P < 0.01. The 
correlation between the two variables was estimated by linear regression analysis (y = 2.56x + 5.60, R2 = 0.10, P < 0.001) and is indicated as a red line on 
the graph. (B) PQS analysis among randomised RHAU target sequences. The sequences of the 106 transcripts specifically enriched by RHAU were shuffled, 
retaining single- or di-nucleotide base composition of the original transcripts. The box plot represents the density of PQS (PQS∙kb−1) among the original (not 
rand.), di-nucleotide shuffled (di-NT rand.) and single-nucleotide shuffled (single-NT rand.) sequences. Statistical significance was determined by one-way 
repeated measures ANOVA and the Dunnett's test. (C) Proportions of RNAs bearing stable PQS as a function of their level of enrichment by RHAU. The 
pink rectangle refers to the group of 106 RNAs specifically enriched by RHAU. The dashed red line denotes the proportion of sequences showing stable 
PQS in the input fraction. Significant (P < 0.001) association between the magnitudes of the two variables was estimated by the chi-square-test-for-trend.
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roles (317,328,329). However, after discarding these less-stable G4 structures from 
the analysis, we still observed a significant relationship between the proportion 
of  sequences bearing potentially stable G4-forming sequences (composed of  
three or more stacked G-quartets) and the magnitude of  RNA enrichment by 
RHAU (Figure 28C). Indeed, with more than half  of  the sequences presenting 
potentially stable G4-forming sequences, the group of  106 RNAs identified 
as true RHAU targets presents one of  the highest incidences of  potentially 
stable G4-forming motifs. In summary, the present data are consistent with 
preferential association of  RHAU with transcripts containing potential G4-
forming sequences, suggesting direct recognition of  G4-RNA structures by 
RHAU. To further test this hypothesis, we selected one of  the identified RHAU 
targets and addressed the molecular basis of  its interaction with RHAU.
RHAU associates with TERC through its G4 motif sequence
Within the pool of  transcripts enriched by RHAU and showing a high 
potential to form stable G4, TERC is the only RNA reported previously to form 
a stable and parallel G4 structure in vitro (Figure 29A; ref. 224). TERC was also 
found to be one of  the most abundant RNAs enriched by RHAU in several 
independent RIP-chip assays using various cell lines (Supplementary Table II and 
unpublished data). To address the role of  the TERC G4 structure in its efficient 
co-immunoprecipitation by RHAU, we cloned the TERC gene, including its 
promoter and 3′ flanking genomic sequence. The 5′ extremity of  the TERC 
sequence was subsequently mutated (G4-MT) or truncated (∆G4) to prevent G4 
formation (Figure 29B). To avoid effects on the structurally conserved P1 helix by 
the introduced substitutions, guanine residues that are part of  both the predicted 
G4 structure and the P1a helix region were left intact. The recombinant forms 
of  TERC were transiently transfected into HEK293T cells and the accumulation 
of  stable TERC transcripts was monitored by RT-qPCR (Figure 29C). After 
24 hours, HEK293T cells transiently transfected with the TERC(WT) construct 
but not with the vector alone showed a substantial (~200-fold) increase in 
TERC abundance relative to endogenous TERC levels. Importantly, mutations 
of  the G4 motif  (G4-MT or ∆G4) did not influence the steady-state level of  
exogenous TERC expression in these cells since recombinant wild-type, G4-MT 
and ∆G4 forms of  TERC accumulated to comparable levels.
To examine the significance of  the G4 motif  sequence for co-precipitation 
of  TERC with RHAU, we repeated the RIP assay using HEK293T cells 
transiently overexpressing the wild-type or G4-MT and ∆G4 mutated forms of  
TERC. Immunoprecipitations were carried out on endogenous RHAU using a 
monoclonal antibody against RHAU and TERC RNA abundance was analysed 
by RT-qPCR (Figure 29D). As already shown for endogenous TERC, a substantial 
amount of  overexpressed TERC(WT) was also recovered with endogenous 
RHAU, as evidenced by a 25-fold enrichment of  TERC transcript over the 
mock transfection (Figure 29D, compare lanes 4 and 2). In marked contrast, both 
G4 motif  mutated forms of  TERC were barely co-immunoprecipitated with 
RHAU, judged by the 95 % reduction in TERC abundance in the corresponding 
fractions compared with the WT control (Figure 29D, compare lanes 5 and 6 to 
lane 4). The drastic reduction in immunoprecipitation of  the TERC mutants was 
not due to nonspecific RNA degradation in these fractions. Indeed, comparable 
levels of  nonspecifically co-immunoprecipitated GAPDH RNA were found to 
contaminate all of  these fractions. Taken together, these results indicate that the 
intact G4 motif  sequence is a prerequisite for TERC association with RHAU in 
vivo.
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RHAU binds TERC through a G4 structure in the TERC 5′-region
In the absence of  Mg∙NTPs, RHAU specifically binds to tetramolecular 
G4-RNA structures with high affinity (88,89). The strict requirement for the G4 
motif  sequence for effective recovery of  TERC by RHAU in vivo suggested that 
RHAU may also form a stable complex with TERC through direct binding of  
the G4-RNA forming structure. To address this question in vitro, we performed 
RNA electromobility shift assays (REMSA) using purified recombinant GST-
tagged RHAU protein and in vitro transcribed radiolabelled full-length (1–451 
nt) and 5′-end (1–71 nt) TERC fragments. In the absence of  protein, the 
32P-labelled probes migrated as a single species in the gel (Figure 30A and B). 
Addition of  increasing amounts of  RHAU to both full-length and 5′-end TERC 
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Figure 29 | RHAU associates with TERC through its G4-motif sequence. (A) Schematic representation of the secondary structure of human TERC 
bearing a parallel G4 structure in the 5′-extremity as described by Mergny et al. (224). (B) Nucleotide sequence of the WT and G4 motif mutant (G4-MT 
and ∆G4) forms of TERC. Guanine tracts that are predicted to form a stable G4 structure are shown bold. Nucleotide substitutions or deletions in mutant 
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recombinant WT and G4 motif mutant forms of TERC in HEK293T cells. Expression was quantified by RT-qPCR, normalised to GAPDH expression and 
endogenous TERC levels set to 1. Data represent the mean ± SEM of three independent experiments. (D) RT-qPCR analysis of the abundance of WT 
and G4 motif mutant forms of TERC that co-immunoprecipitated with endogenous RHAU protein. RNA levels in IP fractions are represented in function of 
their respective abundance in the input fraction. Immunoprecipitation with mouse IgGs (mIgG) served as a control to assess nonspecific interactions. In 
lanes 4, 5 and 6, yellow hatches represent the fraction related to endogenous TERC signal and violet hatches represent the fraction of TERC RNA that 
non-specifically interacts with the antibody matrix or the beads. Data represent the mean ± SEM of five independent experiments. Comparable efficiency of 
RHAU immunoprecipitation in the various fractions was verified by Western blot analysis with anti-RHAU antibodies.
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fragments resulted in the appearance of  a high-affinity (estimated K
d
 of  10 nM) 
ribonucleoprotein complex of  reduced mobility. In contrast, the stability of  the 
RHAU-TERC interaction was strongly impaired (~20-fold reduction) when 
formation of  the G4 structure was prevented by mutation of  the G4 motif  
sequence (G4-MT, Figure 30C). Similarly, conditions that are unfavourable to G4 
stability (substitution of  K+ for Li+) impaired the RHAU-TERC interaction to 
comparable extent (Figure 30D). Replacing K+ by Li+ was indeed shown to strongly 
reduce the thermodynamic stability of  the TERC G4 structure (224). Thus, these 
results demonstrate a direct and specific interaction between RHAU and TERC 
dependent on RNA folding into a stable G4 structure. This is consistent with 
the above finding that RHAU can co-immunoprecipitate the wild-type but not 
the G4 motif  mutated forms of  TERC. Together these observations argue that 
a fraction of  TERC RNA forms a G4 structure that can be further bound by 
RHAU, in vivo.
RHAU associates with telomerase RNPs by direct interaction with 
TERC
In cells, the biogenesis of  the active telomerase enzyme follows a stepwise 
RNP assembly. Upon transcription, nascent TERC is first bound by proteins 
dyskerin, NHP2 and NOP10 and subsequently joined by GAR1 (for review, see 
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Figure 30 | Gel mobility shift assay for TERC G4 binding by RHAU. (A) Radiolabelled full-length (1–451 nt) and (B) 5′-end (1–71 nt) TERC fragments at a 
concentration of 100 pM were incubated without protein (−) or with increasing amounts (1, 3.2, 10, 32, 100 and 320 nM) of GST-tagged RHAU in the absence 
of ATP. The reaction mixtures were analysed by non-denaturing PAGE. An autoradiogram of the gel is shown. The positions of the free RNA substrate and 
the protein-RNA complex are indicated on the left. At concentrations up to 320 nM, GST protein alone had no effect on TERC mobility (data not shown). 
(C) RNA-binding assay with WT and G4 motif mutant (G4-MT) forms of TERC 5′-end (1–71 nt) fragments. Radio-labelled TERC fragments were incubated 
without protein (−) or with increasing amounts (3.2, 10, 32 and 100 nM) of GST-tagged RHAU. (D) Cation dependency of RHAU interaction with TERC. 
The 5′-end WT TERC fragment was incubated under standard (100 mM K+) or lithium-based (100 mM Li+) REMSA conditions without protein (−) or with 
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ref. 330). The co-transcriptional binding of  this RNP complex is essential 
for the processing and accumulation of  TERC transcripts. Finally, the 
catalytic protein component telomerase reverse transcriptase (TERT) 
assembles with the processed telomerase RNPs and forms the 
active telomerase holoenzyme. To determine whether RHAU was 
exclusively interacting with TERC during the transcriptional process 
or whether it was also part of  the telomerase RNP, we performed co-
immunoprecipitation assays and examined whether endogenous RHAU 
co-fractionated with endogenous dyskerin or FLAG-tagged TERT 
proteins. Immunoblot analysis showed that RHAU was present in both 
dyskerin and TERT immunoprecipitated fractions but absent in the 
control IP (Figure 31A and B, compare lanes 1 and 2). The association of  
RHAU with components of  the telomerase holoenzyme proved to be 
strictly dependent on the ability of  RHAU to bind the 5′-end of  TERC, 
since overexpression of  wild-type but not the G4 motif  mutated forms 
of  TERC resulted in extensive enrichment of  coprecipitating RHAU 
protein (Figure 31A and B, compare lane 2 to lanes 3, 4 and 5). Although 
mutations of  the TERC G4 motif  sequence severely impinged on 
the recruitment of  RHAU to the telomerase, they had no apparent 
repercussions on the steady-state expression level (Figure 31C) nor on the 
assembly of  the core components of  telomerase. Indeed, as shown in 
Figure 31D (compare lane 2 to lanes 3, 4 and 5), similar levels of  TERT 
protein co-fractionated with dyskerin following transient overexpression 
of  either wild-type or G4 motif  mutated forms of  TERC. These results 
suggest that RHAU does not strictly bind TERC in the course of  its 
biogenesis but that a fraction of  RHAU also associates with the fully 
assembled telomerase holoenzyme through direct interaction with the 
G4 motif  sequence of  TERC.
RHAU associates with telomerase activity
As RHAU binding to TERC requires a G4 structure, the 
finding that RHAU co-immunoprecipitated with components of  the 
telomerase complex suggested the existence of  an alternatively folded 
form of  TERC bearing a G4 structure in a fraction of  telomerase RNP. 
To address this further, immunopurified RHAU RNP complexes were 
analysed for telomerase activity by TRAP assay. In all the subsequent 
experiments, parallel immunopurification of  dyskerin served as 
a positive control for telomerase activity (331). In agreement with 
previous observations, TRAP assays of  antibody-bound complexes 
confirmed that substantial telomerase activity was recovered with 
RHAU but not with control IgGs (Figure 32A, top). Coomassie staining 
demonstrated similar yields of  immunoprecipitated RHAU and dyskerin 
proteins (Figure 32A, bottom) and protein identity was subsequently verified 
by Western blotting (Figure 32B).
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Figure 31 | Association of RHAU with telomerase holoenzyme subunits. (A) TERC G4 motif dependent association of RHAU with dyskerin. Proteins 
from whole HEK293T cell lysates of either mock-transfected (−) cells or transiently expressing WT or G4 motif mutant (G4-MT, ∆G4) forms of TERC were 
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To further examine the apparent significance of  G4 binding by RHAU for 
its recruitment to the telomerase holoenzyme, we transiently expressed a FLAG-
tagged mutant version of  RHAU (∆RSM, Figure 32C) that was unable to bind 
to G4 structures (88). Western blot analysis confirmed that the wild-type and 
G4 binding-deficient (∆RSM) forms of  RHAU were expressed and recovered 
to similar levels (Figure 32D). Immunopurified RHAU fractions were further 
assayed for telomerase activity and enrichment of  TERC (Figure 32E and F). As 
previously observed for endogenous RHAU, immunopurified FLAG-tagged 
RHAU(WT) efficiently recovered telomerase activity and co-precipitated TERC. 
In contrast, negligible telomerase activity and TERC signal were retrieved from 
the FLAG-tagged RHAU(∆RSM) mutant, showing that G4 binding by RHAU 
is a prerequisite for RHAU binding to TERC. Altogether, these findings provide 
persuasive evidence that a fraction of  RHAU associates with a subpopulation of  
RHAU
In
pu
t
Dyskerin
1 2 3 4
R
H
A
U
m
Ig
G
D
ys
k.
IP
B
A
R
H
A
U
m
Ig
G
D
ys
k.
IP
RHAU
Dyskerin
50
60
70
80
90
100
120
IgGHC
1 2 3
E
W
T
D
ys
k.
∆R
S
M
M
oc
k
1 2 3 4
IP
W
T
W
T
∆R
S
M
∆R
S
M
IPInput
RHAU-FLAG
1 432
D
F
0
2
4
6
8
W
T
M
oc
k
TE
R
C
 R
N
A
 le
ve
l
∆R
S
M
IP
WT
I Ia IbII III IV V VI
∆RSM
RSMGly-rich
C
182 1831 625 1008626HCRNTR CTR
Figure 32 | Association of RHAU with telomerase activity. (A) TRAP assay of immunopurified endogenous RHAU and dyskerin RNP complexes. RHAU 
or dyskerin RNP complexes were enriched by immunoprecipitation and a fraction of the immunopurified RNP was essayed for telomerase activity by the 
TRAP assay. Mouse IgGs (mIgG) served as a control to assess nonspecific interactions to the antibody matrix. A fraction of the immunopurified RNP was 
separated by SDS-PAGE. The Coomassie stained gel was scanned on a LI-COR Odyssey infrared imaging system. Positions of the immunoprecipitated 
proteins as well as the immunoglobulin heavy chains (IgGHC) are indicated at the right. Positions and sizes (kDa) of marker proteins are shown at the left. 
(B) Western blot analysis of the immunopurified RNP complexes assayed for telomerase activity. (C) Schematic representation of WT and G4 binding-
deficient (∆RSM) forms of RHAU. The conserved ATPase/helicase motifs I–VI of the DEAH-box family are indicated within the helicase core region (HCR) 
by vertical bars. The N-terminal Gly-rich (aa. 10–51) and RSM (RHAU-specific motif, aa. 54–66) domains are indicated. (D) Western blot analysis of the 
expression and enrichment of FLAG-tagged WT and ∆RSM forms of RHAU. (E) TRAP assay of immunopurified FLAG-tagged WT and ∆RSM forms of 
RHAU RNP complexes. (F) RT-qPCR analysis of the levels of endogenous TERC co-immunoprecipitating with FLAG-tagged WT and ∆RSM forms of RHAU 
RNP complexes. TERC RNA levels in IP fractions were normalised to endogenous levels of the input.
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the active telomerase holoenzyme in vivo through direct interaction with the G4-
motif  sequence of  TERC.
Finally, to determine the proportion of  telomerase activity associated with 
RHAU, we carried out immunodepletion studies of  RHAU in HEK293T cell 
lysates and subsequently quantified the residual TERC level and telomerase 
activity within these fractions (Figure 33A and B). Depletion with RHAU antibody 
significantly ablated telomerase activity in an aliquot of  the supernatant by 
25 %, while nearly 70 % of  the telomerase activity of  the input fraction was lost 
following depletion of  endogenous dyskerin. As a control, immunodepletion 
with control mouse IgGs produced no significant reduction in telomerase 
activity. Western blot analysis of  the supernatants confirmed that both RHAU 
and dyskerin proteins were effectively depleted from the corresponding 
fractions (Figure 33C). Furthermore, the quantification by RT-PCR of  RNA 
levels in the immunodepleted fractions was consistent with the above findings. 
Indeed, approximately one quarter of  input TERC, but not unrelated RNAs 
such as β-actin mRNA, vanished following depletion of  endogenous RHAU. 
These results not only corroborate the association of  RHAU with telomerase, 
but also show that the fraction of  telomerase interacting with RHAU accounts 
for merely 25 % of  the total telomerase activity. Nevertheless, these data provide 
indirect but explicit evidence of  the existence of  an alternatively folded TERC 
structure bearing a G4 scaffold in the fully assembled telomerase holoenzyme.
ATPase-dependent interaction of RHAU with TERC
The fact that only one quarter of  telomerase activity is linked to RHAU 
may reflect a dynamic interaction between RHAU and TERC. Indeed, most 
of  the DEAH-box RNA helicases only transiently interact with nucleic acid, 
because they do not remain bound after the ATPase-dependent remodelling 
of  their substrate (47,80,94,332). To gain insight into the role of  ATP-hydrolysis 
by RHAU in its interaction with TERC, we repeated gel mobility shift assays 
with 5′ TERC fragments in the presence of  Mg2+ or ATP or both. As shown in 
Figure 34A, ATP or Mg2+ alone had little effect on the binding affinity of  RHAU 
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Figure 33 | Quantification of the fraction of 
TERC and telomerase activity associated 
with RHAU. (A) qTRAP analysis of the 
residual telomerase activity present in 
immunodepleted HEK293T cell lysates. 
Data represent the mean ± SEM of three 
independent experiments. Statistical 
significance was determined by one-way 
ANOVA and the Bonferroni t-test. *P < 0.05; 
**P < 0.01; ***P < 0.001. (B) RT-qPCR 
analysis of the residual levels of TERC and 
β-actin RNAs in immunodepleted HEK293T 
cell lysates. The RNA signal was normalised 
to GAPDH. Data represent the mean ± SEM 
of three independent experiments. Statistical 
significance was determined by one-way 
ANOVA and the Bonferroni t-test. (C) Western 
blot analysis of input and immunodepleted 
HEK293T cell lysates. Heat shock protein 70 
cognate (HSC70) was used as a loading 
control.
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for TERC. In contrast, under conditions supporting ATP hydrolysis (Mg∙ATP), 
RHAU displayed reduced binding affinity for TERC, as evidenced by a 10-fold 
increase in the apparent equilibrium K
d
 value (Figure 34C). Such a reduction in the 
affinity of  RHAU for TERC was not observed when Mg∙ATP was substituted 
with the non-hydrolysable ATP analogue Mg∙AMP-PNP (Figure 34B and C). 
Thus, the present data suggest that intrinsic RHAU ATP hydrolysis rather than 
ATP binding is essential for disrupting the interaction of  RHAU with TERC. 
To further validate this, we turned to the previously described RHAU(DAIH) 
mutant in which the E335A amino acid substitution within the Walker B site 
abolishes RHAU ATPase activity (88). Unlike wild-type RHAU, the binding 
affinity of  RHAU(DAIH) mutant for TERC was similar in the absence and 
presence of  Mg∙ATP (Figure 34B and C). The absence of  RHAU helicase activity 
as a consequence of  the loss of  ATPase activity probably prevents RHAU 
dissociation from its substrate. In fact, a similar reduction in in vivo RNA 
binding dynamics after suppression of  RHAU intrinsic ATPase activity was 
reported previously in studies of  the shuttling of  RHAU in cytoplasmic stress 
granules (268). Taken together, these data corroborate the idea that RHAU is not 
permanently associated with TERC but dissociates upon ATP hydrolysis.
Apart from a high affinity for G4 structures, RHAU has also been shown 
to couple ATP hydrolysis with tetramolecular G4-RNA resolving activity (88,89). 
These biochemical properties prompted us to test whether RHAU could catalyse 
the conversion of  TERC G4 structure to ssRNA form. However, the faster 
rate of  refolding of  intramolecular G4 structures with regard to tetramolecular 
G4-RNAs made it technically difficult to monitor the G4 resolving activity of  
RHAU using standard non-denaturing gel electrophoresis.
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Figure 34 | Role of Mg∙ATP on the 
interaction of RHAU with TERC. (A) Gel 
mobility shift assay for TERC G4 binding 
by RHAU. Radiolabelled 5′-end (1–71 nt) 
TERC fragment at a concentration of 
100 pM was incubated without protein (−) 
or with increasing amounts (3.2, 10, 32 and 
100 nM) of purified recombinant GST-tagged 
RHAU in the presence of 1 mM Mg2+, ATP or 
Mg∙ATP (as indicated). The reaction mixtures 
were analysed by non-denaturing PAGE. An 
autoradiogram of the gel is shown. (B) Gel 
mobility shift assay of TERC G4 binding by 
the ATPase deficient RHAU(DAIH) mutant. 
Radiolabelled 5′-end TERC fragment 
was incubated without protein (−) or with 
increasing amounts (3.2, 10, 32 and 100 nM) 
of purified recombinant WT or DAIH mutant 
GST-tagged RHAU in the presence of 1 mM 
Mg2+, Mg∙ATP or Mg∙AMP-PNP (as indicated). 
(C) Quantification of gel mobility shift assays of 
WT and RHAU(DAIH) mutant binding to TERC 
5′-end (1–71 nt) fragment. The data represent 
the mean of three independent experiments. 
Error bars for SEM are omitted for clarity.
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Telomere lengthening phenotype in RHAU knocked-down cells
As evident in some human telomeropathies, deficiencies in proteins essential 
to telomerase biogenesis have often been related to decreased telomerase activity 
and accelerated telomere erosion phenotypes (333). Thus, to clarify the functional 
impact of  RHAU on telomerase activity, we undertook to assess telomere length 
in T-REx-HeLa cell lines stably transfected with doxycycline-inducible vector of  
shRNA against RHAU (shRHAU). As a control, we included a shRNA construct 
directed against the heterologous GFP mRNA (shGFP). After cells were treated 
for seven days with doxycycline, RHAU protein levels were efficiently reduced 
in shRHAU cells, whereas doxycycline had no detectable effect on shGFP 
control cells (Figure 35A). The cells were cultured further for 16 more days with 
doxycycline and telomere length was assessed by quantitative FISH (Q-FISH, 
ref. 334). As shown in Figure 35B, we found that in average the cells in which RHAU 
was down-regulated had slightly longer telomeres (~5.0 kb) than did the control 
cells (~3.5 kb). As the effect was not very pronounced after 16 days of  culture, 
the experiment was repeated but the cells were let to divide for a 42-day period. 
After six weeks of  culture, the mean telomere length from RHAU knocked-
down cells was about 3-fold higher compared to telomeres from control 
cells (Figure 35D). Although RHAU knocked-down cells had marked telomere 
length heterogeneity (Figure 35C), short and undetectable telomeres in these cells 
were nearly inexistent (Figure 35E and F). Reciprocally, more than 80 % of  RHAU 
knocked-down cells presented telomeres longer than 5 kb while only 30 % of  
control cell telomeres exceeded this value (Figure 35G). Taken together, these two 
time course experiments show that telomeres get gradually longer (~100 bp 
per day) in cells where RHAU expression was dampened, suggesting a possible 
direct or indirect negative role of  RHAU on human telomere homeostasis.
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Figure 35 | Telomeres get gradually longer 
in RHAU knock-down cells. (A) Western 
blot analysis of the efficiency of RHAU 
downregulation in HeLa T-REx cell lines 
stably transfected with doxycycline-inducible 
vector of shRNA against RHAU (shRHAU). 
(B) Mean telomere length of HeLa T-REx cell 
lines stably downregulated for RHAU after 
0, 9 and 16 days of culture in the presence 
of 1 μg∙ml−1 doxycycline. (C–G) Telomere 
length analysis of HeLa T-REx cell lines stably 
transfected with doxycycline-inducible shRNA 
expression plasmids after 42 days of culture 
in the presence of 1 μg∙ml−1 doxycycline. 
(D) Mean telomere length. (E) Undetectable 
telomeres. (F) Short (< 1.5 kb) telomeres. 
(G) Long (> 5 kb) telomeres.
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DIScUSS IoN
The propensity of  nucleic acid guanine-rich sequences to self-assemble 
into G4 structures in vitro has been recognised for several decades. Although 
RNA is also prone to form such structures, G4-RNA has not attracted as much 
attention as G4-DNA. Nevertheless, a growing body of  evidence indicates a 
significant role for G4 structure formation during RNA metabolism (207,335). 
As a consequence, G4 structures emerged as a plausible post-transcriptional 
means of  regulating the function of  coding and non-coding RNAs. However, 
little is known about the mechanisms by which G4-RNA formation is regulated 
in the cells. Indeed, only a few proteins have been reported so far to interact 
with G4-RNAs in vitro (254,259,262,265,267) and, apart from FMRP and FMR2P, 
experimental data on their biological activity subsequent to their interaction with 
G4-RNAs is scarce. Of  these G4-RNA binding proteins, RHAU is one of  the 
rare proteins that exhibits robust in vitro ATPase-dependent G4-RNA resolving 
activity, in addition to a high affinity and specificity for its target RNAs (89). 
These particular biochemical features promote RHAU as an ideal candidate for 
regulating G4-dependent RNA metabolism, although its in vivo RNA targets 
have not yet been determined. The present study aimed to identify naturally 
occurring RHAU targets with the emphasis on RNAs containing potential G4-
forming sequences. By RIP-chip assays, 106 RNAs were found to be significantly 
enriched with RHAU. Importantly, more than half  of  these RNAs contained 
G-rich sequences with potential to form stable G4 structures. In addition, there 
was a weak but significant correlation between the predicted G4 motif  density 
per transcript and the magnitude of  RNA enrichment by RHAU. Nevertheless, 
because RHAU appears to show significant affinity for RNAs not bearing G4-
forming sequences, we do not exclude the possibility that RHAU has affinity to 
other RNA structural features.
In-depth studies revealed that TERC, one of  the identified RNAs, was a 
bona fide target of  RHAU. Several independent RIP-chip assays using various cell 
lines further showed TERC to be one of  the most abundant RNAs enriched by 
RHAU. TERC bears a 5′ G-rich sequence that was previously shown to adopt a 
stable intramolecular G4 structure in vitro (224). Further investigations dissecting 
the basis of  the interaction between RHAU and TERC showed RHAU binding 
to be strictly dependent on G4 structure formation in the 5′ region of  TERC 
and to require the N-terminal RSM domain of  RHAU, an ancillary domain 
necessary for specific recognition of  G4 by RHAU (88). Moreover, RHAU was 
found to interact transiently with TERC in a manner dependent on its own 
ATPase activity. Together, these data provide the first evidence of  a specific 
and direct interaction between a G4 resolvase enzyme and a potentially relevant 
intramolecular G4-RNA substrate. Furthermore, in agreement with our previous 
reports (88,89), these data attest that G4-RNAs are naturally occurring substrates 
of  RHAU in vivo.
The 5′ extremity of TERC folds into an intramolecular G4 structure 
in vivo
In agreement with the observations presented here, Mergny and co-workers 
reported previously the formation in vitro of  a G4 structure in the 5′ region of  
human TERC (224). However, as for the great majority of  nucleic acid structures, 
direct experimental demonstration of  G4 structures in vivo is inherently difficult 
to prove. As such, our results do not directly prove the existence of  G4 
structures in vivo, but strongly support the notion that TERC can form a G4 
structure in the cells. Notably, RHAU can only bind TERC provided that all 
conditions necessary for the formation of  an intramolecular G4 structure (RNA 
76	 Chapter 3
sequence and ionic conditions) are met. Modifying any one of  the conditions 
is sufficient to reduce substantially the affinity of  RHAU for TERC. Moreover, 
we predict that formation of  a G4 structure in TERC is not exclusive to human 
cells, since the majority of  the mammalian orthologues of  TERC – with the 
notable exception of  the rodent forms – also harbours a potential 5′ G4-forming 
sequence (Figure 36). Insofar as the G4-RNA binding and resolving activities of  
RHAU are conserved in higher eukaryotes (88), it would not be surprising to find 
that RHAU binds the telomerase RNA moiety of  other mammals.
As reported previously (224), folding of  the 5′ region of  TERC into a G4 
structure is likely to interfere with the widely adopted secondary structure of  
human TERC (Figure 37). Indeed, according to the standard model of  TERC 
secondary structure (336), two of  the guanine tracts that are part of  the 
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GGGUUGCGGAGGGUGGGCCUGGGAGGGGUGGUGGCCAUUUUUUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCUGGGAGGGGUGGUGGCCAUUUUUUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCUGGGAGAGGUGGCGGCCAUUUUUUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCUGGGA-GGGUGGUGGCCAUUUUUUUUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCUGGGAGGGGUGGCGGUCGUUUUAUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCUCGGGAGGGGUGGCGGUCAUUUUCUGUCUAACCCUAACUGAA
GGGUGGGGGAGAGUGGGUCUGGGCGGGGCGGCGGUCACGUUUUGUCUAACCCUAACUGAG
GGGUGGGGGAGAGUGGGUCUGGGCGGGGCGGCGGUCACGUUUUGUCUAACCCUAACUGAG
GGGUGGGGGAGAGUGGGUCUGGGCGGGGCGGCGGUCACGUUUUGUCUAACCCUAACUGAG
GGGUGGGGGAGAGUGGGUCUGGGCGGGGCGGCGGUCACGUUUUGUCUAACCCUAACUGAG
GGGUUGUGGAGGGUGGGCCUGGGAGGGGAAGCGGUCAGUUUUUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCCAGGAGCGGUGGCGGCCAUUUUUUGUCUAACCCUAACUGAA
GGGUUGCGGAGGGUGGGCCCCGGGUUGGUGGCAGCCAUUUCUCAUCUAACCCUAAUUGAG
GGGUUGCGGAGGGUGGGCCCCGGGUUGGUGGCAGCCAUUUCUCAUCUAACCCUAAUUGAG
GGGUUGCGGAGGGUGGGCCCGGGAGUGGUGGCUGCCAUUUCGUGUCUAACCCUAACUGAG
GGGUUGCGGAGGGAGGGCCCGGGAGGGGUGAGCGUCCAUUAUCGUCUAACCCUAACUGAG
GGGUUGCGGAGGGUGGGCCCGGGAGGGGUGGGCGUCCUCUCUUAUCUAACCCUAACUAAG
GGGUUGCGGAGGGUGGGCCCGGGAGGGGUGGCGGUCACCCUUUUUCUAACCCUAACUAAG
GGGCUGAGGAGGGUGGGCUCGGGAGGGGC-CCGGUCAUUUCUCAUCUAACCCUAACUGAG
GGGUUGAGGUGGGUCAUCCCGGGUCGGCCGAGGGUCGCUGGUCUUCUAACCCUAACUGAU
GGGUUGAGGAUGGCGCCCCCGGGUCGGGCAGUGGUCUUUUUUGUUCUAACCCUAACUGGC
GGGUUGAGGAGGGUACGCCCGGGA-GGGCGGUGGUCUGUUCUGUUCUAACCCUAACUGAU
GGGUUGAGGAGGGUACGCCCGGGA-GGGCAGUGGUCUGUUCUGUUCUAACCCUAACUGAU
GGGUUGCGGAGGGUGGGCCCGGGAGGGGUGUCGGCCA-UUAGUGCCUAACCCUAACUGAG
GGGUUGCGGAGGGU-GGCCCGGGCCGGGUGAUGGCCGCAGCUCAUCUAACCCUAUUUGGG
GGGUUGAGAAUGGUGGG-CCGGGAGGGGAGGUGGGCAUGUUUUGUCUAACCCUAACGGAG
AGCCUGCGAGCCGCUGGGCCGGGAGGGGUGGUGGUCU-UCCCUGUCUAACCCUAAGUGAA
GGG-AGUGGAGGGUGGGCCCGGGACGGGCGCGGACCC--GGUAAUCUAACCCUGACUCAA
: GUGGCUCGGCCGGCGUGCCUGGGAGGGGGGGCUGGUCCCACUCUUCUAACCCUAAGGGUG
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GGGCUGCGGACGGGCUGCGUGGGCGGGUCGUCCGUCCUGGCACAUCUAACCCUAA-----
-----------------------------
-----------------------------
--------------ACCUAACCCUGAUUUUA
-------------------------------------------ACCUAACCCUGAUUUUA
-------------------------------------------ACCUAACCCUGAUUUUA
-------------------------------------
-------------------------------------
------GUCUAACCCUAUUGUU-
GACGCGCG--CCUCUUCUAACCCUAAAAACG
:Cricetulus griseus ------GUCUAACCCUGAAUUCG
-------GGCGGGUUG--CGGGAGCUGCGAGCGGCCG--UCUCGUCUAACCCUAA-AGAG
-------GCGUGGCGGGU---GGAAGGCU-CCGCUGU------GCCUAACCCUAAUGGGA
GGGGCGCGCGUGGCGGAU--GGGGAGGCU-CCAGUCU------CACUAACCCUAAU----
UG--------CGGCGG--CAGGUGGGGGC-UCAGUCU------UUCUAACCCUAAG----
AGGUCUUCGAUCUCCGGC--UGGGAGGCU-CUCGCUA------UUCUAACCCUAAC----
AGGCC--CUCCAGCGGUA-AUAGGAGAGU-UCUAUCC------UUCUAACCCUAAU----
GGCU----UACAGUGGGA--AUAGGAGGGGUCUAUAU------UUCUAACCCUAAU----
AAUCCGUGCUCAAUGUGG--ACGGAGGUC-UCUGUUU------CGCUAACCCUAAUACUG
AAUCCGUGCUCAAUGUGG--ACGGAGGUC-UCUGUUU------CGCUAACCCUAAUACUG
GUAUUUUCGGUAGUUUAAUUAGAGGGAUUGAAGGUUCCGCUUAUGCUAACCCUAAU----
GAAU-GUUACAGGCUCUCCGGAGAGGGGCGGUUUCUC--UGUCUUCUAACCCUAAU---G
GGGU-GUAAGGGGCUCUCUGGAGCGGGGCGAUUUCUC--UUCCUUCUAACCCUAAU---G
GCGCUGUAUGCAGCAUUCCGGAGAGGGGCGUUUUCUU--CUUUCUCUAACCCUAAU---G
AGGUCCGACAGCGCCGCGCUGCGGGGAG--AAAGUGUCGUU--CUCUAACCCUAAUGCGG
AGGUCCGGCGGCGCCGUGCUGCGGGGGAG-ACAGUGUCGCU--CUCUAACCCUAAUGUGG
GAGUGGCUUGCUG-----CGGGGUGGAGG-CGAUUUU------AACUAACCCUAAUAGAU
GCAUGCCUUGCUG-----CGGGGUGGAGG-CGUUUUU------AACUAACCCUAAUAGAU
----------------------ACGGAGU-GUCUC--------UUCUAACCCUAAA----
----------------------GCGGAGU-GUCUC--------UUCUAACCCUAAG----
----------------------ACGGAGU-GUCUC--------UUCUAACCCUAAA----
----------------------GCGGGGU-GUUCU--------ACCUAACCCUAAU----
----------------------GCAGAGU-ACUUU--------CUCUAACCCUAAC----
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Figure 36 | Conservation of the 5′ G4 motif 
sequence among mammalian orthologues 
of TERC. Multiple sequence alignment of the 
5′-regions of various TERC orthologues was 
carried out with MAFFT (version 6, ref. 313). 
Guanine tracts that are predicted to form 
a stable G4 structure are underlined. The 
P1 helix as well as the template region are 
indicated.
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intramolecular G4 also form the P1a helix. As a consequence, the P1a helix and 
G4 represent two mutually exclusive structures and may correspond to different 
functional states of  TERC. Insofar as helix P1 is required for template boundary 
definition in mammalian telomerase (337), formation of  a G4 structure in TERC 
may be detrimental to telomerase activity. On the other hand, G4 structure 
formation may protect TERC from degradation during telomerase biogenesis. 
Such a scenario was suggested quite recently by Collins and co-workers, who 
found that nucleotide substitutions within the G4-forming sequence markedly 
reduced accumulation of  the mature form of  TERC, thereby causing telomere 
shortening (34). Similar to our data, they also found that RHAU associates 
with the G4-forming sequence of  TERC in vivo, but in contrast to our finding, 
detected negligible telomerase activity with immunopurified RHAU fraction. 
Thus, further experiments are necessary to clarify the functional impact of  G4 
formation in TERC on telomerase biogenesis and activity.
In cells, the P1 duplex- and G4-folded forms of  TERC are likely to 
coexist in dynamic equilibrium. However, under physiological conditions, 
restoration of  helix P1 base pairing from the G4-folded conformation of  TERC 
is likely to require a catalyst due to the high thermodynamic stability of  the 
quadruplex (224). The biochemical properties and substrate specificity of  RHAU 
make it a likely candidate for catalysing such a reaction. Quite apart from its high 
affinity for TERC, RHAU manifests robust tetramolecular G4-RNA resolving 
activity (88,89) and was also shown to unwind various intramolecular G4-DNA 
structures in vitro (39). These data suggest that RHAU can resolve G4 structures 
irrespective of  the strand stoichiometry of  the G4 stem. Although unwinding 
of  TERC G4 by RHAU has not yet been demonstrated experimentally, our 
observation that RHAU dissociates from TERC upon ATP-hydrolysis, but not 
upon ATP-binding, supports the idea that RHAU couples ATP-hydrolysis to 
conformational changes of  TERC, resulting in the resolution of  the G4 and 
further release of  RHAU from its target RNA.
Finally, our data show clearly that RHAU does not exclusively interact 
with TERC during the early stages of  telomerase RNP assembly, but that it is 
also part of  a fraction of  the fully assembled telomerase holoenzyme. Notably, 
RHAU could be co-immunoprecipitated with TERT, the catalytic subunit 
of  telomerase, and substantial telomerase activity could also be recovered 
with purified endogenous RHAU. Insofar as the association of  RHAU with 
telomerase components relies exclusively on the presence of  a G4 structure 
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Figure 37 | Dynamic equilibrium between 
the P1a duplex- and G4-folded forms of 
TERC. RHAU may couple ATP-hydrolysis with 
unwinding of the 5′ G4 structure to restore 
helix P1 base-pairing.
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in TERC, these data provide circumstantial arguments for the existence of  an 
alternatively conformational state of  TERC bearing a G4 structure in a fraction 
of  telomerase holoenzyme. Based on the fraction of  telomerase activity co-
precipitating with RHAU, we can estimate that at least 25 % of  telomerase in 
HEK293T cells bears a G4 structure in its RNA moiety. Whether this minor 
fraction retains partial or fully telomerase activity is still an open question 
that needs to be addressed in future. Besides, further studies are necessary to 
provide explanations for the apparent negative effect of  RHAU on human 
telomere homeostasis. Currently, these results are somewhat inconsistent with 
the proposal of  a non-functional G4 conformational state of  TERC or with the 
observed telomere shortening phenotype in cells expressing G4 motif  mutated 
forms of  TERC (34). However, since RHAU interacts with many RNAs in cells 
and manifests disparate biological functions, it is above all necessary to clarify 
whether the telomere lengthening phenotype in RHAU knockdown cells results 
from a direct or indirect effect of  RHAU on telomerase activity.
RHAU may target other RNAs containing G4 structures
Apart from TERC, 54 further RNAs found to be associated with RHAU are 
predicted to form stable G4 structures (Supplementary Table II). The determination 
of  the modalities and the significance of  these interactions are essential issues 
to be addressed in the future. Nonetheless, the finding that RHAU associates 
preferentially with transcripts bearing potential G4-forming sequences strongly 
suggests that RHAU targets G4-RNA structures in cells. Although nearly 
three-quarters of  these G4-forming sequences are located in 5′ or 3′ UTRs of  
mRNAs (Supplementary Table II), it is important to stress that, to date, we have not 
observed any suppressive action of  RHAU on translational repression by G4 
formation in 5′-UTRs. Therefore, RHAU is unlikely to function as a general 
translational activator but may instead intervene in other aspects of  mRNA 
metabolism, such as pre-mRNA processing or mRNA turnover. Indeed, 
RHAU localises predominantly in the nucleus, where it concentrates in nuclear 
speckles (269). These are sites of  high transcriptional activity and mRNA splicing. 
Furthermore, RHAU relocalises to cytoplasmic stress granules in response to 
various cellular stresses (268). Although recruitment of  RHAU to stress granules 
is mediated by interaction with RNA, we have not yet examined whether 
this phenomenon depends upon binding of  RHAU to G4-RNA structures. 
However, considering that RSM-domain mutated forms of  RHAU deficient in 
G4-RNA binding also show reduced relocalisation to stress granules, it is likely 
that a fraction of  RHAU binds G4 structures in stress granules.
Collectively, the data presented here provides compelling evidence that 
RHAU is a bona fide G4 binding protein and of  the existence of  a G4 structure 
in TERC. Our results corroborate another study conducted by Collins and co-
workers, who found that the presence of  the G4 motif  sequence in TERC was an 
essential determinant for its interaction with RHAU and for optimal progression 
of  telomerase assembly (34). Therefore, the G4-dependent interaction between 
RHAU and TERC seems fairly well established. Nonetheless, it remains to be 
further clarified whether RHAU also contributes to regulating telomerase activity 
apart from its role during the biogenesis process. Besides, considering that G4 
structures may also form at telomeres or on telomeric RNA repeats (TERRA), 
one should keep in mind that RHAU may also intervene in telomere homeostasis 
independently of  its activity on telomerase. Finally, various lines of  evidence 
argue that telomerase has extra non-canonical functions which are unrelated 
to telomere maintenance (338). Insofar as TERC is still required for some of  
these functions, one should consider whether RHAU also plays a role in these 
telomere lengthening-independent processes.
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Structural model of the helicase core and HA 
regions of RHAU
AImS AND RAT IoNALE
As previously shown for Prp43, acquiring structural data of  helicases is 
a crucial step towards a better understanding of  the mechanisms by which 
these molecular motors bind and process their substrates. However, hitherto, 
our attempts to purify high yields of  soluble recombinant RHAU protein 
have not been successful which has precluded further crystallographic studies. 
Nonetheless, we took advantage of  the reasonable degree of  sequence similarity 
between paralogous DEAH-box proteins to build a homology model of  RHAU. 
Homology modelling is currently the most accurate computational method to 
generate reliable three-dimensional models of  proteins presenting high sequence 
similarity to another known protein structure (339,340). In order to interpret 
our biochemical data from a structural perspective, we generated a model of  
RHAU based on the high-quality and high-resolution crystal structure of  the 
prototypical DEAH-box protein Prp43 (113). With this approach, it emerges that 
the helicase core and the C-terminal HA region of  RHAU are likely adopting 
a comparable fold to that of  Prp43. These two regions in RHAU likely define 
the minimal functional catalytic unit for translocation along single-stranded 
nucleic acid. Overall, these computational structural data are consistent with our 
biochemical data and offer some valuable clues as to way RHAU may bind and 
unwind G4 nucleic acid structures.
RESULTS  AND DIScUSS IoN
Modelling and model quality assessment
Template selection and sequence alignments identified Prp43 as the 
best structural candidate with the highest similarity and sequence coverage 
for building a model of  RHAU. Indeed, a large part of  Prp43 amino-acid 
sequence (aa. 81–721) displays reasonable similarity (30 % identity and 50 % 
similarity) over 70 % (aa. 195–913) of  RHAU sequence (Supplementary Figure 14).
The three-dimensional model was generated by MODELLER (297) and had 
first to be refined as the program failed to provide structural predictions for three 
regions (1–182, 400–470 and 918–1008) of  RHAU due to insufficient sequence 
similarity with Prp43. Nonetheless, MODELLER successfully produced a 
664-amino-acid model of  RHAU including the helicase core and the HA 
region. ModFOLD (300) and QMEAN (299) programs were further employed to 
estimate the overall quality of  the refined model (Supplementary Figure 13). QMEAN 
program credited the modelled structure a QMEAN Z-score value of  −1.50 that 
is indicative of  an intermediate overall quality model. Likewise, the computed 
RHAU structure obtained a ModFOLD global model quality score value 
of  0.216 with a 2.3 % probability of  incorrectness. As shown in Supplementary 
Figure 13D and F the less reliable sections of  the computational model correspond 
to the C-terminal part (aa. 700–917) and some loop regions. Nevertheless, on 
the basis of  the results provided by the two verification algorithms (Supplementary 
Figure 13B and E), we considered the modelled structure of  RHAU of  sufficient 
quality to provide meaningful insights regarding the mechanisms of  nucleic 
acids binding and rNTP selectivity.
Overall comparison of RHAU and Prp43 structures
Despite a moderate sequence similarity, the helicase core and the HA 
region of  RHAU show a remarkable structural similarity to that of  Prp43, with 
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a C
α
 RMSD value of  1.71 Å over 632 residues (Figure 38A). The main structural 
discrepancies include several mismatched loops corresponding to residues: 
255–258, 512–516, 542–544, 655–656, 769–779, 815–826, 850–858 and 875–
882. Besides, as mentioned earlier, a 71 amino acid-long region (400–470) in 
the N-terminal region of  the RecA2 domain of  RHAU could not be modelled 
because of  the lack of  sequence similarity with Prp43. Such an extension of  
the RecA2 domain is only found in the DEAH-box proteins of  the RHA 
group and is totally absent in the other (spliceosomal) DEAH-box proteins like 
Prp43 (Supplementary Figure 1). Besides, no known function has yet been attributed to 
this short sequence. Even so, the overall structural organisation of  the modelled 
region of  RHAU is nearly identical to that of  Prp43. Indeed, the helicase core 
region folds into two universal and tandemly linked RecA-like domains while the 
HA region consists of  three distinct domains: (a.) a winged-helix (WH) domain, 
(b.) a seven-helical bundle, referred as the ‘ratchet’ domain, and (c.) an OB-fold 
motif  arranged in a five-stranded β-barrel (Figure 38B and C). Therefore, in view 
of  the structural similarities of  the helicase core and HA regions of  RHAU with 
those of  Prp43, it is probable that both proteins function and unwind RNA by 
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Figure 38 | Structural model of the helicase 
core and HA regions of RHAU. (A) Three-
dimensional protein structure superposition 
between RHAU model (pink) and Prp43 
(yellow, RCSB PDB ID: 2XAU chain A). (B) 
Front and (C) side views of RHAU structural 
model (residues 183–399 + 471–917). The 
helicase core (RecA1 and RecA2 domains) 
as well as the HA regions [winged-helix (WH), 
Ratchet and OB-fold domains] are coloured in 
green and blue, respectively.
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a comparable mechanism. This result at least agrees with the concept that most 
DEAH-box proteins share a similar overall structural organisation that combines 
a minimal functional unit, the helicase core and the HA domains, with flanking 
regions of  various lengths and sequences (30). Unfortunately, both homology 
and ab initio modelling methods did not permit to get meaningful predictions for 
the unique N- (aa. 1–182) and C-terminal (aa. 918–1008) peripheral regions of  
RHAU. In consequence, our understanding of  how the N-terminal region binds 
and endows affinity for G4 structures remains very limited.
Recognition and binding of NTPs by RHAU
The interface between the two RecA-like domains in RHAU forms a cavity 
that defines the NTP-binding and hydrolysis site (Figures 39A and 40B). RHAU likely 
binds NTPs in analogous fashion to Prp43. Indeed, RHAU lacks the Q-motif  
that provides ATP-binding specificity for most of  SF2 helicases (Supplementary 
Figure 14). Instead, RHAU harbours the R- and F-motifs which non-specifically 
maintain the nucleobase moiety ring by hydrophobic effect between the side 
chains of  Arg-275 and Phe-537. Accordingly, just like other DEAH-box 
proteins (57,83,96,107,118,131,132), RHAU was expected not to manifest a particular 
preference for ATP when catalysing the conversion of  G4 structure to single-
stranded nucleic acid. To further validate this hypothesis, RHAU G4 unwinding 
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A Figure 39 | Binding and recognition of 
NTPs by RHAU. (A) Close-up view of the 
NTP binding and hydrolysis site in RHAU. 
NTP (pink) is bound in a cavity formed at the 
interface of the RecA1 (dark green) and the 
RecA2 (light green) domains. The nucleotide 
base is stacked between the side chains 
(cyan) of Arg-275 (R-motif, RecA1) and 
Phe-537 (F-motif, RecA2). (B) All rNTPs and 
(C) dNTPs cofactors support unwinding of 
G4-RNA structures by RHAU. Radiolabelled 
tetramolecular rAGA at a concentration 
of 4 nM was incubated in the presence of 
purified recombinant GST-tagged RHAU and 
increasing amounts (0.03, 0.10, 0.32 and 
1.00 mM) of NTPs or AMP-PNP (as indicated). 
The reaction products were resolved by native 
PAGE. An autoradiogram of the gel is shown.
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activity was investigated in the presence of  various rNTP and dNTP cofactors. 
As shown in Figure 39B and C, each of  the rNTPs and dNTPs, but not AMP-
PNP, supported unwinding of  G4-rAGA substrate by RHAU. However, the 
unwinding activity was substantially higher with purine cofactors than with 
pyrimidine rNTPs/dNTPs, with CTP/dCTP being almost inert. A comparable 
slight preference for purine over pyrimidine nucleotides was previously observed 
for the DEAH-box proteins Prp2 (107) and Prp16 (96) but not for Prp43 that 
showed maximal catalytic activity in the presence of  UTP/dTTP (118). Thus, 
although our structural model of  RHAU provided some valuable insights into 
the mechanism of  nucleotide binding by RHAU, it did not permit to further 
clarify the molecular bases behind the observed purine nucleotide bias. Finally, 
considering the relatively high degree of  amino acid conservation for the R- 
and F-motifs in RHAU as well as in other DEAH-box proteins, we predict 
that mutation of  either the Arg or Phe residues in DEAH-box helicases should 
considerably reduce their respective binding affinities for NTP cofactors. 
Nucleic acid binding and G4 structure recognition by RHAU
In Prp43, the junction between the helicase core and the HA region 
forms a groove (Figure 6C) that was proposed to accommodate the translocated 
single-stranded nucleic acid (113). According to this model, the RNA is held in 
a sequence-independent manner by amino acid residues of  the helicase motifs 
Ia, Ib, Ic, IV, IVa and V as well as some residues of  the HA region. Based on 
the high structural similarities between Prp43 and the 3′-to-5′ helicases NS3 and 
Hel308, the 5′ double-stranded substrate region of  the translocated RNA is likely 
positioned proximal to the RecA2 side of  Prp43 (113). This would be at least 
consistent with the observation that most of  DEAH-box helicases translocate 
with a 3′-to-5′ directionality (Table III and references therein). Similar to Prp43, 
RHAU harbours a cavity between the helicase core and the HA region (Figures 38C 
and 40A). Its diameter is wide enough to hold a single nucleic acid strand but there 
is clearly not sufficient space to accommodate a ~26-Å-wide G4-scaffold. This 
suggests that the four stranded structure lies outside of  the core protein and 
that only the 3′ single-stranded extremity of  the nucleic acid spans the helicase 
domain (Figure 40B). That the helicase core region of  RHAU does not directly bind 
the G4 structure is consistent with our previous observations showing that much 
of  the G4 binding affinity is endowed by the N-terminal region (88). Although 
our computational approach did not permit to get structural information about 
this peripheral region (aa. 1–182), the N-terminal RSM likely binds the G4 
structure near the RecA2 domain (Figure 40C). Furthermore, our current model 
suggests that the bound 3′ tail of  the translocated RNA consists of  about ten 
nucleotides. This is clearly in agreement with the observation that unwinding 
of  G4 structures by RHAU is dependent on the presence of  a minimal 9-nt 
3′-overhang (Figure 15C).
Even if  little is known regarding the G4 unwinding mechanism of  RHAU, 
its core structure has all the aspects of  a processive helicase such as Hel308. 
RHAU notably shares with Hel308 the WH and Ratchet domains that have 
previously shown to play an essential role for DNA unwinding (29). A particular 
common feature is the ~20 amino acid-long central α-helix (α22 in Supplementary 
Figure 14) of  the Ratchet domain that may function as a hook for directional 
transport of  the single-stranded nucleic acid across the helicase core groove. 
For Hel308, Büttner et al. suggested that antagonistic interactions between the 
base moieties of  the translocated nucleic acid and side-chain residues of  the 
Ratchet domain confer extra stability to the unwound DNA and are probably 
important for translocation processivity (29). Thus, in view of  the overall 
structural similarities between RHAU and Hel308, both helicases may share 
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an analogous NTP-driven single-strand translocation mechanism for resolving 
nucleic acid structures. Nevertheless, a doubt subsists regarding the degree 
of  similarity between the two translocation mechanisms. Indeed, the helicase 
core region of  RHAU and Prp43 more resembles to that of  the viral NS3-like 
helicases than to that of  Hel308. In particular, RHAU and Prp43 harbour a long 
and twisted antiparallel β-hairpin in their RecA2 domain that protrudes into a 
cleft of  the HA region (Figures 38C and 40A). Walbott et al. proposed that in Prp43 
this β-hairpin functions similarly to that of  Hel308 and may be responsible 
for double-strand separation (113). However, studies on NS3 helicase indicates 
that the corresponding β-hairpin rather functions as a pivot point that permits 
to lock the RecA2 domain orientation in the ADP-bound state relative to the 
rest of  the protein (125). Therefore, there is still some degree of  uncertainty 
regarding the role of  this β-hairpin and additional investigations are necessary 
to clarify the mechanisms underlying unwinding of  nucleic acid structure by 
DEAH-box helicases. Solving a particular DEAH-box protein structure in 
different conformational states would be one way to put the above ideas under 
experimental testing. In such a case, RHAU bound to TERC G4 structure would 
certainly provide an appropriate prototype.
Figure 40 | G4 structure binding by RHAU. (A) Side view of the modelled RHAU bound to ssRNA. (B) Front view of the modelled RHAU bound to G4-RNA. 
(C) Schematic and hypothetical representation of the binding and RSM-depend recognition of G4 structure by RHAU.
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Substantial effort has been expendend in characterising the 
biochemical properties and biological role of  RHAU since its early 
description as a facilitator of  uPA mRNA deadenylation and decay in 
2004 (32). Since then, RHAU was found to be essential for embryogenesis 
and haematopoiesis in mouse (90), to sense microbial nucleic acids in 
human dendritic cells (281,341) and to mediate transcription of  tissue-
nonspecific alkaline phosphatase in osteoblasts (TNAP, ref. 342). 
Subcellular localisation studies identified RHAU as a nucleocytoplasmic 
shuttling protein with a predominant nuclear localisation (32,269). 
However, RHAU was also found to accumulate in cytoplasmic stress 
granules upon stress-induced translational inhibition (268). Thus, it 
becomes clear that RHAU harbours multiple facets taking part in various 
aspects of  nucleic acid metabolism and may show an apparent eclectic 
diversity in the recognition of  nucleic acid structures.
In the present study, a great deal of  attention has been expended in 
examining the G4 binding and G4 resolving activities of  RHAU. Actually, 
when this research work was initiated, not much was known about the 
biochemical properties of  RHAU. Unlike most DEAH-box proteins, 
RHAU did not manifest unwinding activity on ordinary dsDNA or 
dsRNA substrates (Tran, H., unpublished data). Besides, although RHAU 
had been identified as an ARE-associated factor of  uPA mRNA, it could 
not bind the AREuPA sequence directly, but required the presence of  the 
auxiliary ARE-binding protein NFAR1/NF90 as a cofactor (Akimitsu, N., 
unpublished data). Thus, G4 nucleic acid structures constituted an ideal 
substrate to characterise the enzymatic activity of  RHAU in vitro. Of  
importance, the finding that RHAU binds an intramolecular G4 structure 
in TERC has later provided proof-of-concept that G4-RNA structures 
serves as physiologically relevant target for RHAU in cells. Even so, we 
still lack a good understanding of  the actual contribution of  RHAU in 
resolving G4 structures in cells and about the fraction of  RHAU that is 
dedicated to that task. A valuable clue to the first question came from 
immunodepletion experiments identifying RHAU as the main source of  
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tetramolecular G4 resolving activity in HeLa cell lysates (33,89). As for the second 
query, our RIP-chip analysis revealed a preferential association of  RHAU with 
RNAs bearing PQS, suggesting that RHAU may target other RNAs containing 
G4 structures in cells. Nonetheless, these data need to be interpreted with caution 
since the presently available G4 prediction algorithms cannot reliably predict the 
likelihood of  G4 formation in cellular RNAs. Notably, these predictions tools 
do not allow for the presence of  nearby competing secondary structures and/
or the cellular context of  RNAs bound to proteins. Therefore, only systematic 
and empirical investigations will permit to confirm the presence of  extra G4 
structures in RHAU RNA targets.
Linking up RHAU-dependent phenotypes with 
the processing of G4 nucleic acid structures
Possible reduction of G4-induced inhibition of gene expression 
by RHAU
At present, there is admittly quite limited functional data underpinning 
a model in which RHAU would play a decisive role in regulating G4 in cells. 
Formation of  G4 structures in promoters and 5′-UTRs is well documented 
to hinder gene expression to various extents depending on the position and 
stability of  the G4 (207,316). Thus, one would assume that a reduction of  RHAU 
levels in cells would alter expression of  genes bearing PQS. However, thus far, 
only contrasting results were obtained from computational search for PQS of  
deregulated genes in RHAU-deficient cells. Transcriptome analysis of  RHAU 
knockout proerythroblast unveiled a higher prevalence of  PQS in promoters 
of  genes showing differential expression patterns (90), while no significant 
difference was previously observed in HeLa cells in which RHAU expression 
was dampened by RNA interference (269). It should also be stressed that we have 
not yet observed any suppressive action of  RHAU on translational repression 
by G4 formed in 5′-UTRs (343). Nonetheless, RHAU may instead be implicated 
in some other aspects of  nucleic acid metabolism since G4 structures have 
also been shown to affect subcellular sorting of  mRNAs (344), transcription 
termination and polyadenylation (218,219), pre-mRNA splicing and mRNA 
turnover (213,215,216). Besides, overall, RHAU appears to be facultative for most 
fundamental cellular processes since knockdown of  RHAU does not affect the 
viability or the proliferation of  many common human and mouse cell lines when 
cultured under standard conditions. On the other hand, the penetrance of  the 
RHAU knockout phenotype in haematopoitic cells is variable in severity, time of  
onset, and lineages concerned. Altogether, these data rather indicate that RHAU 
is mostly required at some specific stages that control cell lineage commitment. 
This would be at least consistent with the observations that PQS are more 
prevalent in genes requiring higher levels of  regulatory control (187). Therefore, 
in order to uncover biologically relevant RNA targets of  RHAU, one should 
consider repeating RIP-chip assays using cells presenting more pronounced 
phenotypes upon altered RHAU expression.
Implication of RHAU in mouse telomeres homeostasis
We have not yet examined a possible and direct contribution of  RHAU 
in telomere homeostasis in other models than human cell lines. However, 
it turns out that the murine transcript of  Terc is substantially shorter than its 
human paralogue and cannot adopt a G4 conformation at its 5′-end (Figure 36). 
As a consequence, we can almost rule out the possibility that the abnormal 
progression of  gastrulation and haematopoiesis in RHAU knockout mice arises 
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because of  reduced accumulation of  mature Terc transcripts. Beyond that, mice 
are generally not considered as a model of  choice to address telomere erosion 
and its implications on cellular senescence. Indeed, mouse telomeres are about 5 
to 10 times longer than their equivalents in human cells. Thus, telomere erosion 
phenotypes arise only after several generations and usually animals do not 
manifest the habitual symptoms of  human telomeropathies (e.g. bone marrow 
failure, hepatic cirrhosis, pulmonary fibrosis). In consequence, RHAU knockout 
mice and murine cell lines in general cannot serve as appropriate models to 
characterise the interaction of  human RHAU with telomerase holoenzyme.
Does RHAU function as an intracellular sensor of microbial G4 
structures?
In a recent study, Kim and co-workers suggested that RHAU function as 
an intracellular sensor of  microbial DNA in plasmacytoid dendritic cells (281). 
The authors proposed that RHAU senses viral CpG motifs (unmethylated CG 
dinucleotides in bacterial and viral genomic DNA) and promotes the expression of  
the anti-viral cytokine IFN-α via the MyD88/IRF-7 signalling pathway (Figure 41). 
However, one interesting but uninvestigated aspect of  this study is that RHAU 
specifically recognises class A CpG oligodeoxynucleotides (CpG-A ODN) 
but not class B. CpG-A ODNs differ from class B in that they bear poly(dG) 
sequences at their extremities (345,346). It was previously shown that CpG-A 
ODNs self-assemble to higher order nanoparticles via oligomerisation of  
their poly(dG) tails into tetramolecular G4 structures. Of  importance, this G4-
dependent oligomerisation process is prerequisite to trigger the IFN-α response 
in plasmacytoid dendritic cells (347). Therefore, it might be possible that contrary 
to Kim and colleagues’ model RHAU recognises the G4 scaffolds formed by 
CpG-A ODNs rather than the oligodeoxynucleotide sequence alone. Indeed, 
previous in vitro binding competition studies showed that RHAU does not bind 
specifically to ssDNA sequences and present much higher affinity and specificity 
for G4-DNA structures (33). In order to consolidate their hypothesis, Kim and 
colleagues challenged plasmacytoid dendritic cells with Herpes simplex (CpG-
rich dsDNA virus) or Influenza A (ssRNA virus employed as a control) viruses 
and showed that downregulation of  RHAU reduced the production of  IFN-α 
upon infection with Herpes simplex but not upon infection with Influenza A. 
However, the two viruses do not only differ by the biochemical nature of  
their genetic material. Herpes simplex virus genome presents notably a very 
high density of  PQS with approximately 500 potentially stable G4 forming 
motifs (Table VI). In contrast, both positive- and negative-sense RNA strands 
of  Influenza A genomic material are devoid of  potentially stable G4 forming 
sequences.
Table VI | Computational analysis of potential intramolecular G4-forming sequences (PQS) 
in human Herpes simplex 1 (HSV-1) and Influenzy A (H1N1) viruses. The NG4(2)–NG4(5) fields 
denote the number of predicted G4 composed of 2, 3, 4 or 5 successive G-quartets, respectively.
HSV-1 Influenza	A	(H1N1)
Temp.	strand Comp.	strand Temp.	strand Comp.	strand
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NG4(2) 1'678 1'914 49 12
NG4(3) 210 227 0 0
NG4(4) 32 27 0 0
NG4(5) 1 2 0 0
G+C content 68 % 43 %
Genome 152'261 bp (dsDNA) 13'588 nt (8× neg.-sense ssRNAs)
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Although speculative at this point, the idea that RHAU functions as a 
cytoplasmic sensor of  microbial G4 structures may be of  relevance given 
its very high specificity for G4 structures. Implicitly, this would also indicate 
that microbial G4 structures define a novel category of  pathogen-associated 
molecular patterns (PAMPs). Cells recognise PAMPs by means of  the so-called 
‘pattern recognition receptors’ (PRRs, e.g. Toll-like receptors) which are primitive 
and evolutionary conserved factors of  innate cell immunity. We have previously 
shown that RHAU is conserved from choanoflagelates to humans (268) and that 
it retains the ability to bind G4 structures in higher eukaryotes. Thus, one may 
speculate that RHAU shares a similar G4 sensing function in other organisms, 
a property which in turn would be consistent with the evolutionary conserved 
aspect of  PRRs. In support of  our model, several helicases such as those from 
the RIG-I-like family (RIG-I, MDA-5, LGP2 and Dicer) have been shown to be 
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Figure 41 | TLR9-dependant and -independent detection of microbial CpG motifs. According to the classical pathway, microbial DNA containing 
unmethylated CpG motifs are specifically recognised in endosomes by Toll-like receptor 9 (TLR9). Activation of TLR9 pathway induces the secretion of the 
antiproliferative cytokines type I interferons (IFN-α and IFN-β). In plasmacytoid dentritic cells, TLR9-independent recognition of viral cytoplasmic CpG motifs 
may occur through the DEAH-box proteins RHAU and RHA (281). RHA specifically recognises class B CpG oligodeoxynucleotides (CpG-B) and promotes 
the production of both TNF-α and IL-6 through the activation of the NF-κB pathway. RHAU instead senses class A CpGs (CpG-A) and triggers the expression 
of IFN-α via the MyD88/IRF-7 signalling pathway. Adapted from the 'Toll-like Receptor Signaling' pathway (source: Cell Singaling Technology, Inc., version 
Nov. 2010).
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implicated in sensing pathogenic nucleic acids in cells (ref. 285,286; Figure 41). Thus, 
additional analyses are necessary to investigate the potential role of  RHAU in 
detecting pathogen-associated G4 structures. However, RHAU could emerge as 
a promising novel component of  the innate immunity.
Current status and future prospects
Structural insight into the recognition of G4 stuctures by RHAU
G4 structures constitute a family with extremely heterogeneous structural 
variations regarding the length and the conformation of  the quadruplex 
stem (intra-, bi- or tetramolecular structures; parallel, antiparallel or mixed 
configurations; syn or anti glycosidic conformations of  guanines), as well as 
the sequences, length and orientation of  the intervening loops. Computational 
surveys identified about 300'000 and 200'000 PQS in human genome and 
transcriptome, respectively (186,188,217). Besides, over the past two decades, 
several proteins have been shown to bind to various synthetic and bona fide G4 
nucleic acid structures (260,348,349). However, although most of  these proteins 
execute specific tasks in cells, several of  them can bind a broad array of  G4 
conformations when analysed in vitro. Actually, not much is know regarding 
the molecular details about G4–protein interactions and specificity. Currently, 
only three experimental structures of  proteins bound to G4 in a complex are 
publicly accessible (350-353). Intriguingly, in all three structures the protein moiety 
makes few, if  any, contacts with the quadruplex core. Instead, most of  the 
G4–protein interactions implicate the connecting loops and/or the protruding 
strands of  the G4. It was suggested that from a thermodynamic standpoint, 
the interaction of  proteins with constrained loops, rather than random coils, is 
favoured due to the reduced entropic binding cost (176,354). However, given the 
current small size of  the structural data, it is somewhat premature to establish 
common structural principles on G4 binding specificity. Likewise, comparative 
analyses of  various G4 recognition motifs in proteins show that it is currently 
not possible to establish consensual sequences or motifs involved specifically in 
the recognition of  G4 structures. Notably, some G4 binding proteins bind their 
targets through canonical RNA-binding motifs such as RGG (FMRP, ref. 254,353) 
or RRM (nucleolin, ref. 355) motifs, while other proteins resort to more family-
restricted motifs such as the RQC domain (RecQ-like helicases, ref. 302) or the 
RSM (RHAU).
The data presented here together with previous studies show that in vitro, 
RHAU can bind and unwind with almost the same efficiency many different 
types of  tetra- (TP, Z33, rD4 and AGA) and intra- (c-Myc, Zic1, YY1 and 
TERC) molecular G4 structures (33,39,89,343). This suggests that, at least 
in vitro, no particular sequence element in the overhang strand and/or in the 
connecting loops is essential for the recognition of  G4 structures by RHAU. 
It emerges also that the connecting loops are likely to play an incidental role 
since RHAU efficiently binds tetramolecular G4 structures which are devoid 
of  intervening sequence elements. The presence of  a minimal 9-nt 3'-overhang 
strand is currently the only known structural requirement for binding and 
resolving G4 structures by RHAU. Similar requirements hold for WRN 
and BLM helicases (356), and it is assumed that the single-stranded extremity 
is bound by the helicase core region and permits the 3'-to-5' tranlocation of  
the catalytic unit towards the G4 structure. In this regard, both experimental 
and computational data are consistent and show that the helicase core region 
alone cannot account for the recognition of  G4 structures by RHAU. Besides, 
we could reproducibly show both in vitro and in vivo that the N-terminal RSM 
domain makes a decisive contribution in the G4 binding process. However, 
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further structural and biochemical experiments are necessary to provide a more 
detailed model of  the binding mechanism. Indeed, our mutational analysis of  
the RSM domain did not permit to truly pinpoint the residues interacting with 
the nucleic acid structure since the G4 binding deficiency for the RSM mutated 
forms of  RHAU was systematically less severe than for the RSM deleted form. 
Thus, it might be possible that some of  the contacts to the nucleic acid require 
only the peptide backbone of  the RSM or that other less conserved residues take 
part in the interaction. Furthermore, truncation of  the catalytic unit showed that 
although necessary, the N-terminal region alone does not fully account for the 
high affinity for G4 structure of  the whole protein. We had previously suggested 
that substantial additional binding activity could also stem from the helicase core 
region through its interaction with the 3'-overhang strand (88). However, it is also 
conceivable that the N-terminal region can form a functional and high affinity 
G4 binding domain only in the presence of  the adjacent catalytic core region. In 
any cases, this is an important point that needs to be considered for the design 
of  future experimental structural analyses of  RHAU.
Targetting RHAU and TERC as therapeutic approaches against 
cancers
Following the discovery that telomerase activity in vitro could be hindered 
by formation of  G4 structures (184), stabilisation of  G4 by means of  small 
molecule ligands has emerged as a promising anticancer chemotherapeutic 
approach. Indeed, a large majority (80–90%) of  tumor cells overexpress this 
enzyme while most of  the somatic cells harbour low, if  any, levels of  telomerase 
activity (357,358). Since this finding, considerable efforts have been investigated 
in the design and development of  small molecule compounds selective for G4 
structures and presenting minimal affinity for dsDNA (359-361). Although several 
G4 ligands demonstrated efficient antitumor activities, it appeared actually 
that only a few compounds truly interfered with telomerase function. In fact, 
most of  these ligands caused unspecific short-term cellular cytotoxicity by 
altering the integrity of  the telomere capping complex or interfered with other 
unrelated cellular processes (193,362). To date, none of  these compounds has 
yet proven to be therapeutically effective and most of  them did not progress 
beyond the experimental stage. Currently, one of  the main challenges lies in 
developing G4 ligand compounds presenting high selectivity for a particular 
G4 conformation in order to minimise off-target effects on other biologically 
relevant G4 structures. One such approach was recently undertaken by Mergny 
and co-workers that screened a library of  known G4 ligands for compounds 
presenting high selectivity for the G4 structure formed at the 5'-extremity of  
human TERC (363). Part of  the rationale was that extra-stabilisation of  the 
G4 conformation of  TERC should hinder telomerase activity by preventing 
P1 helix formation (Figure 37). Although the authors of  this study identified a 
few ligands manifesting higher selectivity for TERC G4 structure over various 
telomeric and promoter G4-DNAs, it turned out that the differential affinity was 
not sufficient to harness them as potentially selective chemotherapeutic agents. 
Thus much effort needs to be expended in developing even more selective G4 
ligands. However this is not a trivial task considering the incidence and the broad 
polymorphism of  G4 structures in human genome. 
Alternatively, G4-based aptamers may offer a potentially attractive 
approach to interfere with some biological processes involving G4 binding 
proteins. G4-based aptamers may be employed as competitive reversible 
inhibitors of  G4 binding and resolving proteins. Indeed, several in vitro selected 
G-rich oligonucleotides folds into G4 structures and harbour promising 
antiproliferative properties on various cancer cells (364,365). Thus, the selective 
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inhibition of  RHAU G4 binding and resolving activities by means of  in vitro 
selected G4 aptamers might be an appealing alternative solution to prevent P1 
helix formation in TERC. However, for now, it is above all fundamental to clarify 
the modalities that caused excessive telomere elongation in cells deficient for 
RHAU. Otherwise, inhibition of  RHAU activity may not induce the expected 
antiproliferative effect on cancer cells.
It might be also worth to further explore the functional crosstalk 
between RHAU and TLR9 pathways that both lead to the production of  the 
antiproliferative IFN-α cytokine (Figure 41; ref. 281). TLR9 agonists have indeed 
demonstrated potential as anticancer chemotherapeutics and are also used as 
vaccine adjuvants (366). As antineoplastic agents, TLR9 agonists are assumed 
to promote the activation and maturation of  plasmacytoid dendritic cells and 
enhance the differentiation of  B cells into antibody-secreting plasma cells, 
potentially promoting Ig-dependent cellular cytotoxicity against tumor cells. 
To date, several pharmaceutical and biotechnology companies undertook to 
develop synthetic CpG ODN agonists for TLR9 as a novel immunotherapeutic 
approach to the treatment of  cancers. However, synthetic ODNs need to be 
chemically modified or encapsulated into virus-like particles to limit their 
degradation by endonucleases. Assuming that RHAU support sensing of  G4-
DNA in cytoplasm, one may count on comparable antiproliferative effects by 
treating plasmacytoid dendritic cells or B cells with in vitro selected G4 ODNs. 
Compared to classical CpG ODNs, G4-based nucleic acids are usually much 
more resistant against endonucleolytic cleavage which may improve the intrinsic 
bioavailability. Thus, targeting RHAU by means of  G4 ODNs may open new 
perspectives for the treatment of  infectious diseases, allergies and possibly 
cancers.
Together with more recent findings that RHAU is required for the survival 
of  ras-transformed cells (Lai, J.C., unpublished data), the observations presented 
here suggest that RHAU may represent a potentially interesting target for cancer 
therapy. However, one has to keep in mind that altered expression of  RHAU in 
healthy tissues can also produce severe phenotypes such as the strong anaemia (90) 
or the neuromuscular paralytic disorders (Lai, J.C. and Wu, P., unpublished data) 
observed in RHAU knockout mice. Thus, further experimentations are necessary 
to establish whether molecular targeted treatments specific to RHAU offer a 
sufficiently wide therapeutic window with both specific and efficient curative 
effects.
Concluding remarks
Together with our previous findings that RHAU binds and exhibits robust 
resolvase activity on various types of  G4 structures, the data presented here 
bring forth the idea that G4-RNAs and especially intramolecular G4-RNAs serve 
as physiologically relevant targets for RHAU in cells. We notably showed that 
RHAU binds a G4 structure in the 5'-region of  TERC and suggest that RHAU 
catalyses the conversion of  the G4 scaffold to ssRNA, thus allowing formation 
of  helix P1. In addition, we established that the N-terminal RSM domain is a 
major affinity and specificity determinant for the recognition of  G4-RNA 
structures by RHAU. This finding may open up new avenues for exploring more 
extensively the concrete contribution of  RHAU in G4 nucleic acid metabolism. 
The development of  a knock-in mouse model of  RHAU carrier of  a non-
functional RSM domain would be one way to study its G4 binding and resolving 
properties in a more physiologically relevant context and may allow to identify 
potentially new RNA targets. Identification of  naturally occurring substrates of  
RNA helicases is a crucial step to any further investigation of  their biochemical 
properties in vitro. However, although most of  the RNA helicases achieve highly 
specific tasks in vivo, they often show only little or even no nucleic acid binding 
specificity in vitro. Currently, our major limitation towards understanding the 
mechanisms whereby RNA helicases melt nucleic acid structures stem from 
the difficulty of  identifying such physiologically relevant substrates. Hence, few 
detailed molecular models available for studying RNA helicases in vitro. However, 
with the finding that the 5′ region of  TERC constitutes a biologically relevant 
substrate, RHAU emerges as a novel and promising prototype of  DEAH-
box protein and deserves more investigations to explore its functions as a G4 
resolving enzyme.
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Supplementary Figure 1 ► | Amino acid sequence conservation among paralogous DEAH-
box proteins from E. coli, S. cerevisiae, C. elegans, D. melanogaster and H. sapiens. Sequence 
alignment was carried out with MAFFT (version 6, ref. 313). Similarity analysis was performed with 
GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. Similarity is shown in red for 100 %, yellow 
for 99–80 % and blue for 79–60 %. The position of five structural domains (RecA1, RecA2, WH, Ratchet 
and OB-fold) as well as the conserved ATPase/helicase motifs I–VI is shown as coloured boxes beneath 
the sequence alignment.
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HCV-NS3 :
MVEV-NS3 :
YFV-NS3 :
Prp43 :
* * * * * *
PAVPQTFQVAHL PTGSGKST PAAYAAQ--G-Y--K-VL NPSVAA -GFGAYM--SKAHGI---DPNIRTGVRT-I--TTGA
EMLK-KRQLTVL HPGAGKTR LPQIIKDAIQ-KRLR-TA APTRVV -EMAEAL--R---GL---PVRYLTPAVQRE-HSGNE
HMLK-KGMTTVL HPGAGKTR LPQILAECAR-RRLR-TL APTRVV -EMKEAF--H---GL---DVKFHTQAFS-AHGSGRE
LYQN-N-QIMVF ETGSGKTT PQFVLFDEMPHLENTQVA QPRRVA SVAQRVAEEM---DVKLGEEVGYSIRFE-NKTSNKT
HCV-NS3 :
MVEV-NS3 :
YFV-NS3 :
Prp43 :
* * * * * *
PITY YGK ADGG--CSGGA-YDIII EC TDSTTILGIGTVLDQAETAG-ARLVVL A -PG SVTV---------PHP-N-
IVDV HAT HRLMSPLRVPN-YNLFV EA TDPASIAARGYIATRVEAGE-A-AAIF A PGTSDPF---------PDTNSP
VIDA HAT YRMLEPTRVVN-WEVII EA LDPASIAARGWAAHRARANE-S-ATIL A PGTSDEF---------PHSNGE
ILKY DGM REAME-DHDLSRYSCII EA RTLATDILMGLLKQVVKRRPDL-KIII A DAEKFQRYFNDAPLLAVPGRTY
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VHDVSSE---I-PDRAWS-SGF-EWIT-DYA--GKTV VASVK NEIAQCLQRAG-----------KRV LNRKSYD -EYPKC
IEDVQTD---I-PSEPWN-TGH-DWIL-ADK--RPTA LPSIR NVMAASLRKAG-----------KSV LN-RK-- -FE---
PVELYYTPEFQRDYLDSA-IRTVLQIHATEEA-GDIL LTGED EDAVRKISLEGDQLVREEGCGPLSV LYGSL-- HQQQRI
HCV-NS3 :
MVEV-NS3 :
YFV-NS3 :
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* * * * * *
---------PTSG---------DV V DALM-TG GDFDSVIDCNTCVTQTVDFSLDPTFTIETTT-VPQDAVSR RRGRTG
K--------N--GD--------WD I DISE-MG FGASRVIDCRKSVKPTILDEG--EGRVILSVPSAITSASA RRGRVG
-REYPTIKQK--K---------PD L DIAE-MG LCVERVLDCRTAFKPVLVDE---GRKVAIKGPLRISASSA RRGRIG
F--------EP-APESHNGRPGRK I NIAETSL DGIVYVVDPGFSKQKVYNPR---IRVESLLV-SPISKASA RAGRAG
HCV-NS3 :
MVEV-NS3 :
YFV-NS3 :
Prp43 :
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Supplementary Figure 2 | Sequence and structural similarities between Prp43 and viral NS3 DExH-box helicases. The structure based sequences 
alignment of the helicase core region of Prp43 (RCSB PDB ID: 2XAU) with three flavivirin NS3 related helicase structures (RCSB PDB IDs: 3KQN, 2WV9, 
1YKS) was performed with STRAP application (368,369). Similarity analysis was performed with GeneDoc (version 2.7) using the BLOSUM62 scoring 
matrix. Identical and similar amino acids are shaded in black and grey, respectively. Residues implicated in NTP-binding or nucleic acid binding are depicted 
in yellow and pink, respectively. The RecA2 β-hairpin is depicted in blue. HCV: hepatitis C virus, MVEV: Murray Valley encephalitis virus, YFV: yellow fever 
virus.
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Hjm :
Hel308 :
Prp43
Hjm
Hel308
Prp43
:
* * * * 50 * * *
---FYPPQAE-ALKSGILEGKNALI PTASGKTL EIAMVHRILT-QG-GKAV VPLKAL EKFQEFQ-DWEKIGLR MATGDY
IEELFPPQAE-AVEK-VFSGKNLLL PTAAGKTL EMAMVREAIK-GG--KSL VPLRAL EKYESFK-KWEKIGLR ISTGDY
RRELPVHAQRDEFLKLYQNNQIMVF ETGSGKTT PQFVLFDEMPHLENTQVA QPRRVA SVAQRVAEEMDVKLGE GYSIRF
: 106
: 106
: 179
Hjm :
Hel308 :
Prp43 :
100 * * * 150 * * *
SKDEWLGKYDIII AEK SLLRHGSSWIKDVKILV EI IGSRDRGATLEVILAHML---G--K--AQIIG A GNPEELAEWL
SRDEHLGDCDIIV SEK SLIRNRASWIKAVSCLV EI LDSEKRGATLEILVTKMRRMNK--A--LRVIG A PNVTEIAEWL
N-K-TSNKTILKY DGM REAMEDHD-LSRYSCII EA R-----TLATDILMGLLKQV-VKRRPDLKIII A -DAEKFQRYF
: 189
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* 200 * * * 250 * *
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D-ADYYVSDWRPVPLVEGVLCEGTLELFDGAFSTSRRVK-FEELVEECVAENGGVLVFES---TR-RGAEKTAVKLSA-ITA-KY--V-E
NDAPLLAVPGR-TYPVELYYTPE----FQRDYLDSAI-RTVLQIHATE--EAGDILLFLTGEDEIEDAVRKISLEGDQLVREEGC--G--
: 271
: 271
: 337
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Hjm :
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Prp43 :
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ALNELADS-L--EENPTNEKLAKAIRGGVAFHHA-GLGRDERVLVEENFRKG----IIKA AT TLSA---GI PAFRVIIRDIWRYS
N-EGLEKAILEENEGEMSRKLAECVRKGAAFHHA-GLLNGQRRVVEDAFRRG----NIKV AT T-L-AAGV- PARRVIVRSLYRF-
--------------------------PLSVYPLYGSLPPHQQQRIFEPAPESHNGRPGRK IS NIAET--SL DGIVYVVDPGFSKQ
: 350
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: 399
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Prp43 :
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--------------DGYSKRIKVSEY MAGRAG GMDERGEAIIIVGKRDREIAVKRYIFGEPERITSKLGVETHLRFHSLSIICDGY
KVYNPRIRVESLLV----SPISKASA RAGRAG --R-PGKCFRLY---T-EEAFQKE--LIEQSYPEILRSN--LSSTVLELKK-LG
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AKTLEELEDFFADTFFFKQN-EIS-LSYELERVVRQLENWGMVVEA--AHLAPTKLGSLVSRLYIDPLTGFIFHDVLSRME--LSDIGAL
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HLICRTPDMERLTVR----KT--DSWVEEEAFRLRKELSYYPSDF-SV---EYDWFLSEVKTALCLKDWIE-EK--DEDEICAKYGIAPG
IVAML--SVPNVFIRPTKDKKRADDAKNIFAH--P-----DGD------------H--ITLLNVYHAFKSDEAYEYGIHKWCRDHYLNYR
: 598
: 588
: 611
Hjm
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Prp43
Hjm :
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Prp43 :
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DLRRIVETAEWLSNAMNRIAEE-V-GNT--SVSGLTERIKHGVKEELLELVRIRHIGRVRARKLYNAGIRNAEDIVRHR-EKVASLIGRG
SLSAADNIRSQLERLMNRY-NL--ELNTTDYESPKYFDNIRKALASGFFMQVAKKRSGAKGYITVKDNQDVLIHPSTVLGHDAEWVIYNE
: 688
: 673
: 698
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Supplementary Figure 3 | Sequence and structural similarities between Prp43 and Ski2-related helicases. The structure based sequences alignment 
of the helicase core and HA regions of Prp43 (RCSB PDB ID: 2XAU) with two Ski2-related helicases [RCSB PDB IDs: 2ZJA (Hjm), 2P6U (Hel308)] was 
performed with STRAP (368,369). Similarity analysis was performed with GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. Identical and similar 
amino acids are shaded in black and grey, respectively. Residues implicated in NTP-binding or nucleic acid binding are depicted in yellow and pink, 
respectively. The RecA2 β-hairpin and the ratchet helix are depicted in blue and green, respectively. The helix-loop-helix (HLH) domain 5 in Hjm and Hel308 
is depicted in yellow.
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B
-- --CspA
Prp43 :
CspE :
CspA :
* * * * 50 * *
--------VAKKRSGAK-------GYITVKD-NQDVLIHPS-T-----VLGHDAEWVIYNEFVLT-SKNYIRT TS-
SHMS--KIKGN
I
K
VK---WFNESKGFGFITPEDGSKDVFVHFSAIQTNGFKTLAEGQRVEF-EITNGAKGPSAANVTAL
----SGKMTG VK---WFNADKGFGFITPDDGSKDVFVHFSAIQNDGYKSLDEGQKVSF-TIESGAKGPAAGNVTSL
: 712
: 71
: 69
CspB : ------MLEG VK---WFNSEKGFGFIEVE-GQDDVFVHFSAIQGEGFKTLEEGQAVSF-EIVEGNRGPQAANVTKE : 66
Prp43
- -- --CspB
β1 β2 β3 η1 β4 β5
-- --CspE
β17 β18 β19 β20 β21
V
A
C
Supplementary Figure 4 | Structural similarities between Prp43 OB-fold domain and prokaryotic cold shock proteins (Csp). (A) Structure based 
sequence alignment between the OB-fold domain of Prp43 (RCSB PDB ID: 3KX2, aa. 660–712) and three bacterial Csps [RCSB PDB IDs: 3I2Z (Salmonella 
Typhimurium CspE), 1MJC (E. coli CspA), 3PF5 (Bacillus subtilis CspB)]. The alignment was performed with STRAP (368,369). Similarity analysis was 
carried out with GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. Coloured amino acids in Prp43 sequence denote reciprocal conserved 
residues in paralogous DEAH-box proteins (yellow, 99–80 % similarity; blue, 79–60 % similarity; cf. Supplementary Figure 1). For CspB, residues implicated 
in nucleic acid binding are depicted in pink. Pink hexagons and circles denote respectively base stacking and polar interactions betwen CspB and the 
oligoribonucleotide. (B) Three-dimensional protein structure superposition of Prp43 OB-fold domain (white, RCSB PDB ID: 3KX2, aa. 643–725) with E. coli 
CspA (transparent light blue, RCSB PDB ID: 1MJC, aa. 2–70). (C) Model of Prp43 OB-fold domain in complex with an rU6 oligoribonucleotide. The model 
was constructed by simple fitting of B. subtilis CspB/RNA complex to the OB-fold domain of Prp43 and masking CspB protein structure.
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Supplementary Figure 5 ► | Amino acid sequence conservation within RHAU and orthologous 
proteins. Sequence alignment was carried out with MAFFT (version 6, ref. 313). Similarity analysis was 
performed with GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. Similarity is shown in red for 
100 %, yellow for 99–80 % and blue for 79–60 %. Species and accession numbers of RHAU orthologues 
listed are: human (Homo sapiens, NP_065916), mouse (Mus musculus, NP_082412), chicken (Gallus 
gallus, XP_422834), frog (Xenopus tropicalis, ENSXETP00000016958), zebrafish (Danio rerio, 
NP_001122016), fruit fly (Drosophila melanogaster, NP_610056), blood fluke (Schistosoma mansoni, 
XP_002577014), placozoan (Trichoplax adhaerens, XP_002110272), choanoflagellate (Monosiga 
brevicollis, XP_001747335). The position of the RSM, the five structural domains (RecA1, RecA2, WH, 
Ratchet and OB-fold) as well as the conserved ATPase/helicase motifs I–VI is shown as coloured boxes 
beneath the sequence alignment.
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Supplementary Figure 6 ► | RHAU mRNA expression in various human, mouse and Drosophila 
tissues. (A) Human, (B) mouse and (C) Drosophila. The red line represents the median expression 
value. The green line is equivalent to 3-fold the median expression value. Sources: BioGPS (273) and 
FlyAtlas (370) databases.
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Human DHX36 mRNA expression
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Mouse Dhx36 mRNA expression
0 500 1000 1500 2000 2500 3000
Uterus
Umbilical cord
Thymocyte SP CD8+
Thymocyte SP CD4+
Thymocyte DP CD4+, CD8+
Testis
T-cells FOXP3+
T-cells CD8+
T-cells CD4+
Stomach
Stem cells HSC
Spleen
Spinal cord
Skeletal muscle
Salivary gland
Retinal pigment epithelium
Retina
RAW 264.7
Prostate
Placenta
Pituitary
Pancreas
Ovary
Osteoclasts
Osteoblast day 21
Osteoblast day 14
Osteoblast day 5
Olfactory bulb
Nucleus accumbens
NK cells
NIH 3T3
Neuro-2a
MIN6
mIMCD3
Microglia
Mega erythrocyte progenitor
MEF
Mast cells IgE + antigen 6 h
Mast cells IgE + antigen 1 h
Mast cells IgE
Mast cells
Mammary gland non-lactating
Mammary gland lact
Macrophage peri LPS thio 7 h
Macrophage peri LPS thio 1 h
Macrophage peri LPS thio 0 h
Macrophage bone marrow 24 h LPS
Macrophage bone marrow 6 h LPS
Macrophage bone marrow 2 h LPS
Macrophage bone marrow 0 h
Lymph nodes
Lung
Liver
Lens
Lacrimal gland
Kidney
Iris
Intestine small
Intestine large
Hypothalamus
Hippocampus
Heart
Granulocytes Mac-1+, Gr-1+
Granulo mono progenitor
Follicular B-cells
Eyecup
Epidermis
Embryonic stem line V26.2 (p16)
Embryonic stem line BRUCE-4 (p13)
Dorsal striatum
Dorsal root ganglia
Dendritic plasmacytoid B220+
Dendritic cells myeloid CD8a−
Dendritic cells lymphoid CD8a+
Cornea
Common myeloid progenitor
Ciliary bodies
Cerebral cortex prefrontal
Cerebral cortex
Cerebellum
C3H10T1/2
C2C12
Bone marrow
Bone
Bladder
Baf3
B-cells marginal zone
B-cells (GL7 positive KLH)
B-cells (GL7 positive Alum)
B-cells (GL7 negative KLH)
B-cells (GL7 negative Alum)
Amygdala
Adrenal gland
Adipose white
Adipose brown
3T3-L1
B
Supplementary material	 119
Drosophila CG9323 mRNA expression
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Human :
Mouse :
* * * * 50 * * * *
MSYDYHQNWGRDGGPRSSGGGYGGGPAGGHGGNRGSGGGGGGGGGGRGGRGRHPGHLKGREIGMWYAKKQGQKNKEAERQERAVVHMDER
MSYDYHQSWSRDGGPRGSGQ---GSSGGGGGGSRGS----GGGGGGRGGRGRHPAHLKGREIGLWYAKKQTQKNKEAERQERAVVHMDER
: 90
: 83
Human :
Mouse :
100 * * * * 150 * * *
REEQIVQLLNSVQAKNDKESEAQISWFAPEDHGYGTEVSTKNTPCSENKLDIQEKKLINQEKKMFRIRNRSYIDRDSEYLLQENEPDGTL
REEQIVQLLNSVQAKTDKDSEAQISWFAPEDHGYGTEVSSEKKINSEKKLDNQEKKLLNQEKKTFRITDKSYIDRDSEYLLQENEPNLSL
: 180
: 173
Human :
Mouse :
* 200 * * * * 250 * *
DQKLLEDLQKKKNDLRYIEMQHFREKLPSYGMQKELVNLIDNHQVTVISGETGCGKTTQVTQFILDNYIERGKGSACRIVCTQPRRISAI
DQHLLEDLQRKKTDPRYIEMQRFRKKLPSYGMQKELVNLINNHQVTVISGETGCGKTTQVTQFILDNYIERGKGSACRIVCTQPRRISAI
: 270
: 263
Human :
Mouse :
* * 300 * * * * 350 *
SVAERVAAERAESCGSGNSTGYQIRLQSRLPRKQGSILYCTTGIILQWLQSDPYLSSVSHIVLDEIHERNLQSDVLMTVVKDLLNFRSDL
SVAERVATERAESCGNGNSTGYQIRLQSRLPRKQGSILYCTTGIILQWLQSDSRLSSVSHIVLDEIHERNLQSDVLMTVIKDLLHFRSDL
: 360
: 353
Human :
Mouse :
* * * 400 * * * * 450
KVILMSATLNAEKFSEYFGNCPMIHIPGFTFPVVEYLLEDVIEKIRYVPEQKEHR QFKRGFMQGHVNRQEKEEKEAIYKERWPDYVREL
KVILMSATLNAEKFSEYFGNCPMIHIPGFTFPVVEYLLEDIIEKIRYVPDQKEHR QFKRGFMQGHVNRQEKEEKEAIYKERWPAYIKEL
: 450
: 443
Human :
Mouse :
* * * * 500 * * * *
RRRYSASTVDVIEMMEDDKVDLNLIVALIRYIVLEEEDGAILVFLPGWDNISTLHDLLMSQVMFKSDKFLIIPLHSLMPTVNQTQVFKRT
RTRYSASTVDVLQMMDDDKVDLNLIAALIRYIVLEEEDGAILVFLPGWDNISTLHDLLMSQVMFKSDKFLIIPLHSLMPTVNQTQVFKKT
: 540
: 533
Human :
Mouse :
550 * * * * 600 * * *
PPGVRKIVIATNIAETSITIDDVVYVIDGGKIKETHFDTQNNISTMSAEWVSKANAKQRKGRAGRVQPGHCYHLYNGLRASLLDDYQLPE
PPGVRKIVIATNIAETSITIDDVVYVIDGGKIKETHFDTQNNISTMSAEWVSKANAKQRKGRAGRVQPGHCYHLYNGLRASLLDDYQLPE
: 630
: 623
Human :
Mouse :
* 650 * * * * 700 * *
ILRTPLEELCLQIKILRLGGIAYFLSRLMDPPSNEAVLLSIRHLMELNALDKQEELTPLGVHLARLPVEPHIGKMILFGALFCCLDPVLT
ILRTPLEELCLQIKILRLGGIAYFLSRLMDPPSNEAVVLSIKHLMELSALDKQEELTPLGVHLARLPVEPHIGKMILFGALFCCLDPVLT
: 720
: 713
Human :
Mouse :
* * 750 * * * * 800 *
IAASLSFKDPFVIPLGKEKIADARRKELAKDTRSDHLTVVNAFEGWEEARRRGFRYEKDYCWEYFLSSNTLQMLHNMKGQFAEHLLGAGF
IAASLSFKDPFVIPLGKEKIADARRKELAKETRSDHLTVVNAFEGWEEAKRRGFRYEKDYCWEYFLSSNTLQMLHNMKGQFAEHLLGAGF
: 810
: 803
Human :
Mouse :
* * * 850 * * * * 900
VSSRNPKDPESNINSDNEKIIKAVICAGLYPKVAKIRLNLGKKRKMVKVYTKTDGLVAVHPKSVNVEQTDFHYNWLIYHLKMRTSSIYLY
VSSRSPKDPKANINSDNEKIIKAVICAGLYPKVAKIRLNLGKKRKMVKVHTKSDGLVSIHPKSVNVEQTDFHYNWLIYHLKMRTSSIYLY
: 900
: 893
Human :
Mouse :
* * * * 950 * * * *
DCTEVSPYCLLFFGGDISIQKDNDQETIAVDEWIVFQSPARIAHLVKELRKELDILLQEKIESPHPVDWNDTKSRDCAVLSAIIDLIKTQ
DCTEVSPYCLLFFGGDISIQKDKDQEIIAVDEWIVFQSPERIAHLVKGLRKELDSLLQEKIESPHPVDWDDTKSRDCAVLSAILDLIKTQ
: 990
: 983
Human :
Mouse :
1000
EKATPRNFPPRFQDGYYS
KKATPRNLPPRSQDGYYS
: 1008
: 1001
S
S
Supplementary Figure 7 | Pairwise alignment of human RHAU and its mouse orthologue. Sequence alignment was carried out with MAFFT (version 6, 
ref. 313). Similarity analysis was performed with GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. Identical and similar amino acids are shaded 
in black and grey, respectively.
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Supplementary Figure 8 | Recombinant RHAU protein purification. SDS-PAGE separation and 
Coomassie staining of purified GST-tagged recombinant wild-type (WT) and N-terminal fragment (1–200) 
of RHAU (2 μg protein per lane). The positions and sizes (kDa) of marker proteins are indicated at the 
left. The mark (◄) on the right indicates the position of the purified proteins.
122	 Chapter 6
B
0
1
2
3
4
Re
l. 
fre
q.
 (b
its
)
130 135 140 145 150 155
A
Mammals
Homo sapiens :
Pan troglodytes :
Macaca mulatta :
Sue scroffa :
Mus musculus :
Rattus norvegicus :
Canis familiaris :
Monodelphis domestica :
Bos taurus :
Echinops telfairi :
Loxodonta africana :
Oryctolagus cuniculus :
Dasypus novemcinctus :
Spermophilus tridecemlineatus :
Tupaia belangeri :
Tursiops truncatus :
Birds
Gallus g
s
allus :
Reptile
Anolis carolinensis :
Amphibians
Xenopus tropicalis :
Fishes
Tetraodon nigroviridis :
Danio rerio :
Fugu rubripes :
Gasterosteus aculeatus :
Oryzias latipes :
Cephalochordates
Branchiostoma floridae :
Echinoderms
Strongylocentrotus purpuratus :
Arthropods
Apis mellifera :
Culex pipiens quinquefasciatus :
Aedes aegypti :
Anopheles gambiae :
Tribolium castaneum :
Nasonia vitripennis :
Drosophila melanogaster :
* 20 * 40
GRG-----GR-GRHPGHLKGREIGMWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGREIGMWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGREIGMWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKNKEA
GRG-----GR-GRHPAHLKGREIGLWYAKKQTQKNKEA
GRG-----GR-GRHPAHLKGREIGLWYAKKQTQKNKEA
G
G
R
R
G-----GR-GR
G GR GR
HPGHLKGREIGLWYAKKQGQKNKEA
----- - HPGHLKGRDIGLWYARKQGQKSKDA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGRQIGLWYARLQGQKNKEA
GRG-----GR-GRHPGHLKGREIGLWYAKKQTQKNKDA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKSKDA
GRG-----GR-GRHPGHLKGREIGLWYAKKQTQKNKDA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKNKEA
GRG-----GR-GRHPGHLKGREIGLWYAKKQGQKNKEA
RGG-----GR-GRHPSHLKGREIGLWYARKQGQKSKET
RGG-----GR-GRPPPHLKGREIGLWYARRQGAKSKEA
GGE-----QR-EKPPPHLKGREIGLWHARRQGQRSKEK
-RG-----QR-DRPPPHLRGREIGLWYARYGAVRRKQA
RRG-----GR-GKHPSHLKGREIGLWYAKWGGIKKSEA
-SG-----QR-DRPPPHLKGREIGLWYAKYGAVRRKQA
-GG-----ERLDRPPPHLKGREIGLWYAKFGAVRRKQG
ASG-----PR-DRPPPHLKGREIGLWYARYGAVRRKQA
GRG-----GR-RGHPSGLRGKDIGLFYARKSKDREKRE
GGG-----GR-GGPPPGLTGRDIGMWYAQRGRGKKKDQ
ARG-----RG-QGHPPWLSGKEIGLYYRDKAKAKAKQK
ERDDQVVTGR-DRPPPGLRGRALGLYYRDRNSAKNRER
ARDDEVVTGGDERPPPGLRGKALGLFYRDRQTRKKKEK
QRDVRLEDQAEERRPPNLRGKALGLYYRDRQTAQKRQR
KEG-----NH-ERPPSHLRGKQIGMYYAQRNRERNEAN
GSGMSRVQRG-GGHPPHLRGKAIGLYYRDKYIAKNGKK
SSG---SNARKGNRPPGLRGKDIGLYYRNLARQQKKDR
Annelids
Capitella sp. I :
Molluscs
Lottia gigantea :
Platyhelminthes
Schistosoma japonicum :
Schistosoma mansoni :
Cnidarians
Nematostella vectensis :
Placozoans
Trichoplax adhaer
s
ens :
Choanoflagellate
Monosiga brevicollis :
GRG-----GR-GGHPNGLCGREIGLFYAAKSKAK-KEM
GRG-----RG-GRPPPGLKGREIGMWYARKSQAAKDKR
SHA-----KK-NHRPPGLRGKEIGLWYAAQSKIKGKDH
SRA-----NK-GHRPPGLRGKEIGLWHAAQSKNRCTGH
RRG-----GR-GRHPSGLSGKDIGLWYASKSKEKKKKR
GRG-----GG-VGRPPGLSGKEIGMYYANLSRTRKKEK
GGG-----GG-GGPPAGLSGRDIGMWYARQGQAARKQQ
* * * **
*
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQE------
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVRM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
---------ERQERAVVHM
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Supplementary Figure 9 | Conserved residues within the RSM region. (A) Sequence alignment of the RSM-containing region of 40 different RHAU 
orthologues. Multiple sequence alignment was carried out with MAFFT (version 6, ref. 313). Similarity analysis was made by GeneDoc (version 2.7) using 
the BLOSUM62 scoring matrix. Similarity is shown in red for 100 %, yellow for 99–80 % and blue for 79–60 %. Amino acids that are identical among all 
sequences are indicated by asterisks below the alignment. The RSM is underlined. (B) Sequence logo (371) derived from the multiple sequence alignment 
in (A). Amino acids are coloured according to their biochemical properties: green for polar (G, S, T, Y, C, Q, N), blue for basic (K, R, H), red for acidic (D, E) 
and black for hydrophobic (A, V, L, I, P, W, F, M). The RSM is underlined.
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Supplementary Figure 10 | Recombinant CG9323 protein purification. SDS-PAGE separation and 
Coomassie staining of purified FLAG-tagged recombinant wild-type (WT) and RSM mutant (RSM-mut2) 
CG9323 protein (2 μg protein per lane). The positions and sizes (kDa) of marker proteins are indicated at 
the left. The mark (◄) on the right indicates the position of the purified proteins.
Supplementary Figure 11 | Recombinant RHAU protein purification. SDS-PAGE separation and 
Coomassie staining of purified GST-tagged recombinant wild-type (WT) and ATPase-deficient mutant 
(DAIH) RHAU proteins (2 μg protein per lane). The positions and sizes (kDa) of marker proteins are 
indicated at the left. The mark (◄) on the right indicates the position of the purified protein.
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Supplementary Figure 12 | Computational analysis of potential intramolecular G4-forming sequences (PQS) among RNAs enriched by RHAU. 
(A) Box plot representation of the normalised ∑(G4-score) value per transcript as a function of their level of enrichment by RHAU. The pink rectangle 
refers to the group of 106 RNAs specifically enriched by RHAU and serves as a control group for multiple comparisons analysis. Statistical significance was 
determined by Kruskal-Wallis one-way ANOVA on ranks and the Dunn’s test. nsP ≥ 0.05; *P < 0.05; **P < 0.01. The correlation between the two variables 
was estimated by a linear regression model (y = 47x + 93, R2 = 0.10, P < 0.001) and is indicated as a red line on the graph. (B) PQS analysis among 
randomised RHAU target sequences. The sequences of the 106 transcripts specifically enriched by RHAU were shuffled, retaining single- or di-nucleotide 
base composition of the original transcripts. The box plot represents the normalised ∑(G4-score) value per transcript among the original (not rand.), di-
nucleotide shuffled (di-NT rand.) and single-nucleotide shuffled (single-NT rand.) sequences. Statistical significance was determined by Friedman repeated 
measures ANOVA on ranks and the Dunnett's test.
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Supplementary Figure 13 | Quality prediction for RHAU 3-D model. Quality assessment of the modelled RHAU structure by QMEAN6 (A–D, G) and 
ModFOLD (E–G) algorithms. (A) Comparison of the normalised QMEAN score value for RHAU structural model with non-redundant set of PDB structures. 
(B) Absolute QMEAN score value together with the six scoring function terms contributing to the QMEAN score. A distance-dependent pairwise Cβ potential 
as well as an all-atom potential with 167 atom types are used to assess long-range interactions. The solvation potential describes the burial status of the 
residues. The local geometry is analysed by a torsion angle potential over three consecutive amino acids. ‘SSE agreement’ and ‘ACC agreement’ scores 
describe respectively the agreement of predicted and calculated secondary structure and solvent accessibility. High-resolution X-ray structures on average 
have a QMEAN score equal to zero. (C) Density plot visualising the normalised QMEAN6 score distribution of PDB structures ranging from 602 to 736 
amino acids. The window size (660 ± 67 amino acids, N = 133) corresponds to the yellow rectangle depicted in (A). The normalised QMEAN6 score for 
RHAU structural model is indicated in red. (D) RHAU structural model coloured according to local error prediction by QMEAN algorithm. (E) Estimation of 
RHAU structural quality by ModFOLD algorithm. (F) RHAU structural model coloured according to local error prediction by ModFOLD algorithm. (G) Linear 
and coloured representation of the local error prediction for RHAU structural model.
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Supplementary Figure 14 ► | Sequence and structural similarities between Prp43 and RHAU 
structural model. The structure based sequence alignment of the helicase core and HA regions of Prp43 
(RCSB PDB ID: 2XAU) with RHAU structural model (Figure 38) was performed with STRAP (368,369). 
Similarity analysis was performed with GeneDoc (version 2.7) using the BLOSUM62 scoring matrix. 
Identical and similar amino acids are shaded in black and grey, respectively. Coloured amino acids in 
Prp43 and RHAU sequences denote reciprocal conserved residues in paralogous DEAH-box proteins 
(red, 100 % similarity; yellow, 99–80 % similarity; blue, 79–60 % similarity; cf. Supplementary Figure 1). 
The RecA2 β-hairpin and the ratchet helix are depicted in blue and green, respectively.
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Supplementary Table I | List of oligodeoxynucleotides employed for RT-PCR and TRAP assays.
Gene name Oligo ID Oligo name Sequence (5' - 3')
166 ACTB_Fw CAC CCC GTG CTG CTG ACC
167 ACTB_Rv CCA GAG GCG TAC AGG GAT AGC
244 ARL3_Fw GAA GAG ACG GGT CAG GAA CTA GC
245 ARL3_Rv GAC TCG GTC GCG GAT GGT ATG
246 CEP57_Fw CAT GGT TCG GCA TTC TTC ATC TCC
247 CEP57_Rv TCT GCC TGA ATC CTC TCA AGT TCC
248 DYNLL2_Fw ACA CAC GAG ACA AAG CAC TTC ATC
249 DYNLL2_Rv AGT AGC ACA GCC ATT GGA GAG G
162 GAPDH_Fw CGC TCT CTG CTC CTC CTG TTC
163 GAPDH_Rv CGC CCA ATA CGA CCA AAT CCG
200 HBXIP_Fw CCT CTG ACC CCA CTG ATA TTC CTG
201 HBXIP_Rv CAC CGT GAT GCC ATC GTG TTT C
230 IGFBP6_Fw GGA ATC CAG GCA CCT CTA CCA C
231 IGFBP6_Rv TGA GTC CAG ATG TCT ACG GCA TG
224 MAGOH_Fw TGG GGC ACA AGG GCA AGT TC
225 MAGOH_Rv CTT CCC GTC CGG TCG AAA CTC
234 PAAF1_Fw CCA AGG GCT CCG GTA CAA GTC
235 PAAF1_Rv ATC TGC TTC TCC CAT GTG GCT AC
250 PABPC1_Fw AGA ACC GTG CTG CAT ACT ATC CTC
251 PABPC1_Rv TGA CTC GTG GAA CCT GTG AAG AAG
266 TERC_Fw GGC GAG GGC GAG GTT CAG
267 TERC_Rv GCA CGT CCC ACA GCT CAG G
238 TMEM55B_Fw CCT TGC CTT TGG CAC ATG GAA G
239 TMEM55B_Rv TCA TCA GGC TCA GGA GAA GTT CTG
260 U2AF1_Fw AAG ATG CGG AAA AGG CTG TGA TTG
261 U2AF1_Rv TCT CTG GAA ATG GGC TTC AAA TGC
240 WBP4_Fw GTA ACC AGC ACT ATC CCA CCT ACC
241 WBP4_Rv TTT CTC CCA CTG AGA TGC TCC TG
270 TS AAT CCG TCG AGC AGA GTT
271 Cy5-TS Cy5 -AAT CCG TCG AGC AGA GTT
273 ACX GCG CGG CTT ACC CTT ACC CTT ACC CTA ACC
IGFBP6
MAGOH
ACTB
ARL3
CEP57
DYNLL2
U2AF1
WBP4
TRAP assay
PAAF1
PABPC1
TERC
TMEM55B
GAPDH
HBXIP
Supplementary material	 129
1
N
R
_0
01
56
6
●
TE
R
C
0
1
4
411
8.252
1.11
039.1
 tnenop
moc 
A
N
R esare
moleT
2
N
M
_0
01
10
08
80
●
0
0
7
321
2.291
9.01
078.1
 02 yticinegiro
mut fo rosserppu
S
02T
S
3
N
M
_0
25
15
5
●
P
A
A
F1
0
0
31
102
8.621
2.8
657.1
 1 rotcaf detaicossa-esa
PT
A la
mosaetor
P
2
0
2
91
343
8.031
0.8
607.1
 121 nietorp regnif gni
R
121F
N
R
023810_
M
N
4
331
8.67
0.4
826.1
 yli
maf enegocno 
S
A
R reb
me
m ,82
B
A
R
82
B
A
R
979710100_
M
N
5
6
1
0
1 1
0
1
71
403
1.141
4.8
526.1
 4 nia
mod taeper 
D
W
4
R
D
W
966810_
M
N
6 7
N
M
_0
06
40
2
●
H
B
X
IP
0
0
6
77
1.09
0.7
685.1
 nietorp gnitcaretni x suriv 
B sititape
H
1
0
1
81
433
2.731
8.7
385.1
 31
C xoboe
mo
H
31
C
X
O
H
014710_
M
N
8
1
0
1
31
522
4.661
4.01
185.1
 1 esarefsnartlysobir-
A
N
Rt eniueu
Q
1T
RT
Q
902130_
M
N
9 1 0
X
M
_4
97
45
0
LO
C
44
17
22
P
R
E
D
IC
TE
D
: s
im
ila
r t
o 
U
2 
sm
al
l n
uc
le
ar
 R
N
A
 a
ux
ill
ar
y 
fa
ct
or
 1
 
1.
55
5
8.
9
16
8.
9
15
2
7
1
0
1
51
764
9.232
0.01
845.1
 3 esanik nietorp detavitca-negoti
M
3
K
P
A
M
650040100_
M
N
11
4
1
2
2
1
12
N
M
_0
01
02
52
04
U
2A
F1
0
0
8
731
0.231
7.7
445.1
 1 rotcaf yrailixua 
A
N
R raelcun lla
ms 2
U
13
N
M
_0
04
31
7
●
1
1
0
2
8
791
8.151
7.7
045.1
 1 golo
moh ,gnidnib-
PT
A ,retropsnart etinesra 
Asr
A
1
A
N
S
A
0
0
5
98
3.05
8.2
825.1
 21 tinubus xelp
moc rotargetnI
21
ST
NI
593020_
M
N
41 1 5
N
M
_2
03
47
2
●
0
0
31
322
6.271
1.01
515.1
 
S nietorponele
S
SL
E
S
16
N
M
_0
20
17
9
●
0
0
9
631
9.831
2.9
705.1
 57 e
marf gnidaer nepo 11 e
moso
morh
C
57fro11
C
2
0
2
12
004
4.471
0.01
574.1
 91 gniniatnoc nia
mod 
E
V
YF ,regnif cniZ
91
E
V
YFZ
862770100_
M
N
71 18
N
M
_0
05
45
2
●
0
0
42
983
6.461
2.01
474.1
 64 nia
mod taeper 
D
W
64
R
D
W
19
N
M
_0
04
31
1
A
R
L3
2
0
2
22
914
7.701
2.6
564.1
 3 ekil-rotcaf noitalysobir-
P
D
A
20
N
M
_0
07
18
7
W
B
P
4
821
4.45
4.3
854.1
)12 nietorp gnidnib ni
mrof( 4 nietorp gnidnib nia
mod 
W
W
7
1
0
1
1
0
1
02
763
5.241
2.8
244.1
 5 esanik rotpecer delpuoc-nietorp 
G
5
K
R
G
803500_
M
N
12
0
0
3
55
1.33
8.1
534.1
 1 nietorp yrotibihni gnidnib 21
K3
P
A
M
PI
B
M
685610_
M
N
22 23
B
C
02
42
37
●
551
0.89
4.4
124.1
23 e
marf gnidaer nepo 22 e
moso
morh
C
23fro22
C
6
1
0
1
24
N
M
_1
33
49
1
●
S
A
T2
S
pe
rm
id
in
e/
sp
er
m
in
e 
N
1-
ac
et
yl
tra
ns
fe
ra
se
 fa
m
ily
 m
em
be
r 2
 
1.
41
7
11
.2
17
0.
9
16
8
11
0
0
25
N
M
_0
22
04
4
●
1
0
1
31
852
5.492
0.61
673.1
 1 ekil-2 rotcaf devired-llec la
mort
S
1L2F
D
S
0
0
2
24
5.46
1.3
053.1
 4 golo
moh nohcinro
C
4
HI
N
C
481410_
M
N
62
1
0
1
3
59
6.811
0.5
733.1
 golo
moh yratne
midur fo recnahn
E
H
R
E
054400_
M
N
72
1
0
1
51
292
6.541
0.8
823.1
 5 reb
me
m ,83 yli
maf reirrac etulo
S
5
A83
CL
S
815330_
M
N
82
0
0
7
901
9.531
7.8
623.1
 1 
mrofosi 
VI tinubus esadixo c e
morhcoty
C
1I4
X
O
C
168100_
M
N
92
1
0
1
41
702
0.63
6.2
023.1
 2
C rotcaf llec tso
H
2
CF
C
H
023310_
M
N
03
0
0
8
141
1.402
6.11
813.1
 F tinubus 1
V ,a
Dk41 la
mososyl ,gnitropsnart +
H ,esa
PT
A
F1
V6
PT
A
132400_
M
N
13
0
0
91
462
4.001
2.7
013.1
 nietorp detaicossa nia
mod-htae
D
X
X
A
D
053100_
M
N
23
1
0
1
8
251
9.811
0.7
392.1
 3 xelp
moc elcitrap nietorp gnikciffarT
3
C
P
P
A
RT
804410_
M
N
33 3 4
N
M
_0
01
10
08
14
●
TM
E
M
55
B
2
1
0
3
31
053
3.202
2.9
292.1
 
B55 nietorp enarb
me
msnarT
35
N
M
_0
13
33
0
●
0
0
5
58
6.15
0.3
972.1
7 sllec citatsate
m-no
N
7
E
M
N
1
0
1
32
044
1.671
6.9
372.1
 3 esaditpep cificeps 3T
M
S/nirtnes/1
O
M
U
S
3
P
N
E
S
076510_
M
N
63
3
1
2
21
443
0.931
1.6
372.1
 51 setycortsa ni dehcirne nietorpohpsoh
P
51
A
E
P
867300_
M
N
73
G
4 
de
ns
ity
 
[P
Q
S
·k
b−
1 ]
E
nr
ic
hm
en
t 
(lo
g 2
)
N
or
m
al
is
ed
 
∑
(G
4-
sc
or
e)
∑
(G
4-
sc
or
e)
R
k
A
cc
es
si
on
G
en
e
D
ef
in
iti
on
5'-UTR
CDS
3'-UTR
N
G4
(2)
N
G4
(3)
N
G4
(4)
Su
pp
le
m
en
ta
ry
 Ta
bl
e 
II 
| L
is
t o
f R
NA
s 
si
gn
ifi
ca
nt
ly
 e
nr
ic
he
d 
by
 R
HA
U 
in
 H
eL
a 
ce
lls
. T
he
 e
nr
ich
em
en
t v
al
ue
 is
 ca
lcu
la
te
d 
as
 th
e 
lo
g 2
 o
f t
he
 ra
tio
 IP
FL
AG
/in
pu
t FL
AG
. T
he
 N
G
4(2
), 
N G
4(3
) a
nd
 N
G
4(4
) fi
el
ds
 co
rre
sp
on
d 
to
 th
e 
nu
m
be
r 
of
 p
re
di
ct
ed
 G
4 
co
m
po
se
d 
of
 2
, 3
 o
r 4
 s
uc
ce
siv
e 
G
-q
ua
rte
ts
, r
es
pe
ct
ive
ly.
 F
or
 R
NA
s 
be
ar
in
g 
N G
4(3
) a
nd
 N
G
4(4
), 
th
ei
r l
oc
at
io
n 
in
 th
e 
tra
ns
cr
ip
t i
s 
in
di
ca
te
d 
(5
'-U
TR
, C
DS
, 3
'-U
TR
). 
Tr
an
sc
rip
ts
 w
ho
se
 e
nr
ich
m
en
t b
y 
RH
AU
 h
as
 
be
en
 v
al
id
at
ed
 b
y 
RT
-P
CR
 a
re
 c
ol
ou
re
d 
in
 re
d.
 T
ra
ns
cr
ip
ts
 w
ho
se
 e
nr
ich
m
en
t b
y 
RH
AU
 h
as
 b
ee
n 
ob
se
rv
ed
 in
 b
ot
h 
He
La
 a
nd
 H
EK
29
3T
 c
el
l li
ne
s 
ar
e 
pr
ec
ed
ed
 b
y 
a 
fu
ll b
la
ck
 d
ot
.
130	 Chapter 6
G
4 
de
ns
ity
 
[P
Q
S
·k
b−
1 ]
E
nr
ic
hm
en
t 
(lo
g 2
)
N
or
m
al
is
ed
 
∑
(G
4-
sc
or
e)
∑
(G
4-
sc
or
e)
R
k
A
cc
es
si
on
G
en
e
D
ef
in
iti
on
5'-UTR
CDS
3'-UTR
N
G4
(2)
N
G4
(3)
N
G4
(4) 0
0
11
271
4.56
2.4
962.1
 
A golo
moh 33 gnitros nietorp ralouca
V
A33
S
P
V
619220_
M
N
83
0
0
5
67
0.95
9.3
942.1
 lairdnohcoti
m ,1
B rotcaf noitpircsnarT
M1
BFT
020610_
M
N
93 40
N
M
_0
05
46
6
●
0
0
5
89
9.27
7.3
742.1
 6 tinubus xelp
moc rotaide
M
6
D
E
M
0
0
11
951
9.64
2.3
542.1
8 reb
me
m ,)ni
mublavo( 
B edalc ,rotibihni esaditpep nipre
S
8
B
NI
P
R
E
S
046200_
M
N
14
81
015
7.812
9.9
732.1
 867 nietorp regnif cniZ
867F
NZ
176420_
M
N
24
4
1
1
1
3
43
N
M
_0
30
81
5
●
0
0
21
781
1.531
7.8
432.1
 1 detaluger ega
mad-
A
N
D dna 35
P
1
G
R
D
P
44
N
M
_0
04
37
4
●
0
0
4
46
5.96
3.4
522.1
 cI
V tinubus esadixo c e
morhcoty
C
C6
X
O
C
45
N
M
_0
07
24
1
●
1
0
1
01
402
4.661
0.9
022.1
 golo
moh ,tinubus xelp
moc II-T
R
C
S
E ,8F
N
S
8F
N
S
46
N
M
_0
02
17
8
IG
FB
P
6
1
0
1
9
191
9.491
2.01
812.1
 6 nietorp gnidnib rotcaf ht
worg ekil-nilusnI
1
0
1
31
542
0.431
7.7
212.1
 a
Dk03 ,4 rotcaf cificeps noitalynedaylop dna egavael
C
4F
S
P
C
396600_
M
N
74 48
N
M
_0
03
34
1
U
B
E
2E
1
U
bi
qu
iti
n-
co
nj
ug
at
in
g 
en
zy
m
e 
E
2E
 1
 (U
B
C
4/
5 
ho
m
ol
og
, y
ea
st
)
1.
20
8
3.
4
94
.0
13
9
3
1
1
1
1
1
0
1
2
66
4.411
2.5
702.1
 2 nietorp detaicossa etyconitare
K
2
P
A
CT
R
K
258371_
M
N
94
0
0
8
451
3.022
4.11
702.1
 3 gniniatnoc nia
mod kcolbdao
R
3
DL
B
O
R
710410_
M
N
05
0
0
01
561
0.611
0.7
402.1
 ekil-diob
mohr ,detaicossa nilineser
P
L
R
A
P
226810_
M
N
15 5 2
N
M
_0
03
97
7
●
0
0
21
471
2.931
6.9
002.1
 nietorp gnitcaretni rotpecer nobracordyh lyr
A
PI
A
2
0
2
21
072
3.981
8.9
391.1
 
A
N
R
m ,
B reb
me
m ,001 ytirali
mis ecneuqes hti
w yli
maF
115530
C
B
35
1
0
1
72
905
9.502
3.11
881.1
 9 esanik tnedneped-nilcy
C
9
K
D
C
162100_
M
N
45
0
0
7
021
3.731
0.8
481.1
))
H
P
D
A
N( esatcuder nivalf( 
B esatcuder nidrevili
B
B
R
VL
B
317000_
M
N
55
61
413
8.451
9.8
381.1
 01 rotcaretni rotpecer eno
mroh dioryhT
01
PI
RT
042400_
M
N
65
2
0
1
1
0
0
9
471
4.821
6.6
971.1
 ahpla ,elbicudni-ega
mad-
A
N
D dna tserra ht
wor
G
A54
D
D
A
G
429100_
M
N
75
1
0
1
12
143
3.371
2.11
871.1
 1 reb
me
m yli
maf nia
mod 6-F
A/
S
D
Gla
R noitaicossa sa
R
1F
S
S
A
R
281700_
M
N
85
2
2
0
4
42
545
9.972
4.41
461.1
 1 reb
me
m ,yli
maf gniniatnoc nia
mod Z
D
P 
C
PI
G
1
C
PI
G
617500_
M
N
95 60
N
M
_1
74
88
9
N
D
U
FA
F2
N
A
D
H
 d
eh
yd
ro
ge
na
se
 (u
bi
qu
in
on
e)
 1
 a
lp
ha
 s
ub
co
m
pl
ex
, a
ss
em
bl
y 
fa
ct
or
 2
1.
16
1
8.
3
13
4.
9
97
6
0
0 0
0
6
79
9.37
6.4
061.1
 
A
N
R
m ,531 e
marf gnidaer nepo 1 e
moso
morh
C
531fro1
C
902000
C
B
16 6 2
N
M
_0
22
07
7
●
1
0
1
5
921
1.39
3.4
641.1
 ekil-la
mososyl ,
A ateb ,esadisonna
M
L
A
B
N
A
M
63
N
M
_0
80
67
7
D
Y
N
LL
2
2
1
0
3
41
363
5.832
2.11
541.1
 2 epyt-8
CL ,niahc thgil ,nieny
D
0
0
72
914
6.721
2.8
341.1
 1 nietorp nia
mod gnidnib 
Gp
C-lyhte
M
1
D
B
M
648510_
M
N
46 65
N
M
_0
02
93
1
●
4
0
4
41
593
5.622
3.01
241.1
 1 nietorp regnif gni
R
1
G
NI
R
0
0
9
851
9.911
8.6
131.1
 nietorp gnitcaretni 3
C
M
S
P
PI3
C
M
S
P
092310_
M
N
66 67
N
M
_0
05
08
9
ZR
S
R
2
C
C
C
H
 ty
pe
 z
in
c 
fin
ge
r (
R
N
A
-b
in
di
ng
 m
ot
if 
an
d 
se
rin
e/
ar
gi
ni
ne
 ri
ch
 2
)
1.
12
9
7.
9
13
3.
6
20
2
12
0
0 0
0
3
44
9.53
4.2
211.1
 golo
moh 12
S
M
M ,2 tne
mele 
C
M
S-no
N
2
E
C
M
S
N
586371_
M
N
86
0
0
02
233
6.951
6.9
111.1
 2 ,
D yli
maf negitna a
monale
M
2
D
E
G
A
M
995410_
M
N
96
0
0
01
551
1.46
1.4
601.1
 esalordyh nicy
moel
B
H
ML
B
683000_
M
N
07 7 1
N
M
_1
82
70
5
●
2
0
2
22
124
1.801
2.6
101.1
 
B reb
me
m ,101 ytirali
mis ecneuqes hti
w yli
maF
B101
M
AF
0
0
1
61
1.53
2.2
001.1
 F1 nienoihtollate
M
F1T
M
949500_
M
N
27
1
0
1
23
985
8.081
1.01
690.1
 ahpla ,rotpecer 72 nikuelretnI
A
R72LI
348400_
M
N
37
0
0
9
951
9.09
1.5
090.1
 13 ninapsarteT
13
N
A
P
ST
189500_
M
N
47
0
0
1
12
4.18
9.3
090.1
 ekil-638646
C
OL nietorp deziretcarahcnu :
D
ET
CI
D
E
R
P
638646
C
OL
397929_
M
X
57
2
1
0
3
82
355
4.281
2.01
090.1
 1 nietorp detaicossa 1
PI
R
G
1
P
A
PI
R
G
731020_
M
N
67 7 7
N
M
_0
06
32
1
●
0
0
52
214
0.101
1.6
480.1
 2 golo
moh endair
A
2
HI
R
A
78
N
M
_0
02
13
3
●
0
0
21
371
7.701
5.7
380.1
1 )gnilcyced( esanegyxo e
me
H
1
X
O
M
H
Supplementary material	 131
G
4 
de
ns
ity
 
[P
Q
S
·k
b−
1 ]
E
nr
ic
hm
en
t 
(lo
g 2
)
N
or
m
al
is
ed
 
∑
(G
4-
sc
or
e)
∑
(G
4-
sc
or
e)
R
k
A
cc
es
si
on
G
en
e
D
ef
in
iti
on
5'-UTR
CDS
3'-UTR
N
G4
(2)
N
G4
(3)
N
G4
(4) 0
0
3
15
9.51
9.0
180.1
 ekil-3 nietorpohpsohp iglo
G
L3
H
PL
O
G
871810_
M
N
97
0
0
12
623
5.711
6.7
070.1
 3 tnenop
moc xelp
moc tsycox
E
3
C
O
X
E
772700_
M
N
08 81
N
M
_0
24
40
8
●
N
O
TC
H
2
N
ot
ch
 2
 
1.
06
8
4.
0
58
.1
66
4
46
0
0 0
0
31
981
3.07
8.4
560.1
 esaditpep enietsyc detaler-sisotpopa ,3 esapsa
C
3
P
S
A
C
643400_
M
N
28
1
0
1
31
272
5.981
8.9
460.1
 2 ekil-nietorp la
mososyl gnitcaretni ba
R
2L
PLI
R
850541_
M
N
38
3
1
0
4
42
825
7.981
1.01
650.1
 golo
moh 
E
R
A
N
S-v 6T
K
Y
6T
K
Y
555600_
M
N
48
0
0
8
441
6.841
3.8
550.1
 rotcaf cihportoruen devired-etycortsa cilahpecnese
M
F
N
A
M
010600_
M
N
58 8 6
N
M
_0
21
93
4
●
0
0
81
703
6.012
3.21
150.1
 44 e
marf gnidaer nepo 21 e
moso
morh
C
44fro21
C
87
N
M
_0
02
88
2
●
401
6.711
8.6
640.1
 1 nietorp gnidnib 
N
A
R
1
P
B
N
A
R
5
1
0
1
88
N
M
_0
02
37
0
M
A
G
O
H
1
0
1
3
97
2.311
7.5
540.1
 detaicossa-noitarefilorp ,golo
moh ihsan-oga
M
1
0
1
32
653
3.331
0.9
340.1
 67 nietorp regnif cniZ
67F
NZ
724300_
M
N
98 90
N
M
_1
81
47
1
●
0
0
31
142
5.041
6.7
340.1
 a
Dk 04  ,2 )1 rotavitca( 
C rotcaf noitacilpe
R
2
CF
R
91
N
M
_0
14
02
6
●
1
0
1
21
952
8.171
6.8
730.1
 regnevacs ,e
myzne gnippace
D
S
P
C
D
1
0
1
12
763
9.212
8.21
730.1
 golo
moh rotaluger sisenegoib e
mosobir 1
S
R
R
1
S
R
R
961510_
M
N
29 9 3
N
M
_0
15
37
8
●
1
1
0
2
46
7001
6.16
0.4
530.1
 
D golo
moh 31 gnitros nietorp ralouca
V
D31
S
P
V
0
0
8
711
8.211
7.7
920.1
 1 gniniatnoc nia
mod 
CLT
1
D
CLT
364831_
M
N
49
2
1
1
9
812
7.77
9.3
820.1
 1 nietorp enarb
me
m lailehtip
E
1
P
M
E
324100_
M
N
59 96
N
M
_0
15
05
7
●
0
0
95
298
4.95
9.3
620.1
 2 nietorp gnidnib 
C
Y
M
2
P
B
C
Y
M
1
0
1
9
561
6.85
6.3
320.1
 4 gniniatnoc nia
mod 
C
H
C
C ,regnif cniZ
4
C
H
C
CZ
639420_
M
N
79
1
0
1
32
034
8.851
9.8
510.1
 4 nietorp gnidnib nanorulay
H
4
P
B
A
H
282410_
M
N
89
63
807
5.222
3.21
310.1
 ekil-5 nietorp nia
mod gnidnib-3
H
S
L5
P
B3
H
S
546030_
M
N
99
3
0
1
1
1
1
0
1
12
483
5.461
4.9
210.1
 5 esarefsnartlyteca enisyL
5T
A
K
017281_
M
N
001 10
1
N
M
_0
19
89
6
●
0
0
4
37
8.201
6.5
900.1
)tinubus 21p( 4 nolispe ,)detcerid-
A
N
D( esare
mylo
P
4
EL
O
P
10
2
N
M
_2
13
64
9
●
0
0
9
231
3.49
4.6
700.1
 4 nixelforedi
S
4
N
XF
S
10
3
N
M
_0
02
81
0
P
S
M
D
4
P
ro
te
as
om
e 
(p
ro
so
m
e,
 m
ac
ro
pa
in
) 2
6S
 s
ub
un
it,
 n
on
-A
TP
as
e,
 4
 
1.
00
5
9.
8
15
1.
7
20
2
13
0
0
10
4
N
M
_0
02
81
2
●
P
S
M
D
8
P
ro
te
as
om
e 
(p
ro
so
m
e,
 m
ac
ro
pa
in
) 2
6S
 s
ub
un
it,
 n
on
-A
TP
as
e,
 8
1.
00
4
7.
1
12
2.
8
19
1
10
1
0
1 1
1
0
2
43
426
9.041
1.8
300.1
 601 e
marf gnidaer nepo 6 e
moso
morh
C
601fro6
C
492420_
M
N
501
1
0
1
6
041
7.621
3.6
200.1
 
A5 nietorp regnif 
D
H
P
A5F
H
P
857230_
M
N
601
TO
TA
L
2 5
24
43

Chapter 7 References
134	 Chapter 7
References	 135
 1. Gu, J. and Reddy, R. (2001) Cellular RNAs: Varied Roles. Encyclopedia 
of Life Sciences, 1-7.    Full Text 
 2. Schroeder, R., Barta, A. and Semrad, K. (2004) Strategies for RNA 
folding and assembly. Nat Rev Mol Cell Biol, 5, 908-919.    Abstract    
Full Text 
 3. Russell, R. (2008) RNA misfolding and the action of chaperones. Front 
Biosci, 13, 1-20.    Abstract    Full Text 
 4. Lorsch, J.R. (2002) RNA chaperones exist and DEAD box proteins get a 
life. Cell, 109, 797-800.    Abstract    Full Text 
 5. Silverman, E., Edwalds-Gilbert, G. and Lin, R.J. (2003) DExD/H-box 
proteins and their partners: helping RNA helicases unwind. Gene, 312, 
1-16.    Abstract    Full Text 
 6. Hilbert, M., Karow, A.R. and Klostermeier, D. (2009) The mechanism of 
ATP-dependent RNA unwinding by DEAD box proteins. Biol Chem, 390, 
1237-1250.    Abstract    Full Text 
 7. Linder, P. (2006) Dead-box proteins: a family affair--active and passive 
players in RNP-remodeling. Nucleic Acids Res, 34, 4168-4180.    Abstract    
Full Text 
 8. Jankowsky, E. and Bowers, H. (2006) Remodeling of ribonucleoprotein 
complexes with DExH/D RNA helicases. Nucleic Acids Res, 34, 4181-
4188.    Abstract    Full Text 
 9. Anantharaman, V., Koonin, E.V. and Aravind, L. (2002) Comparative 
genomics and evolution of proteins involved in RNA metabolism. 
Nucleic Acids Res, 30, 1427-1464.    Abstract    Full Text 
 10. Shiratori, A., Shibata, T., Arisawa, M., Hanaoka, F., Murakami, Y. and Eki, 
T. (1999) Systematic identification, classification, and characterization 
of the open reading frames which encode novel helicase-related 
proteins in Saccharomyces cerevisiae by gene disruption and 
Northern analysis. Yeast, 15, 219-253.    Abstract    Full Text 
 11. Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., 
Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A. et al. (2001) The 
sequence of the human genome. Science, 291, 1304-1351.    Abstract    
Full Text 
 12. Gorbalenya, A.E. and Koonin, E.V. (1993) Helicases: amino acid 
sequence comparisons and structure-function relationships. Curr Opin 
Struct Biol, 3, 419-429.    Abstract    Full Text 
 13. Singleton, M.R., Dillingham, M.S. and Wigley, D.B. (2007) Structure and 
mechanism of helicases and nucleic acid translocases. Annu Rev 
Biochem, 76, 23-50.    Abstract    Full Text 
 14. Fairman-Williams, M.E., Guenther, U.P. and Jankowsky, E. (2010) SF1 and 
SF2 helicases: family matters. Curr Opin Struct Biol, 20, 313-324.    
Abstract    Full Text 
 15. Durr, H., Flaus, A., Owen-Hughes, T. and Hopfner, K.P. (2006) Snf2 family 
ATPases and DExx box helicases: differences and unifying concepts 
from high-resolution crystal structures. Nucleic Acids Res, 34, 4160-
4167.    Abstract    Full Text 
 16. Tuteja, N. and Tuteja, R. (2004) Prokaryotic and eukaryotic DNA 
helicases. Essential molecular motor proteins for cellular machinery. 
Eur J Biochem, 271, 1835-1848.    Abstract    Full Text 
 17. Tuteja, N. and Tuteja, R. (2004) Unraveling DNA helicases. Motif, 
structure, mechanism and function. Eur J Biochem, 271, 1849-1863.    
Abstract    Full Text 
 18. Caruthers, J.M. and McKay, D.B. (2002) Helicase structure and 
mechanism. Curr Opin Struct Biol, 12, 123-133.    Abstract    Full Text 
 19. Patel, S.S. and Picha, K.M. (2000) Structure and function of hexameric 
helicases. Annu Rev Biochem, 69, 651-697.    Abstract    Full Text 
 20. Enemark, E.J. and Joshua-Tor, L. (2008) On helicases and other motor 
proteins. Curr Opin Struct Biol, 18, 243-257.    Abstract    Full Text 
 21. Bachrati, C.Z. and Hickson, I.D. (2008) RecQ helicases: guardian angels 
of the DNA replication fork. Chromosoma, 117, 219-233.    Abstract    
Full Text 
 22. Chu, W.K. and Hickson, I.D. (2009) RecQ helicases: multifunctional 
genome caretakers. Nat Rev Cancer, 9, 644-654.    Abstract    Full Text 
 23. Wu, Y., Suhasini, A.N. and Brosh, R.M., Jr. (2009) Welcome the family of 
FANCJ-like helicases to the block of genome stability maintenance 
proteins. Cell Mol Life Sci, 66, 1209-1222.    Abstract    Full Text 
 24. Kokavec, J., Podskocova, J., Zavadil, J. and Stopka, T. (2008) Chromatin 
remodeling and SWI/SNF2 factors in human disease. Front Biosci, 13, 
6126-6134.    Abstract    Full Text 
 25. Bleichert, F. and Baserga, S.J. (2007) The long unwinding road of RNA 
helicases. Mol Cell, 27, 339-352.    Abstract    Full Text 
 26. de la Cruz, J., Kressler, D. and Linder, P. (1999) Unwinding RNA in 
Saccharomyces cerevisiae: DEAD-box proteins and related families. 
Trends Biochem Sci, 24, 192-198.    Abstract    Full Text 
 27. Sengoku, T., Nureki, O., Nakamura, A., Kobayashi, S. and Yokoyama, S. 
(2006) Structural basis for RNA unwinding by the DEAD-box protein 
Drosophila Vasa. Cell, 125, 287-300.    Abstract    Full Text 
 28. Linder, P. and Jankowsky, E. (2011) From unwinding to clamping - the 
DEAD box RNA helicase family. Nat Rev Mol Cell Biol, 12, 505-516.    
Abstract    Full Text 
 29. Buttner, K., Nehring, S. and Hopfner, K.P. (2007) Structural basis for DNA 
duplex separation by a superfamily-2 helicase. Nat Struct Mol Biol, 14, 
647-652.    Abstract    Full Text 
 30. He, Y., Andersen, C.B. and Nielsen, K.H. (2011) The function and 
architecture of DEAH/RHA helicases. BioMolecular Concepts, 2, 315-
326.    Full Text 
 31. Cordin, O., Banroques, J., Tanner, N.K. and Linder, P. (2006) The DEAD-
box protein family of RNA helicases. Gene, 367, 17-37.    Abstract    
Full Text 
 32. Tran, H., Schilling, M., Wirbelauer, C., Hess, D. and Nagamine, Y. (2004) 
Facilitation of mRNA deadenylation and decay by the exosome-bound, 
DExH protein RHAU. Mol Cell, 13, 101-111.    Abstract    Full Text 
 33. Vaughn, J.P., Creacy, S.D., Routh, E.D., Joyner-Butt, C., Jenkins, G.S., 
Pauli, S., Nagamine, Y. and Akman, S.A. (2005) The DEXH protein 
product of the DHX36 gene is the major source of tetramolecular 
quadruplex G4-DNA resolving activity in HeLa cell lysates. J Biol 
Chem, 280, 38117-38120.    Abstract    Full Text 
 34. Sexton, A.N. and Collins, K. (2011) The 5' guanosine tracts of human 
telomerase RNA are recognized by the G-quadruplex binding domain 
of the RNA helicase DHX36 and function to increase RNA 
accumulation. Mol Cell Biol, 31, 736-743.    Abstract    Full Text 
 35. Harosh, I. and Deschavanne, P. (1991) The RAD3 gene is a member of 
the DEAH family RNA helicase-like protein. Nucleic Acids Res, 19, 6331.    
Abstract    Full Text 
 36. Company, M., Arenas, J. and Abelson, J. (1991) Requirement of the RNA 
helicase-like protein PRP22 for release of messenger RNA from 
spliceosomes. Nature, 349, 487-493.    Abstract    Full Text 
 37. Tanner, N.K. and Linder, P. (2001) DExD/H box RNA helicases: from 
generic motors to specific dissociation functions. Mol Cell, 8, 251-262.    
Abstract    Full Text 
 38. Zhang, S. and Grosse, F. (1994) Nuclear DNA helicase II unwinds both 
DNA and RNA. Biochemistry, 33, 3906-3912.    Abstract 
 39. Giri, B., Smaldino, P.J., Thys, R.G., Creacy, S.D., Routh, E.D., Hantgan, 
R.R., Lattmann, S., Nagamine, Y., Akman, S.A. and Vaughn, J.P. (2011) 
G4 Resolvase 1 tightly binds and unwinds unimolecular G4-DNA. 
Nucleic Acids Res, 39, 7161-7178.    Abstract    Full Text 
 40. Arenas, J.E. and Abelson, J.N. (1997) Prp43: An RNA helicase-like factor 
involved in spliceosome disassembly. Proc Natl Acad Sci U S A, 94, 
11798-11802.    Abstract    Full Text 
 41. Martin, A., Schneider, S. and Schwer, B. (2002) Prp43 is an essential 
RNA-dependent ATPase required for release of lariat-intron from the 
spliceosome. J Biol Chem, 277, 17743-17750.    Abstract    Full Text 
 42. Tanaka, N., Aronova, A. and Schwer, B. (2007) Ntr1 activates the Prp43 
helicase to trigger release of lariat-intron from the spliceosome. Genes 
Dev, 21, 2312-2325.    Abstract    Full Text 
 43. Lebaron, S., Froment, C., Fromont-Racine, M., Rain, J.C., Monsarrat, B., 
Caizergues-Ferrer, M. and Henry, Y. (2005) The splicing ATPase prp43p 
is a component of multiple preribosomal particles. Mol Cell Biol, 25, 
9269-9282.    Abstract    Full Text 
 44. Combs, D.J., Nagel, R.J., Ares, M., Jr. and Stevens, S.W. (2006) Prp43p is 
a DEAH-box spliceosome disassembly factor essential for ribosome 
biogenesis. Mol Cell Biol, 26, 523-534.    Abstract    Full Text 
 45. Leeds, N.B., Small, E.C., Hiley, S.L., Hughes, T.R. and Staley, J.P. (2006) 
The splicing factor Prp43p, a DEAH box ATPase, functions in 
ribosome biogenesis. Mol Cell Biol, 26, 513-522.    Abstract    Full Text 
 46. Koo, J.T., Choe, J. and Moseley, S.L. (2004) HrpA, a DEAH-box RNA 
helicase, is involved in mRNA processing of a fimbrial operon in 
Escherichia coli. Mol Microbiol, 52, 1813-1826.    Abstract    Full Text 
 47. Schwer, B. and Gross, C.H. (1998) Prp22, a DExH-box RNA helicase, 
plays two distinct roles in yeast pre-mRNA splicing. EMBO J, 17, 2086-
2094.    Abstract    Full Text 
 
136	 Chapter 7
 48. Wagner, J.D., Jankowsky, E., Company, M., Pyle, A.M. and Abelson, J.N. 
(1998) The DEAH-box protein PRP22 is an ATPase that mediates ATP-
dependent mRNA release from the spliceosome and unwinds RNA 
duplexes. EMBO J, 17, 2926-2937.    Abstract    Full Text 
 49. McPheeters, D.S., Schwer, B. and Muhlenkamp, P. (2000) Interaction of 
the yeast DExH-box RNA helicase prp22p with the 3' splice site during 
the second step of nuclear pre-mRNA splicing. Nucleic Acids Res, 28, 
1313-1321.    Abstract    Full Text 
 50. Schwer, B. (2008) A conformational rearrangement in the spliceosome 
sets the stage for Prp22-dependent mRNA release. Mol Cell, 30, 743-
754.    Abstract    Full Text 
 51. Mayas, R.M., Maita, H. and Staley, J.P. (2006) Exon ligation is proofread 
by the DExD/H-box ATPase Prp22p. Nat Struct Mol Biol, 13, 482-490.    
Abstract    Full Text 
 52. Graham, P.L., Schedl, T. and Kimble, J. (1993) More mog genes that 
influence the switch from spermatogenesis to oogenesis in the 
hermaphrodite germ line of Caenorhabditis elegans. Dev Genet, 14, 
471-484.    Abstract    Full Text 
 53. Puoti, A. and Kimble, J. (2000) The hermaphrodite sperm/oocyte switch 
requires the Caenorhabditis elegans homologs of PRP2 and PRP22. 
Proc Natl Acad Sci U S A, 97, 3276-3281.    Abstract    Full Text 
 54. Colaiacovo, M.P., Stanfield, G.M., Reddy, K.C., Reinke, V., Kim, S.K. and 
Villeneuve, A.M. (2002) A targeted RNAi screen for genes involved in 
chromosome morphogenesis and nuclear organization in the 
Caenorhabditis elegans germline. Genetics, 162, 113-128.    Abstract 
 55. Walstrom, K.M., Schmidt, D., Bean, C.J. and Kelly, W.G. (2005) RNA 
helicase A is important for germline transcriptional control, 
proliferation, and meiosis in C. elegans. Mech Dev, 122, 707-720.    
Abstract    Full Text 
 56. Kuroda, M.I., Kernan, M.J., Kreber, R., Ganetzky, B. and Baker, B.S. (1991) 
The maleless protein associates with the X chromosome to regulate 
dosage compensation in Drosophila. Cell, 66, 935-947.    Abstract    
Full Text 
 57. Lee, C.G., Chang, K.A., Kuroda, M.I. and Hurwitz, J. (1997) The 
NTPase/helicase activities of Drosophila maleless, an essential factor 
in dosage compensation. EMBO J, 16, 2671-2681.    Abstract    Full Text 
 58. Lee, C.G., Reichman, T.W., Baik, T. and Mathews, M.B. (2004) MLE 
functions as a transcriptional regulator of the roX2 gene. J Biol Chem, 
279, 47740-47745.    Abstract    Full Text 
 59. Aratani, S., Kageyama, Y., Nakamura, A., Fujita, H., Fujii, R., Nishioka, K. 
and Nakajima, T. (2008) MLE activates transcription via the minimal 
transactivation domain in Drosophila. Int J Mol Med, 21, 469-476.    
Abstract 
 60. Morra, R., Smith, E.R., Yokoyama, R. and Lucchesi, J.C. (2008) The MLE 
subunit of the Drosophila MSL complex uses its ATPase activity for 
dosage compensation and its helicase activity for targeting. Mol Cell 
Biol, 28, 958-966.    Abstract    Full Text 
 61. Reenan, R.A., Hanrahan, C.J. and Ganetzky, B. (2000) The mle(napts) 
RNA helicase mutation in drosophila results in a splicing catastrophe 
of the para Na+ channel transcript in a region of RNA editing. Neuron, 
25, 139-149.    Abstract    Full Text 
 62. Zhang, S. and Grosse, F. (2004) Multiple functions of nuclear DNA 
helicase II (RNA helicase A) in nucleic acid metabolism. Acta Biochim 
Biophys Sin (Shanghai), 36, 177-183.    Abstract    Full Text 
 63. Nakajima, T., Uchida, C., Anderson, S.F., Lee, C.G., Hurwitz, J., Parvin, 
J.D. and Montminy, M. (1997) RNA helicase A mediates association of 
CBP with RNA polymerase II. Cell, 90, 1107-1112.    Abstract    Full Text 
 64. Anderson, S.F., Schlegel, B.P., Nakajima, T., Wolpin, E.S. and Parvin, J.D. 
(1998) BRCA1 protein is linked to the RNA polymerase II holoenzyme 
complex via RNA helicase A. Nat Genet, 19, 254-256.    Abstract    
Full Text 
 65. Aratani, S., Fujii, R., Oishi, T., Fujita, H., Amano, T., Ohshima, T., 
Hagiwara, M., Fukamizu, A. and Nakajima, T. (2001) Dual roles of RNA 
helicase A in CREB-dependent transcription. Mol Cell Biol, 21, 4460-
4469.    Abstract    Full Text 
 66. Myohanen, S. and Baylin, S.B. (2001) Sequence-specific DNA binding 
activity of RNA helicase A to the p16INK4a promoter. J Biol Chem, 276, 
1634-1642.    Abstract    Full Text 
 67. Tetsuka, T., Uranishi, H., Sanda, T., Asamitsu, K., Yang, J.P., Wong-Staal, 
F. and Okamoto, T. (2004) RNA helicase A interacts with nuclear factor 
kappaB p65 and functions as a transcriptional coactivator. Eur J 
Biochem, 271, 3741-3751.    Abstract    Full Text 
 68. Tang, H., Gaietta, G.M., Fischer, W.H., Ellisman, M.H. and Wong-Staal, F. 
(1997) A cellular cofactor for the constitutive transport element of type 
D retrovirus. Science, 276, 1412-1415.    Abstract    Full Text 
 69. Li, J., Tang, H., Mullen, T.M., Westberg, C., Reddy, T.R., Rose, D.W. and 
Wong-Staal, F. (1999) A role for RNA helicase A in post-transcriptional 
regulation of HIV type 1. Proc Natl Acad Sci U S A, 96, 709-714.    
Abstract    Full Text 
 70. Roy, B.B., Hu, J., Guo, X., Russell, R.S., Guo, F., Kleiman, L. and Liang, C. 
(2006) Association of RNA helicase a with human immunodeficiency 
virus type 1 particles. J Biol Chem, 281, 12625-12635.    Abstract    
Full Text 
 71. He, Q.S., Tang, H., Zhang, J., Truong, K., Wong-Staal, F. and Zhou, D. 
(2008) Comparisons of RNAi approaches for validation of human RNA 
helicase A as an essential factor in hepatitis C virus replication. J Virol 
Methods, 154, 216-219.    Abstract    Full Text 
 72. Hartman, T.R., Qian, S., Bolinger, C., Fernandez, S., Schoenberg, D.R. and 
Boris-Lawrie, K. (2006) RNA helicase A is necessary for translation of 
selected messenger RNAs. Nat Struct Mol Biol, 13, 509-516.    Abstract    
Full Text 
 73. Robb, G.B. and Rana, T.M. (2007) RNA helicase A interacts with RISC in 
human cells and functions in RISC loading. Mol Cell, 26, 523-537.    
Abstract    Full Text 
 74. Pellizzoni, L., Charroux, B., Rappsilber, J., Mann, M. and Dreyfuss, G. 
(2001) A functional interaction between the survival motor neuron 
complex and RNA polymerase II. J Cell Biol, 152, 75-85.    Abstract    
Full Text 
 75. Pertschy, B., Schneider, C., Gnadig, M., Schafer, T., Tollervey, D. and Hurt, 
E. (2009) RNA helicase Prp43 and its co-factor Pfa1 promote 20 to 18 S 
rRNA processing catalyzed by the endonuclease Nob1. J Biol Chem, 
284, 35079-35091.    Abstract    Full Text 
 76. Imamura, O., Sugawara, M. and Furuichi, Y. (1997) Cloning and 
characterization of a putative human RNA helicase gene of the DEAH-
box protein family. Biochem Biophys Res Commun, 240, 335-340.    
Abstract    Full Text 
 77. Gee, S., Krauss, S.W., Miller, E., Aoyagi, K., Arenas, J. and Conboy, J.G. 
(1997) Cloning of mDEAH9, a putative RNA helicase and mammalian 
homologue of Saccharomyces cerevisiae splicing factor Prp43. Proc 
Natl Acad Sci U S A, 94, 11803-11807.    Abstract    Full Text 
 78. Fouraux, M.A., Kolkman, M.J., Van der Heijden, A., De Jong, A.S., Van 
Venrooij, W.J. and Pruijn, G.J. (2002) The human La (SS-B) autoantigen 
interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase. 
RNA, 8, 1428-1443.    Abstract    Full Text 
 79. King, D.S. and Beggs, J.D. (1990) Interactions of PRP2 protein with pre-
mRNA splicing complexes in Saccharomyces cerevisiae. Nucleic Acids 
Res, 18, 6559-6564.    Abstract    Full Text 
 80. Teigelkamp, S., McGarvey, M., Plumpton, M. and Beggs, J.D. (1994) The 
splicing factor PRP2, a putative RNA helicase, interacts directly with 
pre-mRNA. EMBO J, 13, 888-897.    Abstract 
 81. Kim, S.H. and Lin, R.J. (1996) Spliceosome activation by PRP2 ATPase 
prior to the first transesterification reaction of pre-mRNA splicing. Mol 
Cell Biol, 16, 6810-6819.    Abstract 
 82. Imamura, O., Saiki, K., Tani, T., Ohshima, Y., Sugawara, M. and Furuichi, 
Y. (1998) Cloning and characterization of a human DEAH-box RNA 
helicase, a functional homolog of fission yeast Cdc28/Prp8. Nucleic 
Acids Res, 26, 2063-2068.    Abstract    Full Text 
 83. Pisareva, V.P., Pisarev, A.V., Komar, A.A., Hellen, C.U. and Pestova, T.V. 
(2008) Translation initiation on mammalian mRNAs with structured 
5'UTRs requires DExH-box protein DHX29. Cell, 135, 1237-1250.    
Abstract    Full Text 
 84. Parsyan, A., Shahbazian, D., Martineau, Y., Petroulakis, E., Alain, T., 
Larsson, O., Mathonnet, G., Tettweiler, G., Hellen, C.U., Pestova, T.V. et al. 
(2009) The helicase protein DHX29 promotes translation initiation, cell 
proliferation, and tumorigenesis. Proc Natl Acad Sci U S A, 106, 22217-
22222.    Abstract    Full Text 
 85. Ye, P., Liu, S., Zhu, Y., Chen, G. and Gao, G. (2010) DEXH-Box protein 
DHX30 is required for optimal function of the zinc-finger antiviral 
protein. Protein Cell, 1, 956-964.    Abstract    Full Text 
 86. Alli, Z., Chen, Y., Abdul Wajid, S., Al-Saud, B. and Abdelhaleem, M. (2007) 
A role for DHX32 in regulating T-cell apoptosis. Anticancer Res, 27, 
373-377.    Abstract 
 87. Longman, D., Plasterk, R.H., Johnstone, I.L. and Caceres, J.F. (2007) 
Mechanistic insights and identification of two novel factors in the C. 
elegans NMD pathway. Genes Dev, 21, 1075-1085.    Abstract    Full Text 
References	 137
 88. Lattmann, S., Giri, B., Vaughn, J.P., Akman, S.A. and Nagamine, Y. (2010) 
Role of the amino terminal RHAU-specific motif in the recognition and 
resolution of guanine quadruplex-RNA by the DEAH-box RNA helicase 
RHAU. Nucleic Acids Res, 38, 6219-6233.    Abstract    Full Text 
 89. Creacy, S.D., Routh, E.D., Iwamoto, F., Nagamine, Y., Akman, S.A. and 
Vaughn, J.P. (2008) G4 resolvase 1 binds both DNA and RNA 
tetramolecular quadruplex with high affinity and is the major source of 
tetramolecular quadruplex G4-DNA and G4-RNA resolving activity in 
HeLa cell lysates. J Biol Chem, 283, 34626-34634.    Abstract    Full Text 
 90. Lai, J.C., Ponti, S., Pan, D., Kohler, H., Skoda, R.C., Matthias, P. and 
Nagamine, Y. (2012) The DEAH-box helicase RHAU is an essential 
gene and critical for mouse hematopoiesis. Blood, 119, 4291.    Abstract    
Full Text 
 91. Colley, A., Beggs, J.D., Tollervey, D. and Lafontaine, D.L. (2000) Dhr1p, a 
putative DEAH-box RNA helicase, is associated with the box C+D 
snoRNP U3. Mol Cell Biol, 20, 7238-7246.    Abstract    Full Text 
 92. Dragon, F., Gallagher, J.E., Compagnone-Post, P.A., Mitchell, B.M., 
Porwancher, K.A., Wehner, K.A., Wormsley, S., Settlage, R.E., 
Shabanowitz, J., Osheim, Y. et al. (2002) A large nucleolar U3 
ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature, 
417, 967-970.    Abstract    Full Text 
 93. Grandi, P., Rybin, V., Bassler, J., Petfalski, E., Strauss, D., Marzioch, M., 
Schafer, T., Kuster, B., Tschochner, H., Tollervey, D. et al. (2002) 90S pre-
ribosomes include the 35S pre-rRNA, the U3 snoRNP, and 40S subunit 
processing factors but predominantly lack 60S synthesis factors. Mol 
Cell, 10, 105-115.    Abstract    Full Text 
 94. Schwer, B. and Guthrie, C. (1991) PRP16 is an RNA-dependent ATPase 
that interacts transiently with the spliceosome. Nature, 349, 494-499.    
Abstract    Full Text 
 95. Schwer, B. and Guthrie, C. (1992) A dominant negative mutation in a 
spliceosomal ATPase affects ATP hydrolysis but not binding to the 
spliceosome. Mol Cell Biol, 12, 3540-3547.    Abstract 
 96. Schwer, B. and Guthrie, C. (1992) A conformational rearrangement in 
the spliceosome is dependent on PRP16 and ATP hydrolysis. EMBO J, 
11, 5033-5039.    Abstract    Full Text 
 97. Tseng, C.K., Liu, H.L. and Cheng, S.C. (2011) DEAH-box ATPase Prp16 
has dual roles in remodeling of the spliceosome in catalytic steps. 
RNA, 17, 145-154.    Abstract    Full Text 
 98. Graham, P.L. and Kimble, J. (1993) The mog-1 gene is required for the 
switch from spermatogenesis to oogenesis in Caenorhabditis elegans. 
Genetics, 133, 919-931.    Abstract 
 99. Zhou, Z. and Reed, R. (1998) Human homologs of yeast prp16 and 
prp17 reveal conservation of the mechanism for catalytic step II of 
pre-mRNA splicing. EMBO J, 17, 2095-2106.    Abstract    Full Text 
 100. Gillespie, D.E. and Berg, C.A. (1995) Homeless is required for RNA 
localization in Drosophila oogenesis and encodes a new member of 
the DE-H family of RNA-dependent ATPases. Genes Dev, 9, 2495-2508.    
Abstract    Full Text 
 101. Stapleton, W., Das, S. and McKee, B.D. (2001) A role of the Drosophila 
homeless gene in repression of Stellate in male meiosis. Chromosoma, 
110, 228-240.    Abstract    Full Text 
 102. Kennerdell, J.R., Yamaguchi, S. and Carthew, R.W. (2002) RNAi is 
activated during Drosophila oocyte maturation in a manner dependent 
on aubergine and spindle-E. Genes Dev, 16, 1884-1889.    Abstract    
Full Text 
 103. Vagin, V.V., Sigova, A., Li, C., Seitz, H., Gvozdev, V. and Zamore, P.D. 
(2006) A distinct small RNA pathway silences selfish genetic elements 
in the germline. Science, 313, 320-324.    Abstract    Full Text 
 104. Savitsky, M., Kwon, D., Georgiev, P., Kalmykova, A. and Gvozdev, V. 
(2006) Telomere elongation is under the control of the RNAi-based 
mechanism in the Drosophila germline. Genes Dev, 20, 345-354.    
Abstract    Full Text 
 105. Shoji, M., Tanaka, T., Hosokawa, M., Reuter, M., Stark, A., Kato, Y., 
Kondoh, G., Okawa, K., Chujo, T., Suzuki, T. et al. (2009) The TDRD9-
MIWI2 complex is essential for piRNA-mediated retrotransposon 
silencing in the mouse male germline. Dev Cell, 17, 775-787.    Abstract    
Full Text 
 106. Iost, I. and Dreyfus, M. (2006) DEAD-box RNA helicases in Escherichia 
coli. Nucleic Acids Res, 34, 4189-4197.    Abstract    Full Text 
 107. Kim, S.H., Smith, J., Claude, A. and Lin, R.J. (1992) The purified yeast 
pre-mRNA splicing factor PRP2 is an RNA-dependent NTPase. EMBO 
J, 11, 2319-2326.    Abstract 
 108. Herold, N., Will, C.L., Wolf, E., Kastner, B., Urlaub, H. and Luhrmann, R. 
(2009) Conservation of the protein composition and electron 
microscopy structure of Drosophila melanogaster and human 
spliceosomal complexes. Mol Cell Biol, 29, 281-301.    Abstract    
Full Text 
 109. Ono, Y., Ohno, M. and Shimura, Y. (1994) Identification of a putative 
RNA helicase (HRH1), a human homolog of yeast Prp22. Mol Cell Biol, 
14, 7611-7620.    Abstract 
 110. Ohno, M. and Shimura, Y. (1996) A human RNA helicase-like protein, 
HRH1, facilitates nuclear export of spliced mRNA by releasing the 
RNA from the spliceosome. Genes Dev, 10, 997-1007.    Abstract    
Full Text 
 111. Gencheva, M., Kato, M., Newo, A.N. and Lin, R.J. (2010) Contribution of 
DEAH-box protein DHX16 in human pre-mRNA splicing. Biochem J, 
429, 25-32.    Abstract    Full Text 
 112. Puoti, A. and Kimble, J. (1999) The Caenorhabditis elegans sex 
determination gene mog-1 encodes a member of the DEAH-Box 
protein family. Mol Cell Biol, 19, 2189-2197.    Abstract 
 113. Walbott, H., Mouffok, S., Capeyrou, R., Lebaron, S., Humbert, O., van 
Tilbeurgh, H., Henry, Y. and Leulliot, N. (2010) Prp43p contains a 
processive helicase structural architecture with a specific regulatory 
domain. EMBO J.    Abstract    Full Text 
 114. Edwalds-Gilbert, G., Kim, D.H., Silverman, E. and Lin, R.J. (2004) 
Definition of a spliceosome interaction domain in yeast Prp2 ATPase. 
RNA, 10, 210-220.    Abstract    Full Text 
 115. Hotz, H.R. and Schwer, B. (1998) Mutational analysis of the yeast 
DEAH-box splicing factor Prp16. Genetics, 149, 807-815.    Abstract 
 116. Wang, Y. and Guthrie, C. (1998) PRP16, a DEAH-box RNA helicase, is 
recruited to the spliceosome primarily via its nonconserved N-terminal 
domain. RNA, 4, 1216-1229.    Abstract    Full Text 
 117. Schneider, S. and Schwer, B. (2001) Functional domains of the yeast 
splicing factor Prp22p. J Biol Chem, 276, 21184-21191.    Abstract    
Full Text 
 118. Tanaka, N. and Schwer, B. (2006) Mutations in PRP43 that uncouple 
RNA-dependent NTPase activity and pre-mRNA splicing function. 
Biochemistry, 45, 6510-6521.    Abstract    Full Text 
 119. Bernstein, D.A. and Keck, J.L. (2003) Domain mapping of Escherichia 
coli RecQ defines the roles of conserved N- and C-terminal regions in 
the RecQ family. Nucleic Acids Res, 31, 2778-2785.    Abstract    Full Text 
 120. Lee, J.W., Kusumoto, R., Doherty, K.M., Lin, G.X., Zeng, W., Cheng, W.H., 
von Kobbe, C., Brosh, R.M., Jr., Hu, J.S. and Bohr, V.A. (2005) Modulation 
of Werner syndrome protein function by a single mutation in the 
conserved RecQ domain. J Biol Chem, 280, 39627-39636.    Abstract    
Full Text 
 121. He, Y., Andersen, G.R. and Nielsen, K.H. (2010) Structural basis for the 
function of DEAH helicases. EMBO Rep, 11, 180-186.    Abstract    
Full Text 
 122. Gu, M. and Rice, C.M. (2010) Three conformational snapshots of the 
hepatitis C virus NS3 helicase reveal a ratchet translocation 
mechanism. Proc Natl Acad Sci U S A, 107, 521-528.    Abstract    
Full Text 
 123. Assenberg, R., Mastrangelo, E., Walter, T.S., Verma, A., Milani, M., Owens, 
R.J., Stuart, D.I., Grimes, J.M. and Mancini, E.J. (2009) Crystal structure 
of a novel conformational state of the flavivirus NS3 protein: 
implications for polyprotein processing and viral replication. J Virol, 
83, 12895-12906.    Abstract    Full Text 
 124. Wu, J., Bera, A.K., Kuhn, R.J. and Smith, J.L. (2005) Structure of the 
Flavivirus helicase: implications for catalytic activity, protein 
interactions, and proteolytic processing. J Virol, 79, 10268-10277.    
Abstract    Full Text 
 125. Frick, D.N. (2007) The hepatitis C virus NS3 protein: a model RNA 
helicase and potential drug target. Curr Issues Mol Biol, 9, 1-20.    
Abstract 
 126. Oyama, T., Oka, H., Mayanagi, K., Shirai, T., Matoba, K., Fujikane, R., 
Ishino, Y. and Morikawa, K. (2009) Atomic structures and functional 
implications of the archaeal RecQ-like helicase Hjm. BMC Struct Biol, 9, 
2.    Abstract    Full Text 
 127. Tanner, N.K., Cordin, O., Banroques, J., Doere, M. and Linder, P. (2003) 
The Q motif: a newly identified motif in DEAD box helicases may 
regulate ATP binding and hydrolysis. Mol Cell, 11, 127-138.    Abstract    
Full Text 
138	 Chapter 7
 128. Tanner, N.K. (2003) The newly identified Q motif of DEAD box 
helicases is involved in adenine recognition. Cell Cycle, 2, 18-19.    
Abstract    Full Text 
 129. Luo, D., Xu, T., Watson, R.P., Scherer-Becker, D., Sampath, A., Jahnke, 
W., Yeong, S.S., Wang, C.H., Lim, S.P., Strongin, A. et al. (2008) Insights 
into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. 
EMBO J, 27, 3209-3219.    Abstract    Full Text 
 130. Theissen, B., Karow, A.R., Kohler, J., Gubaev, A. and Klostermeier, D. 
(2008) Cooperative binding of ATP and RNA induces a closed 
conformation in a DEAD box RNA helicase. Proc Natl Acad Sci U S A, 
105, 548-553.    Abstract    Full Text 
 131. Tanaka, N. and Schwer, B. (2005) Characterization of the NTPase, RNA-
binding, and RNA helicase activities of the DEAH-box splicing factor 
Prp22. Biochemistry, 44, 9795-9803.    Abstract    Full Text 
 132. Lee, C.G. and Hurwitz, J. (1992) A new RNA helicase isolated from HeLa 
cells that catalytically translocates in the 3' to 5' direction. J Biol Chem, 
267, 4398-4407.    Abstract 
 133. Bono, F., Ebert, J., Lorentzen, E. and Conti, E. (2006) The crystal 
structure of the exon junction complex reveals how it maintains a 
stable grip on mRNA. Cell, 126, 713-725.    Abstract    Full Text 
 134. Nielsen, K.H., Chamieh, H., Andersen, C.B., Fredslund, F., Hamborg, K., Le 
Hir, H. and Andersen, G.R. (2009) Mechanism of ATP turnover inhibition 
in the EJC. RNA, 15, 67-75.    Abstract    Full Text 
 135. Ahmadian, M.R., Stege, P., Scheffzek, K. and Wittinghofer, A. (1997) 
Confirmation of the arginine-finger hypothesis for the GAP-stimulated 
GTP-hydrolysis reaction of Ras. Nat Struct Biol, 4, 686-689.    Abstract    
Full Text 
 136. Elles, L.M. and Uhlenbeck, O.C. (2008) Mutation of the arginine finger in 
the active site of Escherichia coli DbpA abolishes ATPase and 
helicase activity and confers a dominant slow growth phenotype. 
Nucleic Acids Res, 36, 41-50.    Abstract    Full Text 
 137. Polach, K.J. and Uhlenbeck, O.C. (2002) Cooperative binding of ATP and 
RNA substrates to the DEAD/H protein DbpA. Biochemistry, 41, 3693-
3702.    Abstract    Full Text 
 138. Collins, R., Karlberg, T., Lehtio, L., Schutz, P., van den Berg, S., Dahlgren, 
L.G., Hammarstrom, M., Weigelt, J. and Schuler, H. (2009) The DEXD/H-
box RNA helicase DDX19 is regulated by an {alpha}-helical switch. J 
Biol Chem, 284, 10296-10300.    Abstract    Full Text 
 139. von Moeller, H., Basquin, C. and Conti, E. (2009) The mRNA export 
protein DBP5 binds RNA and the cytoplasmic nucleoporin NUP214 in 
a mutually exclusive manner. Nat Struct Mol Biol, 16, 247-254.    Abstract    
Full Text 
 140. Lam, A.M., Keeney, D. and Frick, D.N. (2003) Two novel conserved 
motifs in the hepatitis C virus NS3 protein critical for helicase action. J 
Biol Chem, 278, 44514-44524.    Abstract    Full Text 
 141. Schneider, S., Campodonico, E. and Schwer, B. (2004) Motifs IV and V in 
the DEAH box splicing factor Prp22 are important for RNA unwinding, 
and helicase-defective Prp22 mutants are suppressed by Prp8. J Biol 
Chem, 279, 8617-8626.    Abstract    Full Text 
 142. Lin, C. and Kim, J.L. (1999) Structure-based mutagenesis study of 
hepatitis C virus NS3 helicase. J Virol, 73, 8798-8807.    Abstract 
 143. Arcus, V. (2002) OB-fold domains: a snapshot of the evolution of 
sequence, structure and function. Curr Opin Struct Biol, 12, 794-801.    
Abstract    Full Text 
 144. Holm, L. and Rosenstrom, P. (2010) Dali server: conservation mapping 
in 3D. Nucleic Acids Res, 38 Suppl, W545-549.    Abstract    Full Text 
 145. Ermolenko, D.N. and Makhatadze, G.I. (2002) Bacterial cold-shock 
proteins. Cell Mol Life Sci, 59, 1902-1913.    Abstract    Full Text 
 146. Horn, G., Hofweber, R., Kremer, W. and Kalbitzer, H.R. (2007) Structure 
and function of bacterial cold shock proteins. Cell Mol Life Sci, 64, 
1457-1470.    Abstract    Full Text 
 147. Theobald, D.L., Mitton-Fry, R.M. and Wuttke, D.S. (2003) Nucleic acid 
recognition by OB-fold proteins. Annu Rev Biophys Biomol Struct, 32, 
115-133.    Abstract    Full Text 
 148. Izzo, A., Regnard, C., Morales, V., Kremmer, E. and Becker, P.B. (2008) 
Structure-function analysis of the RNA helicase maleless. Nucleic 
Acids Res, 36, 950-962.    Abstract    Full Text 
 149. Schneider, S., Hotz, H.R. and Schwer, B. (2002) Characterization of 
dominant-negative mutants of the DEAH-box splicing factors Prp22 
and Prp16. J Biol Chem, 277, 15452-15458.    Abstract    Full Text 
 150. Schwer, B. and Meszaros, T. (2000) RNA helicase dynamics in pre-
mRNA splicing. EMBO J, 19, 6582-6591.    Abstract    Full Text 
 151. Campodonico, E. and Schwer, B. (2002) ATP-dependent remodeling of 
the spliceosome: intragenic suppressors of release-defective mutants 
of Saccharomyces cerevisiae Prp22. Genetics, 160, 407-415.    Abstract 
 152. Plumpton, M., McGarvey, M. and Beggs, J.D. (1994) A dominant negative 
mutation in the conserved RNA helicase motif 'SAT' causes splicing 
factor PRP2 to stall in spliceosomes. EMBO J, 13, 879-887.    Abstract 
 153. Edwalds-Gilbert, G., Kim, D.H., Kim, S.H., Tseng, Y.H., Yu, Y. and Lin, R.J. 
(2000) Dominant negative mutants of the yeast splicing factor Prp2 
map to a putative cleft region in the helicase domain of DExD/H-box 
proteins. RNA, 6, 1106-1119.    Abstract    Full Text 
 154. Pause, A. and Sonenberg, N. (1992) Mutational analysis of a DEAD box 
RNA helicase: the mammalian translation initiation factor eIF-4A. 
EMBO J, 11, 2643-2654.    Abstract 
 155. Gross, C.H. and Shuman, S. (1998) The nucleoside triphosphatase and 
helicase activities of vaccinia virus NPH-II are essential for virus 
replication. J Virol, 72, 4729-4736.    Abstract 
 156. Karow, A.R. and Klostermeier, D. (2009) A conformational change in the 
helicase core is necessary but not sufficient for RNA unwinding by the 
DEAD box helicase YxiN. Nucleic Acids Res, 37, 4464-4471.    Abstract    
Full Text 
 157. Kos, M. and Tollervey, D. (2005) The Putative RNA Helicase Dbp4p Is 
Required for Release of the U14 snoRNA from Preribosomes in 
Saccharomyces cerevisiae. Mol Cell, 20, 53-64.    Abstract    Full Text 
 158. Bernstein, K.A., Granneman, S., Lee, A.V., Manickam, S. and Baserga, S.J. 
(2006) Comprehensive mutational analysis of yeast DEXD/H box RNA 
helicases involved in large ribosomal subunit biogenesis. Mol Cell Biol, 
26, 1195-1208.    Abstract    Full Text 
 159. Granneman, S., Bernstein, K.A., Bleichert, F. and Baserga, S.J. (2006) 
Comprehensive mutational analysis of yeast DEXD/H box RNA 
helicases required for small ribosomal subunit synthesis. Mol Cell Biol, 
26, 1183-1194.    Abstract    Full Text 
 160. Banroques, J., Doere, M., Dreyfus, M., Linder, P. and Tanner, N.K. (2010) 
Motif III in superfamily 2 "helicases" helps convert the binding energy 
of ATP into a high-affinity RNA binding site in the yeast DEAD-box 
protein Ded1. J Mol Biol, 396, 949-966.    Abstract    Full Text 
 161. Banroques, J., Cordin, O., Doere, M., Linder, P. and Tanner, N.K. (2008) A 
conserved phenylalanine of motif IV in superfamily 2 helicases is 
required for cooperative, ATP-dependent binding of RNA substrates in 
DEAD-box proteins. Mol Cell Biol, 28, 3359-3371.    Abstract    Full Text 
 162. Gallivan, J.P. and Dougherty, D.A. (1999) Cation-pi interactions in 
structural biology. Proc Natl Acad Sci U S A, 96, 9459-9464.    Abstract    
Full Text 
 163. Levin, M.K., Gurjar, M. and Patel, S.S. (2005) A Brownian motor 
mechanism of translocation and strand separation by hepatitis C virus 
helicase. Nat Struct Mol Biol, 12, 429-435.    Abstract    Full Text 
 164. Appleby, T.C., Anderson, R., Fedorova, O., Pyle, A.M., Wang, R., Liu, X., 
Brendza, K.M. and Somoza, J.R. (2011) Visualizing ATP-dependent RNA 
translocation by the NS3 helicase from HCV. J Mol Biol, 405, 1139-1153.    
Abstract    Full Text 
 165. Raney, K.D., Sharma, S.D., Moustafa, I.M. and Cameron, C.E. (2010) 
Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional 
antiviral target. J Biol Chem, 285, 22725-22731.    Abstract    Full Text 
 166. Wang, Y., Wagner, J.D. and Guthrie, C. (1998) The DEAH-box splicing 
factor Prp16 unwinds RNA duplexes in vitro. Curr Biol, 8, 441-451.    
Abstract    Full Text 
 167. Gellert, M., Lipsett, M.N. and Davies, D.R. (1962) Helix formation by 
guanylic acid. Proc Natl Acad Sci U S A, 48, 2013-2018.    Abstract    
Full Text 
 168. Ralph, R.K., Connors, W.J. and Khorana, H.G. (1962) Secondary 
Structure and Aggregation in Deoxyguanosine Oligonucleotides. J Am 
Chem Soc, 84, 2265-2266.    Full Text 
 169. Rich, A. (1993) DNA comes in many forms. Gene, 135, 99-109.    
Abstract 
 170. Doktycz, M.J. (2002) Nucleic Acids: Thermal Stability and Denaturation. 
Encyclopedia of Life Sciences, 1-7.    Full Text 
 171. Wells, R.D. (2007) Non-B DNA conformations, mutagenesis and 
disease. Trends Biochem Sci, 32, 271-278.    Abstract    Full Text 
 172. König, S., Evans, A. and Huppert, J. (2010) Seven essential questions on 
G-quadruplexes. Biomol Concepts, 1, 197-213.    Full Text 
 173. Lane, A.N., Chaires, J.B., Gray, R.D. and Trent, J.O. (2008) Stability and 
kinetics of G-quadruplex structures. Nucleic Acids Res, 36, 5482-5515.    
Abstract    Full Text 
References	 139
 174. Hud, N.V. and Plavec, J. (2006) In Neidle, S. and Balasubramanian, S. 
(eds.), Quadruplex Nucleic Acids. RSC Publishing, Cambridge, UK, pp. 
100-130. 
 175. Engelhart, A.E., Plavec, J., Persil, O. and Hud, N.V. (2008) In Glover, D. M. 
(ed.), Nucleic Acid-Metal Ion Interactions. RSC Publishing, Cambridge, UK, 
pp. 118-153. 
 176. Davis, J.T. (2004) G-quartets 40 years later: from 5'-GMP to molecular 
biology and supramolecular chemistry. Angew Chem Int Ed Engl, 43, 
668-698.    Abstract    Full Text 
 177. Bang, I. (1910) Untersuchung über die Guanylsäure. Biochem Ztschr, 
26, 293-311.    
 178. Guschlbauer, W., Chantot, J.F. and Thiele, D. (1990) Four-stranded 
nucleic acid structures 25 years later: from guanosine gels to telomer 
DNA. J Biomol Struct Dyn, 8, 491-511.    Abstract 
 179. Sen, D. and Gilbert, W. (1990) A sodium-potassium switch in the 
formation of four-stranded G4-DNA. Nature, 344, 410-414.    Abstract    
Full Text 
 180. Henderson, E., Hardin, C.C., Walk, S.K., Tinoco, I., Jr. and Blackburn, E.H. 
(1987) Telomeric DNA oligonucleotides form novel intramolecular 
structures containing guanine-guanine base pairs. Cell, 51, 899-908.    
Abstract    Full Text 
 181. Oka, Y. and Thomas, C.A., Jr. (1987) The cohering telomeres of 
Oxytricha. Nucleic Acids Res, 15, 8877-8898.    Abstract    Full Text 
 182. Williamson, J.R., Raghuraman, M.K. and Cech, T.R. (1989) Monovalent 
cation-induced structure of telomeric DNA: the G-quartet model. Cell, 
59, 871-880.    Abstract    Full Text 
 183. Sundquist, W.I. and Klug, A. (1989) Telomeric DNA dimerizes by 
formation of guanine tetrads between hairpin loops. Nature, 342, 825-
829.    Abstract    Full Text 
 184. Zahler, A.M., Williamson, J.R., Cech, T.R. and Prescott, D.M. (1991) 
Inhibition of telomerase by G-quartet DNA structures. Nature, 350, 718-
720.    Abstract    Full Text 
 185. Mergny, J.L., Gros, J., De Cian, A., Bourdoncle, A., Rosu, F., Sacca, B., 
Guittat, L., Amrane, S., Mills, M., Alberti, P. et al. (2006) In Neidle, S. and 
Balasubramanian, S. (eds.), Quadruplex Nucleic Acids. RSC Publishing, 
Cambridge, UK, pp. 31-80. 
 186. Huppert, J.L. and Balasubramanian, S. (2005) Prevalence of 
quadruplexes in the human genome. Nucleic Acids Res, 33, 2908-2916.    
Abstract    Full Text 
 187. Huppert, J.L. and Balasubramanian, S. (2007) G-quadruplexes in 
promoters throughout the human genome. Nucleic Acids Res, 35, 406-
413.    Abstract    Full Text 
 188. Todd, A.K., Johnston, M. and Neidle, S. (2005) Highly prevalent putative 
quadruplex sequence motifs in human DNA. Nucleic Acids Res, 33, 
2901-2907.    Abstract    Full Text 
 189. Hershman, S.G., Chen, Q., Lee, J.Y., Kozak, M.L., Yue, P., Wang, L.S. and 
Johnson, F.B. (2008) Genomic distribution and functional analyses of 
potential G-quadruplex-forming sequences in Saccharomyces 
cerevisiae. Nucleic Acids Res, 36, 144-156.    Abstract    Full Text 
 190. Kumari, S., Bugaut, A., Huppert, J.L. and Balasubramanian, S. (2007) An 
RNA G-quadruplex in the 5' UTR of the NRAS proto-oncogene 
modulates translation. Nat Chem Biol, 3, 218-221.    Abstract    Full Text 
 191. Huppert, J.L., Bugaut, A., Kumari, S. and Balasubramanian, S. (2008) G-
quadruplexes: the beginning and end of UTRs. Nucleic Acids Res, 36, 
6260-6268.    Abstract    Full Text 
 192. Eddy, J. and Maizels, N. (2008) Conserved elements with potential to 
form polymorphic G-quadruplex structures in the first intron of human 
genes. Nucleic Acids Res, 36, 1321-1333.    Abstract    Full Text 
 193. Neidle, S. (2010) Human telomeric G-quadruplex: the current status of 
telomeric G-quadruplexes as therapeutic targets in human cancer. 
FEBS J, 277, 1118-1125.    Abstract    Full Text 
 194. Zhou, W., Brand, N.J. and Ying, L. (2011) G-quadruplexes-novel 
mediators of gene function. J Cardiovasc Transl Res, 4, 256-270.    
Abstract    Full Text 
 195. Besnard, E., Babled, A., Lapasset, L., Milhavet, O., Parrinello, H., Dantec, 
C., Marin, J.M. and Lemaitre, J.M. (2012) Unraveling cell type-specific 
and reprogrammable human replication origin signatures associated 
with G-quadruplex consensus motifs. Nat Struct Mol Biol, 19, 837-844.    
Abstract    Full Text 
 196. Chang, C.C., Chu, J.F., Kao, F.J., Chiu, Y.C., Lou, P.J., Chen, H.C. and 
Chang, T.C. (2006) Verification of antiparallel G-quadruplex structure 
in human telomeres by using two-photon excitation fluorescence 
lifetime imaging microscopy of the 3,6-Bis(1-methyl-4-
vinylpyridinium)carbazole diiodide molecule. Anal Chem, 78, 2810-
2815.    Abstract    Full Text 
 197. Schaffitzel, C., Berger, I., Postberg, J., Hanes, J., Lipps, H.J. and 
Pluckthun, A. (2001) In vitro generated antibodies specific for telomeric 
guanine-quadruplex DNA react with Stylonychia lemnae macronuclei. 
Proc Natl Acad Sci U S A, 98, 8572-8577.    Abstract    Full Text 
 198. Paeschke, K., Simonsson, T., Postberg, J., Rhodes, D. and Lipps, H.J. 
(2005) Telomere end-binding proteins control the formation of G-
quadruplex DNA structures in vivo. Nat Struct Mol Biol, 12, 847-854.    
Abstract    Full Text 
 199. Grand, C.L., Han, H., Munoz, R.M., Weitman, S., Von Hoff, D.D., Hurley, 
L.H. and Bearss, D.J. (2002) The cationic porphyrin TMPyP4 down-
regulates c-MYC and human telomerase reverse transcriptase 
expression and inhibits tumor growth in vivo. Mol Cancer Ther, 1, 565-
573.    Abstract 
 200. Siddiqui-Jain, A., Grand, C.L., Bearss, D.J. and Hurley, L.H. (2002) Direct 
evidence for a G-quadruplex in a promoter region and its targeting 
with a small molecule to repress c-MYC transcription. Proc Natl Acad 
Sci U S A, 99, 11593-11598.    Abstract    Full Text 
 201. Fernando, H., Rodriguez, R. and Balasubramanian, S. (2008) Selective 
recognition of a DNA G-quadruplex by an engineered antibody. 
Biochemistry, 47, 9365-9371.    Abstract    Full Text 
 202. Fernando, H., Sewitz, S., Darot, J., Tavare, S., Huppert, J.L. and 
Balasubramanian, S. (2009) Genome-wide analysis of a G-quadruplex-
specific single-chain antibody that regulates gene expression. Nucleic 
Acids Res, 37, 6716-6722.    Abstract    Full Text 
 203. Sacca, B., Lacroix, L. and Mergny, J.L. (2005) The effect of chemical 
modifications on the thermal stability of different G-quadruplex-
forming oligonucleotides. Nucleic Acids Res, 33, 1182-1192.    Abstract    
Full Text 
 204. Mergny, J.L., De Cian, A., Ghelab, A., Sacca, B. and Lacroix, L. (2005) 
Kinetics of tetramolecular quadruplexes. Nucleic Acids Res, 33, 81-94.    
Abstract    Full Text 
 205. Joachimi, A., Benz, A. and Hartig, J.S. (2009) A comparison of DNA and 
RNA quadruplex structures and stabilities. Bioorg Med Chem, 17, 6811-
6815.    Abstract    Full Text 
 206. Arora, A. and Maiti, S. (2009) Differential biophysical behavior of human 
telomeric RNA and DNA quadruplex. J Phys Chem B, 113, 10515-10520.    
Abstract    Full Text 
 207. Beaudoin, J.D. and Perreault, J.P. (2010) 5'-UTR G-quadruplex 
structures acting as translational repressors. Nucleic Acids Res, 38, 
7022-7036.    Abstract    Full Text 
 208. Arora, A., Dutkiewicz, M., Scaria, V., Hariharan, M., Maiti, S. and Kurreck, 
J. (2008) Inhibition of translation in living eukaryotic cells by an RNA 
G-quadruplex motif. RNA, 14, 1290-1296.    Abstract    Full Text 
 209. Morris, M.J. and Basu, S. (2009) An unusually stable G-quadruplex 
within the 5'-UTR of the MT3 matrix metalloproteinase mRNA 
represses translation in eukaryotic cells. Biochemistry, 48, 5313-5319.    
Abstract    Full Text 
 210. Gomez, D., Guedin, A., Mergny, J.L., Salles, B., Riou, J.F., Teulade-Fichou, 
M.P. and Calsou, P. (2010) A G-quadruplex structure within the 5'-UTR 
of TRF2 mRNA represses translation in human cells. Nucleic Acids Res, 
38, 7187-7198.    Abstract    Full Text 
 211. Bonnal, S., Schaeffer, C., Creancier, L., Clamens, S., Moine, H., Prats, A.C. 
and Vagner, S. (2003) A single internal ribosome entry site containing a 
G quartet RNA structure drives fibroblast growth factor 2 gene 
expression at four alternative translation initiation codons. J Biol 
Chem, 278, 39330-39336.    Abstract    Full Text 
 212. Morris, M.J., Negishi, Y., Pazsint, C., Schonhoft, J.D. and Basu, S. (2010) 
An RNA G-quadruplex is essential for cap-independent translation 
initiation in human VEGF IRES. J Am Chem Soc, 132, 17831-17839.    
Abstract    Full Text 
 213. Gomez, D., Lemarteleur, T., Lacroix, L., Mailliet, P., Mergny, J.L. and Riou, 
J.F. (2004) Telomerase downregulation induced by the G-quadruplex 
ligand 12459 in A549 cells is mediated by hTERT RNA alternative 
splicing. Nucleic Acids Res, 32, 371-379.    Abstract    Full Text 
140	 Chapter 7
 214. Kostadinov, R., Malhotra, N., Viotti, M., Shine, R., D'Antonio, L. and Bagga, 
P. (2006) GRSDB: a database of quadruplex forming G-rich sequences 
in alternatively processed mammalian pre-mRNA sequences. Nucleic 
Acids Res, 34, D119-124.    Abstract    Full Text 
 215. Didiot, M.C., Tian, Z., Schaeffer, C., Subramanian, M., Mandel, J.L. and 
Moine, H. (2008) The G-quartet containing FMRP binding site in FMR1 
mRNA is a potent exonic splicing enhancer. Nucleic Acids Res, 36, 
4902-4912.    Abstract    Full Text 
 216. Marcel, V., Tran, P.L., Sagne, C., Martel-Planche, G., Vaslin, L., Teulade-
Fichou, M.P., Hall, J., Mergny, J.L., Hainaut, P. and Van Dyck, E. (2011) G-
quadruplex structures in TP53 intron 3: role in alternative splicing and 
in production of p53 mRNA isoforms. Carcinogenesis, 32, 271-278.    
Abstract    Full Text 
 217. Kikin, O., Zappala, Z., D'Antonio, L. and Bagga, P.S. (2008) GRSDB2 and 
GRS_UTRdb: databases of quadruplex forming G-rich sequences in 
pre-mRNAs and mRNAs. Nucleic Acids Res, 36, D141-148.    Abstract    
Full Text 
 218. Wanrooij, P.H., Uhler, J.P., Simonsson, T., Falkenberg, M. and Gustafsson, 
C.M. (2010) G-quadruplex structures in RNA stimulate mitochondrial 
transcription termination and primer formation. Proc Natl Acad Sci U S 
A, 107, 16072-16077.    Abstract    Full Text 
 219. Decorsiere, A., Cayrel, A., Vagner, S. and Millevoi, S. (2011) Essential role 
for the interaction between hnRNP H/F and a G quadruplex in 
maintaining p53 pre-mRNA 3'-end processing and function during 
DNA damage. Genes Dev, 25, 220-225.    Abstract    Full Text 
 220. Randall, A. and Griffith, J.D. (2009) Structure of long telomeric RNA 
transcripts: the G-rich RNA forms a compact repeating structure 
containing G-quartets. J Biol Chem, 284, 13980-13986.    Abstract    
Full Text 
 221. Martadinata, H. and Phan, A.T. (2009) Structure of propeller-type 
parallel-stranded RNA G-quadruplexes, formed by human telomeric 
RNA sequences in K+ solution. J Am Chem Soc, 131, 2570-2578.    
Abstract    Full Text 
 222. Xu, Y., Kaminaga, K. and Komiyama, M. (2008) G-quadruplex formation 
by human telomeric repeats-containing RNA in Na+ solution. J Am 
Chem Soc, 130, 11179-11184.    Abstract    Full Text 
 223. Xu, Y., Suzuki, Y., Ito, K. and Komiyama, M. (2010) Telomeric repeat-
containing RNA structure in living cells. Proc Natl Acad Sci U S A, 107, 
14579-14584.    Abstract    Full Text 
 224. Gros, J., Guedin, A., Mergny, J.L. and Lacroix, L. (2008) G-Quadruplex 
formation interferes with P1 helix formation in the RNA component of 
telomerase hTERC. Chembiochem, 9, 2075-2079.    Abstract    Full Text 
 225. Wu, Y. and Brosh, R.M., Jr. (2010) G-quadruplex nucleic acids and 
human disease. FEBS J, 277, 3470-3488.    Abstract    Full Text 
 226. Fry, M. and Loeb, L.A. (1999) Human werner syndrome DNA helicase 
unwinds tetrahelical structures of the fragile X syndrome repeat 
sequence d(CGG)n. J Biol Chem, 274, 12797-12802.    Abstract    
Full Text 
 227. Sun, H., Karow, J.K., Hickson, I.D. and Maizels, N. (1998) The Bloom's 
syndrome helicase unwinds G4 DNA. J Biol Chem, 273, 27587-27592.    
Abstract    Full Text 
 228. Wu, Y., Shin-ya, K. and Brosh, R.M., Jr. (2008) FANCJ helicase defective 
in Fanconia anemia and breast cancer unwinds G-quadruplex DNA to 
defend genomic stability. Mol Cell Biol, 28, 4116-4128.    Abstract    
Full Text 
 229. London, T.B., Barber, L.J., Mosedale, G., Kelly, G.P., Balasubramanian, S., 
Hickson, I.D., Boulton, S.J. and Hiom, K. (2008) FANCJ is a structure-
specific DNA helicase associated with the maintenance of genomic 
G/C tracts. J Biol Chem, 283, 36132-36139.    Abstract    Full Text 
 230. Wu, Y., Sommers, J.A., Khan, I., de Winter, J.P. and Brosh, R.M., Jr. (2012) 
Biochemical characterization of Warsaw breakage syndrome helicase. 
J Biol Chem, 287, 1007-1021.    Abstract    Full Text 
 231. van der Lelij, P., Chrzanowska, K.H., Godthelp, B.C., Rooimans, M.A., 
Oostra, A.B., Stumm, M., Zdzienicka, M.Z., Joenje, H. and de Winter, J.P. 
(2010) Warsaw breakage syndrome, a cohesinopathy associated with 
mutations in the XPD helicase family member DDX11/ChlR1. Am J Hum 
Genet, 86, 262-266.    Abstract    Full Text 
 232. Parish, J.L., Rosa, J., Wang, X., Lahti, J.M., Doxsey, S.J. and Androphy, 
E.J. (2006) The DNA helicase ChlR1 is required for sister chromatid 
cohesion in mammalian cells. J Cell Sci, 119, 4857-4865.    Abstract    
Full Text 
 233. Sanders, C.M. (2010) Human Pif1 helicase is a G-quadruplex DNA 
binding protein with G-quadruplex DNA unwinding activity. Biochem J, 
430, 119-128.    Abstract    Full Text 
 234. Zhang, D.H., Zhou, B., Huang, Y., Xu, L.X. and Zhou, J.Q. (2006) The 
human Pif1 helicase, a potential Escherichia coli RecD homologue, 
inhibits telomerase activity. Nucleic Acids Res, 34, 1393-1404.    Abstract    
Full Text 
 235. Duxin, J.P., Dao, B., Martinsson, P., Rajala, N., Guittat, L., Campbell, J.L., 
Spelbrink, J.N. and Stewart, S.A. (2009) Human Dna2 is a nuclear and 
mitochondrial DNA maintenance protein. Mol Cell Biol, 29, 4274-4282.    
Abstract    Full Text 
 236. Zheng, L., Zhou, M., Guo, Z., Lu, H., Qian, L., Dai, H., Qiu, J., 
Yakubovskaya, E., Bogenhagen, D.F., Demple, B. et al. (2008) Human 
DNA2 is a mitochondrial nuclease/helicase for efficient processing of 
DNA replication and repair intermediates. Mol Cell, 32, 325-336.    
Abstract    Full Text 
 237. Lee, C.G., da Costa Soares, V., Newberger, C., Manova, K., Lacy, E. and 
Hurwitz, J. (1998) RNA helicase A is essential for normal gastrulation. 
Proc Natl Acad Sci U S A, 95, 13709-13713.    Abstract    Full Text 
 238. Chakraborty, P. and Grosse, F. (2011) Human DHX9 helicase 
preferentially unwinds RNA-containing displacement loops (R-loops) 
and G-quadruplexes. DNA Repair (Amst), 10, 654-665.    Abstract    
Full Text 
 239. Cheung, I., Schertzer, M., Rose, A. and Lansdorp, P.M. (2002) Disruption 
of dog-1 in Caenorhabditis elegans triggers deletions upstream of 
guanine-rich DNA. Nat Genet, 31, 405-409.    Abstract    Full Text 
 240. Kruisselbrink, E., Guryev, V., Brouwer, K., Pontier, D.B., Cuppen, E. and 
Tijsterman, M. (2008) Mutagenic capacity of endogenous G4 DNA 
underlies genome instability in FANCJ-defective C. elegans. Curr Biol, 
18, 900-905.    Abstract    Full Text 
 241. Piazza, A., Boule, J.B., Lopes, J., Mingo, K., Largy, E., Teulade-Fichou, 
M.P. and Nicolas, A. (2010) Genetic instability triggered by G-
quadruplex interacting Phen-DC compounds in Saccharomyces 
cerevisiae. Nucleic Acids Res, 38, 4337-4348.    Abstract    Full Text 
 242. Lopes, J., Piazza, A., Bermejo, R., Kriegsman, B., Colosio, A., Teulade-
Fichou, M.P., Foiani, M. and Nicolas, A. (2011) G-quadruplex-induced 
instability during leading-strand replication. EMBO J, 30, 4033-4046.    
Abstract    Full Text 
 243. Huber, M.D., Lee, D.C. and Maizels, N. (2002) G4 DNA unwinding by 
BLM and Sgs1p: substrate specificity and substrate-specific 
inhibition. Nucleic Acids Res, 30, 3954-3961.    Abstract    Full Text 
 244. Sun, H., Bennett, R.J. and Maizels, N. (1999) The Saccharomyces 
cerevisiae Sgs1 helicase efficiently unwinds G-G paired DNAs. Nucleic 
Acids Res, 27, 1978-1984.    Abstract 
 245. Ribeyre, C., Lopes, J., Boule, J.B., Piazza, A., Guedin, A., Zakian, V.A., 
Mergny, J.L. and Nicolas, A. (2009) The yeast Pif1 helicase prevents 
genomic instability caused by G-quadruplex-forming CEB1 sequences 
in vivo. PLoS Genet, 5, e1000475.    Abstract    Full Text 
 246. Masuda-Sasa, T., Polaczek, P., Peng, X.P., Chen, L. and Campbell, J.L. 
(2008) Processing of G4 DNA by Dna2 helicase/nuclease and 
replication protein A (RPA) provides insights into the mechanism of 
Dna2/RPA substrate recognition. J Biol Chem, 283, 24359-24373.    
Abstract    Full Text 
 247. Sarkies, P., Murat, P., Phillips, L.G., Patel, K.J., Balasubramanian, S. and 
Sale, J.E. (2012) FANCJ coordinates two pathways that maintain 
epigenetic stability at G-quadruplex DNA. Nucleic Acids Res, 40, 1485-
1498.    Abstract    Full Text 
 248. Wang, W. (2007) Emergence of a DNA-damage response network 
consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet, 8, 
735-748.    Abstract    Full Text 
 249. Bochman, M.L., Sabouri, N. and Zakian, V.A. (2010) Unwinding the 
functions of the Pif1 family helicases. DNA Repair (Amst), 9, 237-249.    
Abstract    Full Text 
 250. Ellis, N.A., Groden, J., Ye, T.Z., Straughen, J., Lennon, D.J., Ciocci, S., 
Proytcheva, M. and German, J. (1995) The Bloom's syndrome gene 
product is homologous to RecQ helicases. Cell, 83, 655-666.    Abstract 
 251. Yu, C.E., Oshima, J., Fu, Y.H., Wijsman, E.M., Hisama, F., Alisch, R., 
Matthews, S., Nakura, J., Miki, T., Ouais, S. et al. (1996) Positional 
cloning of the Werner's syndrome gene. Science, 272, 258-262.    
Abstract 
References	 141
 252. Levran, O., Attwooll, C., Henry, R.T., Milton, K.L., Neveling, K., Rio, P., 
Batish, S.D., Kalb, R., Velleuer, E., Barral, S. et al. (2005) The BRCA1-
interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet, 
37, 931-933.    Abstract    Full Text 
 253. Levitus, M., Waisfisz, Q., Godthelp, B.C., de Vries, Y., Hussain, S., 
Wiegant, W.W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M.A., 
Pals, G. et al. (2005) The DNA helicase BRIP1 is defective in Fanconi 
anemia complementation group J. Nat Genet, 37, 934-935.    Abstract    
Full Text 
 254. Darnell, J.C., Jensen, K.B., Jin, P., Brown, V., Warren, S.T. and Darnell, 
R.B. (2001) Fragile X mental retardation protein targets G quartet 
mRNAs important for neuronal function. Cell, 107, 489-499.    Abstract    
Full Text 
 255. Lu, R., Wang, H., Liang, Z., Ku, L., O'Donnell W, T., Li, W., Warren, S.T. 
and Feng, Y. (2004) The fragile X protein controls microtubule-
associated protein 1B translation and microtubule stability in brain 
neuron development. Proc Natl Acad Sci U S A, 101, 15201-15206.    
Abstract    Full Text 
 256. Castets, M., Schaeffer, C., Bechara, E., Schenck, A., Khandjian, E.W., 
Luche, S., Moine, H., Rabilloud, T., Mandel, J.L. and Bardoni, B. (2005) 
FMRP interferes with the Rac1 pathway and controls actin 
cytoskeleton dynamics in murine fibroblasts. Hum Mol Genet, 14, 835-
844.    Abstract    Full Text 
 257. Westmark, C.J. and Malter, J.S. (2007) FMRP mediates mGluR5-
dependent translation of amyloid precursor protein. PLoS Biol, 5, e52.    
Abstract    Full Text 
 258. Liao, L., Park, S.K., Xu, T., Vanderklish, P. and Yates, J.R., 3rd. (2008) 
Quantitative proteomic analysis of primary neurons reveals diverse 
changes in synaptic protein content in fmr1 knockout mice. Proc Natl 
Acad Sci U S A, 105, 15281-15286.    Abstract    Full Text 
 259. Bensaid, M., Melko, M., Bechara, E.G., Davidovic, L., Berretta, A., Catania, 
M.V., Gecz, J., Lalli, E. and Bardoni, B. (2009) FRAXE-associated mental 
retardation protein (FMR2) is an RNA-binding protein with high affinity 
for G-quartet RNA forming structure. Nucleic Acids Res, 37, 1269-1279.    
Abstract    Full Text 
 260. Millevoi, S., Moine, H. and Vagner, S. (2012) G-quadruplexes in RNA 
biology. Wiley Interdiscip Rev RNA, 3, 495-507.    Abstract    Full Text 
 261. Melko, M., Douguet, D., Bensaid, M., Zongaro, S., Verheggen, C., Gecz, J. 
and Bardoni, B. (2011) Functional characterization of the AFF 
(AF4/FMR2) family of RNA-binding proteins: insights into the 
molecular pathology of FRAXE intellectual disability. Hum Mol Genet, 
20, 1873-1885.    Abstract    Full Text 
 262. Khateb, S., Weisman-Shomer, P., Hershco, I., Loeb, L.A. and Fry, M. 
(2004) Destabilization of tetraplex structures of the fragile X repeat 
sequence (CGG)n is mediated by homolog-conserved domains in 
three members of the hnRNP family. Nucleic Acids Res, 32, 4145-4154.    
Abstract    Full Text 
 263. Takahama, K., Kino, K., Arai, S., Kurokawa, R. and Oyoshi, T. (2011) 
Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and 
RNA-binding protein. FEBS J, 278, 988-998.    Abstract    Full Text 
 264. Nagata, T., Kurihara, Y., Matsuda, G., Saeki, J., Kohno, T., Yanagida, Y., 
Ishikawa, F., Uesugi, S. and Katahira, M. (1999) Structure and 
interactions with RNA of the N-terminal UUAG-specific RNA-binding 
domain of hnRNP D0. J Mol Biol, 287, 221-237.    Abstract 
 265. Davidovic, L., Bechara, E., Gravel, M., Jaglin, X.H., Tremblay, S., Sik, A., 
Bardoni, B. and Khandjian, E.W. (2006) The nuclear microspherule 
protein 58 is a novel RNA-binding protein that interacts with fragile X 
mental retardation protein in polyribosomal mRNPs from neurons. 
Hum Mol Genet, 15, 1525-1538.    Abstract    Full Text 
 266. Biffi, G., Tannahill, D. and Balasubramanian, S. (2012) An intramolecular 
G-quadruplex structure is required for TERRA RNA binding to the 
telomeric protein TRF2. J Am Chem Soc, 134, 11974-11976.    Abstract    
Full Text 
 267. Bashkirov, V.I., Scherthan, H., Solinger, J.A., Buerstedde, J.M. and Heyer, 
W.D. (1997) A mouse cytoplasmic exoribonuclease (mXRN1p) with 
preference for G4 tetraplex substrates. J Cell Biol, 136, 761-773.    
Abstract    Full Text 
 268. Chalupnikova, K., Lattmann, S., Selak, N., Iwamoto, F., Fujiki, Y. and 
Nagamine, Y. (2008) Recruitment of the RNA helicase RHAU to stress 
granules via a unique RNA-binding domain. J Biol Chem, 283, 35186-
35198.    Abstract    Full Text 
 269. Iwamoto, F., Stadler, M., Chalupnikova, K., Oakeley, E. and Nagamine, Y. 
(2008) Transcription-dependent nucleolar cap localization and 
possible nuclear function of DExH RNA helicase RHAU. Exp Cell Res, 
314, 1378-1391.    Abstract    Full Text 
 270. Askjaer, P., Rosendahl, R. and Kjems, J. (2000) Nuclear export of the 
DEAD box An3 protein by CRM1 is coupled to An3 helicase activity. J 
Biol Chem, 275, 11561-11568.    Abstract    Full Text 
 271. Anderson, P. and Kedersha, N. (2006) RNA granules. J Cell Biol, 172, 
803-808.    Abstract    Full Text 
 272. Anderson, P. and Kedersha, N. (2008) Stress granules: the Tao of RNA 
triage. Trends Biochem Sci, 33, 141-150.    Abstract    Full Text 
 273. Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, 
C.L., Haase, J., Janes, J., Huss, J.W., 3rd et al. (2009) BioGPS: an 
extensible and customizable portal for querying and organizing gene 
annotation resources. Genome Biol, 10, R130.    Abstract    Full Text 
 274. Su, A.I., Wiltshire, T., Batalov, S., Lapp, H., Ching, K.A., Block, D., Zhang, 
J., Soden, R., Hayakawa, M., Kreiman, G. et al. (2004) A gene atlas of the 
mouse and human protein-encoding transcriptomes. Proc Natl Acad 
Sci U S A, 101, 6062-6067.    Abstract    Full Text 
 275. Su, A.I., Cooke, M.P., Ching, K.A., Hakak, Y., Walker, J.R., Wiltshire, T., 
Orth, A.P., Vega, R.G., Sapinoso, L.M., Moqrich, A. et al. (2002) Large-
scale analysis of the human and mouse transcriptomes. Proc Natl Acad 
Sci U S A, 99, 4465-4470.    Abstract    Full Text 
 276. Fukuda, T., Yamagata, K., Fujiyama, S., Matsumoto, T., Koshida, I., 
Yoshimura, K., Mihara, M., Naitou, M., Endoh, H., Nakamura, T. et al. 
(2007) DEAD-box RNA helicase subunits of the Drosha complex are 
required for processing of rRNA and a subset of microRNAs. Nat Cell 
Biol, 9, 604-611.    Abstract    Full Text 
 277. Fukunaga, A., Tanaka, A. and Oishi, K. (1975) Maleless, a recessive 
autosomal mutant of Drosophila melanogaster that specifically kills 
male zygotes. Genetics, 81, 135-141.    Abstract 
 278. Gonzalez-Reyes, A., Elliott, H. and St Johnston, D. (1997) Oocyte 
determination and the origin of polarity in Drosophila: the role of the 
spindle genes. Development, 124, 4927-4937.    Abstract 
 279. English, M.A., Lei, L., Blake, T., Wincovitch, S.M., Sr., Sood, R., Azuma, M., 
Hickstein, D. and Paul Liu, P. (2012) Incomplete splicing, cell division 
defects and hematopoietic blockage in dhx8 mutant zebrafish. Dev 
Dyn, 241, 879-889.    Abstract    Full Text 
 280. Hoffbrand, A.V., Moss, P.A.H. and Pettit, J.E. (2006), Essential 
Haematology. 5th ed. Blackwell Publishing Ltd, Oxford, UK, pp. 123-128. 
 281. Kim, T., Pazhoor, S., Bao, M., Zhang, Z., Hanabuchi, S., Facchinetti, V., 
Bover, L., Plumas, J., Chaperot, L., Qin, J. et al. (2010) Aspartate-
glutamate-alanine-histidine box motif (DEAH)/RNA helicase A 
helicases sense microbial DNA in human plasmacytoid dendritic cells. 
Proc Natl Acad Sci U S A.    Abstract    Full Text 
 282. Hokeness-Antonelli, K.L., Crane, M.J., Dragoi, A.M., Chu, W.M. and 
Salazar-Mather, T.P. (2007) IFN-alphabeta-mediated inflammatory 
responses and antiviral defense in liver is TLR9-independent but 
MyD88-dependent during murine cytomegalovirus infection. J 
Immunol, 179, 6176-6183.    Abstract 
 283. Jung, A., Kato, H., Kumagai, Y., Kumar, H., Kawai, T., Takeuchi, O. and 
Akira, S. (2008) Lymphocytoid choriomeningitis virus activates 
plasmacytoid dendritic cells and induces a cytotoxic T-cell response 
via MyD88. J Virol, 82, 196-206.    Abstract    Full Text 
 284. Hochrein, H., Schlatter, B., O'Keeffe, M., Wagner, C., Schmitz, F., 
Schiemann, M., Bauer, S., Suter, M. and Wagner, H. (2004) Herpes 
simplex virus type-1 induces IFN-alpha production via Toll-like 
receptor 9-dependent and -independent pathways. Proc Natl Acad Sci U 
S A, 101, 11416-11421.    Abstract    Full Text 
 285. Hopfner, K.P., Cui, S., Kirchhofer, A. and Pippig, D. (2010) In Jankowsky, 
E. (ed.), RNA Helicases. The Royal Society of Chemistry, Cambridge, UK, 
pp. 121-148. 
 286. Loo, Y.M. and Gale, M., Jr. (2011) Immune signaling by RIG-I-like 
receptors. Immunity, 34, 680-692.    Abstract    Full Text 
 287. Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K. and Pease, L.R. (1989) 
Site-directed mutagenesis by overlap extension using the polymerase 
chain reaction. Gene, 77, 51-59.    Abstract    Full Text 
 288. Horton, R.M., Hunt, H.D., Ho, S.N., Pullen, J.K. and Pease, L.R. (1989) 
Engineering hybrid genes without the use of restriction enzymes: 
gene splicing by overlap extension. Gene, 77, 61-68.    Abstract    
Full Text 
142	 Chapter 7
 289. Zheng, L., Baumann, U. and Reymond, J.L. (2004) An efficient one-step 
site-directed and site-saturation mutagenesis protocol. Nucleic Acids 
Res, 32, e115.    Abstract    Full Text 
 290. Gentleman, R.C., Carey, V.J., Bates, D.M., Bolstad, B., Dettling, M., Dudoit, 
S., Ellis, B., Gautier, L., Ge, Y., Gentry, J. et al. (2004) Bioconductor: 
open software development for computational biology and 
bioinformatics. Genome Biol, 5, R80.    Abstract    Full Text 
 291. Carvalho, B.S. and Irizarry, R.A. (2010) A framework for oligonucleotide 
microarray preprocessing. Bioinformatics, 26, 2363-2367.    Abstract    
Full Text 
 292. Smyth, G.K. (2004) Linear models and empirical bayes methods for 
assessing differential expression in microarray experiments. Stat Appl 
Genet Mol Biol, 3, Article3.    Abstract    Full Text 
 293. Kikin, O., D'Antonio, L. and Bagga, P.S. (2006) QGRS Mapper: a web-
based server for predicting G-quadruplexes in nucleotide sequences. 
Nucleic Acids Res, 34, W676-682.    Abstract    Full Text 
 294. Altschul, S.F. and Erickson, B.W. (1985) Significance of nucleotide 
sequence alignments: a method for random sequence permutation 
that preserves dinucleotide and codon usage. Mol Biol Evol, 2, 526-538.    
Abstract 
 295. Livak, K.J. and Schmittgen, T.D. (2001) Analysis of relative gene 
expression data using real-time quantitative PCR and the 2(-Delta 
Delta C(T)) Method. Methods, 25, 402-408.    Abstract    Full Text 
 296. Herbert, B.S., Hochreiter, A.E., Wright, W.E. and Shay, J.W. (2006) 
Nonradioactive detection of telomerase activity using the telomeric 
repeat amplification protocol. Nat Protoc, 1, 1583-1590.    Abstract    
Full Text 
 297. Sali, A., Potterton, L., Yuan, F., van Vlijmen, H. and Karplus, M. (1995) 
Evaluation of comparative protein modeling by MODELLER. Proteins, 
23, 318-326.    Abstract    Full Text 
 298. Eswar, N., Eramian, D., Webb, B., Shen, M.Y. and Sali, A. (2008) Protein 
structure modeling with MODELLER. Methods Mol Biol, 426, 145-159.    
Abstract    Full Text 
 299. Benkert, P., Biasini, M. and Schwede, T. (2011) Toward the estimation of 
the absolute quality of individual protein structure models. 
Bioinformatics, 27, 343-350.    Abstract    Full Text 
 300. McGuffin, L.J. and Roche, D.B. (2010) Rapid model quality assessment 
for protein structure predictions using the comparison of multiple 
models without structural alignments. Bioinformatics, 26, 182-188.    
Abstract    Full Text 
 301. Schrodinger, LLC. (2010) The PyMOL Molecular Graphics System, 
Version 1.5. 
 302. Huber, M.D., Duquette, M.L., Shiels, J.C. and Maizels, N. (2006) A 
conserved G4 DNA binding domain in RecQ family helicases. J Mol 
Biol, 358, 1071-1080.    Abstract    Full Text 
 303. Baran, N., Pucshansky, L., Marco, Y., Benjamin, S. and Manor, H. (1997) 
The SV40 large T-antigen helicase can unwind four stranded DNA 
structures linked by G-quartets. Nucleic Acids Res, 25, 297-303.    
Abstract    Full Text 
 304. Parkinson, G.N., Lee, M.P. and Neidle, S. (2002) Crystal structure of 
parallel quadruplexes from human telomeric DNA. Nature, 417, 876-
880.    Abstract    Full Text 
 305. Phan, A.T. and Patel, D.J. (2003) Two-repeat human telomeric 
d(TAGGGTTAGGGT) sequence forms interconverting parallel and 
antiparallel G-quadruplexes in solution: distinct topologies, 
thermodynamic properties, and folding/unfolding kinetics. J Am Chem 
Soc, 125, 15021-15027.    Abstract    Full Text 
 306. Gray, D.M., Wen, J.D., Gray, C.W., Repges, R., Repges, C., Raabe, G. and 
Fleischhauer, J. (2008) Measured and calculated CD spectra of G-
quartets stacked with the same or opposite polarities. Chirality, 20, 
431-440.    Abstract    Full Text 
 307. Kypr, J., Kejnovska, I., Renciuk, D. and Vorlickova, M. (2009) Circular 
dichroism and conformational polymorphism of DNA. Nucleic Acids 
Res, 37, 1713-1725.    Abstract    Full Text 
 308. Paramasivan, S., Rujan, I. and Bolton, P.H. (2007) Circular dichroism of 
quadruplex DNAs: applications to structure, cation effects and ligand 
binding. Methods, 43, 324-331.    Abstract    Full Text 
 309. Tang, C.F. and Shafer, R.H. (2006) Engineering the quadruplex fold: 
nucleoside conformation determines both folding topology and 
molecularity in guanine quadruplexes. J Am Chem Soc, 128, 5966-5973.    
Abstract    Full Text 
 310. Pilch, D.S., Plum, G.E. and Breslauer, K.J. (1995) The thermodynamics of 
DNA structures that contain lesions or guanine tetrads. Curr Opin 
Struct Biol, 5, 334-342.    Abstract    Full Text 
 311. Kim, J.L., Morgenstern, K.A., Griffith, J.P., Dwyer, M.D., Thomson, J.A., 
Murcko, M.A., Lin, C. and Caron, P.R. (1998) Hepatitis C virus NS3 RNA 
helicase domain with a bound oligonucleotide: the crystal structure 
provides insights into the mode of unwinding. Structure, 6, 89-100.    
Abstract    Full Text 
 312. Del Campo, M. and Lambowitz, A.M. (2009) Structure of the Yeast DEAD 
box protein Mss116p reveals two wedges that crimp RNA. Mol Cell, 35, 
598-609.    Abstract    Full Text 
 313. Katoh, K. and Toh, H. (2008) Recent developments in the MAFFT 
multiple sequence alignment program. Brief Bioinform, 9, 286-298.    
Abstract    Full Text 
 314. Cole, C., Barber, J.D. and Barton, G.J. (2008) The Jpred 3 secondary 
structure prediction server. Nucleic Acids Res, 36, W197-201.    Abstract    
Full Text 
 315. Aasland, R., Abrams, C., Ampe, C., Ball, L.J., Bedford, M.T., Cesareni, G., 
Gimona, M., Hurley, J.H., Jarchau, T., Lehto, V.P. et al. (2002) 
Normalization of nomenclature for peptide motifs as ligands of 
modular protein domains. FEBS Lett, 513, 141-144.    Abstract    Full Text 
 316. Qin, Y. and Hurley, L.H. (2008) Structures, folding patterns, and 
functions of intramolecular DNA G-quadruplexes found in eukaryotic 
promoter regions. Biochimie, 90, 1149-1171.    Abstract    Full Text 
 317. Wieland, M. and Hartig, J.S. (2007) RNA quadruplex-based modulation 
of gene expression. Chem Biol, 14, 757-763.    Abstract    Full Text 
 318. Kang, Y.H., Lee, C.H. and Seo, Y.S. (2010) Dna2 on the road to Okazaki 
fragment processing and genome stability in eukaryotes. Crit Rev 
Biochem Mol Biol, 45, 71-96.    Abstract    Full Text 
 319. Singleton, M.R. and Wigley, D.B. (2002) Modularity and specialization in 
superfamily 1 and 2 helicases. J Bacteriol, 184, 1819-1826.    Abstract    
Full Text 
 320. Karginov, F.V., Caruthers, J.M., Hu, Y., McKay, D.B. and Uhlenbeck, O.C. 
(2005) YxiN is a modular protein combining a DEx(D/H) core and a 
specific RNA-binding domain. J Biol Chem, 280, 35499-35505.    
Abstract    Full Text 
 321. Grohman, J.K., Del Campo, M., Bhaskaran, H., Tijerina, P., Lambowitz, 
A.M. and Russell, R. (2007) Probing the mechanisms of DEAD-box 
proteins as general RNA chaperones: the C-terminal domain of CYT-19 
mediates general recognition of RNA. Biochemistry, 46, 3013-3022.    
Abstract    Full Text 
 322. Mohr, G., Del Campo, M., Mohr, S., Yang, Q., Jia, H., Jankowsky, E. and 
Lambowitz, A.M. (2008) Function of the C-terminal domain of the DEAD-
box protein Mss116p analyzed in vivo and in vitro. J Mol Biol, 375, 
1344-1364.    Abstract    Full Text 
 323. Diges, C.M. and Uhlenbeck, O.C. (2001) Escherichia coli DbpA is an 
RNA helicase that requires hairpin 92 of 23S rRNA. EMBO J, 20, 5503-
5512.    Abstract    Full Text 
 324. Tsu, C.A., Kossen, K. and Uhlenbeck, O.C. (2001) The Escherichia coli 
DEAD protein DbpA recognizes a small RNA hairpin in 23S rRNA. 
RNA, 7, 702-709.    Abstract    Full Text 
 325. Kossen, K., Karginov, F.V. and Uhlenbeck, O.C. (2002) The carboxy-
terminal domain of the DExDH protein YxiN is sufficient to confer 
specificity for 23S rRNA. J Mol Biol, 324, 625-636.    Abstract    Full Text 
 326. Gibson, T.J. and Thompson, J.D. (1994) Detection of dsRNA-binding 
domains in RNA helicase A and Drosophila maleless: implications for 
monomeric RNA helicases. Nucleic Acids Res, 22, 2552-2556.    Abstract    
Full Text 
 327. Ji, X., Sun, H., Zhou, H., Xiang, J., Tang, Y. and Zhao, C. (2011) Research 
progress of RNA quadruplex. Nucleic Acid Ther, 21, 185-200.    Abstract    
Full Text 
 328. Fry, M. and Loeb, L.A. (1994) The fragile X syndrome d(CGG)n 
nucleotide repeats form a stable tetrahelical structure. Proc Natl Acad 
Sci U S A, 91, 4950-4954.    Abstract    Full Text 
 329. Usdin, K. and Woodford, K.J. (1995) CGG repeats associated with DNA 
instability and chromosome fragility form structures that block DNA 
synthesis in vitro. Nucleic Acids Res, 23, 4202-4209.    Abstract    
Full Text 
 330. Collins, K. (2008) Physiological assembly and activity of human 
telomerase complexes. Mech Ageing Dev, 129, 91-98.    Abstract    
Full Text 
References	 143
 331. Mitchell, J.R., Wood, E. and Collins, K. (1999) A telomerase component 
is defective in the human disease dyskeratosis congenita. Nature, 402, 
551-555.    Abstract    Full Text 
 332. Bohnsack, M.T., Martin, R., Granneman, S., Ruprecht, M., Schleiff, E. and 
Tollervey, D. (2009) Prp43 bound at different sites on the pre-rRNA 
performs distinct functions in ribosome synthesis. Mol Cell, 36, 583-
592.    Abstract    Full Text 
 333. Savage, S.A. and Alter, B.P. (2009) Dyskeratosis congenita. Hematol 
Oncol Clin North Am, 23, 215-231.    Abstract    Full Text 
 334. Canela, A., Vera, E., Klatt, P. and Blasco, M.A. (2007) High-throughput 
telomere length quantification by FISH and its application to human 
population studies. Proc Natl Acad Sci U S A, 104, 5300-5305.    Abstract    
Full Text 
 335. Halder, K., Wieland, M. and Hartig, J.S. (2009) Predictable suppression 
of gene expression by 5'-UTR-based RNA quadruplexes. Nucleic Acids 
Res, 37, 6811-6817.    Abstract    Full Text 
 336. Chen, J.L., Blasco, M.A. and Greider, C.W. (2000) Secondary structure of 
vertebrate telomerase RNA. Cell, 100, 503-514.    Abstract    Full Text 
 337. Chen, J.L. and Greider, C.W. (2003) Template boundary definition in 
mammalian telomerase. Genes Dev, 17, 2747-2752.    Abstract    
Full Text 
 338. Parkinson, E.K., Fitchett, C. and Cereser, B. (2008) Dissecting the non-
canonical functions of telomerase. Cytogenet Genome Res, 122, 273-
280.    Abstract    Full Text 
 339. Krieger, E., Nabuurs, S.B. and Vriend, G. (2003) Homology modeling. 
Methods Biochem Anal, 44, 509-523.    Abstract 
 340. Xiang, Z. (2006) Advances in homology protein structure modeling. 
Curr Protein Pept Sci, 7, 217-227.    Abstract 
 341. Zhang, Z., Kim, T., Bao, M., Facchinetti, V., Jung, S.Y., Ghaffari, A.A., Qin, 
J., Cheng, G. and Liu, Y.J. (2011) DDX1, DDX21, and DHX36 helicases 
form a complex with the adaptor molecule TRIF to sense dsRNA in 
dendritic cells. Immunity, 34, 866-878.    Abstract    Full Text 
 342. Kim, H.N., Lee, J.H., Bae, S.C., Ryoo, H.M., Kim, H.H., Ha, H. and Lee, 
Z.H. (2011) Histone deacetylase inhibitor MS-275 stimulates bone 
formation in part by enhancing Dhx36-mediated TNAP transcription. J 
Bone Miner Res, 26, 2161-2173.    Abstract    Full Text 
 343. Huang, W., Smaldino, P.J., Zhang, Q., Miller, L.D., Cao, P., Stadelman, K., 
Wan, M., Giri, B., Lei, M., Nagamine, Y. et al. (2012) Yin Yang 1 contains 
G-quadruplex structures in its promoter and 5'-UTR and its expression 
is modulated by G4 resolvase 1. Nucleic Acids Res, 40, 1033-1049.    
Abstract    Full Text 
 344. Subramanian, M., Rage, F., Tabet, R., Flatter, E., Mandel, J.L. and Moine, 
H. (2011) G-quadruplex RNA structure as a signal for neurite mRNA 
targeting. EMBO Rep, 12, 697-704.    Abstract    Full Text 
 345. Hartmann, G., Weiner, G.J. and Krieg, A.M. (1999) CpG DNA: a potent 
signal for growth, activation, and maturation of human dendritic cells. 
Proc Natl Acad Sci U S A, 96, 9305-9310.    Abstract 
 346. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., 
Ballas, Z.K., Endres, S., Krieg, A.M. and Hartmann, G. (2001) 
Identification of CpG oligonucleotide sequences with high induction of 
IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol, 31, 2154-
2163.    Abstract    Full Text 
 347. Kerkmann, M., Costa, L.T., Richter, C., Rothenfusser, S., Battiany, J., 
Hornung, V., Johnson, J., Englert, S., Ketterer, T., Heckl, W. et al. (2005) 
Spontaneous formation of nucleic acid-based nanoparticles is 
responsible for high interferon-alpha induction by CpG-A in 
plasmacytoid dendritic cells. J Biol Chem, 280, 8086-8093.    Abstract    
Full Text 
 348. Fry, M. (2007) Tetraplex DNA and its interacting proteins. Front Biosci, 
12, 4336-4351.    Abstract    Full Text 
 349. Sissi, C., Gatto, B. and Palumbo, M. (2011) The evolving world of 
protein-G-quadruplex recognition: a medicinal chemist's perspective. 
Biochimie, 93, 1219-1230.    Abstract    Full Text 
 350. Padmanabhan, K. and Tulinsky, A. (1996) An ambiguous structure of a 
DNA 15-mer thrombin complex. Acta Crystallogr D Biol Crystallogr, 52, 
272-282.    Abstract    Full Text 
 351. Russo Krauss, I., Merlino, A., Giancola, C., Randazzo, A., Mazzarella, L. 
and Sica, F. (2011) Thrombin-aptamer recognition: a revealed 
ambiguity. Nucleic Acids Res, 39, 7858-7867.    Abstract    Full Text 
 352. Horvath, M.P. and Schultz, S.C. (2001) DNA G-quartets in a 1.86 A 
resolution structure of an Oxytricha nova telomeric protein-DNA 
complex. J Mol Biol, 310, 367-377.    Abstract    Full Text 
 353. Phan, A.T., Kuryavyi, V., Darnell, J.C., Serganov, A., Majumdar, A., Ilin, S., 
Raslin, T., Polonskaia, A., Chen, C., Clain, D. et al. (2011) Structure-
function studies of FMRP RGG peptide recognition of an RNA duplex-
quadruplex junction. Nat Struct Mol Biol, 18, 796-804.    Abstract    
Full Text 
 354. Wen, J.D. and Gray, D.M. (2002) The Ff gene 5 single-stranded DNA-
binding protein binds to the transiently folded form of an 
intramolecular G-quadruplex. Biochemistry, 41, 11438-11448.    Abstract 
 355. Gonzalez, V. and Hurley, L.H. (2010) The C-terminus of nucleolin 
promotes the formation of the c-MYC G-quadruplex and inhibits c-
MYC promoter activity. Biochemistry, 49, 9706-9714.    Abstract    
Full Text 
 356. Mohaghegh, P., Karow, J.K., Brosh, R.M., Jr., Bohr, V.A. and Hickson, I.D. 
(2001) The Bloom's and Werner's syndrome proteins are DNA 
structure-specific helicases. Nucleic Acids Res, 29, 2843-2849.    
Abstract 
 357. Kim, N.W., Piatyszek, M.A., Prowse, K.R., Harley, C.B., West, M.D., Ho, 
P.L., Coviello, G.M., Wright, W.E., Weinrich, S.L. and Shay, J.W. (1994) 
Specific association of human telomerase activity with immortal cells 
and cancer. Science, 266, 2011-2015.    Abstract 
 358. Shay, J.W. and Wright, W.E. (2006) Telomerase therapeutics for cancer: 
challenges and new directions. Nat Rev Drug Discov, 5, 577-584.    
Abstract    Full Text 
 359. De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., 
Riou, J.F. and Mergny, J.L. (2008) Targeting telomeres and telomerase. 
Biochimie, 90, 131-155.    Abstract    Full Text 
 360. Monchaud, D. and Teulade-Fichou, M.P. (2008) A hitchhiker's guide to G-
quadruplex ligands. Org Biomol Chem, 6, 627-636.    Abstract    Full Text 
 361. Balasubramanian, S., Hurley, L.H. and Neidle, S. (2011) Targeting G-
quadruplexes in gene promoters: a novel anticancer strategy? Nat Rev 
Drug Discov, 10, 261-275.    Abstract    Full Text 
 362. Lipps, H.J. and Rhodes, D. (2009) G-quadruplex structures: in vivo 
evidence and function. Trends Cell Biol, 19, 414-422.    Abstract    
Full Text 
 363. Lacroix, L., Seosse, A. and Mergny, J.L. (2011) Fluorescence-based 
duplex-quadruplex competition test to screen for telomerase RNA 
quadruplex ligands. Nucleic Acids Res, 39, e21.    Abstract    Full Text 
 364. Bates, P.J., Laber, D.A., Miller, D.M., Thomas, S.D. and Trent, J.O. (2009) 
Discovery and development of the G-rich oligonucleotide AS1411 as a 
novel treatment for cancer. Exp Mol Pathol, 86, 151-164.    Abstract    
Full Text 
 365. Reyes-Reyes, E.M., Teng, Y. and Bates, P.J. (2010) A new paradigm for 
aptamer therapeutic AS1411 action: uptake by macropinocytosis and 
its stimulation by a nucleolin-dependent mechanism. Cancer Res, 70, 
8617-8629.    Abstract    Full Text 
 366. Krieg, A.M. (2008) Toll-like receptor 9 (TLR9) agonists in the treatment 
of cancer. Oncogene, 27, 161-167.    Abstract    Full Text 
 367. Katoh, K. and Toh, H. (2008) Improved accuracy of multiple ncRNA 
alignment by incorporating structural information into a MAFFT-based 
framework. BMC Bioinformatics, 9, 212.    Abstract    Full Text 
 368. Gille, C. and Frommel, C. (2001) STRAP: editor for STRuctural 
Alignments of Proteins. Bioinformatics, 17, 377-378.    Abstract    
Full Text 
 369. Gille, C., Lorenzen, S., Michalsky, E. and Frommel, C. (2003) KISS for 
STRAP: user extensions for a protein alignment editor. Bioinformatics, 
19, 2489-2491.    Abstract    Full Text 
 370. Chintapalli, V.R., Wang, J. and Dow, J.A. (2007) Using FlyAtlas to 
identify better Drosophila melanogaster models of human disease. Nat 
Genet, 39, 715-720.    Abstract    Full Text 
 371. Crooks, G.E., Hon, G., Chandonia, J.M. and Brenner, S.E. (2004) 
WebLogo: a sequence logo generator. Genome Res, 14, 1188-1190.    
Abstract    Full Text 
 
 

Chapter 8 Publications
146	 Chapter 8
Publications	 147
Recruitment of the RNA Helicase RHAU to Stress Granules via
a Unique RNA-binding Domain*□S
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In response to environmental stress, the translation machin-
ery of cells is reprogrammed. Themajority of actively translated
mRNAs are released frompolysomes anddriven to specific cyto-
plasmic foci called stress granules (SGs) where dynamic changes
in protein-RNA interaction determine the subsequent fate of
mRNAs. Here we show that the DEAHbox RNAhelicase RHAU
is a novel SG-associated protein. Although RHAU protein was
originally identified as an AU-rich element-associated protein
involved in urokinase-type plasminogen activatormRNAdecay,
it was not clear whether RHAU could directly interact with
RNA. We have demonstrated that RHAU physically interacts
with RNA in vitro and in vivo through a newly identified N-ter-
minal RNA-binding domain, which was found to be both essen-
tial and sufficient for RHAU localization in SGs. We have also
shown that theATPase activity of RHAUplays a role in the RNA
interaction and in the regulation of protein retention in SGs.
Thus, our results show that RHAU is the fourth RNA helicase
detected in SGs, after rck/p54, DDX3, and eIF4A, and that its
association with SGs is dynamic and mediated by an RHAU-
specific RNA-binding domain.
Posttranscriptional regulation of gene expression is impor-
tant and highly regulated in response to developmental, envi-
ronmental, and metabolic signals (1). During stress conditions
such as heat shock, oxidative stress, ischemia, or viral infection,
mRNA translation is reprogrammed and allows the selective
synthesis of stress response and repair proteins (2). Under these
conditions, the translation of housekeeping genes is arrested,
and untranslated mRNAs accumulate in cytoplasmic foci
known as stress granules (SGs) (3). SG3 formation is triggered
by translation initiation arrest involving eIF2 phosphorylation
or by inhibition of eIF4A helicase function. Phosphorylation of
eIF2 can be mediated by several stress-induced protein
kinases (for a review, see Ref. 4), suggesting that the formation
of SGs is highly regulated and that eIF2 plays a pivotal role in
sensing stress. Upon translational arrest, polysome-free 48 S
preinitiation complexes containing initiation factors, small
ribosomal subunits, and poly(A)-binding protein 1 (PABP-1)
aggregate into SGs (3, 5). Several known SG-associated
mRNA-binding proteins have been identified and shown to
induce or inhibit SG aggregation when overexpressed. It is pre-
sumed that the overexpression of mRNA-binding proteins,
which are able to oligomerize, disturb the equilibrium of
mRNA distribution between polysomes and polysome-free
ribonucleoprotein (RNP) complexes and thus induce SG for-
mation by their aggregation (6). Nevertheless some RNA-bind-
ing proteins do not induce SG formation upon overexpression,
e.g. a zipcode-binding protein 1 (ZBP1), heterogeneous nuclear
RNP A1, or PABP-1 (7–9). Under normal conditions, most
RNA-binding proteins are involved in various aspects ofmRNA
metabolism, such as translation (TIA-1, TIA-1-related protein,
PCBP2, Pumilio 2, and cytoplasmic polyadenylation element-
binding protein), degradation (G3BP, TTP, Brf1, rck/p54, KH
domain RNA binding protein [KSRP], and PMR1), stability
(HuR), and specific intracellular localization (ZBP1, Staufen,
Smaug, Caprin-1, and FMRP) (for a review, see Ref. 10). The
differing flux of these SG-associated proteins and poly(A)
mRNAs revealed by fluorescent recovery after photobleaching
(FRAP) analysis suggests that SGs are dynamic foci (6, 9,
11–14). They are also considered to be sites at which RNPs
undergo structural and compositional remodeling and may be
temporally stored, returned to polysomes for translation, or
packaged for degradation (6).
Immediately after transcription, RNA forms with RNA-
binding proteins RNPs that are dynamic and take part in RNA
metabolism. RNP remodeling, which is essential for the cellular
localization, processing, function, and fate of RNA (15), is
mainly regulated by a large family of proteins called RNA heli-
cases. These enzymes use energy released by ATP hydrolysis to
unwind secondary structures of RNA or displace proteins from
RNA (16). Themajority of RNAhelicases are assigned to super-
* This work was supported in part by CREST grant (to Y. F.) from The Science
and Technology Agency of Japan. The costs of publication of this article
were defrayed in part by the payment of page charges. This article must
therefore be hereby marked “advertisement” in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. 1 and 2.
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nidem-chlorophenylhydrazone; CLIP, cross-linking immunoprecipitation;
ARE, AU-rich element; RSM, RHAU-specific motif; uPA, urokinase-type plas-
minogen activator; PABP-1, poly(A)-bindingprotein 1; ZBP1, zipcode-binding
protein 1; aa, amino acids; TTP, tristetraprolin; HuR, ELAV-like protein 1 (Hu-
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saline; PIPES, 1,4-piperazinediethanesulfonic acid; DAPI, 4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family 2 (SF2), which is divided into three subfamilies named
after the sequence in the helicase motif II: DEAD, DEAH, and
DEXH (17). Several DEX(H/D) proteins have been shown to
unwind double-stranded RNA in an ATP-dependent manner
in vitro (16, 18), but most are involved in the ATP-dependent
remodeling of RNPs (16). Although RNA helicases contain a
highly conserved helicase core region, they are involved in all of
the RNA processes ranging from transcription, pre-mRNA
splicing, ribosome biogenesis, RNA export, and translation ini-
tiation toRNAdecay (for reviews, seeRefs. 19–21). The specific
functions of individual enzymes are attributed to the less con-
served N/C termini, which are responsible for substrate speci-
ficity, subcellular localization, and cofactor requirements
(22–25).
RHAU is a DEAH box helicase (DHX36) originally identified
as an RNA helicase associated with AU-rich element (ARE) of
urokinase-type plasminogen activator (uPA) mRNA together
with NF90 and HuR (26). RHAU is a nucleocytoplasmic shut-
tling protein found predominantly in the nucleus and to a lesser
extent in the cytoplasm. As with other helicases (27–29),
ATPase activity is necessary for RHAU function in the decay of
uPAmRNA and for its nuclear localization (26, 30). Despite the
role of RHAU as a factor destabilizing uPAmRNA, global anal-
ysis of gene expression in RHAU knockdown cells revealed that
changes in steady-state levels of mRNAs were only partially
influenced by mRNA decay regulation (30). Indeed the nuclear
localization of RHAU and its guanine quadruplex (G4) DNA/
RNA-resolving activity (31) may reflect that RHAU regulates
gene expression at various steps other than mRNA decay.
Given that SGs are sites at which dynamic changes in pro-
tein-RNA interaction determine the fate of mRNAs during and
after stress, it is surprising that the role of SG-associated RNA
helicaseswith an essential function in remodeling protein-RNA
interactions is largely unknown. Here we show that RHAU is a
novel component of SGs and that its recruitment to SGs is
mediated by an RNA interaction. Although identified as an
ARE-associated protein involved in ARE-mediated mRNA
decay of uPA, it was not immediately clear whether RHAU
directly binds RNA. Here we show that RHAU physically inter-
acts with RNA in vitro and in vivo via a unique N-terminal
RNA-binding domain composed of a G-rich region and an
RHAU-specific motif (RSM) that is highly conserved between
RHAU orthologs. The same RNA-binding domain is necessary
and sufficient for RHAU recruitment to SGs. Finally we show
that the ATPase activity of RHAU is involved in the dynamic
regulation of RHAU shuttling into and out of SGs.
EXPERIMENTAL PROCEDURES
Plasmid Constructs—The plasmids pTER-shRHAU and
pTER-shLuc were described previously (30). Plasmids EGFP-
RHAU, EGFP-Nter, EGFP-HCR, and EGFP-Cterwere based on
pEGFP-C1 (Clontech) and EGFP-E335A (also termed DAIH in
this study), which was derived from EGFP-RHAU by point
mutation in motif II as described previously (30). Plasmids
RHAU-EGFP, (50–1008)-EGFP, (105–1008)-EGFP, (1–130)-
EGFP, and (1–105)-EGFP were based on pEGFP-N1 (Clontech)
by inserting corresponding fragments into the BglII (XhoI for
RHAU full length) and AgeI sites of the vector. Plasmids EGFP-
(50–1008) and EGFP-(105–1008) were prepared by inserting
the corresponding fragments between BglII and BamHI sites of
pEGFP-C1. RHAU-FLAG, (50–1008)-FLAG, (105–1008)-FLAG,
(1–105)-FLAG, and (1–130)-FLAG were prepared by inserting
correspondingRHAU fragments into theBglII (NheI for RHAU
full length) and AgeI sites of pIRES.EGFP-N1-FLAG. The vec-
tor was prepared by insertion of IRES.EGFP between AgeI and
NotI of pEGFP-N1 (Clontech). The IRES.EGFP insert was
designed by PCR using the pIRES.ECMV-EGFP vector, which
was kindly provided by D. Schmitz Rohmer and B. A. Hem-
mings, as a template. The PCR product of the IRES.EGFP insert
contained FLAG sequence with the AgeI site on the 5 end and
theNotI site on the 3 end. Plasmids-gal-(1–52)-EGFP,-gal-
(1–130)-EGFP, and -gal-(52–200)-EGFP were prepared by
inserting corresponding RHAU fragments into EcoRI and SalI
sites of p-gal-EGFP.4 The GST-RHAU vector was designed as
described previously (26). GST-Nter was prepared by inserting
the fragment (1–200 aa) between BamHI and EcoRI sites of
pGEX-2T (Amersham Biosciences). The oligonucleotides used
in this work and detailed descriptions of the plasmid construc-
tion are available upon request.
Antibodies—Mouse monoclonal anti-RHAU antibody (12F33)
was generated against a peptide corresponding to the C termi-
nus of RHAU, 991–1007 aa, as described previously (31). Com-
mercially obtained antibodies were: mouse anti-green fluores-
cent protein (B-2, sc-9996), goat anti-TIA-1 (sc-1751), goat
anti-eIF3b (N-20, sc-16377), mouse anti-HuR (3A2, sc-5261),
and rabbit anti-eIF2 (FL-315, sc-11386) (Santa Cruz Biotech-
nology, Santa Cruz, CA); mouse anti-actin (pan Ab-5, Thermo
Fisher Scientific, Fremont, CA); rabbit monoclonal anti-
eIF2-P (Ser-51, 119A11, Cell Signaling Technology, Danvers,
MA); and mouse anti-FLAG M2 (Sigma-Aldrich). The mouse
antibodies were all monoclonal.
Cell Culture, Transfection, and Stress Treatments—HeLa
cells were maintained in Dulbecco’s modified Eagle’s medium
supplementedwith 10% fetal calf serum at 37 °C in the presence
of 5% CO2. T-REx-HeLa cells stably transfected with pTER-
shRHAU were maintained as described previously (30). To
induce short hairpin RNA expression and consequent deple-
tion of endogenous RHAU, cells were treated with 1 g/ml
doxycycline (Sigma-Aldrich) for 7 days as described in supple-
mental Fig. 1. For immunofluorescence analysis, transient
transfection of DNAplasmids using FuGENE 6 (Roche Applied
Science) was performed according to the manual provided
using 1g of plasmid DNA and 3l of FuGENE 6/35-mmdish.
For immunoprecipitation analysis, cells were transfected by
Lipofectamine 2000 (Invitrogen) in Opti-MEM I medium
(Invitrogen). Briefly HeLa cells were seeded at 0.8  106 cells/
35-mm dish and 24 h later were transfected with 4 g of plas-
mid DNA and 10l of Lipofectamine 2000. The cells were used
24 h later for the following experiments. RNA interference
silencing was induced by transient transfection of small inter-
fering RNAs with INTERFERin (Polyplus Transfection, New
York, NY) following the manual instructions. Small interfering
RNAwas added to give a final concentration of 2.5 nM in 2ml of
4 F. Iwamoto and Y. Fujiki, unpublished data.
RHAU Localization in SGs via an RNA-binding Domain
DECEMBER 12, 2008•VOLUME 283•NUMBER 50 JOURNAL OF BIOLOGICAL CHEMISTRY 35187
 by guest, on D
ecem
ber 19, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
Publications	 149
medium and 8 l of INTERFERin for transfection of 40% con-
fluent cells in each 35-mm dish. To test SG formation, 0.5 mM
sodium arsenite (Sigma-Aldrich) or 1 M hippuristanol (kindly
provided by J. Tanaka (32)) was added in conditioned medium
for 45 or 30 min, respectively. To induce SGs with the iono-
phore carbonyl cyanide m-chlorophenylhydrazone (CCCP),
cells werewashedwith 1PBS (PBSwithout Ca2 andMg2)
and cultured in glucose- andpyruvate-freeDulbecco’smodified
Eagle’s medium containing 1 M CCCP. Heat shock was per-
formed at 44 °C in a 5% CO2 incubator for 45 min.
Immunocytochemistry and Image Processing—At 24 h after
transfection by FuGENE 6, HeLa cells were replated in 12-well
dishes with coverslips coated with 0.2% gelatin. The next day,
cells were treated with the indicated stimuli, fixed with 3.8%
paraformaldehyde in 1 PBS for 10 min, permeabilized with
0.2% Triton X-100 in PHEM buffer (25 mM HEPES, 10 mM
EGTA, 60 mM PIPES, 2 mM MgCl2, pH 6.9) for 30 min and
blocked with 5% horse serum in PHEM buffer for 1 h. All steps
were performed at room temperature. Samples were incubated
with primary antibodies (goat anti-TIA-1 (1:200), mouse anti-
HuR (1:200), and goat anti-eIF3b (1:200)) diluted in the block-
ing buffer overnight at 4 °C. Coverslips with fixed cells were
washed three times with 0.2% Triton X-100 in PHEMbuffer and
incubated in the dark with the secondary antibody and 500 ng/ml
DAPI (SantaCruzBiotechnology) to identify the nuclei for 40min
at room temperature. Cy2-, Cy3-, or Cy5-conjugated donkey sec-
ondary antibodies (Jackson ImmunoResearch Laboratories,West
Grove, PA) were used at dilutions of 1:200, 1:2,000, or 1:200 with
2.5% horse serum in PHEM buffer, respectively. The cells were
mounted in FluoroMount reagent (SouthernBiotech, Birming-
ham, AL). Fluorescent images were captured with a confocal
microscope (LSM 510 META, Carl Zeiss, Jena, Germany) as
described previously (30) except that a Plan-NeoFluar 100/1.3
oil differential interference contrast objective was used. The data
obtained were processed using standard image software (Bitplane
Imaris 5.7.1, Adobe Photoshop, and Adobe Illustrator). To quan-
tify association of RHAU with SGs, at least 100 transfected cells
were analyzed under the wide spectrummicroscope (Axioplan 2,
Carl Zeiss) and scored as positive when the green fluorescent pro-
tein signalwasenrichedandco-localizedwithTIA-1 inSGs.Three
(n3) independent transfectionswereanalyzed tocalculatemean
percentages andS.E.
Protein Extraction and Western Blotting—To prepare total
cell lysates, cells were lysed with Nonidet P-40 buffer (50 mM
Tris-HCl, pH 7.5, 120mMNaCl, 1%Nonidet P-40, 1mMEDTA,
5mMNa3VO4, 5mMNaF, 0.5g/ml aprotinin, 1g/ml leupep-
tin) on ice for 10 min and centrifuged at 20,000 g for 15 min
at 4 °C to remove cell debris. Typically 30 g of the total cell
lysate was loaded forWestern blotting. The protein bands were
visualized with the direct infrared fluorescence method or the
chemiluminescence method as described previously (30).
Cross-linking Immunoprecipitation (CLIP)—RHAU and
RNA interaction was determined by the previously reported
CLIP method with slight modifications (33). HeLa cells (0.8 
106/35-mm dish) were rinsed twice with ice-cold PBS and then
UV irradiated (400 mJ/cm2) to induce cross-linking between
protein and RNA. Cells were then lysed with 200 l of RIPA
buffer (1% Nonidet P-40, 1% deoxycholate, 0.1% SDS, 50 mM
NaCl, 10 mM sodium phosphate, pH 7.2, 2 mM EDTA, 50 mM
NaF, 0.2mM sodiumvanadate, 100 units/ml aprotinin)/well in a
6-well dish and shaken for 15min at 4 °C. Pooled lysates from 6
wells were treated with 30l of RQ1 RNase-free DNase (1 unit/
l; Promega, Madison, WI) and with 31 units of RNase A (31
units/l; USB Corp.) as described in the CLIP protocol (33).
Treated samples were centrifuged at 20,000  g for 20 min at
4 °C. The supernatants (600g) were incubatedwith 4.5g of a
mouse anti-RHAUmonoclonal antibody (12F33) or 10 l (bed
volume) of anti-FLAG M2 affinity gel (A2220, Sigma-Aldrich)
with rotation for 2 h at 4 °C. Beads were washed twice with
RIPA buffer, twice with high salt washing buffer (5 PBS, 0.1%
SDS, 0.5% deoxycholate, 0.5%Nonidet P-40) and twice with 1
PNK buffer (50mMTris-HCl, pH 7.4, 10mMMgCl2, 0.5%Non-
idet P-40). The associated nucleic acids were radiolabeled with
[-32P]ATP using T4 polynucleotide kinase (Roche Applied
Science) as described in the CLIP protocol (33), and RHAU-
RNA complexes were resolved in a NuPAGE 4–12% bis-Tris
gel (Invitrogen). Immunoprecipitated RHAU was detected by
Coomassie Blue staining and in-gelWestern blotting according
to the manual of Odyssey In-Gel Western detection (LI-COR
Biosciences). Half of the samples were transferred to a polyvi-
nylidene difluoridemembrane to facilitate better protein detec-
tion byWestern blotting and to remove free RNA. The proteins
were detected by the Odyssey infrared imager as described
above. Radiolabeled RNA was detected by a phosphorimaging
system, Typhoon 9400 (GEHealthcare), and analyzed using the
ImageQuant TL program. To test whether RHAU associates
with RNA, bound nucleic acids were isolated and radiolabeled
according to the CLIP protocol (33). Nucleic acids were mixed
with increasing amounts of RNase A (0.015, 0.15, 1.5, and 15
units) in H2O and 1 unit of RQ1 DNase in 1 RQ1 DNase
reaction buffer. Reactions were incubated for 30 min at 37 °C
and resolved by denaturing 8% PAGE in 1 Tris borate-EDTA
buffer.
Protein Purification—Escherichia coli BL21 (DE3) trans-
formedwith glutathione S-transferase (GST) or GST-Nter pro-
teinswere induced by 1mM isopropyl 1-thio--D-galactopyran-
oside for 12 h at 25 °C and purified by affinity chromatography
with glutathione-Sepharose 4B (Amersham Biosciences)
according to themanufacturer’s instructions. GST-RHAUpro-
tein was expressed in Sf9 cells according to the supplier’s
instructions (BD Biosciences Pharmingen) and purified as
above. The purity of recombinant proteinswas analyzed by 10%
SDS-PAGE and Coomassie Blue staining as reported in supple-
mental Fig. 2.
Double Filter RNABindingAssay—5g of total RNA isolated
from HeLa cells was alkali-treated with 0.1 M NaOH on ice for
10 min and then EtOH-precipitated. Redissolved RNA or
poly(rU) (P9528, Sigma-Aldrich) was 5-end-labeled using
[-32P]ATP (Hartmann Analytic GmbH, Braunschweig, Ger-
many) and T4 polynucleotide kinase (Roche Applied Science)
at 37 °C for 30 min and passed through a G-50 column (GE
Healthcare) to remove free nucleotides. Reaction mixtures (50
l) containing varying amounts of recombinant proteins
(0–150 nM as specified in text), radiolabeled RNA (poly(rU),
10,000 cpm; total RNA, 5,000 cpm) and 2 units of RNase inhib-
itor (RNAguard, Roche Applied Science) in the binding buffer
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(50mMTris-HCl, pH 8.0, 1mMdithiothreitol, 5mMNaCl) were
incubated for 30 min at 37 °C. The double filter RNA binding
assaywas performedwith a slot-blot apparatus using a 0.45-m
nitrocellulose (Protran,Whatman) andnylonmembranes (pos-
itively charged; Roche Diagnostics) that was presoaked in dif-
ferent buffers as described previously (34). Loaded samples
were washed three times with 200 l of the binding buffer.
Retained RNA was detected with a phosphorimaging system,
Typhoon 9400, and analyzed using the ImageQuant TL pro-
gram. The nitrocellulose membrane retains only RNA-protein
complexes, and free RNAs are captured on the nylon mem-
brane. The ratio of RNA that was bound to GST-RHAU or
GST-Nter was calculate using the following formula: bound
RNA (%) 100((signalnitrocellulose)/(signalnitrocellulose signalnylon)).
Bioinformatics—The program RNABindR (35) was used to
predict RNA binding potential in amino acid sequences. Pro-
grams RISP (RNA-Interaction Site Prediction) and BindN
were used to confirm the reliability of the RNABindR pro-
gram: RISP (36) runs with 72.2% RNA binding prediction
accuracy, and BindN (37) runs with 68% RNA binding pre-
diction accuracy. For multiple sequence alignments of N ter-
mini, RHAU orthologs were identified by a BLASTP (version
2.2.18) search of non-redundant protein entries in the
NCBI data base using the entire sequence of RHAU as a
query. Multiple sequence alignment was carried out with
ProbCons (version 1.12) (38). Similarity of groups was gen-
erated using GeneDoc (version 2.7) with the BLOSUM62
scoring matrix.
Fluorescence Recovery after Photobleaching—HeLa cells
(1.5  105/35-mm dish) were plated and transfected by
FuGENE 6 on glass-bottomed dishes (Micro-Dish 35 mm,
Fisher Scientific). FRAP experiments were carried out with a
confocal microscope (LSM 510, Carl Zeiss) using a 63/1.4
numerical aperture oil differential interference contrast objec-
tive. Bleaching was performed using the 488-nm lines from a
40-milliwatt argon laser operating at 75% laser power. Bleach-
ing of circular regions of interest (ROI) was done with three
scan iterations lasting a total of 1.5 s. Fluorescence recoverywas
monitored at low laser intensity (2% of the 40-milliwatt laser)
at 0.5-s intervals. Two additional ROI were monitored in par-
allel to detect fluorescence fluctuations that were independent
of bleaching (ROI of non-bleached SG) and to extract a back-
ground (ROI in the cytoplasm). Raw data of one protein were
obtained from 10 different FRAP analyses from three inde-
pendent transfections. Fluorescence recovery was normalized
with the function ((It  Bt)/(Ct  Bt))/I0 where It is the mean
intensity in ROI of bleached SGs at time point t, Bt is the mean
intensity in ROI of the background at time point t, Ct is the
mean intensity in ROI of control SGs at time point t, and I0
the average intensity in ROI of bleached SGs during prebleach.
The average fluorescence intensities S.E. from at least 10
independent FRAP analyses were extrapolated to the graph as
recovery curves.
RESULTS
RHAU Protein Associates with SGs in Response to Arsenite-
induced Stress—Various research groups have shown that dif-
ferentARE-binding proteins, such asTTP, Brf1,HuR,TIA-1, or
TIA-1-related protein, associate with SGs in cells exposed to
environmental stress (8, 39, 40). To determine whether RHAU
is also recruited to SGs,HeLa cells were transfectedwith EGFP-
FIGURE 1.RHAUhelicase accumulates in SGs in response to all tested stress
stimuli. A, immunofluorescence analysis of RHAU localization in arsenite-in-
ducedSGs.HeLacells, transiently transfectedwithEGFP-RHAUorRHAU-EGFP for
48 h, were treatedwith 0.5mM sodium arsenite for 45min or cultured in normal
conditions. After fixation, cells were stained with DAPI (blue) to visualize nuclei
andwith anti-TIA-1 antibody (red) to detect SGs. Left, distribution of EGFP-RHAU
or RHAU-EGFP (green) under normal and arsenite-treated conditions. Panels
denotedasMERGE showthedigital combinationofEGFP,TIA-1,andDAPI images
under arsenite-treated conditions; enlargements of boxed regions are shown in
small panels indicating merge (a), EGFP (b), and TIA-1 (c). Right, merges of DAPI
and TIA-1 with empty vectors pEGFP-C1 or pEGFP-N1; enlargements of boxed
regions are shown in small panels as above. B, co-localization of RHAUwith eIF3b
and HuR in arsenite-induced SGs. HeLa cells were transfected with EGFP-RHAU
and treated with or without arsenite as above. The extreme left panels show
EGFP-RHAU (green), and the two middle panels are immunofluorescent
images for eIF3b (red) and HuR (white; blue in merge), two SG markers. The
extreme right panels are their merges. C, effects of different stress stimuli on
eIF2 phosphorylation and RHAU localization in SGs. HeLa cells transiently
transfected with EGFP-RHAU were cultured without (1) or with the following
stress inducers: 0.5 mM arsenite for 45 min (2), heat shock (HS) at 42 °C for 45
min (3), 1M hippuristanol (HIPP) for 30min (4), and 1MCCCP for 90min (5).
The images showmerges of EGFP-RHAU (green) and TIA-1 (red). Enlargements
of boxed regions are shown in small panels indicatingmerge (a), EGFP (b), and
TIA-1 (c). The total eIF2 and phosphorylated eIF2 (eIF2-P) were detected
by Western blotting. Bar, 10 m (1 m in enlargements).
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tagged RHAU and treated with arsenite, a typical inducer of
SGs. As shown in Fig. 1A, the arsenite treatment induced, in
addition to diffuse nuclear and cytoplasmic localizations, the
accumulation of RHAU in distinct cytoplasmic foci that co-
localized with TIA-1 protein, an SG marker. Because all avail-
able anti-RHAU antibodies, both commercial and our own
preparation, were not suitable to visualize endogenous RHAU
by immunofluorescence analysis, we examined the intracellular
localization of RHAU by transiently transfecting cells.We used
either EGFP-RHAU or RHAU-EGFP to eliminate the
unwanted effects of EGFP on RHAU structure and subsequent
subcellular localization. Indeed both EGFP-RHAU and RHAU-
EGFP showed similar localization patterns in normal and stress
conditions (Fig. 1A). EGFP itself did not accumulate in SGs (Fig.
1A). The localization of RHAU in arsenite-induced cytoplasmic
foci was confirmed using other SG markers such as HuR and
eIF3b (p116) (Fig. 1B), indicating that RHAU is a novel SG
component.
Although the formation of SGs was not abolished or
reduced in T-Rex-HeLa cells after RNA interference-medi-
ated down-regulation of endogenous RHAU (supplemental
Fig. 1), we asked whether the recruitment of RHAU to SGs is
restricted to a specific type of stress. To address this ques-
tion, we treated EGFP-RHAU transfected HeLa cells with
different SG-inducing stimuli, such as arsenite, CCCP (a
mitochondrial inhibitor), heat shock, and hippuristanol (an
inhibitor of eIF4A RNA binding activity known to induce SG
aggregation independently of eIF2 phosphorylation) (32).
As shown in Fig. 1C, EGFP-RHAU co-localized with TIA-1
in SGs in response to all stimuli tested. The phosphorylation
of eIF2 was detected after treatment with arsenite, heat
shock, and CCCP but, as expected, not with hippuristanol
(Fig. 1C). These results indicate that the formation of SGs,
rather than phosphorylation of eIF2, is required for RHAU
protein recruitment to SGs.
The N-terminal Domain Recruits RHAU to SGs—RHAUpro-
teinconsistsof threemaindomains: theuniqueNterminus (Nter),
theevolutionarily conservedhelicasecore region (HCR), and theC
terminus (Cter) partially conserved among DEAH subfamily
members. To identify domains essential for localization of RHAU
in SGs, we generated deletion mutants of RHAU: EGFP-Nter
(1–200 aa), EGFP-HCR (201–650 aa), and EGFP-Cter (651–1008
aa) (Fig. 2A). As shown in Fig. 2B, the full-length RHAU (WT) as
well as the N terminus alone accumulated in arsenite-induced
SGs. Unlike EGFP-WT and EGFP-Nter, EGFP-HCR and EGFP-
Cterwereexcluded fromthenucleusanddiffused in thecytoplasm
asdescribedpreviously (30).After arsenite treatment, they showed
low level accumulation in small foci other than SGs (Fig. 2B). A
similar proportion of cells positive for EGFP signals in arsenite-
FIGURE 2. The N-terminal domain of RHAU localizes in SGs. A, scheme of
wild-type RHAU and its fragments. Nter, 1–200 aa; HCR, 200–650 aa; Cter,
200–1008 aa. B, intracellular localization of different parts of RHAU. HeLa cells
were transfected with an empty pEGFP-C1 vector or plasmids expressing
EGFP-fused RHAU (WT) or fragments of RHAU, Nter, HCR, and Cter. After 48 h,
cellswere cultured in normal conditions or treatedwith 0.5mMarsenite for 45
min, fixed, and stained for TIA-1 (red). Nuclei were visualizedwith DAPI (blue).
Small panels show enlargements of boxed regions: merge (a), EGFP-fused frag-
ments of RHAU (b) and TIA-1 (c). C, data obtained by quantitative immunoflu-
orescence analysis showing thepercentageof transfected cells inwhichEGFP
signalswere detected in SGs. Values S.E.M. (standard errors ofmeans) were
derived from three independent experiments. Bar, 10 m (1 m in enlarge-
ments). GFP, green fluorescent protein.
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inducedSGswasobservedwithEGFP-WT(78%)- andEGFP-Nter
(83%)-transfected cells, but no positive EGFP signals in arsenite-
inducedSGsweredetectedafter transfectionwithEGFP-HCRand
EGFP-Cter (Fig. 2C). Taken together, these results indicate that
the N terminus of RHAU is essential for stress-induced accumu-
lation of RHAU in SGs.
Because only the first 200 amino acids of RHAUwere neces-
sary for SG localization, we further studied functional domains
within the N terminus. For this we generated two new N-ter-
minally truncated forms of EGFP-fused RHAU by stepwise
deletion as depicted in Fig. 3A where the first deletion mutant
(50–1008 aa) lacked a G-rich region. These truncated mutants
and WT were transfected into HeLa cells. The association of
RHAU and its mutants with arsenite-induced SGs was assessed
by immunofluorescence microscopy (Fig. 3B) and quantified
(Fig. 3C). Deletion of the G-rich region significantly decreased
RHAU associationwith SGs from 81 to 36% of transfected cells.
The truncation of amino acids 1–105 further reduced RHAU
accumulation in SGs to 12%. As shown in a graph (Fig. 3C),
EGFP fusion at theNorC terminuswith theWTor themutants
did not affect their localization efficiency in SGs. Taken
together, these data suggest that the first 105 amino acids of the
N-terminal domain are essential for the recruitment of RHAU
protein to SGs and that an additional site, other than theG-rich
region, plays a role in this recruitment process.
RHAU Binds to RNA via the N-terminal Domain—The
recruitment of proteins to SGs was reported to be mediated
by protein-protein or RNA-protein interactions (10).
Because RHAU is an RNA helicase, we first examined
whether RHAU binds to RNA and, if so, whether RNA bind-
ing activity is required for its accumulation in SGs. To test
this, we used adapted CLIP (33), utilizing irreversible UV
cross-linking between protein and RNA to purify protein-
RNA complexes. The tightly associated RNA molecules
migrating together with immunoprecipitated protein were
radiolabeled with [-32P]ATP and detected with a phospho-
rimaging system. Endogenous RHAU was immunoprecipi-
tated with monoclonal anti-RHAU antibody. Phosphorim-
aging analysis of radiolabeled nucleic acids showed a
prominent signal at 120 kDa corresponding to RHAU (Fig.
4A). The signal was absent when RHAU was depleted by
RNA interference before immunoprecipitation. This indi-
cated that under normal conditions the strong signal at 120
kDa was derived from RHAU-associated nucleic acids. UV
irradiation not only cross-links proteins and RNA but also
proteins and DNA. As the CLIP method includes a stringent
DNase treatment prior to immunoprecipitation, it is likely
that the detected signals involve RNA. Nevertheless to test
this further, we purified co-immunoprecipitated nucleic
acids, radiolabeled them, and examined their sensitivity to
an increasing concentration of RNase (lanes 2–5) and 1 unit
FIGURE 3. The first N-terminal 105 amino acids of RHAUare necessary for
RHAU localization in SG. A, scheme of wild-type RHAU and its deletion
mutants. B, intracellular localization of RHAU N-terminal deletion mutants.
HeLa cells were transfectedwith plasmids expressing EGFP-fused RHAU (WT)
or N-terminal deletion mutants of RHAU, 50–1008 and 105–1008. After 48 h,
cells were treated with 0.5 mM arsenite for 45 min, fixed, and stained for TIA-1
(red). NucleiwerevisualizedwithDAPI (blue). Small panels showenlargementsof
boxed regions: merge (a), EGFP-fused fragments of RHAU (b), and TIA-1 (c).
C, quantitative immunofluorescence analysis showing the percentage of trans-
fectedcells inwhichEGFPsignalsweredetected inSGs.ValuesS.E.M. (standard
errors ofmeans) were derived from three independent experiments. Bar, 10m
(1m in enlargements a–c).GFP, green fluorescent protein.
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of DNase (lane 6). RHAU-associated nucleic acids were
digested by RNase but not by DNase (Fig. 4B) indicating that
RHAU interacts with RNA in vivo.
To confirm our in vivo observation, the binding of RHAU to
RNA was examined in vitro using purified, recombinant GST
and GST-RHAU by double filter RNA binding assays (supple-
mental Fig. 2A and Fig. 4C). As we do not know yet the in vivo
RNA targets of RHAU, we incubated radiolabeled, total RNA
(5,000 cpm) fromHeLa extractwith increasing amounts ofGST
or GST-RHAU (0–40 nM) and filtered the mixture through
nitrocellulose and nylon membranes. As shown in Fig. 4C,
unlike GST itself, GST-RHAU was retained with associated
RNA on nitrocellulose, and moreover it displayed dose-
dependent RNA binding, suggesting that RHAU can directly
associate with RNA. We express the relative binding affinity
(KD) as the concentration of GST-RHAU at which 50% of RNA
was bound. The apparentKD of GST-RHAUwas 7 nM (Fig. 4C).
Next we examined the influence of arsenite stress on the
RHAU-RNA interaction by treating the EGFP- or EGFP-WT-
transfected HeLa cells with arsenite before UV irradiation and
comparing the RNA binding activity of RHAU in normal and
stress conditions. After immunoprecipitation by a monoclonal
anti-RHAU antibody, two radiolabeled RNA bands per the lane
were detected; the lower andupper bands correspond to endog-
enous RHAUand transfected EGFP-WT, respectively (Fig. 4D).
The association of endogenous RHAU with RNA was used as a
loading control. The intensity of the RNA signals normalized
over RHAU protein levels was similar in control and arsenite-
treated conditions, suggesting that the amount of RHAU-asso-
ciated RNA was not influenced by stress. The RNA band
migrating in the region corresponding to EGFP-WT was not
present in extracts of EGFP-transfected cells, verifying that the
RNA signals were derived from RHAU-associated RNA.
Given the apparent significance of the first 105 amino acids
for RHAU localization in SGs, we examined whether the N
terminus was also required for RHAU-RNA interaction. After
cells were transiently transfectedwith EGFP-WT and its N-ter-
minal deletion mutants, the extent of RNA binding to RHAU
and mutants was examined as described above and normalized
over RHAU protein levels. Although the CLIP method is not
a suitable quantitative assay, in six independent assays
EGFP-(50–1008) and EGFP-(105–1008) showed a reproduc-
ible decrease in RNA binding activity of 50 and 20%,
respectively, compared with EGFP-WT (Fig. 4E). A stepwise
decrease in the RNA binding activity of the two deletion
mutants correlated with the decreased RHAU localization in
arsenite-induced SGs (see Fig. 3C). The small amount of
RNA remaining associated with EGFP-(105–1008) may
reflect residual RNA binding activity derived from the heli-
case core domain of RHAU. Thus, the majority of RNA asso-
ciated with RHAU is bound to its N terminus.
Bioinformatics Analysis of the N Terminus Revealed a
Putative RNA-binding Domain—Knowing that RHAU inter-
acts with RNA via the first 105 amino acids, we submitted the
RHAU protein sequence to RNABindR, a computational
program that predicts RNA binding potential of amino acid
residues (35). This program is focused on sequence-based
predictions and runs on a naïve Bayes classifier. According to
this program, residues from 3 to 75 were highly positive for
the RNA interaction (Fig. 5A). A similar prediction was
obtained by two other programs based on different algo-
FIGURE 4.RHAUassociateswith RNA through itsN terminus. A, CLIPmethod
to identify interactions of RHAU with nucleic acids (NA). HeLa cells were tran-
siently transfectedwith small interfering RNAs against RHAU (siRHAU) or lucifer-
ase (siControl). CellswereUV irradiated72h later andharvested. Immunoprecipi-
tation was performed with a RHAU antibody. Bound nucleic acids were
radiolabeled and detected as a band of120 kDa corresponding to RHAU (lane
siControl). However, this band was strongly reduced when endogenous RHAU
wasdepleted(lanesiRHAU).Westernblot (INPUT) showsefficientRHAUdepletion
by small interfering RNAs against RHAU. Actin was used as a loading control.
B, identification of associated nucleic acids as RNA. After immunoprecipitation,
the nucleic acids bound to RHAU were isolated, radiolabeled, and treated with
increasing concentrations (0.015, 0.15, 1.5, and 15 units) of RNaseA and 1unit of
RQ1DNase.Lane1, isolatedandnon-treatednucleicacids (NA); lanes2–5, isolated
nucleic acids treated with increasing concentrations of RNase; lane 6, nucleic
acids treated with DNase. -Fold changes in intensity ratio (NA/digest NA) are
depicted relative to the intensity of non-treated nucleic acids in lane 1, set as 1.
Note thatnucleic acids areRNase-sensitivebutDNase-insensitive. C, RHAUbinds
toRNA in vitro. 0, 2.5, 5, 10,20, and40nMGSTorGST-RHAU(RHAU)was incubated
with5,000cpm5-end-labeledRNAfor30minat37 °Candfilteredthroughnitro-
cellulose andnylonmembranes. Thepercentageof boundRNAwasplotted as a
function of increasing concentration of GST-RHAU. Note that dose-dependent
RNA bindingwas seen only with GST-RHAU. D, effect of stress on RHAU associa-
tionwithRNA in vivo. HeLa cellswere transfectedwith EGFPaloneor EGFP-WT (a
full-length RHAU). Half were treated 24 h later with arsenite (0.5 mM for 45 min)
followed by UV irradiation and radiolabeling of RHAU-associated nucleic acids.
RHAU and associated RNA were analyzed by Western blotting and a phospho-
rimaging system to detect levels of protein expression and the amount of radio-
labeledRNA, respectively.Note that thearsenite treatment () didnotabolishor
dramatically change the RNA binding activity of RHAU. ARS, arsenite. E, compar-
ison of RNA binding activities of wild-type RHAU and its N-terminal deletion
mutants. HeLa cells were transfected with EGFP, EGFP-WT, EGFP-(50–1008), or
EGFP-(105–1008). Protein and associated RNAwere analyzed as in A. Radioactiv-
ity of boundRNAwas normalized to the expression levels of correspondingpro-
teins. In sharp contrast to constant RNA binding of endogenous RHAU in each
lane,N-terminaldeletionmutantsshowedstepwise reductionofRNAinteraction
compared with WT. ‹, overexpressed EGFP-RHAU or its N-terminal deletion
mutants;‹‹, endogenous RHAU.
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rithms, BindN and RISP (36, 37) (Fig. 5A). Moreover
sequence alignment within the first 105 amino acids of
RHAU proteins from choanoflagellate to humans revealed a
novel highly conserved domain (54–66 aa) termed RSMnext
to the already known G-rich region (10–50 aa) with one
RGG box motif (47–49 aa) (Fig. 5B). Although RGG box
motifs have been reported to be involved in RNA binding
(41, 42), RSM has no similarity to any known functional
sequence elements. Thus, RHAU likely harbors an atypical
conserved RNA-binding domain in the N terminus.
The N-terminal RNA-binding Domain Is Essential and
Sufficient for RNA Interaction and Localization of RHAU in
SGs—To further test whether these 105 N-terminal residues
are sufficient for RNA binding and subsequent RHAU
recruitment to SGs, we designed FLAG-tagged truncated
forms of the RHAU protein: WT-FLAG, (50–1008)-FLAG,
(105–1008)-FLAG, (1:105)-FLAG and (1:130)-FLAG. For
the RNA binding experiment, CLIP analyses were performed
using a monoclonal mouse anti-FLAG M2 antibody coupled
to agarose beads. Western blotting confirmed the successful
expression and immunoprecipitation of all fragments with
(1–105)-FLAG and (1–130)-FLAG at higher protein levels
(Fig. 6A, left panel). To analyze the RNA binding activities of
these proteins, the measured radiolabeled RNA levels were
normalized over protein levels. As shown in Fig. 6A (right
panel), compared with WT-FLAG (lane 2), the amounts of
RNA associated with (50–1008)-FLAG (lane 3) and (105–
1008)-FLAG (lane 4) were stepwise reduced to70 and 30%,
respectively. The high levels of RNA binding (before normal-
ization) with (1–105)-FLAGand (1–130)-FLAG (lanes 5 and 6)
may partly reflect their expression levels (Fig. 6A, right panel);
however, they still showed10-fold higher RNA binding activ-
ity than WT-FLAG after normalization. Thus, these results
demonstrate that the first 105 amino acids are essential and
sufficient for RHAU to bind RNA.
Because the N-terminal fragment of RHAU (1–105)-FLAG
has been shown to bind RNA in vivo, we again performed a
double filter RNA binding assay using the recombinant GST-
Nter fragment (1–200 aa). Purified, recombinant GST and
GST-Nter (supplemental Fig. 2B) were incubated with 5-end-
FIGURE 5. Bioinformatics analysis of the RHAU N-terminal domain. A, computational analysis for RNA-binding residues within the RHAU N terminus. The
human RHAU amino acid sequence was subjected to three different programs, BindN, RISP, and RNABindR, available on line. Residues predicted to be
positive for RNAbindingare indicatedby “” anddepictedabove theRHAUaminoacid sequence. Thegray shading corresponds toRNAbinding consensusper
one amino acid in all three programs. Note that the predicted RNA-binding domain is a long stretch from 3 to 75 aa (gray bar) that overlaps with the G-rich
regioncontaininganRGGboxmotif andwith thehighly conservedRSM.B, conservationof theRSMthroughevolution.OrthologsofRHAUused for themultiple
sequence alignment were identified as described under “Experimental Procedures.” Similarity of groups was estimated using GeneDoc (version 2.7) with the
BLOSUM62 scoring matrix. Red, 90–100% similarity; yellow, 70–90% similarity; and blue, 50–70% similarity. Species and NCBI and Ensembl (in case of X.
tropicallis) accession numbers are as follows: human (Homo sapiens, NP_065916), mouse (Musmusculus, NP_082412), chicken (Gallus gallus, XP_422834), frog
(Xenopus tropicalis, ENSXETP00000016953), zebrafish (Danio rerio, CAM56669), fruit fly (Drosophilamelanogaster, NP_610056), trematoda (Schistosoma japoni-
cum, AAW25528), and choanoflagellate (Monosiga brevicollis, EDQ87802).
RHAU Localization in SGs via an RNA-binding Domain
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radiolabeled total RNA or with poly(rU) and then filtered
through nitrocellulose and nylon membranes. As shown in Fig.
6B, the higher dose-dependent amount of RNA, both total RNA
and poly(rU), was associated with GST-Nter rather than GST.
The apparent affinities ofGST-Nter for total RNAand poly(rU)
were 45 and 80 nM, respectively. These data confirmed the in
vivo data that the N terminus is essential and sufficient for
RHAU association with RNA.
To determine whether the N terminus is also sufficient for
RHAU recruitment to SG, we transfected HeLa cells with
N-terminal mutants fused with the EGFP tag at their C termini
as shown in Fig. 7A. Immunofluorescence analysis revealed that
both tested mutants, (1–105)-EGFP and (1–130)-EGFP, co-lo-
calized with TIA-1 protein in SGs (Fig. 7A). Further we tested
whether the N terminus can bring about SG localization of a
protein that does not normally associate with SGs in response
to stress. We fused different fragments of the RHAU N-termi-
nal domain to -gal-EGFP constructs (Fig. 7B) and transfected
them into HeLa cells. In response to arsenite treatment, -gal-
EGFP by itself did not accumulate in SGs but was diffusely
distributed in the cytoplasm as in normal conditions. However,
when -gal-EGFP was fused to the N-terminal 1–130 amino
acids, including the complete putative RNA-binding domain
with the G-rich region and the RSM, the fusion protein local-
ized to SGs. In contrast, SG localization was not detected when
-gal-EGFP was fused with either the G-rich region (-gal-
EGFP(1–51 aa)) or the RSM (-gal-EGFP(52–200 aa)) alone,
indicating that only the complete RNA-binding domain is
required for RHAU recruitment to SGs.
ATP Hydrolysis Plays a Role in RNA Binding and Kinetics of
RHAU in SGs—Previously we showed that anATPase-deficient
RHAUmutant with a DEIH to DAIH point mutation is unable
to accelerate uPA mRNA decay (26) and is excluded from the
nucleus (30). This suggested that the ATPase activity of RHAU
has profound effects on its biological activity and subcellular
localization. Therefore, we examined the role of RHAUATPase
activity on its RNA binding activity and its localization in SGs.
To elucidate the RNA binding potential of ATPase-deficient
RHAU mutants, we performed CLIP analyses. After UV cross-
linking and subsequent immunoprecipitation of EGFP-WT
and EGFP-DAIH with an anti-RHAU antibody, the amount of
associated RNA was normalized to corresponding protein lev-
els. As shown in Fig. 8A, a higher amount of RNA was pulled
down with the ATPase-deficient DAIH mutant than with
EGFP-WT. Based on results of Tanaka and Schwer (34) where
Prp22, a yeast DEAH box helicase, dissociated from the RNA
upon ATP hydrolysis resulting in apparent RNA binding activ-
ity reduction, we concluded that ATPase activity of RHAU is
FIGURE 6. TheN-terminal RNA-binding domain is essential and sufficient
for RNA interaction in vivo and in vitro. A, CLIP method to show RNA bind-
ing activity of the N-terminal 105 amino acid residues of RHAU. HeLa cells
were transfected with an empty vector (lane 1), vectors expressing FLAG-
tagged RHAU wild type (lane 2), or its fragments, (50–1008) (lane 3), (105–
1008) (lane 4), (1–105) (lane 5), and (1–130) (lane 6). Cells were UV irradiated
24h later, harvested, and immunoprecipitatedby FLAGantibody. BoundRNA
was labeled with [-32P]ATP and detected by a phosphorimaging system as
described under “Experimental Procedures.” Left panel, Western blot of
immunoprecipitated FLAG-tagged RHAU and its fragments. Right panel,
boundRNA. The amount of associated RNAwas normalized to the expression
level of proteins.‹, FLAG-tagged RHAU and its fragments. B, the N terminus
of RHAU binds to RNA in vitro. 0, 25, 50, 100, and 150 nM GST or GST-Nter
(1–200 aa) was incubated with 10,000 cpm 5-end-labeled total RNA (left
panel) or poly(rU) (right panel) for 30 min at 37 °C and filtered through nitro-
cellulose andnylonmembranes. Note that thedose-dependent RNAbinding,
both total RNA and poly(rU), was detected only with GST-Nter.
FIGURE 7. The N-terminal RNA-binding domain is also essential and suf-
ficient for SG localization of RHAU. A, immunofluorescent images of HeLa
cells transfected with vectors expressing EGFP-tagged N-terminal fragments
of RHAU, (1–105) and (1–130). After 48 h of transfection, cells were treated
with arsenite (0.5 mM, 45 min) to induce SGs. The merge shows the co-local-
ization of EGFP-tagged RHAU fragments (green) and TIA-1 (red). DAPI (blue)
stains nuclei. B, immunofluorescent images of HeLa cells expressing EGFP--
galactosidase double tagged RHAUN-terminal fragments. Cells were treated
as above to induce SGs. The co-localization of EGFP (green) and eIF3b (red) is
shown in the merge together with DAPI (blue). Note that only the (1–130)
fragment containing an intact RNA-binding domain recruits EGFP--galacto-
sidase to SGs. Enlargements of boxed regions are shown in small panels indi-
cating merge (a), EGFP-fused RHAU N-terminal fragment (b), and eIF3b (c).
Bar, 10 m (1 m in enlargements). GFP, green fluorescent protein.
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involved in releasing RHAU from RNA rather than in binding
to RNA.
Considering the possibility that the N terminus and ATP
hydrolysis contribute to the RNA interaction of RHAU, we
investigated whether the N-terminal RNA-binding domain is
also required for RNA binding of the DAIH mutant and its
accumulation in SGs. For this, we introduced a point mutation
(DEIH to DAIH) into motif II of the helicase core region to
generate DAIH(50–1008) and DAIH(105–1008) fused with
EGFP at their N termini (Fig. 8B). First the truncated fragments
were used in the CLIP analysis. While being aware of CLIP
limitations in quantitative analysis, stepwise deletion of the
N-terminal domain of the DAIH mutant to DAIH(50–1008)
and DAIH(105–1008) nevertheless decreased the amount of
associated RNA to 50 and 15%, respectively, compared with
the DAIH full-length mutant (Fig. 8C). The stepwise decrease
in RNA interaction seen with the two DAIH deletion mutants
corresponds to that seen with RHAUdeletionmutants (see Fig.
4E). Thus, enhanced RNA binding of the DAIH mutant still
required the N terminus.
Having shown that RHAU recruitment to SGs is dependent
on its RNA interaction (see Figs. 3C and 4E), we tested whether
the ATPase-deficient DAIH mutant accumulates in SGs more
than wild type. Indeed the DAIH mutant localized in SGs (Fig.
8D) to a greater extent than the wild type, increasing the num-
ber of transfected cells with EGFP-positive SGs from 81 to
100%. Unlike DAIH full length and DAIH(50–1008),
DAIH(105–100) was not detected in SGs. Therefore, RHAU
recruitment to SGs is independent of its ATPase activity.
Having established that both RHAUwild type and the DAIH
mutant accumulate in SGs, we used the FRAPmethod to exam-
ine whether the dynamics of shuttling into and out of SGs dif-
fers between the two proteins. Cells were transfected with
EGFP-WT, EGFP-DAIH, EGFP-G3BP, or EGFP-FMRP, and
FIGURE 8. Role of RHAU ATPase activity in RNA binding and retention of
protein in SGs.A, RNAbinding activity ofWT and theATPase-deficient RHAU
mutant DAIH. Levels of RHAU-associated RNA were measured by CLIP as
described under “Experimental Procedures” 24 h after transfecting HeLa cells
with EGFP-fusedWTorDAIH. The level of RNAbound to theDAIHmutantwas
much higher than that bound to WT. Note that the level of RNA bound to
endogenous RHAU is comparable in cells expressing exogenousWT or DAIH.
B, schematic representation of N-terminal deletion, DAIH mutants: EGFP-
DAIH, EGFP-DAIH(50–1008) (D(50:1008)), and EGFP-DAIH(105–1008) (D(105:
1008)).C, comparisonof RNAbindingbetweenmutants shown inB. HeLa cells
were transfected with vectors expressing EGFP-DAIH, EGFP-DAIH(50–1008)
(D(50:1008)), or EGFP-DAIH(105–1008) (D(105:1008)), and 24 h later the levels
of RNA associatedwith thesemutants and endogenous RHAUwere assessed
by CLIP as in A. Note that N-terminal deletion mutants show stepwise reduc-
tion of RNA binding compared with DAIH full length (such as WT and its
deletionmutants in Fig. 4E).D, intracellular localization of EGFP-tagged DAIH
mutants listed inB in control andarsenite-treated cells. TransfectedHeLa cells
were treated without (NORMAL) or with 0.5 mM sodium arsenite for 45 min.
Images denotedMERGE are the merger of EGFP (green), TIA-1 (red), and DAPI
(blue). Enlargements of boxed regions show merge (a), EGFP-tagged DAIH
mutants (b), and TIA-1 (c). Bar, 10m (1m in enlargements).‹, EGFP-tagged
DAIH and its deletion mutants;‹‹, endogenous RHAU.
FIGURE 9. ATP hydrolysis takes part in dynamic RHAU shuttling into and
out of SGs. A, fluorescent recovery patterns of RHAU, ATP-deficient RHAU
mutant (DAIH), G3BP, and FMRP. HeLa cells transfected with EGFP-tagged
RHAU, DAIH, G3BP, or FMRP were treated with arsenite and analyzed by the
FRAPmethod. Bleaching of selected SGs was performedwith three scan iter-
ations for a total of 1.5 s. Fluorescence recovery was monitored at 0.5-s inter-
vals for 50 s, and results were analyzed as described under “Experimental
Procedures.” Data were collected from at least 10 independent experiments,
and each curve represents average fluorescence intensityS.E.M. (standard
errors of means) over time. B, representative result of FRAP analysis of EGFP-
tagged RHAU, DAIH, G3BP, or FMRP. SGs were photobleached, and subsequent
fluorescence recoveries are shown in a firemode in the time scale of recovery.Œ
indicates SGs bleaching.
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the FRAP analyses were performed 48 h after transfection. It
has been shown that TIA-1 andG3BP recover rapidly and com-
pletely in SGs within 30 s after bleaching (6, 13). In contrast,
PABP-1, anothermarker formRNAshuttling, showed only 60%
fluorescence recovery after 30 s (3, 6). In our study, we used
EGFP-G3BP as a control for the rapid fluorescence recovery
(Fig. 9, A and B). Although FMRP has never been tested by
FRAP analysis, we included this protein as a control as it is
known to localize in SGs (43). As shown in Fig. 9A, the fluores-
cence signal of G3BP recovered rapidly and completely within
10 s as reported previously (6), but the FMRP signal did not
recover fully within 60 s, suggesting that FMRP is a scaffold SG
component. In this analysis, the wild type and DAIH signals
showed different recovery patterns. The former displayed rapid
recovery (90%) of fluorescence after 8 s similar to G3BP with
the same recovery after 11 s. However, the recovery of the
EGFP-DAIH mutant fluorescent signal was much slower with
only 60% of fluorescence recovery after 30 s of bleaching similar
to PABP-1. The recovery rate reflects the strength of binding
whereby slower recoveries correspond to tighter binding. Thus,
in comparisonwith thewild type, theATPase-deficientmutant,
which cannot release RNA because of its inability to hydrolyze
ATP, is retained longer in SGs, resulting in slower recovery
kinetics. Combining these results, we conclude that theATPase
activity of RHAU is required for its active shuttling into and out
of SGs and may also be important for remodeling and/or
recruitment of RNPs in SGs.
DISCUSSION
In the present study, we have shown that the DEAH box
helicase RHAU is a novel SG-associated protein that is
recruited to SGs via RNA. Its N terminus is necessary and
sufficient for RHAU localization in SGs and simultaneously
for its binding to RNA. Bioinformatics analysis of the RHAU
peptide sequence corroborated the experimental data,
revealing that the N terminus of RHAU harbors a unique
RNA-binding domain consisting of two abutting motifs: the
G-rich region and the RSM. We have also shown that
ATPase activity is involved in RHAU association with RNA
and markedly influences the kinetics of RHAU recovery in
SGs after photobleaching.
The list of proteins identified as components of SGs, co-lo-
calizing with known SG-associated proteins such as TIA-1, is
still expanding. However, a method for isolating SGs to a sig-
nificantly pure level has not yet been established, biochemical
analysis of SGs is very difficult, and thus there is no consensus
on their detailed structure and molecular composition. Fur-
thermore it has not been systematically examined whether SGs
induced by different stresses are qualitatively different. The
presence of qualitatively different SGs is suggested by the fact
that the recruitment of TTP to SGs is induced by carbonyl cya-
nide m-fluorophenylhydrazone but not by arsenite, whereas
TIA-1 is recruited to SGs by both stimuli (39). Our results
clearly demonstrate that RHAU is one of the SG-associated
proteins and that its recruitment to SGs does not depend on the
type of stress. Thus, RHAU appears to be a general SG compo-
nent like TIA-1 or eIF3b. AlthoughRHAU is recruited to SGs, it
does not participate actively in SG formation as RNA interfer-
ence-mediated down-regulation of RHAU had no effect on
arsenite-induced SG formation (supplemental data). Similarly a
further SG-associated protein, ZBP1, did not induce or inhibit
SG formation when overexpressed or knocked down, respec-
tively (7). Although ZBP1 does not modulate SG formation, its
significance for SGs is attributed to its function inmRNA turn-
over regulation. Interestingly the stability of ZBP1 target
mRNAs is not regulated by their recruitment to SGs but by their
retention in SGs to prevent their rapid translocation and sub-
sequent decay in processing bodies or by the exosome (7).
Knowing that RHAU is a cis-acting factor involved in ARE-
mediated decay of uPAmRNA and that its association with SG
is regulated by RNA interaction, we speculate that RHAU acts
in SGs in a manner similar to ZBP1.
Given that several RNA-binding proteins such as FMRP,
TIA-1, G3BP, ZBP1, or Caprin-1 are mostly targeted to SGs via
mRNA (7, 41, 43, 44), we performed CLIP, nitrocellulose filter
binding assays, and bioinformatics analyses to elucidate
whether the N terminus of RHAU, which is necessary and suf-
ficient for RHAU accumulation in SGs, physically interacts
with RNA. The analyses revealed that RHAU does associate
with RNAboth in vitro and in vivo and that only theN-terminal
105 amino acids harbor significant RNA binding activity. In
addition, this region of RHAU contains the computationally
predicted RNA-binding domain (3–75 aa) composed of a
unique, previously unidentified RNA-binding motif. The
domain is located in an unstructured and flexible sequence
composed of two adjacent motifs, the G-rich region (10–50 aa)
and the RSM (54–66 aa). The latter is highly conserved among
RHAU orthologs, but it was not found in other proteins, sug-
gesting that this motif confers a unique function on RHAU.
Interestingly a potential RGG box motif (47–49 aa), which has
been reported previously to be involved in the RNA interaction
of several proteins, is present in theG-rich region of RHAU. For
example, two RGG box sequences identified at the C terminus
of the FMRP protein were shown to be necessary for an RNA
and G-quadruplex interaction of FMRP and also for the induc-
tion of SG formation by EGFP-FMRP overexpression (42, 43).
Moreover Caprin-1, an SG-associated protein, contains three
RGG boxmotifs in its C terminus that are also important for its
specific RNA interaction and SG induction (41). Our analyses
of the RHAUN terminus shows that the deletion of the G-rich
region together with the RGG box motif reduces RNA binding
activity of RHAU and its accumulation in SGs (42%) suggesting
that the RGGboxmotifmay be involved in the RNA interaction
and RHAU localization in SGs. However, the G-rich region
with the RGGboxmotif alonewas not sufficient for the recruit-
ment of a fused-galactosidase reporter protein to SGs (see Fig.
7B). Only the complete RNA-binding domain enables RHAU
localization in SGs and RNA interaction, indicating that a
domain other than the G-rich region takes part in RHAU
recruitment to SGs. The detailed nature of the cooperation and
the underlying mechanism between the G-rich region and the
RSM remain interesting questions for the future.
According to the classification of putative RNA helicases by
Abdelhaleem et al. (20), RHAUbelongs to theDEAHbox family
containing a highly conservedC terminus next to the conserved
helicase core region. Studies of DEAH proteins in yeast have
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shown that the specific function of eachmember is determined
mainly by its N terminus and that helicase and ATPase activi-
ties are essential for their function during splicing. For example,
Prp16, the ortholog of mammalian DHX38, localizes in the
nucleus and recognizes the spliceosome through its N terminus
(25). Its C terminus enhances spliceosome binding, whereas the
helicase core region drives the process by binding and hydro-
lyzing ATP. Similarly Prp22 (DHX8), another splicing factor,
requires the N-terminal domain for its ATPase and helicase
function (24, 45). Our results show that the RHAU helicase
follows the same principle because its specific localization in
SGs and RNA interaction is governed by its N-terminal domain
where the RNA-binding domain is located.
Importantly CLIP analysis confirmed that RHAU is an RNA-
binding protein, which was suggested by our previous work
when RHAU was first identified as an ARE-associated protein
(26) but was not formally tested. Although we do not have
direct evidence that RHAU-associated RNAs are mRNAs, the
correlation between RHAU RNA binding activity and RHAU
accumulation in SGs, which are aggregates of protein-mRNA
complexes, strongly suggests this to be the case. Furthermore
results showing that the abrogation of RHAU ATPase activity
increases the amount of associated RNA (see Fig. 8A) are in
good agreement with the accepted model of the closed and
open conformation of DEX(H/D) box helicases. The structural
and fluorescence resonance energy transfer information of
complete DEAD box helicases has shown that the cooperative
binding of ATP and RNA induces a closed conformation of
helicases that is relaxed upon ATP hydrolysis, leading to the
release of bound RNA (46–49). A similar effect has been
reported for the Prp22 splicing factor that releases bound RNA
uponATP hydrolysis, thereby reducing its apparent RNAbind-
ing affinity (34). In this context, it is noteworthy that the
ATPase-deficient mutant is excluded from the nucleus despite its
strong RNA interaction indicating that it may associate mostly
with mRNA and that the presence of RHAU in the nucleus is not
essential for its localization to SGs. The nuclear exclusion of the
ATPase-deficient mutant DAIH is not a consequence of it being
trapped in the cytoplasm by a strong, irreversible interaction
with RNA as we proposed previously (30). The N terminus-
deleted ATPase-deficient mutant DAIH(105–1008), which
showed markedly reduced RNA interaction and localization in
SGs, remainedmainly in the cytoplasm (Fig. 8D). Therefore, the
nuclear-cytoplasmic translocation of RHAU is most probably
regulated by its ATPase activity. A similar role for ATPase
activity in nuclear export via the CRM1 protein was reported
previously for the DEAD box helicase An3 (27).
Many SG-associated proteins are RNA-binding proteins
involved in different intracellular processesmediated by or act-
ing upon mRNA. Several of these proteins, including TIA-1,
TTP, heterogeneous nuclear RNP A1, PCBP-2, MLN51, and
G3BP (6, 9, 11–13), have been shown by FRAP analysis to rap-
idly shuttle into and out of SGs. This suggests that SGs are not
static storage centers for untranslated mRNA but rather
dynamic structures that sort individual transcripts for storage,
reinitiation, or decay (4, 10). FRAP analysis also revealed that
proteins behave with differing kinetics. For instance the
PABP-1 protein exhibits a slower and only partial recovery
(60%) 30 s after bleaching comparedwith TIA-1 (6, 11, 13). Like
G3BP, wild-type RHAU shows very rapid shuttling into and out
of SGs. In striking contrast, the kinetics of theATPase-deficient
mutant were different from RHAU and G3BP: green fluores-
cent protein signal recovery in SGs was as slow as for PABP-1.
Thus, ATP hydrolysis affects the shuttling kinetics of RHAU
into SGs. Furthermore our analysis showed that the FMRP pro-
tein is not a member of the group of rapidly shuttling RNA-
binding proteins. Rather it exhibits slow shuttling like the Fas-
activated serine/threonine kinase protein and, thus, may play a
scaffolding role in SGs (6). Although RHAU exhibits the rapid
mobility of G3BP, TIA-1, and TTP, it may be involved in RNP
remodeling or their recruitment to SGs as suggested for TIA-1
and TTP (13).
With the detection of RHAU in SGs, we are the first to show
the association of a DEAH box RNA helicase with SGs. Our
FRAP analysis shows the striking difference in SG shuttling
kinetics between fully active RHAU protein and its ATPase-
deficientmutant, tendering the hypothesis that ATPase activity
takes part in the dynamic remodeling of RNPs in SGs. Further-
more the sorting and remodeling of RNPs in SGs presumably
requires energy, which may be provided by RNA helicases that
utilize energy from ATP hydrolysis to rearrange inter- or
intramolecular RNA structures or to dissociate protein-RNA
complexes. To our knowledge, three DEADbox RNAhelicases,
rck/p54 (DDX6), DDX3, and eIF4A, have been shown to local-
ize in SGs (32, 50, 51). Considering that various remodeling
processes take place in these foci, it will be no surprise if the
number of RNAhelicases found associated with SGs is revealed
to be much higher.
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ABSTRACT
Under physiological conditions, guanine-rich se-
quences of DNA and RNA can adopt stable and
atypical four-stranded helical structures called
G-quadruplexes (G4). Such G4 structures have
been shown to occur in vivo and to play a role in
various processes such as transcription, translation
and telomere maintenance. Owing to their high-
thermodynamic stability, resolution of G4 structures
in vivo requires specialized enzymes. RHAU is a
human RNA helicase of the DEAH-box family that
exhibits a unique ATP-dependent G4-resolvase
activity with a high affinity and specificity for its sub-
strate in vitro. How RHAU recognizes G4-RNAs has
not yet been established. Here, we show that the
amino-terminal region of RHAU is essential for
RHAU to bind G4 structures and further identify
within this region the evolutionary conserved RSM
(RHAU-specific motif) domain as a major affinity and
specificity determinant. G4-resolvase activity and
strict RSM dependency are also observed with
CG9323, the Drosophila orthologue of RHAU, in the
amino terminal region of which the RSM is the only
conserved motif. Thus, these results reveal a novel
motif in RHAU protein that plays an important role in
recognizing and resolving G4-RNA structures,
properties unique to RHAU among many known
RNA helicases.
INTRODUCTION
In cells, the strong inclination of RNA for mis-folding or
adopting non-functional conformations is overcome by
the presence of RNA chaperones that facilitate conform-
ational transitions of RNA. Among these chaperones are
the RNA helicases, which couple NTP hydrolysis with
structural and functional rearrangement of the RNA.
The DEAD/H-box proteins constitute a widely spread
subgroup of RNA helicases that have been identified in
all forms of life, including viruses. DEAD/H-box proteins
have been shown to catalyse the disruption of RNA–RNA
interactions (1,2), to remodel ribonucleoprotein (RNP)
complexes (3,4) and to assist the correct folding of RNA
(5,6). In this regard, DEAD/H-box proteins are essential
cellular components that take part in many, if not all,
aspects of RNA metabolism, ranging from transcription
to RNA decay [for review see (7–9)].
Structurally, DEAD/H-box proteins consist of a highly
conserved catalytic core composed of two RecA-like
domains that couples NTP hydrolysis with the helicase
activity. The helicase core domain is often flanked by an-
cillary N- and C-terminal regions of variable length and
sequence. While the core domain of RNA helicases has
been extensively studied, much less is known about the
biological role of the N- and C-terminal regions.
Because of the high degree of amino acid sequence con-
servation within the helicase core of DEAD/H-box
proteins, this region may not contribute directly to the
substrate specificity of the enzyme. In contrast to the
helicase core, the N- and C-terminal flanking regions are
usually unique, with the exception of certain identifiable
sequence features. These regions have been shown to
provide substantial substrate specificity through their
interaction with RNAs or with protein partners that
modulate the activity and/or the specificity of the
helicase (1,10).
Genetic studies in yeast have demonstrated that DEAD/
H-box proteins perform highly specific tasks in vivo. In
most cases, they are required at a specific stage of RNA
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processing and most of them are highly specific for their
substrates. As revealed by the lethality of null mutants in
yeast, most DEAD/H-box proteins are essential, suggest-
ing tight target specificity for each protein (10,11).
However, with the exception of DbpA and related
proteins (12,13) and to a lesser extent Prp5 (14,15),
DEAD/H-box proteins show little or even no RNA spe-
cificity when analysed in vitro (8). This apparent
non-discrimination of target RNA by in vitro analysis
may be due to the absence of essential co-factors that
would direct the helicase to its physiological RNA sub-
strate or, more likely, due to the use of biologically
non-relevant RNA substrates. It is, therefore, a prerequis-
ite to identify the naturally occurring substrates of RNA
helicases in order to characterize them in an in vitro
context.
Unlike most of the RNA helicases that have been
investigated biochemically, the human DEAH-box
protein RHAU (alias DHX36 or G4R1) exhibits a
unique ATP-dependent guanine-quadruplex (G4)
resolvase activity with a high affinity and specificity for
its substrate in vitro (16,17). G4–nucleic acid structures
result from the propensity of guanine-rich sequences of
DNA and RNA to form atypical and thermodynamically
stable four-stranded helical structures under physiological
conditions [for review see (18,19)]. Formation of G4 struc-
tures in vivo is related to impairment of cellular DNA
replication, transcription or translation initiation (20).
G4 structures have also been shown to play a role in im-
munoglobulin gene rearrangement, promoter activation
and telomere maintenance (19). Owing to their
high-thermodynamic stability, resolution of G4 structures
in vivo requires specialized enzymes (21). RHAU binds
G4-RNA with sub-nanomolar affinity (16) and unwinds
G4 structures much more efficiently than double-stranded
nucleic acid [(17) and Tran, H., unpublished data].
Consistent with these biochemical observations, RHAU
was also identified as the major source of tetramolecular
RNA-resolving activity in HeLa cell lysates (16). Despite
these advances, we still lack a corresponding understand-
ing of the mechanism by which RHAU recognizes its
substrate.
Structurally, RHAU consists of a 400-amino acid
helicase core comprising all signature motifs of the
DEAH-box family of helicases (Figure 1A). The core
region is flanked by N- and C-terminal regions of 200
and 400 amino acid, respectively. Previous work showed
that RHAU associates with mRNAs and re-localizes to
stress granules (SGs) upon translational arrest induced
by various environmental stresses (22). Deletion analysis
of the N-terminal region of RHAU revealed that a region
of the first 105 amino acid was critical for RNA binding
and re-localization of RHAU to SGs. Importantly, this
105 amino acid-long region alone had the ability in vivo
to bind RNA and re-localize to SGs. The apparent signifi-
cance of the first 105 amino acid for RHAU interaction
with RNA prompted us to determine whether the
N-terminal domain of RHAU also contributes to the rec-
ognition of G4 structures in vitro. To address this
question, a series of N-terminal deletion mutants of
RHAU was generated as shown in Figure 1A. Through
biochemical analysis of these mutants, we have uncovered
the functional importance of the first 105 amino acids of
RHAU for interaction with G4 structures and further
revealed among this region that the previously identified
RSM (RHAU-specific motif, amino acids 54–66) domain
(22) is essential to the high affinity for G4 structures
shown by RHAU. Here, we show that the N-terminal
region of RHAU alone can bind to G4-RNA structures,
albeit with lower affinity than the full-length protein. We
also show that the G4-resolving activity of RHAU is
conserved in higher eukaryotes, insofar as CG9323, the
Drosophila orthologue of RHAU, readily unwinds G4
structures in the presence of ATP. Finally, we show that
a variant form of CG9323 harbouring mutations in the
RSM domain manifests reduced G4-binding activity, sug-
gesting that RSM functions similarly in Drosophila and
human RHAU proteins.
MATERIALS AND METHODS
Plasmid constructs, cloning and mutagenesis
The plasmid used for the expression of GST-RHAU(1–
200) protein in bacteria and the baculoviral expression
vector used for the expression of GST-RHAU have been
described previously (22,23). Plasmids for the expression of
C-terminal FLAG-tagged recombinant RHAU proteins:
RHAU-FLAG, RHAU(Gly)-FLAG, RHAU(Gly–
RSM)-FLAG, RHAU(DAIH)-FLAG and RHAU(1–
105)-FLAG have been described previously (22). CG9323
cDNA was obtained from the Drosophila Genomics
Resource Center (Bloomington, IN, USA) and was
sub-cloned by PCR amplification into
pIRES.EGFP-FLAG-N1 (22). For the RHAU(RSM)-
FLAG plasmid, the RSM (amino acid 54–66) excision
was performed using a standard overlapping PCR
method (24,25) The resulting PCR product was sub-cloned
into pIRES.EGFP-FLAG-N1. For RHAU(RSM-mutx)-
FLAG and CG9323(RSM-mut), the RSM-coding
sequence was mutagenized using a variation of the classical
QuickChange (Stratagene) site-directed mutagenesis PCR
method (26). Construction of all these plasmids was con-
firmed by sequencing. Sequences of oligonucleotides used
in this work and detailed descriptions of the plasmid con-
structions are available upon request.
Cell culture
Human embryonic kidney HEK293T cells were main-
tained in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal calf serum (FCS) and 2mM
L-glutamine at 37C in a humidified 5% CO2 incubator.
Spodoptera frugiperda Sf9 cells were maintained in Grace’s
insect cells medium (Invitrogen) supplemented with 10%
FCS, 4.11mM L-glutamine, 3.33 g l1 lactalbumin hydrol-
ysate and 3.33 g l1 yeastolate at 27C.
Expression and purification of recombinant RHAU
proteins
GST-RHAU(1–200) protein was expressed in Escherichia
coli strain BL21-CodonPlus (DE3)-RIPL (Stratagene).
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Cultures were inoculated from a single colony of freshly
transformed cells and maintained in logarithmic growth at
37C in 2 YT medium supplemented with ampicillin
(0.1mgml1) to a final volume of 1 l. When the OD600
reached 0.3, the temperature was adjusted to 25C and
cells were cultured to an OD600 of 0.6. Isopropyl b-D-
thiogalactopyranoside was added to 0.4mM and the
cultures were incubated for 12 h at 25C with constant
shaking. Cells were harvested by centrifugation and the
pellets stored at 80C. All subsequent operations were
performed at 4C. The cell pellets were resuspended in
50ml of lysis buffer [1 PBS supplemented with NaCl
to a final concentration of 300mM, 1% Triton X-100,
5mM EDTA, 5mM DTT, 1 protease inhibitor
cocktail (Complete EDTA-free, Roche)]. Lysozyme was
added to 1mgml1 and the suspensions were lysed for
30min, followed by sonication (3 10 s) to reduce viscos-
ity. Insoluble material was removed by centrifugation
(39 000g, 30min, 4C) in a Beckman JA-17 rotor and the
resulting supernatant was filtered through a 0.22-mm
Express PLUS Membrane (Millipore). The resulting
filtrate was applied to an 1-ml GSTrap 4B column (GE
Healthcare). The column was washed with 30ml washing
buffer (1 PBS supplemented with NaCl to a final con-
centration of 300mM, 5mM DTT) and the recombinant
protein was recovered in elution buffer [50mM Tris–HCl
(pH 8.0 at 4C), 10mM reduced glutathione, 5mM
DTT)]. The fraction containing the recombinant protein
were pooled and elution buffer was exchanged to storage
buffer [20mM HEPES-KOH (pH 7.7 at room tempera-
ture), 50mM KCl, 0.01% Nonidet P-40, 0.5mM EDTA,
5mM DTT, 10% glycerol, 2mM AEBSF] by repeated
concentration and dilution steps in Amicon Ultra-15 cen-
trifugal filters (Millipore). Recombinant proteins were
stored at 80C. Purity of protein preparations was
assessed by SDS–PAGE and protein concentrations were
determined photometrically at 280 nm using the calculated
extinction coefficient "=71905M1 cm1.
GST-RHAU protein was expressed in Sf9 cells accord-
ing to the supplier’s instructions (PharMingen). Three
days post-baculoviral infection, cells were harvested by
centrifugation and the pellets were stored at 80C. All
subsequent operations were performed at 4C. The cell
pellets were resuspended in insect cell lysis buffer
[10mM Tris–HCl (pH 7.5 at 4C), 10mM sodium phos-
phate, 300mM NaCl, 1% Triton X-100, 10mM sodium
pyrophosphate, 10% glycerol, 5mM EDTA, 5mM DTT,
1 protease inhibitor cocktail (Complete EDTA-free,
Roche)] and lysed for 30min. All subsequent purification
steps were carried out as described above for the purifica-
tion of GST-RHAU(1–200) protein. Purity of protein
preparations was assessed by SDS–PAGE and protein
concentrations were determined photometrically at
280 nm using the calculated extinction coefficient
"=166 615M1 cm1.
All FLAG-tagged recombinant RHAU and CG9323
proteins [RHAU-FLAG, RHAU(Gly)-FLAG,
RHAU(Gly–RSM)-FLAG, RHAU(RSM)-FLAG,
RHAU(RSM-mutx)-FLAG, RHAU(DAIH)-FLAG,
RHAU(1–105)-FLAG, CG9323-FLAG and
CG9323(RSM-mut2)-FLAG] were transiently expressed
in HEK293T. Transfections were performed with
Lipofectamine 2000 (Invitrogen) according to the manu-
facturer’s instructions. Cells were harvested 24–36 h
post-transfection, washed with ice-cold PBS and resus-
pended in lysis buffer [1 PBS supplemented with NaCl
to a final concentration of 600mM, 1% Nonidet P-40,
2mM EDTA, 2mM AEBSF (4-(2-aminoethyl)-
benzenesulphonyl fluoride hydrochloride), 1 protease in-
hibitor cocktail (Complete EDTA-free, Roche) for 30min.
Cell lysates were sonicated (1 10 s) to reduce the viscosity
and insoluble material removed by centrifugation
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Figure 1. N-terminal deletion mutants of RHAU. (A) Schematic representation of the 1008 amino acid RHAU protein and its N-terminal truncated
mutants. The conserved ATPase/helicase motifs I–VI of the DEAD/H-box family are indicated within the helicase core region (HCR) by vertical
bars. The HCR is flanked by N-terminal (NTR) and C-terminal (CTR) regions of 203 and 393 amino acid, respectively. The N-terminal Gly-rich
(amino acid 10–51) and RSM (RHAU-specific motif, amino acids 54–66) domains are indicated. WT, amino acids 1–1008; Gly, amino acids
50–1008; Gly–RSM, amino acids 105–1008; RSM, RHAU harbouring a deletion of amino acids 54–66; RSM-mut, RHAU with mutagenized
RSM (for details about amino acid substitutions, see Figure 6A); 1–105, amino acids 1–105; DAIH, D335A ATPase deficient mutant. (B) SDS–
PAGE separation and Coomassie staining of purified FLAG-tagged recombinant wild-type (WT) and mutant RHAU proteins (2 mg protein per
lane). The positions and sizes (kDa) of marker proteins are indicated at the left. The filled and open arrows on the right indicate the positions of the
purified proteins.
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(39 000g, 20min, 4�C) in a Beckman JA-17 rotor.
The soluble lysates were mixed for 5 h with 200 ml of a
50% slurry of anti-FLAG M2-agarose affinity gel
(Sigma) that had been equilibrated in lysis buffer. The
resin was recovered by centrifugation, washed 3� with
1ml of lysis buffer follow by three washes with 1ml of
IP-washing buffer [50mM Tris–HCl (pH 7.5), 300mM
NaCl, 0.1% Nonidet P-40, 5mM EDTA]. The bound
proteins were eluted with 600 ml elution solution
[0.1mgml�1 FLAG peptide, 10mM Tris–HCl (pH 7.5),
150mM NaCl] for 10min at 37�C and stored at �20�C.
Purity of protein preparations was assessed by SDS–
PAGE and protein concentrations were determined by
Bradford assay with BSA as the standard.
Tetraplex G4-RNA preparation
Unlabelled and 50-TAMRA-labelled 35-mer oligoribonu-
cleotides 50-A15–G5–A15-30 were used to form
tetramolecular G4-RNA and are referred to hereafter as
‘rAGA’. rAGA were purchased from Dharmacon
Research and were dissolved in RNase-free solution
[100mM KCl, 10mM Tris–HCl (pH 7.5), 1mM EDTA]
to a final concentration of 500 mM. To form
tetramolecular quadruplex by annealing of rAGA, the
solution was aliquoted into PCR tubes and incubated in
a PCR thermocycler at 98�C for 10min and then held at
80�C. EDTA was added immediately to a final concentra-
tion of 25mM and the solution was allowed to cool slowly
to room temperature. rAGA aliquots were pooled
together and stored at 4�C for 2–3 days. By this proced-
ure, the conversion of monomeric rAGA to a stable
tetramolecular quadruplex form was almost complete as
judged by native PAGE (Supplementary Figure S1A and
C). Circular dichroism (CD) analysis of the purified,
annealed rAGA oligomers revealed a typical spectrum of
a parallel G4 structure with positive and negative peaks at
263 and 245 nm, respectively (Supplementary Figure S1B).
The above prepared tetramolecular G4-rAGA were stored
at �20�C.
CD spectropolarimetry
CD experiments were performed with an AVIVModel 202
spectrophotometer equipped with a thermoelectrically
controlled cell holder. G4-rAGA at a concentration of
1 mM were prepared in RNase-free solution [10mM
Tris–HCl (pH 7.5), 1mM EDTA] supplemented with
50mM KCl, NaCl or LiCl. Quartz cells with 1 cm path
length were used for all experiments. CD spectra were
recorded at 25�C in the UV region (200–350 nm) with
1 nm increments and an averaging time of 2 s.
Thermodynamic analysis of the stability of tetramolecular
G4-rAGA structures
Preformed 50-TAMRA-labelled tetramolecular G4-rAGA
at a concentration of 100 nM were prepared in RNase-free
solution [10mM Tris–HCl (pH 7.5), 1mM EDTA) sup-
plemented with 50mM KCl, NaCl or LiCl.
Tetramolecular G4-rAGA structures were incubated for
5min at various temperatures ranging from 20�C to
99�C and were immediately subjected to separation by
electrophoresis for 3 h on a pre-electrophoresed 10% poly-
acrylamide native gel (19:1 acrylamide:bis ratio) in 0.5�
TBE at 25�C. After electrophoresis, gels were scanned on
a Typhoon 9210 Imager (GE Healthcare) and analysed
with Multi Gauge software (Fuji). The fraction of
undenatured G4-rAGA was quantitated as the ratio of
the signal from the tetramolecular form to the sum
of the tetramolecular and the denatured ssRNA. The
apparent temperature of mid-transition (Tm) was
determined by representing the fraction of undenatured
G4-rAGA as a function of the temperature. Reported
Tm values are representative of three independent
experiments.
Electromobility shift assay and apparent Kd determination
Recombinant RHAU proteins at concentrations from 1 to
1000 nM were incubated with 100 pM 50-32P-labelled
G4-RNA in K-Res buffer [50mM Tris–acetate (pH 7.8),
100mM KCl, 10mM NaCl, 3mMMgCl2, 70mM glycine,
10% glycerol], supplemented with 10mM EDTA and
0.2U ml�1 SUPERase-In (Ambion) in a 15-ml reaction.
The reactions were incubated at 37�C for 30min. RNA–
protein complexes were resolved on a pre-electrophoresed
6% polyacrylamide native gel (37.5:1 acrylamide:bis ratio)
in 0.5� TBE at 4�C for 90min. After electrophoresis, gels
were fixed for 1 h in 10% isopropanol/7% acetic acid.
RNA–protein complexes were detected by
Phosphor-Imaging, scanned on a Typhoon 9400 Imager
(GE Healthcare) and analysed with ImageQuant TL
software (Nonlinear Dynamics).
G4-RNA resolvase assay
Recombinant RHAU proteins at concentrations from 1 to
100 nM were incubated with 4 nM 50-32P-labelled
G4-RNA in K-Res buffer supplemented with 1mM ATP
and 0.2U ml�1 SUPERase-In in a 15-ml reaction.
Reactions were allowed to proceed at 30�C for 30min,
stopped by transfer to ice and addition of 1:10 volume
of 10� loading buffer [33mM Tris–HCl (pH 8.0), 25%
(w/v) Ficoll-400, 110mM EDTA, 0.17% SDS]. Reaction
products were resolved on a pre-electrophoresed 10%
polyacrylamide native gel (19:1 acrylamide:bis ratio) in
0.5� TBE at 4�C for 90min. After electrophoresis, gels
were fixed for 1 h in 10% isopropanol/7% acetic acid and
exposed to a Phosphor-Imaging screen.
ATPase assay
Recombinant RHAU proteins at concentrations from 25
to 200 nM were incubated with 1 ml [g-32P]ATP (3000Ci
mmol�1, 0.4mCi ml�1) in ATPase assay buffer [50mM
Tris–HCl (pH8.0), 100mM KCl, 3mM MgCl2, 1mM
ATP, 1mM DTT] supplemented with 0.4U ml�1 RNasin
(Promega) and 1 mg ml�1 homopolymeric poly(U) RNA
(Sigma) in a 20-ml reaction. Reactions were allowed to
proceed at 37�C for 15min. The reactions were stopped
by addition of 1ml of a 5% (w/v) suspension of activated
charcoal (Sigma) in 20mM phosphoric acid. The samples
were incubated on ice for 10min and the charcoal contain-
ing the adsorbed unhydrolysed ATP was pelleted by cen-
trifugation (21 000g, 15min, 4�C). The supernatants
6222 Nucleic Acids Research, 2010, Vol. 38, No. 18
 by guest on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Publications	 165
(containing free g-32Pi) were transferred to new tubes and
the radioactivity was quantified by liquid scintillation
counting (Cerenkov counts).
RESULTS
The first 105 amino acids of RHAU are required for
binding and resolving G4 structures
We demonstrated previously in vivo and in vitro that
amino acids 1–105 of RHAU delineate a functional
domain of prime importance for the interaction of
RHAU with RNA (22). To assess the significance of this
region for the G4-resolvase activity of RHAU, we con-
structed a series of FLAG-tagged N-terminal truncated
mutants of RHAU (Figure 1A). These truncated forms
were expressed in HEK293T cells and purified from
soluble lysates by anti-FLAG immunoaffinity chromatog-
raphy. The purity of these preparations as judged by
Coomassie staining after SDS–PAGE was very similar
(Figure 1B). To test whether the truncated form of
RHAU lacking the first 105 amino acids [RHAU(Gly–
RSM)] could resolve G4 structures, RHAU protein was
incubated with 32P-labelled tetramolecular rAGA and
ATP. The products were analysed by native PAGE after
disruption of RNA–protein interactions by addition of
SDS. The free single-stranded 32P-labelled oligos
migrated faster than the quadruplex substrate. As shown
previously, wild-type (WT) RHAU efficiently resolved G4
structures into single-stranded oligos (Figure 2A). The
labelled product of the resolvase reaction co-migrated
during electrophoresis with the single-stranded species
released by thermal denaturation of the substrate and
was proportional to the level of input protein. In
contrast to RHAU(WT), RHAU(Gly–RSM) failed to
resolve the G4 substrate, suggesting that the N-terminal
region of RHAU is essential for its G4-resolvase activity.
Being critical for the enzymatic activity and containing
an atypical RNA-binding domain (22), the N-terminal
region of RHAU is most likely to play a role in substrate
recognition. Therefore, we examined whether this
N-terminal region was also essential for the recognition
of G4 structures. To address this question, we performed
RNA electromobility shift assays (REMSA) using G4 sub-
strate as the ligand. RHAU protein was incubated with
32P-labelled G4 in the absence of ATP (to prevent G4
resolution) and the mixtures were analysed by native
PAGE. In the absence of protein, the 32P-labelled G4
structures migrated as a single species in the gel
(Figure 2B). Addition of increasing amounts of
RHAU(WT) protein resulted in the appearance of a
protein–G4 complex with reduced mobility. The bound
complexes appeared as two main band regions in the gel
that might reflect multiple forms of the complexes. In
contrast, the RHAU(Gly–RSM) mutant protein failed
to form a stable complex with G4 structures. Taken
together, these results demonstrate that the N-terminal
region encompassing residues 1–105 of RHAU protein is
indispensable for both binding and the resolving of G4
structures by RHAU. These results are in agreement
with our previous report that the N-terminal region of
RHAU is critical for its RNA binding in vivo and its
relocalization to SGs (22).
The N-terminal region of RHAU binds but cannot alone
resolve G4 structures
In view of their uniqueness, the N-terminal regions of
DEAH-box proteins may have regulatory functions such
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Figure 2. G4-RNA unwinding and binding by N-terminal truncated RHAU proteins. (A) G4-RNA unwinding assay: radio-labelled tetramolecular
rAGA at a concentration of 4 nM was incubated in the presence of ATP without protein () or with increasing amounts (1, 3, 10 and 30 nM) of WT
RHAU or Gly–RSM mutant. The reaction products were resolved by native PAGE after disrupting RNA–protein interactions with SDS. An
autoradiogram of the gel is shown. The positions of the tetraplex substrate RNA (G4-RNA) and the unwound single-stranded product (ssRNA) are
denoted on the left. An aliquot of the tetraplex substrate that was heat-denatured (95C, 5min) and then quenched (T) serves as a marker for the
position of ssRNA. (B) G4-RNA binding assay: radio-labelled tetramolecular rAGA at a concentration of 100 pM was incubated without protein ()
or with increasing amounts (1, 3, 10 and 30 nM) of WT RHAU or Gly–RSM mutant in the absence of ATP. The reaction mixtures were analysed
by native PAGE. An autoradiogram of the gel is shown. The positions of the free tetramolecular RNA substrate and the protein–RNA complex are
indicated on the left.
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as sub-cellular localization and/or interaction with RNAs
or other proteins (1,10). With prima facie evidence that the
N-terminal region of RHAU is important for both
binding to and resolving G4 structures, we examined
whether this region has G4-binding activity. As shown
by REMSA, increasing amounts of RHAU(1–105)
protein formed proportionately slow-migrating complexes
with G4-RNA (Figure 3A). That the observed mobility
shift was due to binding of RHAU(1–105) protein was
confirmed by addition of anti-FLAG antibody to
binding reactions. As shown in Figure 3B, anti-FLAG
antibody caused a super shift of the protein–probe
complex but not of the free probe.
Given that some G4-binding proteins destabilize G4
structures in a non-catalytic fashion without requiring
ATP hydrolysis (27), we examined whether the
N-terminal region of RHAU may also destabilize G4
structures in a similar manner. However, as shown in
Figure 3C, binding of the N-terminal region to G4 struc-
tures is not sufficient to destabilize it. In agreement with
the observation that RHAU cannot resolve G4 structures
in the absence of ATP (17), this result demonstrates that
the N-terminal region alone lacks G4-destabilizing activity
and that the G4-resolving activity is likely a property of
the central catalytically active core domain.
The helicase core domain, together with the N-terminal
region, contributes to tight G4 binding of RHAU
Considering that RHAU has a high affinity for G4 struc-
tures (16), we next examined whether the N-terminal
region itself accounts for the high affinity for G4 struc-
tures of the whole protein. N-terminal region [RHAU(1–
200)] and full-length RHAU(WT) were expressed as GST
fusion proteins in bacteria and Sf9 insect cells, respective-
ly, and purified to homogeneity as shown in
Supplementary Figure S2. Their apparent dissociation
constants (Kd) for G4 structures were determined by
REMSA. Titration of RHAU(WT) and RHAU(1–200)
proteins gave half-saturation points for G4 binding of
14 nM and 440 nM, respectively (Figure 4A and B). This
30-fold difference between the two proteins indicates that
the N-terminal region does not constitute by itself an
independent and high-affinity G4-RNA binding domain.
We propose that the helicase core domain provides
RHAU with substantial additional binding activity
through interactions with the RNA phosphate
backbone, as already shown for many DEAD/H-box
proteins (28–34). It should be mentioned that the
observed Kd value obtained here is higher than that pre-
viously reported (16), which may reflect the difference of
the type and location of tags attached to RHAU (N-GST
versus C-His6) and of the way how proteins were purified.
The RSM domain, but not the Gly-rich sequence, in the
N-terminal region is crucial for the recognition and
resolution of G4 structures by RHAU
The functional N-terminal region encompassing residues
1–105 of RHAU protein consists of two abutting domains
(Figure 1A): a 41 amino acid-long low-complexity
Gly-rich domain followed by the evolutionary conserved
13 amino acid-long RSM (amino acids 54–66). We
demonstrated previously in vivo that deletion of the
Gly-rich region [RHAU(Gly)] significantly impinged
on the relocalization of the protein to SGs and on its as-
sociation with RNA (22). To characterize the individual
contributions of each of the two domains to the
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B
Figure 3. G4-RNA binding and resolving activities of the N-terminal
domain of RHAU. (A) Gel mobility shift assay for G4-RNA binding:
radio-labelled tetramolecular rAGA at a concentration of 100 pM was
incubated without protein () or with increasing amounts (30, 100, 300
and 1000 nM) of RHAU(1–105) in the absence of ATP. The reaction
mixtures were analysed by native PAGE. An autoradiogram of the gel
is shown. (B) Super shift of G4-RNA-binding complex by a specific
antibody: radio-labelled tetramolecular rAGA at a concentration of
100 pM was incubated with RHAU(1–105) at 300 nM in the presence
or absence of anti-FLAG antibodies (2.5 mg per lane), as indicated. The
reaction mixtures were electrophoresed on a native gel. An autoradio-
gram of the gel is shown. The positions of the free tetramolecular RNA
substrate, the protein–RNA complex and the super-shifted complex are
indicated on the left. (C) G4-RNA unwinding assay: radio-labelled
tetramolecular rAGA at a concentration of 4 nM was incubated in
the presence of ATP without protein () or with increasing amounts
(1, 3, 10 and 30 nM) of WT RHAU or Gly–RSM mutant (30, 100,
300 and 1000 nM). The reaction products were resolved by native
PAGE after disrupting of RNA–protein interactions with SDS. An
autoradiogram of the gel is shown. An aliquot of the tetraplex substrate
that was heat-denatured (95C, 5min) and then quenched (T) serves
as a marker for the position of ssRNA.
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interaction of RHAU with G4 structures, we performed
REMSA experiments using corresponding deletion
mutants (Figure 5A). As already shown in Figure 2B,
RHAU(Gly–RSM) lacking the first 105 amino acids
failed to form a stable complex with G4 structures. In
contrast, RHAU(Gly) still harbouring the RSM was
able to bind to G4 structures with the same efficiency as
RHAU(WT). Contrary to the deletion of the Gly-rich
sequence, a RHAU mutant with an RSM deletion
[RHAU(RSM)] abrogated the interaction with G4 struc-
tures. We further assessed the consequence of loss of G4
recognition on the in vitro resolvase activity of RHAU
(Figure 5B). As expected, RHAU(RSM), like
RHAU(Gly–RSM), failed to resolve G4 structures,
while RHAU(Gly), like RHAU(WT), did. Similar
results with strict RSM-dependency could also be
reproduced with other G4-RNA structures (data not
shown). Together, these results indicate that the presence
of the RSM but not further sequences of the N-terminal
region is a prerequisite for the recognition and the reso-
lution of G4 structures by RHAU in vitro.
Conserved residues within the RSM domain are essential
for the recognition of G4 structures by RHAU
Multiple-sequence alignments of RHAU orthologues of
various species from choanoflagelates to humans
unveiled a highly conserved cluster of 13 amino acids
presenting the RSM domain embedded in a moderately
conserved region of about 50 amino acids (amino acids
54–100) (Figure 6A). In contrast, the rest of the
N-terminus surrounding this region is poorly conserved.
The RSM consensus sequence as determined from 40 dif-
ferent RHAU orthologue sequences is: P–p–x–L–z–G–
[+]–z–I–G––– [consensus RSM is listed according
to the Seefeld convention (37), symbol nomenclature
stands for: p (pi)= small side chain, z (zeta)=hydro-
philic, [+]=basic,  (Psi)=aliphatic,  (Omega)=
aromatic] (Supplementary Figure S3). The motif consists
of five invariant amino acids (Pro-54, Leu-57, Gly-59,
Ile-62 and Gly-63) and seven highly conserved residues
of similar biochemical properties (p-55, z-58, [+]-60,
z-61, -64, -65, -66). In addition, computation-based
secondary structure prediction of the sequences used for
alignment suggested that RSM is partially structured,
sitting astride an unstructured loop (amino acids 54–59)
and an a-helix (amino acids 60–66) (Figure 6A;
Supplementary Figure S4). We further examined by
site-specific mutagenesis in vitro the contribution of
conserved amino acids within the RSM domain to the
recognition and resolution of G4 structures (Figure 6A).
To this end, conserved residues of the RSM
were substituted with alanines, prolines or glycines. We
focused on Pro-54, Gly-59 and Gly-63 because they may
provide the RSM with substantial structural rigidity
(Pro-54) or flexibility (Gly-59 and Gly-63). As shown in
Figure 6B, mutation of the five invariant residues of the
RSM (RSM-mut2) considerably reduced the binding
affinity of RHAU for G4-RNA, albeit to a lesser extent
than the RSM-deleted form of RHAU (RSM).
Interestingly, substitution of the invariant Gly-59 and
Gly-63 residues with prolines (RSM-mut6) caused a
stronger reduction of G4-binding activity than the
RHAU(RSM-mut2) in which these two amino acids are
mutated to alanines. Since prolines may induce a struc-
tural constraint on the RSM, this result suggests that rec-
ognition of G4 structures may depend on the
conformational organization of the RSM. Finally, as
observed with RHAU(RSM-mut1) and
RHAU(RSM-mut3) mutants, Pro-54 as well as the polar
residues Lys-58, Arg-60 and Glu-61 appear to be
dispensable.
As expected, RHAU proteins with mutated RSM and
displaying strong G4-RNA binding deficiency
(RSM-mut2 and 6) also had reduced G4-resolving
activity (Figure 6C). In contrast, despite the slight
reduction of G4-binding activity observed for
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Figure 4. G4-RNA-binding properties of RHAU and the N-terminal region. (A) Gel mobility shift assay for G4-RNA binding: radio-labelled
tetramolecular rAGA at a concentration of 100 pM was incubated without protein () or with increasing amounts of either GST-tagged
RHAU(WT) or RHAU(1–200) in the absence of ATP. The reaction mixtures were analysed by native PAGE. An autoradiogram of the gel is
shown. At concentrations from 10 to 1000 nM, GST protein alone had no effect on G4-RNA mobility (data not shown). (B) Quantification of gel
mobility shift assays for WT RHAU (WT, filled circle) and RHAU N-terminal region (1–200, open circle) binding to tetramolecular rAGA. The data
represent means ± SEM from three independent experiments.
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RHAU(RSM-mut1) and RHAU(RSM-mut3), these two
mutants unwound G4 structures with an efficiency com-
parable to WT RHAU. We concluded from these in vitro
mutagenesis experiments that the highly conserved
residues in the RSM domain are essential for RHAU
G4-structure binding and resolving activities.
ATPase activity of RHAU N-terminal truncated mutants
Hitherto, it could not be excluded that the introduced mu-
tations caused significant conformational changes in the
helicase core domain that resulted in enzymatically defect-
ive proteins. To define whether loss of G4-resolvase
activity was due to loss of G4 binding by the N-terminal
domain or to impairment of the basic activity of the
helicase core domain, we compared the ATPase activities
of RHAU mutants and WT RHAU. As shown previously
(23), RHAU exhibited significant ATPase activity in the
absence of nucleic acids, which was stimulated substantial-
ly by the presence of homopolymeric poly(U) (Figure 7A).
Both the RNA-dependent and -independent ATPase
activities were proportional to the amount of input
RHAU protein. To exclude the possibility that the
RNA-independent ATPase activity observed was due to
contaminants derived from HEK293T cells, we
substituted the Glu-335 residue with Ala within the
Walker B site (DEIH ! DAIH), which abolishes
RHAU ATPase activity (23). RHAU(DAIH) protein
was prepared according to the protocol employed for
WT RHAU protein, with comparable yield and purity
(data not shown). In contrast to WT RHAU,
RHAU(DAIH) showed no ATPase activity, even in the
presence of poly(U) (Figure 7B). Thus, we concluded that
RHAU harbours intrinsic RNA-independent ATPase
activity, which can be further stimulated by
homopolymeric RNA.
To clarify the biochemical basis of the absence of
G4-resolvase activity in the RHAU(RSM) mutant, we
measured the rate of ATP hydrolysis by this mutant and
compared it to that of the WT RHAU and the
RHAU(Gly) mutant that was still proficient in G4 un-
winding. In the absence of RNA co-factor, the ATPase
activity of RHAU(RSM) protein was the same as
RHAU(WT) and RHAU(Gly) proteins (Figure 7C),
suggesting that the deletion of the Gly-rich (Gly) or
the RSM (RSM) domains does not affect the basal
ATPase activity of RHAU. However, the extent of
poly(U)-dependent stimulation of ATPase activity of
RHAU(RSM) was �60% of that of RHAU(WT) and
similar to that of RHAU(Gly). Taken together, these
results indicate that deletion of the N-terminal region of
RHAU does not cause any significant conformational
changes to the helicase core, but renders the RHAU
protein less responsive to RNA in the stimulation of its
ATPase activity. Given that RHAU(RSM) retained sig-
nificant RNA-dependent ATPase activity, equivalent to
the G4-resolvase proficient RHAU(Gly) mutant, we
concluded that the lack of G4-resolving activity in the
RHAU(RSM) mutant resulted from the loss of G4
binding by the N-terminal domain.
CG9323, the Drosophila ortholog of RHAU efficiently
unwinds G4-RNA
Based on sequence analysis, RHAU has clear orthologs in
almost all species of the animal kingdom ranging from
choanoflagellates to humans. A multiple sequence align-
ment between eight of these orthologs showed the helicase
core (amino acids 204–615) together with the C-terminal
region (amino acids 616–1008) of RHAU to be evolution-
ary conserved (Figure 8A). In contrast, sequences of the
N-terminal region (amino acid 1–203) show little
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B
Figure 5. G4-RNA binding and unwinding by Gly-rich and
RSM-truncated RHAU proteins. (A) Gel mobility shift assay for
G4-RNA binding: radio-labelled tetramolecular rAGA at a concentra-
tion of 100 pM was incubated without protein (�) or with increasing
amounts (6, 20 and 60 nM) of either WT RHAU, or Gly, Gly–RSM
or RSM RHAU mutants in the absence of ATP. The reaction
mixtures were analysed by native PAGE. An autoradiogram of the
gel is shown. (B) G4-RNA unwinding assay: radio-labelled
tetramolecular rAGA at a concentration of 4 nM was incubated in
the presence of ATP without protein (�) or with increasing amounts
(6, 20 and 60 nM) of either WT RHAU, or Gly, Gly–RSM or
RSM RHAU mutants. The reaction products were resolved by
native PAGE after disrupting of RNA–protein interactions with SDS.
An autoradiogram of the gel is shown. An aliquot of the tetraplex
substrate that was heat denatured (95�C, 5min) and then quenched
(T) serves as a marker for the position of ssRNA.
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Figure 6. G4-RNA binding and unwinding by RSM-mutated forms of RHAU. (A) Conservation of the RSM among RHAU orthologues through-
out evolution. Multiple sequence alignment was carried out with MAFFT (version 6) (35). Similarity analysis was made by GeneDoc (version 2.7)
using the BLOSUM62 scoring matrix. Similarity is shown in red for 100%, yellow for 99–80% and blue for 79–60%. Amino acids that are identical
between the nine sequences are indicated by asterisks below the alignment. Secondary structure prediction was performed by JPRED (36) and is
indicated on the top. The RSM and its consensus sequence derived from 40 different RHAU orthologues are shown below the alignment [p (pi) =
small side chain, z (zeta) = hydrophilic, [+] = basic,  (Psi) = aliphatic,  (Omega) = aromatic]. The site-directed substitutions of the RSM
mutants employed in this study are listed with the amino acid changes indicated underneath. Species and accession numbers of RHAU orthologues
listed are: human (Homo sapiens, NP_065916), mouse (Mus musculus, NP_082412), chicken (Gallus gallus, XP_422834), frog (Xenopus tropicalis,
ENSXETP00000016958), zebrafish (Danio rerio, NP_001122016), fruit fly (Drosophila melanogaster, NP_610056), blood fluke (Schistosoma mansoni,
XP_002577014), placozoan (Trichoplax adhaerens, XP_002110272), choanoflagellate (Monosiga brevicollis, XP_001747335). (B) Gel mobility shift
assay for G4-RNA binding: radio-labelled tetramolecular rAGA at a concentration of 100 pM was incubated without protein () or with increasing
amounts (6, 20 and 60 nM) of either WT RHAU or the indicated RSM mutants in the absence of ATP. The reaction mixtures were analysed by
native PAGE. An autoradiogram of the gel is shown. (C) G4-RNA unwinding assay: radio-labelled tetramolecular rAGA at a concentration of 4 nM
was incubated in the presence of ATP without protein () or with increasing amounts (6, 20 and 60 nM) of either WT RHAU or the indicated RSM
mutants. The reaction products were resolved by native PAGE after disrupting RNA–protein interactions with SDS. An autoradiogram of the gel is
shown. An aliquot of the duplex substrate that was heat denatured (95C, 5min) and then quenched (T) serves as a marker for the position of
ssRNA.
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similarity with the exception of the highly conserved RSM
(amino acids 54–66) and its surrounding region (amino
acids 54–100). Considering the apparent importance of
the RSM in the recognition of G4 structures and the
high conservation of its sequence together with the rest
of RHAU protein, we surmised that the G4-binding and
resolving activity of the RHAU protein are conserved
among higher eukaryotes. To validate this hypothesis,
we cloned and characterized CG9323, the Drosophila
ortholog of RHAU.
CG9323 is a 942 amino acid-long protein, which like
RHAU comprises all the typical signature motifs of the
DEAH-box family of RNA helicases (Figure 8B;
Supplementary Figure S5). The overall identity and simi-
larity between CG9323 and RHAU are 34% and 52%,
respectively, but not evenly distributed along the entire
sequence. Sequence homology with RHAU is particularly
high (41% identity and 60% similarity) for the helicase
core and the C-terminal regions of CG9323.
Nevertheless, apart from the conserved RSM, the
CG9323 N-terminal region lacks evident sequence
homology with RHAU. In addition, the CG9323
N-terminal region is 25% shorter than that of RHAU,
mainly due to the absence of the Gly-rich sequence
upstream of the RSM.
To check whether the Drosophila ortholog of RHAU
retains G4 binding and resolving activities, CG9323 was
expressed as a FLAG-tagged recombinant protein and
immunopurified to homogeneity as shown in
Supplementary Figure S6. The ability of purified recom-
binant CG9323 protein to unwind and to bind G4 struc-
tures was assessed under the conditions previously
employed for RHAU. As shown in Figure 9A, CG9323
efficiently unwound the G4-RNA substrate. As for
RHAU, the extent of products resolved by CG9323 was
proportional to the input protein. Furthermore, CG9323
failed to resolve G4 substrates in the presence of the
non-hydrolysable ATP analogue AMP-PNP, indicating
that G4 unwinding by CG9323 requires the hydrolysis of
nucleosides triphosphate.
Similar to RHAU, CG9323 also formed a stable
complex with G4 substrates in the absence of hydrolysable
rNTPs (Figure 9B). In binding experiments, CG9323
turned out to be more specific for G4-RNA relative to
ssRNAs, since CG9323 bound tetramolecular rAGA
with a 10-fold higher affinity than monomeric single-
stranded rAGA oligoribonucleotides of the same
sequence. This observation, by analogy, is consistent
with earlier observations that RHAU has poor
sequence-specific recognition of ssRNAs (16,23). Finally,
a variant form of CG9323, in which highly conserved
residues of the RSM were mutagenized, displayed
reduced G4-binding activity, suggesting that the RSM is
essential for the recognition of G4-structures by CG9323
(Figure 9C). In conclusion, these results provide
compelling evidence that the G4 binding and resolving
activities of RHAU have been conserved from
Drosophila to human, with the RSM playing a pivotal
role.
DISCUSSION
Owing to their bulky and thermodynamically stable
features, G4 structures have been shown in many
respects to impede normal nucleic acid metabolism (38–
45). To cope with this problem, proteins are produced that
mitigate effects of these atypical stable structures. Four
human helicases, including RHAU, have been shown so
far to harbour G4-resolving activity in vitro. These include
the RecQ family proteins BLM (46,47) and WRN (48), as
well as FANCJ (41), a Rad3-like helicase. The latter are
all DNA helicases that have been clearly implicated in the
maintenance of genome integrity (49–51). RHAU, on the
other hand, belongs to the DEAH-box family of RNA
helicases and has very little sequence similarity with the
above mentioned helicases. Curiously, RHAU was
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Figure 7. ATPase activity of WT RHAU and N-terminal mutants. (A) The extent of ATP hydrolysis by WT RHAU in the presence (open circle) or
absence (filled circle) of poly(U) plotted as a function of input RHAU. The ATPase activity is expressed as a function of the activity obtained with
WT RHAU at a concentration of 200 nM when poly(U) was omitted. (B) Influence of poly(U) on the ATPase activity of WT RHAU and DAIH
ATPase-deficient mutant (200 nM). The ATPase activity was represented relatively to that of WT RHAU in the absence of poly(U) that was set to 1.
(C) Influence of poly(U) on the ATPase activity of RHAU (WT) and Gly or RSM RHAU mutants (200 nM). The basal ATPase activity (without
nucleic acid co-factor) of WT RHAU is indicated (dashed line). The data represent the means ± SEM from three independent experiments.
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initially identified as a G4-DNA resolvase enzyme (17).
The possibility that G4-RNA structures are targets of
RHAU emerged from in vivo UV cross-linking results
showing RHAU binding mainly to RNA (22).
Subsequent characterization of RHAU demonstrated its
aptitude to resolve G4-RNA better than G4-DNA (16).
This finding was a remarkable breakthrough, since
RHAU was the first and still the only known helicase to
possess G4-RNA resolvase activity. Furthermore, RHAU
is one of the rare DEAD/H-box proteins that exhibit high
affinity and specificity for its substrate in vitro independent
of accessory proteins. Since this finding, efforts have been
made to understand the mechanism underlying recogni-
tion of G4-structures by RHAU. The present study
shows that the N-terminal region of RHAU is essential
and responsible for binding of RHAU to G4-structures.
Further investigations dissecting the N-terminal region,
coupled with site-directed mutagenesis, have
demonstrated that the RSM makes a decisive contribution
to the high affinity of RHAU for G4-structures. Sequence
comparisons of RHAU orthologs from various species
showed the RSM to be the unique highly conserved part
of the N-terminal region. Hence, we predicted that all
orthologs forms should possess G4-resolving activity
based on the functional significance and sequence conser-
vation of the RSM domain and the catalytic region. This
hypothesis was supported by the robust ATP-dependent
G4-RNA resolvase activity found for CG9323, the
Drosophila form of RHAU. As expected, and also
shown for RHAU, the binding of CG9323 to G4-RNAs
depended on RSM integrity, which further indicated
similar functions for this motif in both proteins.
Recognition of G4-RNA by RHAU depends on the
N-terminal RSM
RHAU shares with most helicases a global scheme of
modular architecture that combines a conserved central
helicase core domain with peripheral regions of various
lengths and sequences (52). Together with previous
findings (22,53–55), our results indicate that the helicase
core alone cannot account for the high specificity of
function usually attributed to DEAD/H-box proteins. In
this regard, these data also agree with numerous structural
observations that the HCR of DEAD-box proteins inter-
acts essentially in a non-sequence-specific manner with the
phosphoribose backbone of single-stranded nucleic acid
(28–32). Such contacts suffice to discriminate RNA from
DNA by means of the 20-hydroxyl groups of the ribose
moieties, but not to distinguish between sequences of
varying nucleotide composition. In the present work, we
have shown the importance of the unique N-terminal
flanking region in adapting the conserved catalytic core
to a specific function. The present investigation has also
shown clearly that, although necessary, ATPase activity
by itself is not sufficient for RHAU to unwind G4 struc-
tures. Our data strongly suggest that the establishment of
a stable complex between RHAU and its G4 substrate is a
prerequisite for the subsequent ATPase-dependent un-
winding of the G4 structure. We propose that the
N-terminal RSM endows the enzyme with specificity by
binding the G4 substrate, thereby positioning the helicase
core in close proximity to the substrate. Likewise, critical
roles for N- and C-terminal flanking regions have been
reported for several DEAD/H-box proteins, exerting
B
A
Figure 8. Amino acid conservation of the N-terminal region of RHAU. (A) Schematic representation of amino acid conservation of human RHAU
throughout evolution. The human RHAU sequence was aligned with eight RHAU orthologues (the sequences shown in Figure 6) by MAFFT
(version 6) (35). Each residue of RHAU is represented with a colour code that indicates its level of conservation amongst the eight orthologous
sequences. Similarity is shown in red for 100%, yellow for 99–80% and blue for 79–60%. Similarity analysis was made by GeneDoc (version 2.7)
using the BLOSUM62 scoring matrix. Average values of identity (Id) and similarity (Sim) for N-terminal (NTR), helicase core (HCR) and
C-terminal (CTR) regions are indicated. (B) Sequence alignment of the N-terminal region of RHAU with its Drosophila ortholog CG9323.
Amino acids that are identical or similar between the two sequences are shaded in black and grey, respectively. The RSM domain as well as
helicase motif I are indicated below the sequences. Gly residues of the Gly-rich domain (amino acid 10–51) of RHAU are bolded. N-terminal region
and a part of the helicase core domain are delineated with a coloured dashed line in red and blue, respectively. For complete alignment between
RHAU and CG9323, see Supplementary Figure S5.
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specific functions by interacting with particular RNA
species/structures or with other regulatory proteins
(53,56–58). For example, the prototypical yeast
DEAH-box proteins Prp16 and Prp22 and the human
ortholog HRH1 (alias DHX8 or hPrp22) have been
shown to associate with the spliceosome via their
non-conserved N-terminal regions (59–61). The
Drosophila maleless (MLE) protein, more closely related
to RHAU, harbours two copies of dsRNA-binding motifs
in its N-terminal region (62). Their deletion, as with the
N-terminal truncation of RHAU, caused the loss of RNA
binding and unwinding activities in vitro and subcellular
mis-localization of the protein in vivo (63). Together, these
examples emphasize the role of the peripheral domains of
DEAD/H-box proteins in adapting a common catalytic
core to a broad spectrum of specific functions.
Potential role of the RSM in RHAU re-localization
to SGs
The present work underscores the essential nature of the
conserved RSM, which endows RHAU with a high
affinity for G4 structures in vitro. Determining the mech-
anisms whereby RHAU resolve G4 substrates in vivo is an
important issue to be addressed in future. It is tempting to
draw a parallel between the present observation and a
previous report that the stress-induced recruitment of
RHAU to SGs is mediated by interactions of RHAU
with RNA (22). Similar to our observations, the region
identified as essential for this activity included the RSM
together with the upstream Gly-rich domain, underscoring
the functional relevance of the RSM and its surrounding
region for the biological activity of RHAU. The
N-terminal region of RHAU alone was also found to be
sufficient to drive RNA binding in vivo as well to
re-localize to SGs (22). This observation, however, con-
trasts with the data presented here in that, although
required for functional specificity, the N-terminal region
alone does not constitute an independent and high-affinity
G4-RNA-binding domain. In this regard, our data rather
suggest that both the N-terminal and HCRs are required
for the productive interaction of RHAU with G4 struc-
tures. Since the nucleic acid binding motifs Ia, Ib, IV and
V of DEAH-box proteins have been proposed to contact
RNA (33,34), we surmise that, for RHAU, the helicase
core may also provide the protein with substantial
binding activity by interacting in a non-specific manner
with the phosphoribose backbone of the single-stranded
tail flanking the tetramolecular G4 structure. Further in-
vestigations into the functional contribution of the
RNA-binding site of the helicase core are needed to
further challenge this hypothesis. In addition, our
previous finding that the ATPase-deficient form of
RHAU [RHAU(DAIH)] stalls in SGs (22) agrees with
the observation that, once bound to G4-RNA,
RHAU(DAIH) cannot dissociate itself from its substrate,
even in the presence of ATP (data not shown). This indi-
cates that the G4-unwinding reaction requires ATP
hydrolysis, rather than ATP binding per se, and further
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Figure 9. G4-RNA unwinding and binding by CG9323. (A) G4-RNA
unwinding assay: radio-labelled tetramolecular rAGA at a concentra-
tion of 4 nM was incubated in the presence of ATP or AMP-PNP
(as indicated) without protein () or with increasing amounts (2, 6,
20 and 60 nM) of purified recombinant CG9323 protein. The reaction
products were resolved by native PAGE after disrupting RNA–protein
interactions with SDS. An autoradiogram of the gel is shown. An
aliquot of the duplex substrate that was heat-denatured (95C, 5min)
and then quenched (T) serves as a marker for the position of ssRNA.
(B) G4- and ssRNA-binding assay: tetramolecular (left) or monomeric
(right) radio-labelled rAGA at a concentration of 100 pM were
incubated without protein () or with increasing amounts (10,
30 and 100 nM) of CG9323 in the absence of ATP. The reaction
mixtures were analysed by native PAGE. An autoradiogram of
the gel is shown. (C) G4-RNA-binding assay: radio-labelled
tetramolecular rAGA at a concentration of 100 pM was incubated
without protein () or with increasing amounts (3, 10 and 30 nM) of
WT or RSM-mut2 CG9323 proteins in the absence of ATP. The
reaction mixture were analysed by native PAGE. An autoradiogram
of the gel is shown.
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suggests that the release of the RNA substrate occurs only
after G4 unwinding. SGs may constitute a favourable en-
vironment for the formation of intermolecular G4-RNA
structures, as they are temporary sites of accumulation of
stress-induced stalled translation initiation RNP
complexes (64,65). However, an important question that
we have not yet addressed is whether RHAU relocalizes to
SGs upon binding to G4-RNA structures. Interestingly,
however, we noticed that RSM-mutated forms of
RHAU that are deficient for G4-structure recognition
in vitro, manifest reduced association with RNA in vivo
concomitantly with reduced relocalization to SGs
(Chalupnikova, K., unpublished data). Thus, this finding
raises the possibility that at least a fraction of RHAU is
recruited to SGs via interactions with G4 structures.
The mechanism by which RHAU recognizes G4 struc-
tures is an important issue that needed to be addressed to
improve our understanding of RHAU. So far, however,
little is known about its biological function as a potential
G4-resolvase enzyme. Recently, G4 structures in RNA
have attracted considerable attention as a plausible
means of regulating gene expression (42). Formation of
G4 structures in the 5 -untranslated region has been
shown to affect mRNA translation (43–45) and bioinfor-
matics studies have identified more than 50 000 potential
G4 structures near splicing and polyadenylation sites of
various human and mouse genes. This raises the possibil-
ity that G4 formation impedes RNA metabolism at many
different stages (66). At the moment, we lack a corres-
ponding understanding of how cells negotiate with G4
structures in various RNA molecules. However, from
the findings presented here, RHAU emerges as a
promising regulator of G4 structure-based RNA metabol-
ism and merits future investigation of its potential roles in
different biological contexts.
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ABSTRACT
Guanine-quadruplexes (G4) consist of non-canonical
four-stranded helical arrangements of guanine-rich
nucleic acid sequences. The bulky and thermo-
dynamically stable features of G4 structures have
been shown in many respects to affect normal
nucleic acid metabolism. conversion of G4
structures to single-stranded nucleic acid requires
specialized proteins with G4 destabilizing/unwind-
ing activity. RHAU is a human DEAH-box RNA
helicase that exhibits G4-RNA binding and resolving
activity. In this study, we employed RIP-chip
analysis to identify RNAs associated
with RHAU . Approximately 100 RNAs were
found to be associated with RHAU and bioinformat-
ics analysis revealed that the majority contained po-
tential G4-forming sequences. Among the most
abundant RNAs selectively enriched with RHAU,
we identified the human telomerase RNA template
TERC as a true target of RHAU. Remarkably, binding
of RHAU to TERC depended on the presence of a
stable G4 structure in the 5 -region of TERC, both
and . RHAU was further found to as-
sociate with the telomerase holoenzyme via the
5 -region of TERC. Collectively, these results provide
the first evidence that intramolecular G4-RNAs
serve as physiologically relevant targets for RHAU.
Furthermore, our results suggest the existence of
alternatively folded forms of TERC in the fully
assembled telomerase holoenzyme.
INTRODUCTION
DNA and RNA sequences containing tandem repeats of
guanine tracts can form G-quadruplex (G4) structures,
non-canonical and thermodynamically stable four-
stranded helical arrangements (1,2). The building block
of G4 structures is the G-quartet, a square-planar
assembly of four guanines held together by Hoogsteen
hydrogen bonding. G4 structures result from the consecu-
tive stacking of G-quartets and are further stabilized by
alkali metal ions such as Na+ or K+ that position along
the helix axis and coordinate the O6 keto oxygens of the
tetrad-forming guanines. G4 scaffolds are extremely poly-
morphic in the relative orientation of strands (parallel,
anti-parallel or mixed configurations), length, sequence
and conformation of the loops connecting the G-tracts.
In addition, G4 structures in vitro can result from the
assembly of one (intramolecular G4) or multiple (bi- or
tetramolecular-G4) nucleic acid strands.
Biochemical and biophysical studies have shown in vitro
that stable G4 structures can form spontaneously from
G-rich regions of single-stranded nucleic acid under near
physiological conditions. Genome-wide computational
surveys have identified more than 300 000 potential intra-
molecular G4-forming sequences in the human genome
(3,4) and revealed a higher prevalence of these sequences
in functional genomic regions such as telomeres, pro-
moters (5,6), untranslated regions [UTRs (7,8)] and first
introns (9). Taken together, these observations suggest that
G4 structures participate in regulating various nucleic acid
processes, such as telomere maintenance or the control of
gene expression. Nevertheless, because of the lack of evi-
dence that such structures really exist in vivo, G4 struc-
tures have often been considered as a structural curiosity
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without relevance for living organisms. There is now rea-
son to believe that G4 structures are not merely an in vitro
artefact, as several recent findings concur with their exist-
ence in cells. First, both a G4-specific dye and antibodies
raised against telomeric G4-DNA specifically stained telo-
meres in human and ciliate cells, respectively (10–12). In
addition, several potential G4-forming sequences in pro-
moters were shown to form intramolecular G4 structures
in vitro and to affect gene expression in vivo (13,14). A
possible contribution of G4 to regulating promoter activity
was indicated by impairment of the transcriptional activity
of several genes by G4-stabilizing ligands (14) or a single-
chain antibody specific for intramolecular G4-DNA (15),
in a manner correlating with the occurrence of predicted
G4 structures in the control regions (16).
Like DNA, RNA can also form G4 structures.
Although, to date, G4-RNAs have not attracted as
much attention as their DNA counterparts, the formation
of G4 structures in RNA is emerging as a plausible regu-
latory factor in gene expression. RNA is more prone than
DNA to form G4 structures due to its single-strandedness,
and G4-RNAs have also proved to be more stable than
their cognate G4-DNA under physiological conditions
(17–19). Bioinformatics analyses of human 50-UTR se-
quences revealed potential G4-forming motifs in as
many as 3000 different RNAs (7,20). Moreover, the for-
mation of G4 structures in 50-UTR was shown to impede
translation initiation (7,21–23). Given that potential G4
sequences have been identified near splicing and poly-
adenylation sites (24–26), G4 formation may also affect
RNA metabolism at several different stages. Furthermore,
formation of parallel G4-RNA structures has also been
reported in vitro for telomeric RNA repeats [TERRA,
(27–29)] and for the human telomerase template RNA
[TERC, (30)], suggesting that G4-RNA formation also
plays a part in regulatory processes at telomeres.
The discovery of proteins that positively or negatively
stabilize such G4 structures is further indirect evidence for
the existence of such structures in vivo. Among the many
proteins from various organisms that bind to G4-DNAs
in vitro (31), several helicases show ATP-dependent
G4-resolving activity (32–36) and have been clearly impli-
cated in the maintenance of genome integrity (37–40).
RHAU (alias DHX36 or G4R1), a member of the
human DEAH-box family of RNA helicases, exhibits
in vitro G4-RNA binding with high affinity for its sub-
strate, and unwinds G4 structures much more efficiently
than double-stranded nucleic acid (41,42). Consistent with
these biochemical observations, RHAU was also shown to
bind to mRNAs in vivo (43) and was identified as the main
source of tetramolecular G4-RNA-resolving activity in
HeLa cell lysates (42).
Although considerable information is available on the
enzymatic activity of RHAU in vitro, almost nothing is
known about its biological function as a G4-binding/
resolving enzyme in vivo. To address this question, we
sought RNAs bound by RHAU in living cells, surmising
that the identification of RHAU-bound RNAs and under-
standing the effects of RHAU should provide important
clues to its function in vivo. To this end, we employed
high-throughput gene array technologies to identify and
quantify the co-purified RNAs on a genome-wide scale.
With this screen, we identified about 100 RNAs significantly
enriched by RHAU. Computational analysis of RNA se-
quences for potential intramolecular G4 structures
revealed the preferential association of RHAU with tran-
scripts bearing G4-forming motifs, suggesting direct tar-
geting of G4-RNA by RHAU. Amongst the RNAs with
the potential to form G4 structures and selectively
enriched with RHAU, we identified TERC as a bona fide
target of RHAU. Characterization of the RHAU-TERC
interaction in vivo and in vitro showed binding of TERC
by RHAU to be strictly dependent on the formation of a
G4 structure on the 50-extremity of TERC RNA. Finally,
we have demonstrated that RHAU not only interacts with
TERC stricto sensu, but is also part of the fully assembled
telomerase complex through direct interaction with TERC
G4 structure. Taken together, these data demonstrate that
intramolecular G4-RNAs are naturally occurring sub-
strates of RHAU in vivo. Moreover, they provide
indirect but strong support for the existence of a
G4-RNA structure in the telomerase RNP.
MATERIALS AND METHODS
Plasmid constructs, cloning and mutagenesis
The baculoviral expression vector employed for the ex-
pression of GST-RHAU and the plasmids used for the
expression of the C-terminal FLAG-tagged recombinant
RHAU proteins RHAU-FLAG and RHAU(RSM)-
FLAG were previously described (43–45). The pIRES.
EGFP-myc-N1 vector expressing the C-terminal myc-
tagged recombinant RHAU protein was derived from
the previously described pIRES.EGFP-FLAG-N1/
RHAU expression vector (43) by substituting the FLAG
sequence with the myc epitope sequence. Human TERT
cDNA (clone: IOH36343, mapped sequence: NM_198253)
was obtained from ImaGenes GmbH (Berlin, Germany) and
subcloned by PCR amplification into the pSL1-FLAG-N1
mammalian expression vector. The pSL1-FLAG-N1 vector
was derived from pEGFP-N1 (Clontech) by replacing the
EGFP open reading frame with the FLAG epitope
sequence. The human TERC genomic region was PCR-
amplified from the genomic DNA of HEK293T cells to
yield a 2.1-kb fragment encompassing 1080bp of the TERC
promoter, its coding sequence, and 553bp of the 30 flanking
genomic region. This fragment was blunt-cloned into
pGEM-T Easy vector (Promega) at the HincII/EcoRV
sites. The G4 motif sequence of TERC was mutagen-
ized using a variation of the classical QuikChange
(Stratagene) site-directed mutagenesis PCR method (46).
To prepare templates for in vitro run-off transcription, the
T7 or SP6 phage promoters were inserted upstream of the
TERC coding sequence by PCR. The resulting PCR
products were cloned into the pSL1-FLAG-N1 vector at
the NheI/AgeI sites. Following linearization with NarI or
AgeI, in vitro transcription of these templates yielded
the TERC (1–71 nt) and full-length TERC (1–451 nt)
RNA fragments, respectively. Constructions of all these
plasmids were confirmed by sequencing. Sequences of
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oligonucleotides used in this work and detailed descrip-
tions of the plasmid constructs are available upon request.
Cell culture and transfection
Human cervical carcinoma HeLa and embryonic kidney
HEK293T cell lines were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal
calf serum (FCS) and 2mM L-glutamine at 37C in a
humidified 5% CO2 incubator. Transient transfections
were performed with Lipofectamine 2000 (Invitrogen) ac-
cording to the manufacturer’s instructions. Transfected
cells were cultured for 24–36 h prior to testing for trans-
gene expression.
RIP-chip assay
Cells were harvested 24–36 h post-transfection, washed
with ice-cold PBS and resuspended in lysis buffer
{1 PBS, 1%v·v1 Nonidet P-40, 2mM EDTA, 2mM
AEBSF [4-(2-aminoethyl)-benzenesulfonyl fluoride hydro-
chloride], 1 protease inhibitor cocktail (Complete EDTA-
free, Roche), 0.2U·ml1 RNasin Plus (Promega)} for
30min. All subsequent operations were performed at
4C. The lysates were cleared by centrifugation (21 000g,
15min) and mixed with 10 ml of a 50% slurry of anti-
FLAG M2-agarose affinity gel (Sigma) that had been
equilibrated in lysis buffer. After gentle agitation for 5 h,
the resin was recovered by centrifugation, washed 3 with
500ml lysis buffer, followed by three washes with 500 ml
IP-washing buffer [50mM Tris–HCl (pH 7.5), 300mM
NaCl, 0.1%v·v1Nonidet P-40, 5mM EDTA,
0.4U·ml1 RNasin Plus]. The resin was resuspended in
1ml TRIzol (Invitrogen) for protein analysis and RNA
extraction. For microarray analysis, 100 ng RNA was con-
verted to cRNA according to the manufacturer’s guide-
lines and the reaction products hybridized to GeneChip
Human Gene 1.0 ST arrays (Affymetrix). The resulting
raw expression values were RMA-normalized using R/
BioConductor (47) and the Oligo Package [version
1.14.0 (48)]. Probesets were linked to Entrez Gene
entries using Affymetrix annotation (NetAffx release 28,
11 March 2009), retaining a single probeset per gene.
Genes not clearly detected in input samples [average
log2(expression value)< 6.0] were discarded. Differential
expression was determined using the Limma package
(49), selecting genes with a minimal fold-change of 2.0
and an FDR-adjusted P< 0.01. RHAU targets were
identified as transcripts enriched in RHAU-FLAG IP
versus RHAU-FLAG input samples but not enriched in
control IP versus control RHAU-myc input samples.
G4-RNA structure prediction and bioinformatics analysis
Human RNA sequences were retrieved from Entrez
Nucleotide database. Non-overlapping putative intramo-
lecular G4-forming sequences (PQS) and the correspond-
ing G4-score values were computed with the QGRS
Mapper algorithm (50) using the default parameters
(window size=30 nt, Min. G-group=2, loop size=
0–36). For each transcript, the
P
(G4-score) value was
calculated as the sum of all non-overlapping G4-scores
computed by QGRS Mapper. To obtain a normalized
P
(G4-score) value, the
P
(G4-score) value was divided
by the RNA length (kb). Randomization of RNA se-
quences by single- or dinucleotide shuffling was performed
using the Altschul-Erickson algorithm (51).
Protein immunoprecipitation assay
Protein immunoprecipitation experiments were performed
under the same conditions employed for the RIP-chip
assay. Cleared cell lysates were mixed with rProtein A or
Protein G SepharoseTM Fast Flow beads (GE Healthcare)
and appropriate antibodies {mouse mAb anti-RHAU
[12F33 (43)], rabbit pAb anti-dyskerin (H-300, Santa
Cruz Biotechnology)}. After gentle agitation for 5 h, the
beads were washed. For telomere repeat amplification
protocol (TRAP) assays, beads were resuspended in
40 ml TRAP lysis buffer [10mM Tris–HCl (pH 8.0),
150mM NaCl, 1mM MgCl2, 1mM EDTA (pH 8.0),
1% v·v1 Nonidet P-40, 0.25mM Na-deoxycholate,
10% v·v1 glycerol, 5mM 2-mercaptoethanol, 0.1mM
AEBSF]. For protein and RNA analysis, beads were re-
suspended in 1ml TRIzol and extraction performed ac-
cording to the manufacturer’s instructions. Input and
co-purified RNA samples were analysed by RT–qPCR.
For protein analysis only, beads were directly resuspended
in sodium dodecyl sulphate (SDS)-gel loading buffer.
Input and immunoprecipitated protein samples were
separated by SDS–PAGE and analysed by western
blotting.
RNA analysis by quantitative (RT–qPCR) and
semi-quantitative RT–PCR
Reverse transcription was performed using the ImProm-
IITM Reverse Transcription System (Promega) with
oligo(dT)15 or random hexamer primers, according to
the manufacturer’s instructions. For monitoring first-
strand cDNA synthesis, the reverse transcription reaction
was performed in the presence of 20 mCi [a-32P]dATP
(3000Ci·mmol1). The reaction products were separated
by agarose gel electrophoresis and visualized by Phosphor-
Imaging. Quantitative and semi-quantitative PCR reactions
were performed in technical duplicates using the
ABsoluteTM QPCR SYBR Green ROX Mix (Thermo
Fisher Scientific), according to the manufacturer’s instruc-
tions, on an ABI Prism 7000 Sequence Detection System
(SDS) and analysed with the ABI Prism 7000 SDS 1.0
Software (Applied Biosystems). Relative transcript levels
were determined using the 2Ct method (52). For each
primer pair (Supplementary Table S1), the efficiency of
amplification was determined to be equal or superior to
1.8. Control reactions lacking the reverse transcriptase or
template RNA confirmed the specificity of the amplifica-
tion reactions.
TRAP assays
Immunopurified ribonucleoprotein (RNP) complexes were
assayed for telomerase activity by the TRAP assay (53).
Four microliters of bead-immobilized RNP complexes in
TRAP lysis buffer were incubated (30min, 25C) in 50 ml
TRAP reaction buffer [20mM Tris–HCl (pH 8.3 at room
temperature), 63mM KCl, 1.5mM MgCl2, 0.2mM dNTP
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mix (50mM each of dATP, dTTP, dGTP and dCTP),
0.05%v·v1 Tween-20, 1mM EGTA (pH 8.0), 4 ng·ml1
Cy5-TS primer, 2 ng·ml1 ACX primer (Supplementary
Table S1), 1U·ml1 RNasin Plus, 0.4mg·ml1 BSA,
0.04U·ml1 Thermo-StartTM Taq DNA Polymerase
(Thermo Fisher Scientific)]. The reaction was followed by
a 15-min incubation step at 95C, followed by 15–17 cycles
of amplification (30 s at 95C, 30 s at 52C, 45 s at 72C).
The reaction products were resolved on a pre-
electrophoresed 10% non-denaturing polyacrylamide gel
(19:1 acrylamide:bis ratio) in 0.5 TBE at 4C for 90min.
After electrophoresis, gels were fixed [500mM NaCl, 50%
v·v1 ethanol, 40mM Na-acetate (pH4.2)] for 30min,
scanned on a Typhoon 9400 Imager (GE Healthcare) and
analysed with ImageQuant TL software (Nonlinear
Dynamics). For immunodepletion experiments of RHAU,
the residual telomerase activity in cell extracts was
quantified by the quantitative TRAP assay [qTRAP,
(53)]. An aliquot of 250 ng protein from immunodepleted
HEK293T cell extracts in TRAP lysis buffer was incu-
bated (30min, 25C) in 25 ml qTRAP reaction buffer
[1ABsoluteTM QPCR SYBR Green ROX Mix, 1mM
EGTA (pH 8.0), 4 ng·ml1 TS primer, 4 ng·ml1 ACX
primer (Supplementary Table S1), 0.2U·ml1 RNasin
Plus]. The reaction was followed by a 15-min incubation
step at 95C, followed by 40 cycles of amplification (15 s at
95C, 60 s at 60C) on an ABI Prism 7000 Sequence
Detector. The relative telomerase activity was determined
using a standard curve and linear equation model (53).
Expression and purification of recombinant RHAU protein
Recombinant wild-type and ATPase deficient
[RHAU(DAIH)] N-terminal GST-tagged RHAU proteins
were expressed in Sf9 cells according to the supplier’s
instructions (PharMingen) and purified to homogeneity
as described previously (45). Purified recombinant GST-
RHAU proteins were stored at 80C. Purity of protein
preparations was assessed by SDS–PAGE (Supplementary
Figure S1) and protein concentrations determined photo-
metrically at 280 nm using the calculated extinction coef-
ficient e=166 615M1·cm1.
In vitro synthesis of 32P-labeled TERC transcripts and
intramolecular G4-RNA preparation
Synthetic radio-labeled wild-type and mutant (G4-MT)
telomerase RNAs were prepared by in vitro transcription
using 50 mCi [a-32P]UTP (3000Ci·mmol1) and T7 or SP6
RNA polymerases (Promega), respectively, according to
the manufacturer’s instructions. The transcripts were
purified by denaturing PAGE, ethanol precipitated and
recovered by centrifugation. The purified RNAs were re-
suspended in potassium- or lithium-based storage buffer
[10mM Li-cacodylate (pH 7.4), 100mMKCl or LiCl] and
annealed by heating at 95C for 2min, followed by slow
cooling to room temperature. G4-annealed radio-labeled
RNAs were stored at 80C.
RNA electromobility shift assay
Purified recombinant GST-RHAU protein at concentra-
tions from 1 to 320 nM was incubated with 100 pM
32P-labeled G4-RNA in K-Res buffer [50mM
Tris–acetate (pH 7.8), 100mM KCl, 10mM NaCl, 3mM
MgCl2, 70mM glycine, 10% glycerol], supplemented with
10mM EDTA and 0.2U·ml1 SUPERase-In (Ambion) in
a 10-ml reaction. The reactions were equilibrated at 22C
for 30min. RNA–protein complexes were resolved on a
pre-electrophoresed 6% non-denaturing polyacrylamide
gel (37.5:1 acrylamide:bis ratio) in 0.5 TBE at 4C for
90min. After electrophoresis, gels were fixed for 1 h in
10% isopropanol/7% acetic acid. RNA–protein com-
plexes were detected by Phosphor-Imaging, scanned on a
Typhoon 9400 Imager (GE Healthcare) and analysed with
ImageQuant TL software (Nonlinear Dynamics).
RESULTS
Microarray identification of RHAU-associated RNAs
To identify endogenous RNAs associated with RHAU
in vivo on a genome-wide scale, we designed a RIP-chip
assay (RNA immunoprecipitation coupled to microarray
analysis). Subsets of RHAU target RNAs were isolated by
immunoprecipitation (IP) assays under optimized conditions
that preserved RNA–protein complexes. Briefly, HeLa cells
were transfected with a vector expressing FLAG-tagged or
myc-tagged RHAU. Immunoprecipitations of non-cross-
linked whole-cell extracts were carried out using anti-
FLAG antibodies. Anti-FLAG IP from cells expressing
myc-tagged RHAU was employed as an IP control
(IPctrl) to assess non-specific interactions that may occur
during RIP. Following IP, co-fractionated RNAs were
recovered and purified by standard phenol–chloroform
extraction and converted to cRNA. Products were subse-
quently hybridized to human oligonucleotide arrays.
Western blot analysis of immunoprecipitated proteins
revealed that RHAU-FLAG, but not RHAU-myc, was
efficiently enriched from HeLa cell extracts following
IP with anti-FLAG antibody (Figure 1A, bottom).
Oligo(dT)-primed reverser-transcription of co-immuno-
precipitated RNAs showed the presence of polyadenylated
RNAs with sizes similar to the input (Figure 1A, top,
compare lane 2 to lanes 3 and 4). With regard to the
RHAU-FLAG IP fraction, 10 times less RNA signal
was detected in the control immunoprecipitate (lane 1),
demonstrating specific co-immunoprecipitation of
mRNAs with RHAU. The association between RHAU
and target RNAs was deemed specific as the anti-FLAG
antibody exhibited no obvious cross-reactivity with other
cellular proteins (data not shown).
Microarray analysis of the purified RNAs recovered
from input and immunoprecipitated fractions revealed
that 9354 (49%) of the 19 089 total genes available on
the chip were significantly expressed in HeLa cells
overexpressing RHAU (data not shown). In order to maxi-
mize the chance of identifying true RNA targets of RHAU
as well as to minimize the occurrence of false positives,
only those RNAs were chosen that were significantly
(adjusted P< 0.01) enriched and were at least 2-fold
more abundant in the RHAU-FLAG IP fraction than in
the control. Of these potential RHAU targets, we dis-
carded those that were also significantly enriched in the
Nucleic Acids Research, 2011, Vol. 39, No. 21 9393
 by guest on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Publications	 181
RHAU-myc expressing cells and might thus be RHAU-
independent RNAs binding non-specifically to the anti-
FLAG antibody matrix.
Thus, of the 9354 genes expressed in HeLa cells, 108
RNAs (1.2%) were found to be significantly enriched in
RHAU-FLAG IP fraction compared with total input
RNA (Figure 1B). Finally, after subtraction of two non-
target RNAs based on the above-mentioned criteria that
were associated with the antibody or the beads, 106 RNAs
were judged to be specifically enriched by RHAU
(Supplementary Table S2). The most abundant transcripts
of these potential RHAU targets were selected for further
analysis.
Validation of potential RHAU target RNAs
To assess independently the validity and reproducibility
of the identified RHAU-associated transcripts, RNA
abundance in total input RNA, control IP and RHAU-
FLAG IP fractions from fresh whole-cell extracts were
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Figure 1. Analysis of the RNAs co-immunoprecipitated with RHAU RNPs. (A) RHAU associates with poly(A)+ RNAs in HeLa cells. First strand
cDNA synthesis from input (lanes 3 and 4) and co-immunoprecipitated (lanes 1 and 2) RNAs was monitored by incorporation of [a-32P]dATP. The
RT–PCR reaction products were separated by agarose gel electrophoresis. An autoradiogram of the gel is shown. The positions and sizes (kb) of
marker DNAs are indicated at the left. Signal intensities are expressed relative to the average signal intensity of the input fractions (lanes 3 and 4).
Expression and specific enrichment of RHAU-FLAG in input and FLAG-IP fractions were verified by Western blot analysis. (B) Scatter plot
representation of the differential enrichment of RHAU-bound versus non-specific RNAs as quantified by microarray analysis. The pink rectangle
delineates the area of RNA specifically enriched by RHAU. RNAs whose enrichment was further validated by semi-quantitative RT–PCR are
indicated. (C) Validation of novel RHAU-bound target RNAs. The abundance of 10 potential RHAU targets and four non-targeted RNAs in total
input RNA (lanes 3 and 4), control IP (lane 1) and RHAU-FLAG IP (lane 2) fractions was monitored by semi-quantitative RT–PCR. Reaction
products were separated by agarose gel electrophoresis and visualized by SYBR Green staining. Band intensities are expressed relative to the average
signal intensity of the input fractions (lanes 3 and 4).
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analysed by semi-quantitative RT–PCR. As shown in
Figure 1C, 10 RNAs randomly selected from the group
of plausible RHAU targets were confirmed to be enriched
>2-fold in the RHAU-FLAG IP fraction than in the
control IP or input fractions. Besides, four non-targeted
RNAs were included as negative control to monitor
RHAU binding to non-specific RNAs. None of them
were found to be enriched in the RHAU-FLAG IP
fraction despite their relatively high abundance in the
input fraction. Taken together, these independents results
validate the previous RIP-chip data. We assume that the
remaining RNA species are also part of RHAU RNPs,
although additional experiments would be necessary to
confirm this supposition.
G4-content analysis for RNAs enriched by RHAU
As RHAU shows a high affinity for G4-RNA structures
in vitro (42), we next carried out a bioinformatics search
for RNAs with potential intramolecular G4 structures.
The rationale was that if RHAU binds G4-RNA in vivo,
the proportion of potential G4-forming sequences should
be higher among RNAs enriched by RHAU than among
non-enriched RNAs. Of the various available methods for
predicting intramolecular G4 motif sequences, we used
QGRS Mapper that identifies and scores each potential
G4-forming sequence according to their predicted stab-
ilities (50). Being aware that only limited experimental
data so far support the scoring method of QGRS
Mapper, we employed the algorithm to identify potential
G4-forming sequences, but we also included the G4-score-
based analysis as Supplementary Data (Supplementary
Figure S2), since the two approaches provided similar
results. In fact, with almost eight potential intramolecular
G4-forming sequences (PQS) per kilobase, the occurrence
of G4 motif sequences was higher in the fraction enriched
by RHAU than in any other fraction (Figure 2A and
Supplementary Figure S2A). In addition, there was a
weak (R2=0.10) but significant positive correlation
between the predicted G4 motif density per transcript
and the magnitude of RNA enrichment by RHAU.
Randomization of RHAU target sequences, retaining
single- or even dinucleotide frequencies of the original
transcripts, significantly reduced the proportion of poten-
tial G4-forming sequences (Figure 2B and Supplementary
Figure S2B). Thus, the proportion of G4 motif sequences
among RHAU-associated transcripts cannot be explained
by a mere bias in nucleotide composition.
It should be mentioned that our prediction is likely to
overestimate the number of G4-forming motif sequences
per transcript. In fact, we also considered G4 structures
consisting of only two successive G-tetrads as these meta-
stable structures have also been demonstrated to have
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Figure 2. Computational analysis of potential intramolecular
G4-forming sequences (PQS) among RNAs enriched by RHAU. (A)
Box plot representation of the density of potential intramolecular
G4-forming sequences per transcript (PQS·kb1) as a function of
their level of enrichment by RHAU. The lower and upper boundaries
of the boxes indicate the 25th and 75th percentiles, respectively. The
white lines within the boxes mark the median. The width of the boxes is
proportional to the number of transcripts found within a group. The
error bars indicate the 10th and 90th percentiles and the filled circles
the 5th and 95th percentiles. The grey rectangle refers to the group of
106 RNAs specifically enriched by RHAU and serves as a control
group for multiple comparison analysis. Statistical significance was
determined by Kruskal–Wallis one-way ANOVA on ranks and the
Dunn’s test. nsP 0.05; *P< 0.05; **P< 0.01. The correlation
between the two variables was estimated by linear regression analysis
(y= 2.56x+5.60, R2=0.10, P< 0.001) and is indicated as a grey line
on the graph. (B) PQS analysis among randomized RHAU target se-
quences. The sequences of the 106 transcripts specifically enriched by
RHAU were shuffled, retaining single- or di-nucleotide base compos-
ition of the original transcripts. The box plot represents the density of
PQS (PQS·kb1) among the original (not rand.), di-nucleotide shuffled
(di-NT rand.) and single-nucleotide shuffled (single-NT rand.) se-
quences. Statistical significance was determined by one-way repeated
Figure 2. Continued
measures ANOVA and the Dunnett’s test. (C) Proportions of RNAs
bearing stable PQS as a function of their level of enrichment by
RHAU. The grey rectangle refers to the group of 106 RNAs specifically
enriched by RHAU. The dashed grey line denotes the proportion of
sequences showing stable PQS in the input fraction. Significant
(P< 0.001) association between the magnitudes of the two variables
was estimated by the chi-square-test-for-trend.
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biologically relevant roles (54). However, after discarding
these less-stable G4 structures from the analysis, we still
observed a significant relationship between the proportion
of sequences bearing potentially stable G4-forming se-
quences (composed of three or more stacked G-quartets)
and the magnitude of RNA enrichment by RHAU
(Figure 2C). Indeed, with more than half of the sequences
presenting potentially stable G4-forming sequences, the
group of 106 RNAs identified as true RHAU targets pre-
sents one of the highest incidences of potentially stable
G4-forming motifs. In summary, the present data are
consistent with preferential association of RHAU with
transcripts containing potential G4-forming sequences,
suggesting direct recognition of G4-RNA structures by
RHAU. To further test this hypothesis, we selected one
of the identified RHAU targets and addressed the molecu-
lar basis of its interaction with RHAU.
RHAU associates with TERC through its G4
motif sequence
Within the pool of transcripts enriched by RHAU and
showing a high potential to form stable G4, TERC is
the only RNA reported previously to form a stable and
parallel G4 structure in vitro (Figure 3A) (30). TERC was
C
BA
D
Figure 3. RHAU associates with TERC through its G4-motif sequence. (A) Schematic representation of the secondary structure of human TERC
bearing a parallel G4 structure in the 50-extremity as described by Mergny et al. (30). (B) Nucleotide sequence of the WT and G4 motif mutant
(G4-MT and G4) forms of TERC. Guanine tracts that are predicted to form a stable G4-structure are shown bold. Nucleotide substitutions or
deletions in mutant forms of TERC are marked in red. The P1 helix subdomains as well as the template region are indicated. (C) RNA expression
levels of endogenous and recombinant WT and G4 motif mutant forms of TERC in HEK293T cells. Expression was quantified by RT–qPCR,
normalized to GAPDH expression and endogenous TERC levels set to 1. Data represent the mean±SEM of three independent experiments.
(D) RT–qPCR analysis of the abundance of WT and G4 motif mutant forms of TERC that co-immunoprecipitated with endogenous RHAU
protein. RNA levels in IP fractions are represented in function of their respective abundance in the input fraction. Immunoprecipitation with mouse
IgGs (mIgG) served as a control to assess non-specific interactions. In lanes 4, 5 and 6, yellow hatches represent the fraction related to endogenous
TERC signal and violet hatches represent the fraction of TERC RNA that non-specifically interacts with the antibody matrix or the beads. Data
represent the mean±SEM of five independent experiments. Comparable efficiency of RHAU immunoprecipitation in the various fractions was
verified by western blot analysis with anti-RHAU antibodies.
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also found to be one of the most abundant RNAs enriched
by RHAU in several independent RIP-chip assays using
various cell lines (Supplementary Table S2 and unpub-
lished data). To address the role of the TERC G4 struc-
ture in its efficient co-immunoprecipitation by RHAU, we
cloned the TERC gene, including its promoter and 30
flanking genomic sequence. The 50 extremity of the TERC
sequence was subsequently mutated (G4-MT) or trun-
cated (G4) to prevent G4 formation (Figure 3B). To
avoid effects on the structurally conserved P1 helix by
the introduced substitutions, guanine residues that are
part of both the predicted G4 structure and the P1a
helix region were left intact. The recombinant forms of
TERC were transiently transfected into HEK293T cells
and the accumulation of stable TERC transcripts was moni-
tored by RT–qPCR (Figure3C). After 24 h, HEK293T
cells transiently transfected with the TERC(WT) construct
but not with the vector alone showed a substantial
(�200-fold) increase in TERC abundance relative to en-
dogenous TERC levels. Importantly, mutations of the G4
motif (G4-MT or G4) did not influence the steady-state
level of exogenous TERC expression in these cells since
recombinant wild-type, G4-MT and G4 forms of TERC
accumulated to comparable levels.
To examine the significance of the G4 motif sequence
for co-precipitation of TERC with RHAU, we repeated
the RIP assay using HEK293T cells transiently overex-
pressing the wild-type or G4-MT and G4 mutated
forms of TERC. Immunoprecipitations were carried out
on endogenous RHAU using a monoclonal antibody
against RHAU and TERC RNA abundance was analysed
by RT–qPCR (Figure 3D). As already shown for en-
dogenous TERC, a substantial amount of overexpressed
TERC(WT) was also recovered with endogenous RHAU,
as evidenced by a 25-fold enrichment of TERC transcript
over the mock transfection (Figure 3D, compare lanes 4
and 2). In marked contrast, both G4 motif mutated forms
of TERC were barely co-immunoprecipitated with
RHAU, judged by the 95% reduction in TERC abun-
dance in the corresponding fractions compared with the
WT control (Figure 3D, compare lanes 5 and 6 to lane 4).
The drastic reduction in immunoprecipitation of the
TERC mutants was not due to non-specific RNA degrad-
ation in these fractions. Indeed, comparable levels of
non-specifically co-immunoprecipitated GAPDH RNA
were found to contaminate all of these fractions. Taken
together, these results indicate that the intact G4 motif
sequence is a prerequisite for TERC association with
RHAU in vivo.
RHAU binds TERC through a G4 structure in the TERC
50-region
In the absence of Mg·NTPs, RHAU specifically binds to
tetramolecular G4-RNA structures with high affinity
(42,45). The strict requirement for the G4 motif sequence
for effective recovery of TERC by RHAU in vivo sug-
gested that RHAU may also form a stable complex with
TERC through direct binding of the G4-RNA forming
structure. To address this question in vitro, we performed
RNA electromobility shift assays (REMSA) using purified
recombinant GST-tagged RHAU protein and in vitro
transcribed radio-labeled full-length (1–451 nt) and 50-end
(1–71 nt) TERC fragments. In the absence of protein, the
32P-labeled probes migrated as a single species in the gel
(Figure 4A and B). Addition of increasing amounts of
RHAU to both full-length and 50-end TERC fragments
resulted in the appearance of a high-affinity (estimated
Kd of 10 nM) ribonucleoprotein complex of reduced
mobility. In contrast, the stability of the RHAU-TERC
interaction was strongly impaired (�20-fold reduction)
when formation of the G4 structure was prevented by
mutation of the G4 motif sequence (G4-MT, Figure 4C).
Similarly, conditions that are unfavourable to G4 stability
(substitution of K+ for Li+) impaired the RHAU-TERC
interaction to comparable extent (Figure 4D). Replacing
K+ by Li+ was indeed shown to strongly reduce the
thermodynamic stability of the TERC G4 structure (30).
Thus, these results demonstrate a direct and specific inter-
action between RHAU and TERC dependent on RNA
folding into a stable G4 structure. This is consistent with
the above finding that RHAU can co-immunoprecipitate
the wild-type but not the G4 motif mutated forms of
TERC. Together these observations argue that a
fraction of TERC RNA forms a G4 structure that can
be further bound by RHAU, in vivo.
RHAU associates with telomerase RNPs by direct
interaction with TERC
In cells, the biogenesis of the telomerase holoenzyme fol-
lows a stepwise RNP assembly. Upon transcription, nas-
cent TERC is first bound by proteins dyskerin, NHP2
and NOP10 and subsequently joined by GAR1 (55).
The co-transcriptional binding of this RNP complex is
essential for the processing and accumulation of TERC
transcripts. Finally, the catalytic protein component tel-
omerase reverse transcriptase (TERT) assembles with the
processed telomerase RNPs and forms the active telomer-
ase holoenzyme. To determine whether RHAU was exclu-
sively interacting with TERC during the transcriptional
process or whether it was also part of the telomerase
RNP, we performed co-IP assays and examined whether
endogenous RHAU co-fractionated with endogenous
dyskerin or FLAG-tagged TERT proteins. Immunoblot
analysis showed that RHAU was present in both
dyskerin and TERT immunoprecipitated fractions but
absent in the control IP (Figure 5A and B, compare
lanes 1 and 2). The association of RHAU with compo-
nents of the telomerase holoenzyme proved to be strictly
dependent on the ability of RHAU to bind the 50-end of
TERC, since overexpression of wild-type but not the G4
motif mutated forms of TERC resulted in extensive en-
richment of co-precipitating RHAU protein (Figure 5A
and B, compare lane 2 to lanes 3, 4 and 5). Although
mutations of the TERC G4 motif sequence severely
impinged on the recruitment of RHAU to the telomerase,
they had no apparent repercussions on the steady-state
expression level (Figure 5C) or on the assembly of the
core components of telomerase. Indeed, as shown in
Figure 5D (compare lane 2 to lanes 3, 4 and 5), similar
levels of TERT protein co-fractionated with dyskerin
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following transient overexpression of either wild-type or
G4 motif mutated forms of TERC. These results suggest
that RHAU does not strictly bind TERC in the course of
its biogenesis but that a fraction of RHAU also associates
with the fully assembled telomerase holoenzyme through
direct interaction with the G4 motif sequence of TERC.
RHAU associates with telomerase activity
As RHAU binding to TERC requires a G4 structure, the
finding that RHAU co-immunoprecipitated with compo-
nents of the telomerase complex suggested the existence of
an alternatively folded form of TERC bearing a G4 struc-
ture in a fraction of telomerase RNP. To address this
further, immunopurified RHAU RNP complexes were
analysed for telomerase activity by TRAP assay. In all
the subsequent experiments, parallel immunopurification
of dyskerin served as a positive control for telomerase
activity (56). In agreement with previous observations,
TRAP assays of antibody-bound complexes confirmed
that substantial telomerase activity was recovered with
RHAU but not with control IgGs (Figure 6A, top).
Coomassie staining demonstrated similar yields of
immunoprecipitated RHAU and dyskerin proteins
(Figure 6A, bottom) and protein identity was subse-
quently verified by Western blotting (Figure 6B). To
further examine the apparent significance of G4 binding
by RHAU for its recruitment to the telomerase holoen-
zyme, we transiently expressed a FLAG-tagged mutant
version of RHAU (RSM, Supplementary Figure S3A)
that was unable to bind to G4 structures (45). Western
blot analysis confirmed that the wild-type and
G4-binding-deficient (RSM) forms of RHAU were ex-
pressed and recovered to similar levels (Supplementary
Figure S3B). Immunopurified RHAU fractions were
further assayed for telomerase activity and enrichment
of TERC (Supplementary Figure S3C and D). As previ-
ously observed for endogenous RHAU, immunopurified
FLAG-tagged RHAU(WT) efficiently recovered telomer-
ase activity and co-precipitated TERC. In contrast,
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Figure 4. Gel mobility shift assay for TERC G4 binding by RHAU. (A) Radio-labeled full-length (1–451 nt) and (B) 50-end (1–71 nt) TERC
fragments at a concentration of 100 pM were incubated without protein (�) or with increasing amounts (1, 3.2, 10, 32, 100 and 320 nM) of
GST-tagged RHAU in the absence of ATP. The reaction mixtures were analysed by non-denaturing PAGE. An autoradiogram of the gel is
shown. The positions of the free RNA substrate and the protein–RNA complex are indicated on the left. At concentrations up to 320 nM, GST
protein alone had no effect on TERC mobility (data not shown). (C) RNA-binding assay with WT and G4 motif mutant (G4-MT) forms of TERC
50-end (1–71 nt) fragments. Radio-labeled TERC fragments were incubated without protein (�) or with increasing amounts (3.2, 10, 32 and 100 nM)
of GST-tagged RHAU. (D) Cation dependency of RHAU interaction with TERC. The 50-end WT TERC fragment was incubated under standard
(100mM K+) or lithium-based (100mM Li+) REMSA conditions without protein (�) or with increasing amounts (10, 32 100 and 320 nM) of
GST-tagged RHAU.
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negligible telomerase activity and TERC signal were
retrieved from the FLAG-tagged RHAU(RSM)
mutant, showing that G4 binding by RHAU is a pre-
requisite for RHAU binding to TERC. Altogether, these
findings provide persuasive evidence that a fraction of
RHAU associates with a subpopulation of the telomerase
holoenzyme in vivo through direct interaction with the
G4-motif sequence of TERC.
Finally, to determine the proportion of telomerase activ-
ity associated with RHAU, we carried out immuno-
depletion studies of RHAU in HEK293T cell lysates and
subsequently quantified the residual TERC level and tel-
omerase activity within these fractions (Figure 6C and D).
Depletion with RHAU antibody significantly ablated tel-
omerase activity in an aliquot of the supernatant by 25%,
while�70% of the telomerase activity of the input fraction
was lost following depletion of endogenous dyskerin. As
a control, immunodepletion with control mouse IgGs
produced no significant reduction in telomerase activity.
Western blot analysis of the supernatants confirmed that
both RHAU and dyskerin proteins were effectively de-
pleted from the corresponding fractions (Figure 6E).
Furthermore, the quantification by RT–PCR of RNA
levels in the immunodepleted fractions was consistent with
the above findings. Indeed, approximately one quarter of
input TERC, but not unrelated RNAs such as b-actin
mRNA, vanished following depletion of endogenous
RHAU. These results not only corroborate the association
of RHAU with telomerase, but also show that the fraction
of telomerase interacting with RHAU accounts for merely
25% of the total telomerase activity. Nevertheless, these
data provide indirect but explicit evidence of the existence
of an alternatively folded TERC structure bearing a G4
scaffold in the fully assembled telomerase holoenzyme.
ATPase-dependent interaction of RHAU with TERC
The fact that only one quarter of telomerase activity is
linked to RHAU may reflect a dynamic interaction be-
tween RHAU and TERC. Indeed, most of the DEAH-
box RNA helicases only transiently interact with nucleic
acid, because they do not remain bound after the ATPase-
dependent remodelling of their substrate (57–60). To gain
insight into the role of ATP-hydrolysis by RHAU in its
interaction with TERC, we repeated gel mobility shift
assays with 50 TERC fragments in the presence of Mg2+
or ATP or both. As shown in Figure 7A, ATP or Mg2+
alone had little effect on the binding affinity of RHAU for
TERC. In contrast, under conditions supporting ATP hy-
drolysis (Mg·ATP), RHAU displayed reduced binding
affinity for TERC, as evidenced by a 10-fold increase in
the apparent equilibrium Kd value (Figure 7C). Such a
reduction in the affinity of RHAU for TERC was not ob-
served when Mg·ATP was substituted with the non-
hydrolysable ATP analogue Mg·AMP-PNP (Figure 7B
and C). Thus, the present data suggest that intrinsic
RHAU ATP hydrolysis rather than ATP binding is essen-
tial for disrupting the interaction of RHAU with TERC.
To further validate this, we turned to the previously
described RHAU(DAIH) mutant in which the E335A
amino-acid substitution within the Walker B site abolishes
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Figure 5. Association of RHAU with telomerase holoenzyme subunits.
(A) TERC G4 motif dependent association of RHAU with dyskerin.
Proteins from whole HEK293T cell lysates of either mock-transfected
(�) cells or transiently expressing WT or G4 motif mutant (G4-MT,
G4) forms of TERC were immunoprecipitated with either control
mouse IgGs (mIgG) or anti-dyskerin antibodies. Immunopurified
RNP complexes were separated by SDS–PAGE and probed with
anti-RHAU or anti-dyskerin antibodies. (B) TERC G4 motif-dependent
association of RHAU with TERT. Protein immunoprecipitation experi-
ments with anti-FLAG antibodies were performed with whole cells
lysates of HEK293T cells transiently expressing TERT–FLAG protein
together with WT or G4 motif mutant (G4-MT, G4) forms of TERC.
Immunopurified RNP complexes were separated by SDS–PAGE and
probed with anti-RHAU or anti-FLAG antibodies. The asterisk
denotes immunoprecipitated TERT–FLAG protein that cross-reacted
unspecifically with the horsearadish peroxidase-conjugated secondary
antibody. (C) Western blot analysis of comparable protein expression
in input HEK293T cell lysates. (D) Protein immunoprecipitation experi-
ments with anti-dyskerin antibodies were performed with whole cells
lysates of HEK293T cells transiently expressing TERT–FLAG protein
together with WT or G4 motif mutant (G4-MT, G4) forms of TERC.
Immunopurified RNP complexes were separated by SDS–PAGE and
probed with anti-FLAG or anti-dyskerin antibodies.
Nucleic Acids Research, 2011, Vol. 39, No. 21 9399
 by guest on D
ecem
ber 19, 2012
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Publications	 187
RHAU ATPase activity (45). Unlike wild-type RHAU,
the binding affinity of RHAU(DAIH) mutant for TERC
was similar in the absence and presence of Mg·ATP
(Figure 7B and C). The absence of RHAU helicase
activity as a consequence of the loss of ATPase activity
probably prevents RHAU dissociation from its substrate.
In fact, a similar reduction in in vivo RNA binding
dynamics after suppression of RHAU intrinsic ATPase
activity was reported previously in studies of the shuttling
of RHAU in cytoplasmic stress granules (43). Taken
together, these data corroborate the idea that RHAU is
not permanently associated with TERC but dissociates
upon ATP hydrolysis.
Apart from a high affinity for G4 structures, RHAU
has also been shown to couple ATP hydrolysis with
tetramolecular G4-RNA resolving activity (42,45). These
biochemical properties prompted us to test whether
RHAU could catalyse the conversion of TERC G4 struc-
ture to ssRNA form. However, the faster rate of refolding
of intramolecular G4 structures with regard to
tetramolecular G4-RNAs made it technically difficult to
monitor the G4-resolving activity of RHAU using
standard non-denaturing gel electrophoresis.
DISCUSSION
The propensity of nucleic acid guanine-rich sequences to
self-assemble into G4 structures in vitro has been recogn-
ized for several decades. Although RNA is also prone to
form such structures, G4-RNA has not attracted as much
attention as G4-DNA. Nevertheless, a growing body
of evidence indicates a significant role for G4 structure
formation during RNA metabolism (20,61). As a conse-
quence, G4 structures emerged as a plausible post-
transcriptional means of regulating the function of
coding and non-coding RNAs. However, little is known
about the mechanisms by which G4-RNA formation is
regulated in the cells. Indeed, only a few proteins have
been reported so far to interact with G4-RNAs in vitro
(62–66) and, apart from FMRP and FMR2P, experimen-
tal data on their biological activity subsequent to their
interaction with G4-RNAs is scarce. Of these G4-RNA
binding proteins, RHAU is the only protein that exhibits
robust in vitro ATPase-dependent G4-RNA resolving
activity, in addition to a high affinity and specificity for
its target RNAs (42). These particular biochemical features
promote RHAU as an ideal candidate for regulating G4-
dependent RNA metabolism, although its in vivo RNA
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Figure 6. Association of RHAU with telomerase activity. (A) TRAP assay of immunopurified endogenous RHAU and dyskerin RNP complexes.
RHAU or dyskerin RNP complexes were enriched by immunoprecipitation and a fraction of the immunopurified RNP was essayed for telomerase
activity by the TRAP assay. Mouse IgGs (mIgGs) served as a control to assess non-specific interactions to the antibody matrix. A fraction of the
immunopurified RNP was separated by SDS–PAGE. The Coomassie stained gel was scanned on a LI-COR Odyssey infrared imaging system.
Positions of the immunoprecipitated proteins as well as the immunoglobulin heavy chains (IgGHC) are indicated at the right. Positions and sizes
(kDa) of marker proteins are shown at the left. (B) Western blot analysis of the immunopurified RNP complexes assayed for telomerase activity.
(C) qTRAP analysis of the residual telomerase activity present in immunodepleted HEK293T cell lysates. Data represent the mean±SEM of three
independent experiments. Statistical significance was determined by one-way ANOVA and the Bonferroni t-test. *P< 0.05; **P< 0.01; ***P< 0.001.
(D) RT–qPCR analysis of the residual levels of TERC and b-actin RNAs in immunodepleted HEK293T cell lysates. The RNA signal was normalized
to GAPDH. Data represent the mean±SEM of three independent experiments. Statistical significance was determined by one-way ANOVA and the
Bonferroni t-test. (E) Western blot analysis of input and immunodepleted HEK293T cell lysates. Heat shock protein 70 cognate (HSC70) was used as
a loading control.
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targets have not yet been determined. The present study
aimed to identify naturally occurring RHAU targets with
the emphasis on RNAs containing potential G4-forming
sequences. By RIP-chip assays, 106 RNAs were found to
be significantly enriched with RHAU. Importantly, more
than half of these RNAs contained G-rich sequences with
potential to form stable G4 structures. In addition, there
was a weak but significant correlation between the pre-
dicted G4 motif density per transcript and the magnitude
of RNA enrichment by RHAU. Nevertheless, because
RHAU appears to show significant affinity for RNAs
not bearing G4-forming sequences, we do not exclude
the possibility that RHAU has affinity to other RNA
structural features.
In-depth studies revealed that TERC, one of the identi-
fied RNAs, was a bona fide target of RHAU. Several in-
dependent RIP-chip assays using various cell lines further
showed TERC to be one of the most abundant RNAs
enriched by RHAU. TERC bears a 5 G-rich sequence
that was previously shown to adopt a stable intramolecu-
lar G4 structure in vitro (30). Further investigations dis-
secting the basis of the interaction between RHAU and
TERC showed RHAU binding to be strictly dependent on
G4 structure formation in the 5 region of TERC and to
require the N-terminal RSM domain of RHAU, an ancil-
lary domain necessary for specific recognition of G4 by
RHAU (45). Moreover, RHAU was found to interact
transiently with TERC in a manner dependent on its
own ATPase activity. Together, these data provide the
first evidence of a specific and direct interaction between
a G4-resolvase enzyme and a potentially relevant intramo-
lecular G4-RNA substrate. Furthermore, in agreement
with our previous reports (42,45), these data attest that
G4-RNAs are naturally occurring substrates of RHAU
in vivo.
The 5 extremity of TERC folds into an intramolecular
G4 structure
In agreement with the observations presented here,
Mergny and co-workers reported previously the formation
in vitro of a G4 structure in the 5 region of human TERC
(30). However, as for the great majority of nucleic acid
structures, direct experimental demonstration of G4 struc-
tures in vivo has proven very difficult. As such, our results
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Figure 7. Role of Mg·ATP on the interaction of RHAU with TERC. (A) Gel mobility shift assay for TERC G4 binding by RHAU. Radio-labeled
5 -end (1–71 nt) TERC fragment at a concentration of 100 pM was incubated without protein ( ) or with increasing amounts (3.2, 10, 32 and
100 nM) of purified recombinant GST-tagged RHAU in the presence of 1mM Mg2+, ATP or Mg·ATP (as indicated). The reaction mixtures were
analysed by non-denaturing PAGE. An autoradiogram of the gel is shown. (B) Gel mobility shift assay of TERC G4 binding by the ATPase deficient
RHAU(DAIH) mutant. Radio-labeled 5 -end TERC fragment was incubated without protein ( ) or with increasing amounts (3.2, 10, 32 and
100 nM) of purified recombinant WT or DAIH mutant GST-tagged RHAU in the presence of 1mM Mg2+, Mg·ATP or Mg·AMP-PNP
(as indicated). (C) Quantification of gel mobility shift assays of WT and RHAU(DAIH) mutant binding to TERC 5 -end (1–71 nt) fragment.
The data represent the mean of three independent experiments. Error bars for SEM were omitted for clarity.
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do not directly prove the existence of G4 structures in vivo,
but strongly support the notion that TERC can form a G4
structure in the cells. Notably, RHAU can only bind
TERC provided that all conditions necessary for the for-
mation of an intramolecular G4 structure (RNA sequence
and ionic conditions) are met. Modifying any one of
the conditions is sufficient to reduce substantially the
affinity of RHAU for TERC. In addition, our data
argue that TERC G4 structure can also be formed in a
fraction of telomerase holoenzyme, since RHAU associ-
ates with TERT and dyskerin proteins and significant
amounts of telomerase activity were recovered with
RHAU. Based on the fraction of telomerase activity
co-precipitating with RHAU, we can estimate that at
least 25% of TERC in the human telomerase holoenzyme
bears a 50 G4 structure. Moreover, we predict that forma-
tion of a G4 structure in TERC is not exclusive to human
cells, since the majority of the mammalian orthologues of
TERC also harbours a potential 50 G4-forming sequence
(Supplementary Figure S4). Insofar as the G4-RNA
binding and resolving activities of RHAU are conserved
in higher eukaryotes (45), it would not be surprising to
find that RHAU is part of the telomerase holoenzymes
of other mammals.
As reported previously (30), folding of the 50 region of
TERC into a G4 structure is likely to interfere with the
widely adopted secondary structure of human TERC
(Supplementary Figure S5). Indeed, according to the
standard model of TERC secondary structure (67), two
of the guanine tracts that are part of the intramolecular
G4 also form the P1a helix. As a consequence, the P1a
helix and G4 represent two mutually exclusive structures
and may correspond to different functional states of
TERC. Insofar as helix P1 is required for template
boundary definition in mammalian telomerase (68), for-
mation of a G4 structure in TERC may be detrimental to
telomerase activity. On the other hand, G4 structure for-
mation may protect TERC from degradation during tel-
omerase biogenesis. Such a scenario was suggested quite
recently by Collins and co-workers, who found that nu-
cleotide substitutions within the G4-forming sequence
markedly reduced accumulation of the mature form of
TERC, thereby causing telomere shortening (69). Similar
to our data, they also found that RHAU associates with
the G4-forming sequence of TERC in vivo, but in contrast
to our finding, detected negligible telomerase activity with
immunopurified RHAU fraction. Thus, further experi-
ments are necessary to clarify the functional impact of
G4 formation in TERC on telomerase biogenesis and
activity.
In cells, the P1 duplex- and G4-folded forms of TERC
are likely to coexist in dynamic equilibrium. However,
under physiological conditions, restoration of helix P1
base pairing from the G4-folded conformation of TERC
is likely to require a catalyst due to the high thermo-
dynamic stability of the quadruplex (30). The biochemical
properties and substrate specificity of RHAU make it a
likely candidate for catalysing such a reaction. Quite apart
from its high affinity for TERC, RHAU manifests robust
tetramolecular G4-RNA resolving activity (42,45) and was
also shown to unwind various intramolecular G4-DNA
structures in vitro (70). These data suggest that RHAU
can resolve G4 structures irrespective of the strand stoi-
chiometry of the G4 stem. Although unwinding of TERC
G4 by RHAU has not yet been demonstrated experimen-
tally, our observation that RHAU dissociates from TERC
upon ATP-hydrolysis, but not upon ATP binding,
supports the idea that RHAU couples ATP-hydrolysis
to conformational changes of TERC, resulting in the reso-
lution of the G4 and further release of RHAU from its
target RNA.
RHAU may target other RNAs containing G4 structures
Apart from TERC, 54 further RNAs found to be
associated with RHAU are predicted to form stable G4
structures (Supplementary Table S2). The determination
of the modalities and the significance of these interactions
are essential issues to be addressed in the future.
Nonetheless, the finding that RHAU associates preferen-
tially with transcripts bearing potential G4-forming se-
quences strongly suggests that RHAU targets G4-RNA
structures in cells. Although nearly three-quarters of
these G4-forming sequences are located in 50 or 30 UTRs
of mRNAs (Supplementary Table S2), it is important to
stress that, to date, we have not observed any suppressive
action of RHAU on translational repression by G4 for-
mation in 50-UTRs. Therefore, RHAU is unlikely to
function as a translational activator but may instead inter-
vene in other aspects of mRNA metabolism, such as pre-
mRNA processing or mRNA turnover. Indeed, RHAU
localizes predominantly in the nucleus, where it concen-
trates in nuclear speckles (71). These are sites of high tran-
scriptional activity and mRNA splicing. Furthermore,
RHAU relocalizes to cytoplasmic stress granules in
response to various cellular stresses (43). Although recruit-
ment of RHAU to stress granules is mediated by inter-
action with RNA, we have not yet examined whether this
phenomenon depends upon binding of RHAU to
G4-RNA structures. However, considering that RSM-
domain mutated forms of RHAU deficient in G4-RNA
binding also show reduced relocalization to stress granules,
it is likely that a fraction of RHAU binds G4 structures in
stress granules.
Together with our previous findings that RHAU binds
and exhibits robust resolvase activity on various types of
G4 structures (41,42,70), the data presented here bring
forth the idea that G4-RNAs and especially intramolecu-
lar G4-RNAs serve as physiologically relevant targets for
RHAU. Identification of naturally occurring substrates of
RNA helicases is a prerequisite to any further investiga-
tion of their biochemical properties in vitro. However,
although most of the RNA helicases achieve highly specific
tasks in vivo, they often show only little or even no nucleic
acid binding specificity in vitro. Currently, our major limi-
tation towards understanding the mechanisms, whereby
RNA helicases melt nucleic acid structures stem from
the difficulty of identifying such physiologically relevant
substrates. Hence, few detailed molecular models available
for studying RNA helicases in vitro. However, with the
finding that the 50 region of TERC constitutes a biologic-
ally relevant substrate, RHAU emerges as a novel and
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promising prototype of DEAH-box protein and deserves
more investigations to explore its functions as a G4
resolving enzyme.
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